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3 SUMMARY 
 
Fibronectin (FN) is a vertebrate-specific high-molecular-weight glycoprotein that is deposited into 
the extracellular matrix by virtually all cell types and is secreted into the blood plasma by hepatocytes. 
Effectively all FN is secreted as globular and dimerised molecules. Dimerisation of FN molecules is 
mediated by disulfide bonds between two pairs of C-terminal cysteine residues; this pair of cysteines 
constitutes the FN dimerisation motif. Cells adhere to FN through integrin cell surface receptors. The 
main FN-binding integrins are integrins α5β1 and αVβ3. The ability of integrins to bind specific 
integrin-binding motifs in FN not only facilitates cell-anchorage to a FN substrate, but also facilitates a 
fundamental step in the conversion of soluble, globular FN into an insoluble, fibrillar matrix. FN 
fibrillogenesis, the assembly of a fibrillar fibronectin matrix, is crucial because the fibrillar form of FN 
is the biologically active form that allows FN to serve as a master scaffolding protein among the 
extracellular matrix proteins and to regulate growth factor bioavailability. A dogma of FN 
fibrillogenesis, originating from early studies of FN fibrillogenesis examined in vitro (Schwarzbauer, 
1991), dictates that FN dimerisation is an absolute requirement for FN fibrillogenesis and hence FN 
function. 
The aim of this PhD project was to characterise the function of the FN dimerisation motif in vivo. 
The strategy was to address the requirement for FN dimerisation with a mouse model carrying mutant 
FN alleles in which the two critical cysteine residues of the dimerisation motif were mutatated to serine 
residues (FNCC>SS/CC>SS).  
The main findings of this study are (1) the FNCC>SS knock-in mutation causes recessive embryonic 
lethality in mice, (2) FNCC>SS/CC>SS mouse embryos die between E9.5 and E11.5, (3) embryonic lethality 
is most prominently associated with severe remodelling defects of the cardiovascular system, affecting 
both embryo proper and extraembryonic tissue and (4) monomerised FNCC>SS is assembled into a 
fibrillar extracellular matrix, which is, however, macroscopically distorted and compromises the 
mechanical properties of the associated extracellular matrix. However, neither integrin signalling nor 
migration speed of fibroblasts on ECM platforms are affected by the presence of FNCC>SS matrix. 
Furthermore, (5) FNCC>SS disrupts the fibrillar morphology, but not the protein level, of latent TGF-β 
binding protein 1 deposited in the extracellular matrix, but (6) does not affect the storage capacity of 
the extracellular matrix transforming growth factor-β storage or the abilty of integrin αVβ6 to release 
transforming growth factor-β from the extracellular matrix, and, finally, (7) neither does FNCC>SS affect 
the levels of vascular endothelial growth factor receptor signalling in embryonic tissue. 
With this study, I demonstrate that monomerised FNCC>SS is assembled into a fibrillar matrix both 
in vivo and in vitro, but that this monomerised FNCC>SS matrix retains partial functionality of dimeric FN 
in vivo. Dimerisation of FN is required to establish robust structural and mechanical features of the 
resulting fibrillar matrix. Although cardiovascular remodelling defects suggest malfunction of integrin 
function and/or growth factor bio-unavailability, these features of the FNCC>SS matrix do not appear to 
affect integrin function or the ability of the ECM to regulate growth factor bioavailability. 
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4 INTRODUCTION 
 
4.1 Cell adhesion and the extracellular matrix 
The ability of cells to adhere to each other and to their immediate environment is a fundamental 
aspect of multi-cellular organisation and order among the Metazoa. With the evolution of complex 
multicellular organisms, individual cells were required to specialise in function. As part of a 
coordinated effort to propagate the survival of the organism, individual cells had to both create and 
interact with a specialised microenvironment of other cells and non-cellular components. Cell adhesion 
to each other and the extracellular matrix (ECM) are fundamental to basic cellular and tissue function. 
These processes guide cellular migration, regulate differentiation and define the spatial dimensions and 
physical limits of higher-order structures. Equally important for the benefit of the multicellular 
organism is strict adherence to a developmental programme that avoids dysplastic growth. For 
example, the survival of many cell types depends critically on contacts they make with each other and 
the (ECM), and without anchorage, these cell types undergo anoikis (Frisch and Francis, 1994). Thus, 
cell adhesion is fundamental to the propagation and protection of multicellular organisms.  
The mechanical integrity of tissues is crucial to its homeostasis and is established through the 
interconnection of cytoskeletal networks and ECM through cell-cell junctions and cell-matrix 
adhesions. By providing a highly interconnected extracellular scaffold, the ECM is responsible for 
much of this mechanical integration. The ECM is an acellular, insoluble protein- and carbohydrate-
based microenvironment, in which composition, supramolecular organisation and degree of 
intramolecular and intermolecular crosslinking create the properties that provide physical cues to cells 
and structural integrity to tissues. Importantly, cells create their own ECM by secreting and 
coordinating the deposition and arrangement of all components of the ECM. While most cells types 
express ECM proteins, the types and amounts of ECM typically relate to the function of the cell and 
tissue. Each of the various components of the ECM, including glycoproteins, proteoglycans and, in the 
case of bone, mineral deposits, confers a specific property to the ECM. The fibrous ECM proteins, 
including collagen, elastin, fibronectin and laminin, form highly fibrillar and cross-linked matrices that 
confer tensile strength and flexibility to tissues, but also have adhesive functions. The proteoglycans 
and their respective glycosaminoglycan chains represent a second major class of ECM components 
that are higly hydrated, fill cell-free spaces and resist compressive forces. In addition to structural and 
mechanical integrity, the ECM provides instructive information. Many ECM glycoproteins are 
recognised by cell surface receptors and allow cells to adhere to and move directionally along ECM. 
Also, both glycoproteins and proteoglycans within the ECM bind specific paracrine growth factors, 
such as fibroblast growth factor (FGF), vascular endothelial growth factor A (VEGF-A) and 
transforming growth factor β (TGF-β), and thereby regulate their bioavailability in space and time. All 
these functions make the ECM an important regulator of developmental and regenerative processes. 
The ECM is a dynamic compartment, as the proteins and carbohydrates within are continuously 
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remodelled, both in response to developmental signals and mechanical stimuli, and this dynamic 
behaviour is fundamental to developing, shaping and maintaining tissue (Aszódi et al., 2006).  
Whether a sponge or a mammal, the ability of a cell to adhere to the ECM relies on cell surface 
receptors that allow cells to recognise, bind, manipulate and respond to the ECM. Therefore, in 
addition to composition, quantity and architecture of ECM components, the profile of cell surface 
receptors that bind ECM proteins are fate-determining factors in cell-ECM adhesion, cell behaviour 
and tissue homeostasis.  
4.2 The integrin family of adhesion receptors 
The integrin family of adhesion receptors represents a major class of metazoan cell surface 
receptors involved in cellular adhesion to the ECM, and in certain cases in vertebrates, to each other 
(Hynes, 2002b). In doing so, integrins play key roles in fundamental biological processes by integrating 
cell migration, differentiation, growth and apoptosis. Consequently, integrins are important regulators 
of diverse biological processes, such as development, the immune response, leukocyte trafficking and 
hemostasis, but are also implicated in diseases including artherosclerosis, autoimmune diseases and 
cancer. 
4.2.1 The integrins and their ligands 
Integrins are heterodimeric type I transmembrane proteins that arise through non-covalent 
association of integrin α and β subunits. These integrin α and β subunits are modular proteins, each of 
which has a large extracellular domain, a single transmembrane α-helix and a short (10-70 amino acid) 
cytoplasmic domain (this is true for all subunits except the β4 subunit, which has large cytoplasmic 
domain of 1072 residues). The mammalian genome encodes eighteen α subunits and eight β subunits, 
which combine into twenty-four distinct αβ heterodimeric integrins (Hynes, 2002b). Alternative 
splicing of integrin transcripts and their tissue-specific expression patterns add further complexity to 
the map of integrins. The combination of α and β chain determines both ligand and signalling 
specificity of the integrin. However, while some integrins are specific in their recognition of ligands, 
others are promiscuous; hence there exists significant redundancy in ligand-recognition, i.e. various 
integrins will recognise the same ligand, and some integrins recognise more than one ligand.  
Generally, integrins are classified into four clusters with respect to ligand-specificity (fig 1). Three 
of these clusters represent ECM-binding integrins: (i) the collagen-binding integrins, (ii) the laminin-
binding integrins and (iii) the integrins that recognise ECM molecules that contain and display an 
arginine-glycine-aspartate (RDG) motif, such as fibronectin, vitronectin, LAP-TGF-β, tenascin, 
osteopontin and thrombospondin in vertebrates (Humphries, 2006) and tiggrin in Drosophila (Hynes, 
2002b). The fourth cluster of integrins does not interact with ECM molecules, but recognises cellular 
counter receptors and thus participates in cell-cell adhesion. These are leukocyte-specific integrins, that 
bind intercellular adhesion molecules (ICAMs), vascular cell-adhesion molecules (VCAMs) and 
mucosal vascular addressin cell adhesion molecules (MadCAMs) and are thereby paramount to cell-cell 
interactions in the hematopoetic system.  
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Figure 4.1. The mammalian family of integrin adhesion receptor heterodimers. Adapted from 
(Barczyk et al., 2009). 
 
4.2.2 Integrin activation 
Integrins are inserted into the plasma membrane in an inactive state that have low affinity for 
extracellular ligands and are thus unable to bind ECM or cellular counter-receptors. Integrins are 
rendered inactive by a closed structural conformation that is enforced by (1) the clasping of the α and 
β subunit tails through both electrostatic and hydrophobic interactions (Vinogradova et al., 2000; 
Vinogradova et al., 2002), (2) a coiled-coil interaction between transmembrane domains of both α and 
β subunits (Gottschalk, 2005) and (3) the bending of the extracellular domains (Xiong et al., 2001) (fig. 
4.2). Upon activation, integrins signal bidirectionally across the plasma membrane. An extracellular 
stimulus, such as the binding of an extracellular ligand to integrins, induces intracellular signalling 
(outside-in signalling), while intracellular signals induced by integrin-independent events can also 
promote signalling cascades that alter the ligand-binding activity of integrins and cause extracellular 
changes (inside-out signalling). Hence, the determining events of integrin activation are conformational 
changes induced by the binding of either an extracellular ligand (outside-in signalling) or cytoplasmic 
proteins (inside-out signalling) and generally involve unclasping of the α and β integrin cytoplasmic 
tails (Kim et al., 2003) and extension of the integrin extracellular domains (Zhu et al., 2007) (fig. 4.2).  
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Figure 4.2. Diagrammatic representation of the integrin heterodimer the conformational 
changes that are associated with integrin activation. The α integrin subunit is shown in green 
and the β is shown in purple. The integrin heterodomer consists of a ligand-binding head 
domain formed of the β propeller of the α integrin subunit and the hybrid and βA domains 
of the β integrin subunit. The βA domain contains Mg2+ and Ca2+ binding sites essential for 
ligand binding. The ligand-binding head domain rests on both α and β integrin subunit 
ectodomains. Specific contacts between the ectodomains, transmembrane domain and 
cytoplasmic domains keep the integrin in a bent conformation, which is inactive. Integrin 
activation occurs with the separation of the ectodomains, transmembrane and cytoplasmic 
domains and an extension of the integrin conformation. Adapted from (Moser et al., 2009b). 
 
The talins and kindlins are key intracellular integrin activators. Inside-out signalling promotes the 
translocation of talin and kindlin to integrin complexes where they drive integrin activation by binding 
the β integrin cytoplasmic tails at membrane-proximal and -distal NPxY motifs, respectively, and by 
promoting the unclasping of the α and β integrin cytoplasmic tails (Calderwood et al., 2002; Jiang et 
al., 2003; Shi et al., 2007; Ma et al., 2008; Montanez et al., 2008; Moser et al., 2008; Ussar et al., 2008; 
Moser et al., 2009a). Kindlins are proposed to aid talin in inducing conformational changes that switch 
the integrins from a bent, inactive and low-affinity state to an extended, active and high-affinity state 
that exposes the ligand-binding site (Xiao et al., 2004; Luo et al., 2007; Montanez et al., 2008; Moser et 
al., 2008) (not sure if these references actually show that kindling promotes this conformational 
change; Shi and Ma demonstrate that it activates integrins. The effect of talin and kindlin on integrin 
activation relies on their ability to interact with phosphoinositides (this might be an exaggeration, PIP 
binding is not necessary for integrin activation) in the plasma membrane (Saltel et al., 2009; Qu et al., 
2011; Liu et al., 2011). Local increases in phosphatidylinositol (4,5)-bisphosphate (PIP2) synthesis at 
the leading edge of cells or within focal complexes creates PIP2-rich lipid rafts that serve as docking 
sites for talin and kindlin, which, upon binding PIP2, undergo conformational changes that allow them 
to bind β integrin tails and capture both vinculin and F-actin filaments (Humphries et al., 2007; 
Goksoy et al., 2008; Saltel et al., 2009; Legate et al., 2011) (nb PI binding is required for kindlins to 
activate integrins, but there is no evidence that PIPs induce conformational changes in kindlin. PIPs 
most likely disrupt the autoinhibitory interaction between the talin head and rod). An additional 
possibility is that activators are needed to displace inhibitors of integrin activation, such as sharpin 
(Rantala et al., 2011) and integrin cytoplasmic domain-associated protein-1 (ICAP-1) (Bouvard et al., 
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2003; Shattil et al., 2010) (nb latter ref is review). However, the crosstalk mechanisms between talin 
and kindlin is still an active field of investigation, and it remains unclear if talin and kindlin function 
sequentially or simultaneously (Moser et al., 2009b) (fig. 4.3), although recent work shows that both 
adaptor proteins can bind the β integrin tail simultaneously (Bledzka et al., 2012) (nb because they 
don’t bind the same sequence). A recent report addressing the role of phosphoinositides in integrin 
activation shows that kindlin accumulates at newly forming focal adhesions at a higher rate than talin 
(Legate et al., 2011), which suggests that kindlin is either always associated with the plasma membrane 
or arrives at focal adhesions first and is followed by talin, although neither talin nor kindlin play a 
direct role in the recruitment of the other partner (Kahner et al., 2012; Bledzka et al., 2012).  
 
 
Figure 4.3. Three possible modes of integrin activation by talin and kindlin. (A) In the model 
for sequential binding, kindlin binding to the membrane distal NxxY motif in β integrin 
subunit tails facilitates talin binding to the same membrane proximal NPxY and concomitant 
displacement of kindlin and integrin activation. (B) Simultaneous binding in cis of kindlin to 
the membrane distal NxxY motif and binding of talin to the membrane proximal NPxY 
motif in β integrin subunit tails could facilitate integrin activation. (C) Cooperation of kindlin 
and talin bound to β integrin subunit tails in trans is speculated as a means of seeding 
integrin clusters. Adapted from (Moser et al., 2009b). 
 
The initial contact between an active integrin and an extracellular ligand, such as FN, leads to the 
formation of nascent adhesions. Nascent adhesions form in the lammelipodium, which is a zone of 
membrane protrusion at the leading edge of the cell that is projected forward by the continuous 
creation of new mesh-like actin networks (Alexandrova et al., 2008; Choi et al., 2008) (fig. 4.5). These 
early integrin complexes are inherently unstable and transient structures. To persist, the integrin-ECM 
bond must be reinforced and the integrin adhesion complex must undergo further maturation. Upon 
activation, integrins undergo conformational changes that expose docking sites within the β integrin 
tail that allow the allosteric recruitment of cytoplasmic proteins. Almost all β integrin tails contain two 
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conserved docking sites consisting of a membrane-proximal NPxY motif and a membrane-distal NxxY 
motif (where x represents any amino acid), which serve as docking sites for phosphotyrosine-binding 
domain-containing adaptor proteins, such as talin (Calderwood et al., 2003; Legate and Fässler, 2009). 
Unlike the integrins themselves, these newly recruited adaptor proteins have scaffolding, enzymatic or 
F-actin-binding and -regulating activity. Together, these adaptor proteins build adhesion structures that 
function both as biochemical signalling hubs and mechanical links between the ECM and the 
cytoskeleton. 
A distinctive feature of integrins in cell-ECM complexes is their tendency to cluster and assemble in 
a hierarchical manner (Miyamoto et al., 1995; Carman and Springer, 2003; Zaidel-Bar et al., 2004). 
Through the progressive clustering of hundreds or even thousands of activated integrins, adaptor 
proteins and actin filaments, collectively referred to as the integrin “adhesome” (Zaidel-Bar et al., 
2007), integrin adhesion complexes mature into large and powerful adhesome-associated signalling 
hubs, referred to as focal adhesions. Focal adhesions exist in various sizes and stages of maturation. 
Despite the continuum of maturation stages, the ultrastructural architecture of all focal adhesions is 
uniform; an approximatly fourty nanometre thick core of focal adhesion proteins arrange vertically 
between the membrane-bound integrin and the actin stress fibre, forming distinct functional layers of 
signalling proteins, force-transducing proteins and actin-regulating proteins (Kanchanawong et al., 
2010) (fig. 4.4).  
 
Figure 4.4. The nanoscale architecture of focal adhesions. The protein positions, but not the 
protein stoichiometry, in this model were experimentally determined. Adapted from 
(Kanchanawong et al., 2010). 
 
Mechanical coupling of integrins, such as integrin α5β1, to the actin cytoskeleton is a key step in 
reinforcing the integrin adhesion complex (Friedland et al., 2009) and enables the cell to perform work 
on its extracellular environment (Li et al., 2005a; Legate et al., 2009). The earliest points of mechanical 
coupling between the integrins, the actin cytoskeleton and extracellular ligand are within focal 
complexes that develop from nascent adhesions at the transition zone between the lamellipodium and 
the lamellum (Choi et al., 2008) (fig. 4.5). The initial link between integrins and the cytoskeleton 
following integrin activation relies on the adaptor function of talin to form a slip bond between the 
integrin β tail and F-actin, which allows the very first application of cytoskeleton-generated force to the 
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extracellular ligand (Jiang et al., 2003). Vinculin binds both talin and actin and thereby cross-links and 
stabilises the talin–actin interaction (Gallant, 2005; Humphries et al., 2007) nb! not sure why Gallant 
was added here, while the presence of the large paxillin molecule provides an assembly platform for 
subsequent waves of focal adhesion adaptor proteins (Laukaitis et al., 2001; Digman et al., 2008) 
Zaidel-Bar 2007 phospho-paxillin study would have been good to add here. Incorporation of α-actinin 
into the integrin adhesion complex promotes the organisation, stabilisation and strengthening of the 
link between integrins and the cytoskeleton by cross-linking F-actin filaments (Brown et al., 2006; Choi 
et al., 2008). A core scaffolding ternary protein complex consisting of integrin-linked kinase (ILK), 
PINCH and parvin (termed the IPP complex) assists in the mechanical coupling of integrins to the 
actin cytoskeleton in effect of ILK binding integrins β tails directly and parvin interacting with F-actin 
(Legate et al., 2006; Wickström et al., 2010). The kindlins also participate in the mechanical coupling of 
integrins to the actin cytoskeleton through their direct binding to integrin β tails (β1 and β3) and by 
interacting with F-actin either through the IPP complex or through a complex of migfilin and filamin 
(Tu et al., 2003; Moser et al., 2008; Montanez et al., 2008; Ussar et al., 2008). Fine-tuning the stability 
of the integrin-actin linkage within focal complexes is in part achieved by focal adhesion kinase (FAK) 
(Ilić et al., 2004), which has both scaffolding and signalling functions.  
 
 
Figure 4.5. A schematic representation of the adhesion structures in a migrating cell. Nascent 
adhesions form in filopodial and lamellipodial protrusions at the cell front. Maturation of 
nascent adhesions to focal complexes and focal adhesions occurs in the transition zone 
between the lamellipodium and lamellum and with the mechanical coupling of integrins to 
cross-linked actin filaments. Focal adhesions are stabilised and grow upon contractile force 
exerted on integrins by actomyosin filaments. Adapted from (Parsons et al., 2010). 
 
Filaments of F-actin connected to adhesion complexes are under tension in effect of pulling by 
non-muscle myosin II (NMII) molecular motors that associate with the actin cytoskeleton 
(actomyosin) and are as such referred to as stress fibres. Along with α-actinin, NMII plays an 
important role in the maturation of focal adhesions and the stability of actomyosin stress fibres that 
become connected to focal adhesions (Even-Ram et al., 2007; Choi et al., 2008) (fig. 4.5). The dynamic 
behaviour of the actomyosin machinery is regulated by the RhoA GTPase family and its effectors 
(Chrzanowska-Wodnicka and Burridge, 1996). In the context of actin cytoskeleton dynamics, the 
prominent members of the Rho GTPases family are RhoA, Rac1 and Cdc42, as they are general 
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regulators of actin cytoskeleton remodelling in response to mechanical stimuli. As a GTPase, each 
member cycles between an active, GTP-bound state and an inactive, GDP-bound state (fig. 4.6). This 
cycle is regulated through the joint effort of guanine nucleotide exchange factors (GEFs), GTPase-
activating proteins (GAPs) and guanine nucleotide-dissociation inhibitors (GDIs). GEFs and GAPs of 
RhoA family proteins are among the many proteins that are recruited to and activated at focal 
adhesions (Jaffe and Hall, 2005). 
  
Figure 4.6. Schematic representation of the RhoA cycle and RhoA effector signalling. Left: 
As a GTPase, RhoA cycles between an inactive GDP-bound form and an active GTP-bound 
form. The exchange of GDP for GTP, i.e. activation, is catalysed by the GEFs, while the 
GAPs stimulate intrinsic GTPase activity and thereby inactivate RhoA. The GDIs sequester 
RhoA in its GDP-bound state and prevents RhoA activation. Right: In its active form, RhoA 
interacts with multiple cytoplasmic effectors that promote actomyosin contractility and actin 
polymer stability. Adapted from (Lessey et al., 2012). 
 
In its active state, RhoA interacts with a number of effectors, one of which is the Rho kinase 
(ROCK1 and ROCK2 in mammals) (fig. 4.6). ROCK enhances NMII activity by promoting 
phosphorylation of the regulatory light chain of NMII, both by (i) directly phosphorylating and 
activating the regulatory myosin light chain subunit of NMII (MLC, also known as myosin regulatory 
light chain) (Amano et al., 1996) and (ii) phosphorylating and inactivating MLC phosphatase (Kimura 
et al., 1996; Totsukawa et al., 2000) (nb – Totsukawa shows that MLCK in the cell periphery 
phosphorylates MLC. Phosphorylation of MLC at serine 19 has an activating effect on the ability of 
NMII to interact with actin and thereby contract and bundle F-actin stress fibres. ROCK also stabilises 
F-actin filaments by phosphorylating and thereby activating LIM kinase, which in turn phosphorylates 
and inactivates the actin-severing activity of cofilin (Maekawa, 1999; Ohashi, 2000). An additional 
effector of RhoA is the mDia1 formin, an actin nucleation factor that cooperates with ROCK to build 
stress fibres (Watanabe et al., 1999; Li and Higgs, 2003) (fig. 4.6). In response to biochemical signals 
from the focal adhesion through the RhoA/ROCK axis, NMII and α-actinin cross-link and bundle F-
actin filaments and thereby promote the clustering of both actin-binding adhesion components and 
integrins. Hence, biochemical signals through the RhoA/ROCK axis changes the dynamics of the 
contractile actinmyosin in response to new sites of adhesion, generating mechanical forces that will 
allow the cell to stabilise its adhesion sites, migrate in a polarised fashion and, as I shall describe in a 
subsequent chapter, modulate the fibrillar architecture of the ECM (Yoneda et al., 2005; Yoneda et al., 
2007) inappropriate to use yoneda 2005 – talks only bout functional diff betw rock 1 and 2. 
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While the generation of contractile force by NMII is not required for nascent adhesion formation, 
the transmission of mechanical force through integrins may drive the maturation of the integrin 
adhesion complex (Stricker et al., 2013). For example, the interaction dynamics of integrin α5β1 
integrins with FN is based on catch bond behaviour, which implies that the lifetime of the integrin-FN 
interaction is increased with the application of force to the bond (in the force range of 10–30 
pN)(Kong et al., 2009). Also, integrin α5β1 is known to transition from a relaxed to a tensioned state 
in response to force transduction, inducing a molecular switch in the integrin-FN interface that allows 
the α5 integrin subunit to engage with the synergy motif in FN and strengthen the integrin-FN 
interaction (Friedland et al., 2009). NMII-dependent tension also brings about dramatic changes in the 
protein profile of the integrin adhesion complex, which serves to mature the adhesion complex (Kuo 
et al., 2011; Schiller and Fässler, 2013). However, the attachment of integrins to F-actin cytoskeleton is 
not only critical to the formation of focal adhesions. By virtue of this association with the actin 
cytoskeleton, integrin-based adhesions can confer to the cell both biochemical, physical and 
topographical information about the immediate microenvironment (Geiger et al., 2009). Given the 
dynamic and highly responsive nature of the actin cytoskeleton in terms of polymerisation and 
actomyosin contraction, environmental sensing by integrins gives the cell the ability to rapidly adjust its 
cytoskeletal organisation, and hence its shape and motility, which is the basis by which integrins 
facilitate cell adhesion, spreading and migration.  
Even after integrins have reached full activation within a focal adhesion, adhesion complexes 
remain highly dynamic in structure and molecular composition. Some cell types, like fibroblasts, have 
very dynamic cell-matrix adhesion complexes, and when anchored to two-dimensional substrates, 
integrin α5β1-containing focal adhesions are remodelled into a structurally and functionally distinct 
class of cell-matrix adhesions called fibrillar adhesions (Katz et al., 2000; Pankov et al., 2000; Zamir et 
al., 2000). Fibrillar adhesions differ from focal adhesions in their location and morphology; rather than 
dots at the cell periphery, which is typical for focal adhesions, fibrillar adhesions are elongated fibrils or 
arrays of dots distributed in more central areas under the cells.  
The formation of fibrillar adhesions was originally described using pulse-chase experiments with 
antibodies targeting the active conformations of integrins (Pankov et al., 2000). Yamada and colleagues 
demonstrated that once a cell anchors to an ECM substrate and the αVβ3- and α5β1-containing focal 
adhesions have matured, integrin α5β1 segregates from the medial end of a mature focal adhesion and 
translocates centripetally from the lamellae towards the cell body, forming the streak-like adhesion 
complexes that were termed fibrillar adhesions (Pankov et al., 2000). These fibrillar adhesions are 
devoid of focal adhesion components such as vinculin and paxillin, and instead acquire tensin (Zaidel-
Bar et al., 2003) nb this reference is inappropriate. Tensin couples integrins to actin via minimum two 
actin-binding domains in the N-terminus and acts as a cross-linker between these integrins and actin 
during during translocation (Lo et al., 1994). Although the rate of translocation differs depending on 
cell type (Pankov et al., 2000; Zamir et al., 2000), the translocation of integrin α5β1 is always driven by 
stress fibre contractility generated by the same actomyosin machinery that was required to stabilise 
focal adhesions (Pankov et al., 2000; Zamir et al., 2000). It will become clear in subsequent chapters 
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that the formation of fibrillar adhesions is a particularly interesting phase of adhesion complex 
maturation and dynamics because it involves FN organisation and remodelling (Pankov et al., 2000).  
4.2.3 Integrin signalling 
In the context of cell adhesion, integrins are just as important as signal transduction receptors as 
they are adhesion receptors. Integrin cell-matrix adhesions are highly active signalling hubs, and 
importantly, integrin signalling does not occur in isolation, but crosstalks with growth factor receptor 
(GFR)-induced signalling pathways to fine-tune the chemical and mechanical integration of the cell 
within their extracellular milieu. 
Important examples of integrin-GFR crosstalk are the integrin-mediated transactivation of receptor 
tyrosine kinases such as FGF receptor (FGFR), epithelial growth factor (EGFR), platelet-derived 
growth factor (PDGFR) and VEGF receptor (VEGFR), which, in turn, are known to amplify an 
integrin signal (Sundberg and Rubin, 1996; Moro et al., 1998; Zou et al., 2012). For example, the 
simultaneous activation of integrins and GFR, such as EGFR and PDGFR, prolongs and intensifies 
the activation of extracellular signal-regulated kinase (ERK) within the mitogen-activated protein 
kinase (MAPK) signalling pathway, to an extent that is not seen with GFR activation alone (Miyamoto 
et al., 1996; Roovers et al., 1999). Also VEGF receptor (VEGFR) signalling in endothelial cells is most 
potent when integrins are activated (Soldi et al., 1999). 
Receptor crosstalk is facilitated by the transient complex formation between integrins, GFR and 
their respective adaptor scaffolding proteins and signalling kinases. For example, at early stages of 
integrin-mediated adhesion of EGF-stimulated fibroblasts, macromolecular complexes form between 
integrins, EGFR, the adaptor protein p130 Crk-associated substrate (p130Cas) and the c-Src kinase 
(Moro et al., 2002). Studies like this suggest that a substantial part of integrin-mediated signal 
tranduction actually could be mediated by integrin-transactivated GFR, as exemplified by the 
requirement for EGFR activation for integrin-mediated cell adhesion (Marcoux and Vuori, 2003). 
At the very early stages of integrin activation, Src and FAK cooperate to initiate a variety of 
biochemical signal transduction pathways. Src is a member of the Src family kinase (SFK) non-receptor 
tyrosine kinases, whose kinase activity is regulated by phosphorylation of a number of internal 
tyrosines and are recruited to and activated at nascent adhesions. FAK is an early component of the 
integrin adhesion complex, acting both as a scaffolding protein and a signalling protein (Kim and Kim, 
2008) (this reference seems inappropriate, it’s about dynamics of FAK phosphoryl.). FAK responds to 
activated integrins by auto-phosphorylating a tyrosine residue (Tyr 397), which creates a docking site 
for SH2 domains in Src, allowing Src to bind FAK and phosphorylate additional tyrosine residues, 
which overall serve to enhance the signalling potential of the Src-FAK complex (Schaller et al., 1994; 
Schlaepfer et al., 1994; Calalb et al., 1995; Calalb et al., 1996; Thomas et al., 1998). 
The Ras-MEK-MAPK pathway is a significant signal transduction pathway downstream of the 
activated Src-FAK complex and is necessary for cellular responses to both activated GFRs and 
integrins. There are multiple points of convergence between GFR/RTK and integrin signalling. One 
point of intersection between activated integrins and EGFR occurs at the level of Raf1, the 
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phosphorylation of which is required for downstream phosphorylation of ERK (Edin and Juliano, 
2005). Another point of convergence occurs at p21-activated kinase 1 (PAK1), which phosphorylates 
MEK and thereby drives the Ras-MEK-MAPK signalling pathway (Slack-Davis et al., 2003). ERK 
phosphorylation modulates focal adhesion dynamics through MLCK-mediated stress fiber 
organisation, but is also necessary for protein synthesis, cell cyle progression and cell proliferation 
(Treisman, 1996; Webb et al., 2004; Walker et al., 2005). 
A second signalling pathway that is regulated by the Src-FAK complex, and which is of major 
importance to the pro-survival effects of integrin activation, involves the serine-threonine kinase Akt 
(also known as protein kinase B, PKB). Upon integrin activation, the autophosphorylation of FAK (at 
Tyr 397) provides a docking site for the SH2 domain of the p85-regulatory subunit of 
phosphoinositide 3-kinase (PI3K) and thereby recruits PI3K to focal adhesions (Chen et al., 1996). 
PI3K catalyses the deposition of phosphoinositide-3,4,5-P3 (PIP3) lipids into the plasma membrane 
surrounding focal adhesions. This local increase in PIP3 concentration recruits proteins with plekstrin-
homology (PH) domains to the focal adhesion, and among these proteins are the PIP3-dependent 
kinase 1 (PDK1) and Akt. Bringing Akt and PDK1 within close proximity of each other allows PDK1 
to phosphorylate and activate Akt (King et al., 1997; Vanhaesebroeck and Alessi, 2000). Complete 
activation and substrate specificity of Akt requires further phosphorylation by mammalian target of 
rapamycin (mTOR) kinase as part of the mTOR complex 2 (mTORC2) (Guertin et al., 2006; Ikenoue 
et al., 2008). It is possible that mTOR is brought to the focal adhesion by ILK (McDonald et al., 2008). 
Akt activation affects a number of cellular responses, and one major consequence of Akt activation is 
the suppression of apoptosis pathways (Kennedy et al., 1997; Downward, 1998; Brunet et al., 1999). 
PI3K has also been shown to be required for the activation of the Ras-Raf1-MEK-MAPK signalling 
pathway, most probably downstream of Ras and upstream of Raf1 (King 1997). 
Within focal adhesions, FAK also regulates focal adhesion turnover and cell migration by recruiting 
and phosphorylating p130Cas (Cary et al., 1998). This initiates the recruitment of a series of adaptor 
proteins (involving adaptor protein Crk (Chicken Tumor Virus 10 regulator of kinase) and the Rac 
GEF Dock180 (180 kDa protein downstream of Crk)) that lead to the activation of the small GTPase 
Rac1 at the plasma membrane to promote actin cytoskeletal rearrangements and focal adhesion 
turnover in preparation for cellular adhesion and migration (Kiyokawa et al., 1998) (nb this ref doesn’t 
refer to ELMO). FAK also associates with p190RhoGEF to stimulate RhoA activity and promote 
actin cytoskeleton contractility (Zhai et al., 2003). 
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Figure 4.7. Integrin outside-in signalling elicits multiple biochemical signalling pathways that 
ultimately lead to changes in gene expression. Integrin outside-in signals are generated in 
response to extracellular mechanical properties and biochemical composition. These integrin-
mediated signals are integrated with growth factor-mediated signals to fine-tune the cellular 
response to microenvironmental cues. Adapted from (Legate et al., 2009). 
 
The composition of integrin-bound proteins affects the signalling properties of the integrin 
complex. As outlined above, some biochemical signalling pathways downstream of integrin adhesions 
have been characterised. Given that integrins interact with hundreds of different molecules, the 
adhesome signalling network becomes very complex. Biochemical signals emanating from the integrin 
adhesome feed into complex signalling pathways that ultimately regulate gene expression, cell cycle 
progression, focal adhesion turnover and actin dynamics. Collectively, this elicits a plethora of 
fundamental, yet diverse cellular outputs such as survival, proliferation, differentiation, migration, 
adhesion and cell polarity (Legate et al., 2009) (fig. 4.7). 
4.2.4 Integrins in mouse development 
Mouse genetic tools have contributed enormously to the wealth of knowledge on the roles that 
integrins play in mouse development as well as their contribution to adult tissue homeostasis and 
regenerative processes. The genetic ablation of integrin genes leads to a variety of phenotypes, ranging 
from apparently normal mice to early embryonic lethality. The diversity of integrin mutant phenotypes 
reflects the many specialised functions of integrins during the development or maintainance of tissue 
integrity.  
Targeting single α and β integrin subunits has been important in elucidating their respective 
functional contributions of specific integrin heterodimers. For example, the genetic disruption of 
integrin β1 essentially ablates the entire subfamily of β1 integrins and results in peri-implantation 
lethality (Fässler and Meyer, 1995; Stephens et al., 1995). However, among the integrin α subunits that 
are known partners of β1 integrin, only the deletion of specific integrin α subunits cause embryonic 
lethality, and none of these α subunit knockout mice show the same degree of severity as integrin β1 
knock out, suggesting a level of functional compensation. 
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To provide an overview of integrin function in mouse development, I have summarised the 
phenotypes for single integrin α or β subunit knockout mice (table 4.1). In subsequent chapters of this 
introduction, I shall describe in greater detail the phenotypes of the FN-binding integrin knockout 
mice in the context of FN function. A large proportion of these constitutive integrin subunit genetic 
manipulations cause recessive embryonic lethality. The study of integrin function in processes related 
to integrin cell adhesion and signalling, but which would normally occur after the time of lethality, is 
grately facilitated by the use of conditional, tissue-specific integrin subunit knockout mouse models. I 
will return to such tissue-specific ablation of FN-binding integrins in subsequent chapters.  
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Table 4.1. Phenotypes of single-integrin-knockout mice. Adapted from (Bouvard et al., 2013). 
Integrin 
subunit 
 
Phenotype 
 
Effect of loss 
 
Reference 
α1 Viable, fertile Defects in collagen synthesis, skin thickening, 
reduced tumour vascularisation. 
(Gardner et al., 1999) 
(Pozzi et al., 2000) 
α2 Viable, fertile Defects in platelet adhesion and response to 
collagen, diminished mammary gland 
branching morphogenesis. 
(Holtkötter et al., 2002) 
(Chen et al., 2002) 
α3 Perinatal lethal Defects in kidney and lung development, skin 
blistering, disorganised basement membrane. 
(Kreidberg et al., 1996) 
(DiPersio et al., 1997) 
α4 Embryonic 
lethal 
Defects in placenta formation, cardiac 
development and abnormal development of 
hematopoietic lineages in fetal liver. 
(Yang et al., 1995) 
(Arroyo et al., 1999) 
(Sengbusch et al., 2002) 
α5 Embryonic 
lethal 
Defects in mesoderm-derived tissues and in 
neural crest cell survival. 
(Yang et al., 1993) 
(Goh et al., 1997) 
α6 Embryonic or 
perinatal lethal 
Vascular hemorrhaging, abnormal vascular 
smooth muscle. Absent hemidesmosomes and 
skin blistering. 
(Flintoff-Dye et al., 2005) 
(Georges-Labouesse et al., 1996) 
α7 Perinatal lethal Muscular dystrophy. (Mayer et al., 1997) 
α8 Perinatal lethal Defects in kidney morphogenesis, inner ear 
stereocilia defects. 
(Müller et al., 1997) 
 
α9 Perinatal lethal Defects in lymphatic valve formation and in 
the development of the lymphatic system, 
chylothorax. 
(Huang et al., 2000b) 
(Bazigou et al., 2009) 
(Danussi et al., 2013) 
α10 Viable, fertile Dwarfism, abnormal chondrocyte behaviour, 
defects in growth plate morphogenesis and 
function. 
(Bengtsson et al., 2005) 
α11 Viable, fertile Dwarfism, increased mortality, most likely due 
to failed incisor eruption. 
(Popova et al., 2007) 
αv Embryonic or 
perinatal lethal 
Deficient placentation, distended blood vessels, 
intracerebral and intestinal hemorrhage, cleft 
palate. 
(Bader et al., 1998) 
αx Viable, fertile Monocyte recruitment and atherosclerosis 
development. 
(Wu et al., 2009) 
αD Viable, fertile T cell defects, reduced immuned response to 
bacterial infections. 
(Wu et al., 2004) 
αL Viable, fertile Impaired immune response, failed tumour 
rejection.  
(Schmits et al., 1996) 
(Shier et al., 1996) 
αM Viable, fertile Impaired phagocytosis and neutrophil 
apoptosis. 
(Coxon et al., 1996) 
αE Viable, fertile Reduced lymphocyte numbers, inflammatory 
skin lesions. 
(Schön et al., 1999) 
 
αΙIb Viable, fertile Impaired blood clot formation, platelet 
abnormalities. 
(Tronik-Le Roux et al., 2000) 
β1 Embryonic 
lethal 
Inner cell mass deterioration, peri-implantation 
defect E5.5, defective BM assembly. 
(Fässler and Meyer, 1995) 
(Stephens et al., 1995) 
β2 Viable, fertile Impaired leucocyte migration, skin infections. (Scharffetter-Kochanek et al., 1998) 
β3 Viable, fertile Impaired blood clot formation, platelet 
abnormalities, enhanced pathological 
angiogenesis, bone defects. 
(Hodivala-Dilke et al., 1999)  
(Reynolds et al., 2002)(McHugh et al., 
2000) 
β4 Perinatal lethal Skin blistering. (Dowling et al., 1996) 
(van der Neut et al., 1996) 
β5 Viable, fertile No apparent phenotype. (Huang et al., 2000a) 
β6 Viable, fertile Inflammation in skin and lungs, TGF-β 
activation defect. 
(Huang et al., 1996) 
(Munger et al., 1999) 
β7 Viable, fertile Impaired T cell migration to Peyer’s patches, 
reduced lymphocyte number associated with 
gut epithelia. 
(Wagner et al., 1996) 
β8 Embryonic or 
perinatal lethal 
Defects in vascular morphogenesis placenta, 
yolk sac, central nervous system and 
gastrointestinal system, cleft palate. 
(Zhu et al., 2002) 
PhD Thesis - Josefine Gibson  Introduction 
 
 20 
 
4.3 Fibronectin (FN) 
FN is a prominent constituent of the vertebrate connective tissue ECM, basal laminae and plasma. 
As a ligand of multiple integrin heterodimers and a binding partner of various ECM components, FN 
plays versatile roles in regulating cellular function. As an integrin ligand, a core function of FN is to 
support cell adhesion and migration of mesenchymal (and hematopoietic) cells. Yet with its many 
extracellular interaction partners, FN supports important biological processes during development and 
in adult physiology. As one of the earliest proteins to assemble within the extracellular space, FN is 
believed to coordinate the assembly of other matrix proteins and can be thought of as a “master 
organiser” of the ECM (Dallas et al., 2006; Schwarzbauer and DeSimone, 2011). FN is also involved in 
the propagation of diseases like cancer, fibrosis and artherosclerosis, and is considered a diagnostic 
marker for various pathologies. 
The fibrillar form of FN is the principal biologically functional form of FN. Yet, cells secrete FN as 
inert globular units, which must undergo fibrillogenesis to become multi-functional supra-molecular 
fibrillar structures. FN fibrillogenesis is a complex, cell-driven assembly process that is initiated and 
governed by integrins and thermodynamics (Singh et al., 2010). The assembly of FN into a fibrillar 
matrix will be described in subsequent chapters, but first I shall introduce the important structural 
features of FN that are required for FN assembly and function.  
4.3.1 Modular composition and alternative splice forms of FN 
FN is a complex glycoprotein with a molecular weight of about 250 kDa and a carbohydrate 
content of 4-10% O-linked and N-linked glycosylation units (Choi and Hynes, 1979; Fibronectin, 
1989; Hynes, 1990). FN is composed of three types of repeating, but structurally and functionally 
defined modules (FNI, FNII and FNIII) arranged in an array along the length of the protein and 
essentially integrating multiple functions into one molecule (Petersen et al., 1983; Hynes, 1990). More 
specifically, FN consists of twelve FNI repeats (FNI1-12), two FNII repeats (FNII1-2) and fifteen FNIII 
repeats (FNIII1-15) (fig. 4.8). Despite FN being an exclusively vertebrate protein, the FNIII module is 
an ancient domain that is found in both intracellular and extracellular proteins expressed by both 
animals (as cell surface receptors and cell adhesion molecules, such as tenascin), plants and bacteria 
(Bork and Doolittle, 1992; Tsyguelnaia and Doolittle, 1998). 
FN is encoded by a single gene, Fn1, that gives rise to significant protein heterogeneity through 
alternative splicing of the Fn1 mRNA transcript. Alternative splicing of the Fn1 transcript shows cell-
type specific and species-specific patterns, which are regulated throughout development, but always 
targets three regions of the Fn1 mRNA transcript, resulting in isoforms with complete or partial 
excision of individual modules; this gives rise to at least twelve isoforms in mouse and twenty isoforms 
in humans (Schwarzbauer et al., 1983; Kornblihtt et al., 1984; Kornblihtt et al., 1985; Schwarzbauer et 
al., 1987; Hynes, 1990). Alternative splicing activity within the polynucleotide array of FNIII1-15 
determines the presence or absence of exons encoding extra FN type III domain B (EIIIB, between 
FNIII7-8) and EIIIA (between FNIII11-12) as well as subdivisions of the variable (V) region (also 
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known as IIICS, between FNIII14-15). Whereas regulated alternative splicing of EIIIA and EIIIB either 
includes or excludes these single extra FN type III-encoding exons, splicing within the V region either 
removes the entire V sequence (V0) or generates segments of varying lengths (generally termed V+ 
and include V64, V89, V95 and V120, where numbers denote the number of amino acids included in 
the V region, and the two latter forms are exclusively found in human). EIIIA- and EIIIB-containing 
FN are predominantly expressed during embryonic development, but are subsequently lost at postnatal 
stages (Pagani et al., 1991; Chauhan et al., 2004) (Ref Chauhan not really relevant). Although the 
expression of these extra FNIII domains is lost in normal adult tissue, they seem to play an essential 
part in the developing embryo; when both alternatively spliced segments are excised from the mouse 
genome by genetic recombination (FN EIIIA-/-/EIIIB-/- double null), mice die during embryonic 
development with multiple severe cardiovascular defects (Astrof et al., 2007). However, mice 
expressing FN that lacks either EIIIA or EIIIB show only mild defects, but are otherwise viable and 
fertile (Fukuda et al., 2002; Muro et al., 2003; Tan et al., 2004). It is peculiar that EIIIA and EIIIB 
isoforms become reexpressed under pathological circumstances such as wound healing (Ffrench-
Constant et al., 1989; Muro et al., 2003; Kilian et al., 2008), cancers (Koukoulis et al., 1993; Villa et al., 
2008), artherosclerosis (Tan et al., 2004; Babaev et al., 2008), thrombosis (Chauhan et al., 2008), lung 
fibrosis (Muro et al., 2008) and kidney disease (Van Vliet et al., 2001). Alternatively spliced forms of 
FN carrying the V region are expressed both during embryogenesis and in adult tissue (Ffrench-
Constant et al., 1989; Oyama et al., 1989). 
 
Figure 4.8. A diagrammatic representation of the modular structure of dimeric FN. FNI 
repeats are indicated in blue, FNII in brown, FNIII in green and the alternatively spliced 
extra FNIII repeats, EIIIA, EIIIB and the V-region are indicated in sand. Prominent binding 
partners of FN to other ECM proteins are indicated above the molecule, while integrin 
heterodimers and their recognition sites in FN are denoted below. Note the dimerisation 
motif mediated by C2458 and C2462 at the C-terminal of FN. Adapted from (Leiss et al., 2008). 
 
Several features of FN are critical for its biological function. FN segregates into two functionally 
distinct pools on the basis of solubility and fibrillity. So-called cellular FN (cFN) is a ubiquitously 
expressed form of FN that becomes converted into an insoluble and fibrillar constituent of the ECM 
or basal laminae of most mesenchymal and epithelial cell types. Hepatocytes, on the other hand, 
secrete large amounts of so-called plasma FN (pFN) into the plasma, reaching concentrations of about 
300 µg/ml. pFN circulates in plasma in a globular and soluble state until converted into an insoluble 
and fibrillar form by activated integrins, typically upon vascular injury or lesions, where fibrillar FN 
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supports the growth and stability of platelet thrombi during haemostasis (Ni et al., 2003; Cho and 
Mosher, 2006). cFN-type isoforms of FN include both EIIIA- and EIIIB-containing FN, whereas 
pFN has no extra domains. pFN isoforms are heterogenous in that FN dimers tend to carry one V0 
subunit and one V+ subunit (V0/V+), whereas cFN is almost always found to contain either full-
length or shortened stretches of the V region (Hynes, 1990). 
As will become clear in subsequent chapters, the conversion of soluble FN into a fibrillar matrix is 
a cell-driven, integrin-dependent process. Indeed, the segregation of cFN and pFN in time and space is 
largely a consequence of the temporal and spatial regulation of integrin activation. Cells depositing FN 
into the ECM or basal lamina constitutively express active forms of integrins that will convert globular 
FN into a fibrillar form. However, haematopoetic cells circultating in the blood, where they are 
constantly exposed to pFN, must temporally restrict the conversion of soluble FN into a fibrillar form 
to times when blood clots are needed to prevent bleeding. By maintaining their repertoire of surface 
integrins in an inactive state and only shifting to an active state in response to signals emanating from 
vascular injury, heamatopoietic cells ensure that pFN is converted into a fibrillar matrix only at the 
right time and place. While pFN plays an important part in blood clotting, it is also implicated in 
artherosclerosis and liver fibrosis. It is also noteworthy that pFN and cFN are not fully separated in 
space; pFN has been found to leak into tissues from the blood and become integrated into the cell-
associated fibrillar matrix (Moretti et al., 2007). 
A crucial feature of FN is its dimerisation. Dimerisation is allegedly required for the de novo 
assembly of a fibrillar FN matrix and thus FN function (Schwarzbauer, 1991). Dimerisation of FN is 
achieved in the endoplasmic reticulum by inter-chain disulfide bond formation between two pairs of 
cysteine residues (C2458 and C2462) in the extreme C-terminus of two FN molecules (Choi and Hynes, 
1979). The dimeric form of FN is by far the most prevalent form in tissues. However, naturally 
occurring single-chain isoforms do exist. In cartilage, a unique pattern of alternative splicing creates a 
FN isoform that lacks the entire V region along with the FNIII15 and FNI10 repeats [termed (V+C)-] 
(MacLeod et al., 1996). Although this FN splice variant retains the two C-terminal cysteine residues 
essential for dimerisation, cellular and/or structural constraints appear to impair the ability to dimerise, 
and as such this FN isoform exists not only as a homodimer but also in an unusual monomeric 
configuration (Burton-Wurster et al., 1999). The tissue-specific expression pattern of this fibronectin 
isoform suggests that it may have an important function in the matrix organisation of cartilage, but the 
contribution of a single-chain form of FN to the properties of the ECM are still unknown. Zebrafish 
express a truncated form of FN (FN2) that lacks the two cysteines that are usually involved in the 
formation of interchain disulfide bonds (Zhao et al., 2001). This single-chain isoform must retain 
important biological activity as it is expressed throughout zebrafish development and supports cell 
adhesion and spreading of fish embryonic cells.  
4.3.2 FN-binding integrins 
FN is an integrin ligand and provides a platform for cell adhesion and migration. While eleven 
integrins have been shown to interact with FN in vitro (Humphries, 2006; Leiss et al., 2008), four of 
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these integrins (α5β1, αVβ3, α4β1 and αIIbβ3) interact with FN to the extent that they regulate FN 
fibril assembly. However, the binding specificity of this group of FN-binding integrins is not always 
limited to FN. A variety of ECM proteins contain an asparagine-glycine-aspartate (RGD) tripeptide 
motif that is recognised by integrins, but the ease by which an integrin can structurally accommodate 
the RDG sequence in a given ECM protein determines relative affinities of the integrin for its various 
ligands. It is also noteworthy that the ability of FN to serve as an adhesive substrate to cells is not 
strictly dependent on integrins; FN binding is also promoted by the interaction of heparin-binding 
domain in FNIII13-14 with heparin or heparan sulphate proteoglycans, such as the syndecans, that are 
expressed on cell membranes (Saunders and Bernfield, 1988; Barkalow and Schwarzbauer, 1991; 
Barkalow and Schwarzbauer, 1994; Couchman, 2010). The interaction between FN and syndecans is 
significant in that it has been shown to synergise with integrin-FN binding in promoting adhesion-
dependent processes such as integrin-based focal adhesion formation and cell spreading (Woods and 
Couchman, 1998; Woods and Couchman, 2001; Klass et al., 2000; Couchman, 2010; Morgan et al., 
2007). I will now focus exclusively on the interaction of FN with integrins. 
Integrins interact with FN at one of two main central “cell-binding sites” to promote cell adhesion 
and FN fibrillogenesis. One central cell-binding domain is represented by the RGD tripeptide motif in 
FNIII10 (Pierschbacher and Ruoslahti, 1984a). Crystal structures of FNIII10 have revealed that the 
RGD motif is on a conformationally flexible loop between two β strands and becomes exposed and 
available for binding by integrins when FN is absorbed to a surface (such as cell culture glass or plastic) 
(Baron et al., 1992; Leahy et al., 1992; Main et al., 1992) then how to thrombin-stimulated, activated 
platelets bind globular FN. The RGD motif in FN is recognised by integrins α5β1, αVβ1, αVβ3, 
αVβ6, α8β1, α9β1 and αIIbβ3 (Humphries, 2006; Leiss et al., 2008) (fig. 4.8) The specificity and 
importance of the interaction between integrins and the RGD motif is demonstrated by the ability of 
RGD motif-containing peptides to support fibroblast attachment to an RGD peptide-coated surface, 
and, when administered in soluble form, to inhibit adhesion of both freshly seeded fibroblasts and 
thrombin-stimulated platelets to FN (Pierschbacher et al., 1983; Pierschbacher and Ruoslahti, 1984a; 
Pierschbacher and Ruoslahti, 1984b; Ginsberg et al., 1985). Furthermore, the addition of RGD motif-
containing peptides to adherent cells abolishes the ability of cells to assemble FN fibrils (Plow et al., 
1985). Deletion of genes in the mouse encoding integrins α5 and αV causes embryonic lethality and is 
associated with a complete failure to assemble a fibrillar FN matrix (Yang et al., 1999). The importance 
of the integrin interaction with the RGD motif is made even more clear by the phenotype of the 
mouse expressing FN in which the aspartic acid residue in the RGD motif was mutated to glutamic 
acid (FNRGE); here, the FN integrins that rely on RGD motif can no longer interact with FNIII10 and 
embryos die with mesodermal and vascular defects, reminiscent of the embryonic lethal phenotype of 
the integrin α5 knock-out mouse (Yang et al., 1993; Takahashi et al., 2007). However, the findings that 
both FNRGE/RGE embryos and integrin α5 knock-out mouse embryos show nearly equal quantities of 
fibrillar FN in the anterior trunk tissue suggested that αV integrins in this tissue were able to interact 
with FN and induce its assembly in an RGD motif-independent manner. This led to the discovery of 
new αV integrin-binding sites at the N-terminus of FN; in FNI5, an asparagine-glycine-arginine (NGR) 
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sequence becomes a high-affinity binding site for integrin αVβ3 through the deamidation of the 
asparagine residue, possibly catalysed by protein l-isoaspartyl methyltransferase, which thereby creates 
a spatially accessible iso-DGR sequence that is recognised by RGD-binding integrin αVβ3 (Curnis et 
al., 2006; Leiss et al., 2008) Leiss 08 is the wrong reference. Use Takahashi 07. Although FN 
deamidation has not been demonstrated in vivo, it presents a plausible mechanism of αV-dependent 
and α5β1-independent FN fibril assembly (in a way it is still RGD dependent because it depends on 
deamindation of the asparagine to arspartic acid) in the embryo anterior trunk (Takahashi et al., 2007).   
Some FN-binding integrins, most notably integrin α5β1 and αIIbβ3 require an additional binding 
motif in FN, called the synergy motif, to maximise binding affinity of the FN-integrin interaction 
(Bowditch et al., 1994; Danen et al., 1995; Chada et al., 2006). The synergy motif comprises the (at 
least) minimal peptide sequence Pro-His-Ser-Arg-Asn (PHSRN) within the centre of FNIII9, and is 
thus placed in the vicinity of the RGD motif in FNIII10 (Nagai et al., 1991; Aota et al., 1994; Bowditch 
et al., 1994; Redick et al., 2000; Chada et al., 2006) (fig 4.9). The synergy motif was once proposed to 
exert its positive effect only when the RGD and the synergy motifs were simultaneously bound by 
integrin β1 and α5 subunits, respectively, but more recent studies have shown that the synergy motif 
does not engage integrins directly, but exerts a positive, indirect effect on the affinity of integrins for 
the RGD motif by (a) optimally orienting the loop containing the RGD motif for integrin binding or, 
alternatively, (b) by so-called long range electrostatic steering whereby electrostatic repulsion between 
negative charges within FNIII7-10 and its binding pocket in the integrin α5 subunit becomes neutralised 
by basic residues within the synergy motif (Takagi et al., 2003). Despite the substantial contribution of 
the synergy motif to overall binding affinity and a report claiming that the synergy motif is essential for 
α5β1-mediated de novo accumulation of a FN matrix (Sechler et al., 1997), it is intriguing that a mouse 
model engineered to express a knock-in mutation that disrupts the synergy motif shows no obvious 
developmental or adult physiological defects (Dr Mercedes Costell, unpublished observation). 
 
 
Figure 4.9. A schematic depiction of FNIII9-10. These two adjacent type III modules contain 
the synergy motif (PHSRN) and the cell-binding RGD motif (both highlighted in red). 
Although probably not in contact with integrin α5β1, the synergy motif is thought to 
increase the binding affinity of integrin α5β1 for the RGD motif. Adapted from (Leiss et al., 
2008). 
 
As described above, the expression of alternatively spliced FN isoforms is spatially and temporally 
regulated during development and disease. This suggests that the various FN isoforms have unique 
functions during both physiological and pathological tissue remodelling. Interestingly, all three major 
sites of alternative splicing flank domains that allow FN to interact with integrins. EIIIA- and EIIIB-
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containing isoforms of cFN are particularly interesting in this respect because they flank the cell-
binding domains in FNIII9-10 and could modulate the ability of integrins to regulate FN fibrillogenesis 
and/or cell adhesion. Alternative splicing could give rise to FN isoforms with different cell-adhesive, 
ligand-binding and solubility properties that allow cells to alter the chemical composition and 
mechanical properties of the ECM in a developmental and tissue-specific manner. Some cell types 
require the presence of EIIIA-containing FN for integrin-mediated adhesion (Manabe et al., 1997); for 
example, EIIIA contains a EDGIHEL sequence that is recognised by integrins α4β1 and α9β1 (Liao 
et al., 2002; Shinde et al., 2008). The contribution of each extra domain to FN fibrillogenesis has also 
been tested in cell culture experiments. These showed that fibroblasts cultured in the presence of 
recombinant FN fragments containing either EIIIA or EIIIB domains would enhance the 
incorporation of the recombinant FN into a pre-existing matrix (Guan et al., 1990). Another study 
showed that EIIIB-/- mouse embryonic fibroblasts (MEFs) tend to deposit less FN into cell-derived 
ECM (Fukuda et al., 2002). Structural studies support the notion that the presence of EIIIB stabilises 
macromolecular fibril formation and integrin clustering (Schiefner et al., 2012). Interestingly, MEFs 
expressing FNEIIIA-/-/EIIIB-/- deposit FN into a fibrillar state in the ECM (Astrof et al., 2007), but such 
an FNEIIIA-/-/EIIIB-/- matrix must contain qualitative distortions that account for the embryonic lethality 
of FNEIIIA-/EIIIB- mice, perhaps by modulating the ability of integrins to interact with FN.  
V+ FN isoforms could also have a role in regulating cell adhesion. The V120 isoform of FN, which 
contains the peptide sequence spanning the Heparin-II (HepII) binding domain and the type III 
connecting segment (IIICS), includes the minimal sequences REDV, which are functionally related to 
the RGD motif, and LDV. Various cell types specifically attach to FN through integrins α4β1 and 
α4β7 by recognition of these sequences (Wayner et al., 1989; Guan and Hynes, 1990; Nojima et al., 
1990; Mould et al., 1991). Other cell types use α4 integrins to bind the V-region (IIICS) of FN and 
thereby initiate FN fibril assembly (Sechler et al., 2000).  
4.3.3 The assembly of a fibrillar FN matrix 
At physiological pH and salt concentration, the native conformation of FN is compact and globular 
due to intramolecular ionic interactions between the two arms of the dimeric FN molecule (Johnson et 
al., 1999), and remains soluble as long as there is no encounter with cells expressing active integrins. 
Activated integrins will bind soluble FN and initiate an elaborate conversion of FN into a highly 
fibrillar and organised form that is chemically cross-linked to a degree that resists solubilisation in 
sodium deoxycholate detergent. In its fibrillar form, FN provides a platform for cell attachment, cell 
migration and tissue organisation as well as a depot to store growth factors. Essentially, FN acquires all 
its functionality once in a fibrillar form, and therefore it is crucial to understand the mechanism 
underlying this conversion. FN fibrillogenesis is the process by which soluble FN transitions into to a 
fibrillar form, and I shall now provide a detailed account of this mechanism.  
4.3.3.1 Integrins initiate FN fibrillogenesis 
While a number of integrins have been found to interact with FN (Zhang et al., 1993), the integrin 
α5β1 is considered the prime integrin responsible for promoting FN fibril assembly. This was 
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demonstrated in early experiments where chinese hamster ovary (CHO) cells transfected with integrin 
α5 showed an enhanced ability to assemble FN fibrils (Giancotti and Ruoslahti, 1990), and in other 
experiments where blocking antibodies against α5 or β1 integrins prevented FN matrix assembly 
(Akiyama et al., 1989; Fogerty et al., 1990). Even small fragments of FN containing the RGD motif 
(i.e. an integrin cell-binding site) will inhibit the assembly of FN fibrils by cells (McDonald et al., 1987), 
and experimental work with chimeric β1 integrins, rendered incapable of binding an ECM ligand, 
inhibit FN fibril assembly (LaFlamme, 1994). However, some cell types lacking α5 integrins will 
initiate FN fibrillogenesis using the αV integrins, which bind FN through either the RGD motif or 
peptide sequences within FNI1-5 (Wennerberg et al., 1996; Wu et al., 1996; Takahashi et al., 2007). The 
employment of αV integrins could account for the FN fibrillogenesis that has been shown to occur in 
α5 knockout mice or in cultures of α5 knockout MEFs (Yang et al., 1993; Yang and Hynes, 1996). 
However, it is widely accepted that integrin α5β1 is superior over integrin αVβ3 in driving de novo 
fibrillogenesis. Firstly, integrin αVβ3 cannot bind soluble FN, whereas α5β1 can (Huveneers et al., 
2008). The RGD motif is not exposed in soluble FN, but the ability of integrin α5β1 to bind the 
synergy motif could stabilise a particular orientation of the RGD motif within FNIII10 that favours its 
ligation to integrin α5β1 (Altroff, 2004). Although integrin α5β1 will bind to FN lacking the synergy 
motif, both the RGD and synergy motifs are necessary for integrin α5β1 to induce fibrillogenesis 
(Danen et al., 1995; Sechler et al., 1997). Secondly, the ability of integrin α5β1 to engage the synergy 
motif in response to tension strengthens the integrin-FN bond, and this could distinguish integrin 
α5β1 from integrin αVβ3 in terms of ability to initiate adhesion and FN fibrillogenesis (Friedland et 
al., 2009). Third, integrin α5β1 is known to stimulate higher levels of RhoA-GTP loading than integrin 
αVβ3 and thereby generate a different degree of tension to allow the process of fibrillar adhesion 
formation and concomitant FN fibrillogenesis (Danen et al., 2002) These differences could explain 
why fibroblasts performing αV integrin-mediated FN assembly creates, at best, a network of stunted 
fibrils. In vivo, however, it is most likely that the two integrin heterodimers cooperate within the same 
focal adhesion to regulate FN fibril architecture. The platelet-specific integrin αIIbβ3 will also 
assemble fibrillar FN matrix upon stimulation (Wu et al., 1995; Olorundare et al., 2001), and this 
process is an important part of thrombus formation. 
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Figure 4.10. Schematic representation of the major steps in FN fibrillogenesis. (A) Integrin 
α5β1 (grey) capture globular FN dimers (orange/brown) in the extracellular matrix. (B) 
Recruitment of signalling and actin-binding cytoplasmic proteins (pink, blue, yellow) to the 
integrin cytoplasmic tail ensures the mechanical coupling of integrins to the contractile 
actomyosin machinery (green). Biochemical signals emanating from integrin signalling 
platforms lead to the generation of contractile force by the actomyosin machinery, which, 
when transduced through integrins, induces conformational changes in FN. (C) Integrin 
clustering and FN-FN interactions promote the build-up of stretches of FN fibrils. (D) The 
presence of multiple FN-binding sites in the FN dimer allows a high degree of intramolecular 
cross-linking in FN, which stabilises the formation of supramolecular (DOC-insoluble) 
structures of FN in a fibrillar matrix. Adapted from (Singh et al., 2010). 
 
The early events of FN fibrillogenesis require the mechanical coupling of the extracellular ligand to 
the contractile actin cytoskeleton via integrins (fig. 4.10 A). This was demonstrated by early 
experiments where cells expressing a recombinant truncated form of integrin β1 cytoplasmic domain 
failed to assemble a FN matrix (Wu et al., 1995) and where the pharmacological interruption of the 
actin cytoskeleton inhibited FN fibrillogenesis (Ali and Hynes, 1977; Christopher et al., 1997). FN 
fibrillogenesis is coupled to the maturation of integrin adhesions into fibrillar adhesions (Pankov et al., 
2000; Yamada et al., 2003). FN is first seen as punctate structures associated with integrins within 
maturing focal adhesions in the lamellae. FN follows the same centripetal segregation pattern as 
integrin α5β1, transitioning into structurally compact fibrils en route that align with stretches of integrin 
α5β1, actin stress fibres and adhesion-associated signalling molecules, such as tensin. Here the role of 
integrins as mechanotransducers is paramount to FN fibrillogenesis; binding of FN by integrins 
stimulates the generation of mechanical force by the contractile actin cytoskeleton, leading to a build-
up of mechanical tension across the ligand-bound integrin, which, when transduced to the bound FN, 
stretches the globular FN molecule. This stretching overcomes intramolecular forces holding the FN 
dimer in a compact globule and pries apart the two arms of the dimer (Baneyx et al., 2002; Smith et al., 
2007) (fig. 4.10 B and 4.11). As will become apparent in the following chapter, FN harbours hidden 
hydrophobic domains that represent cryptic FN-binding sites. The unravelling of these cryptic FN-
binding sites upon integrin binding allows intermolecular FN-FN interactions to drive the propagation 
of a polymerisation reaction that transforms FN into fibrils. 
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Figure 4.11. FN extension within fibrillar adhesions. Transition of integrin α5β1 (blue) from 
focal adhesions at the cell periphery along stress fibres towards the cell body (arrow) forms 
fibrillar adhesions that pull on bound FN (green) and thereby manipulate FN into a fibrillar 
matrix. This transition involves the acquisition of tensin and loss of other focal adhesion 
components such as paxillin and vinculin. Adapted from (Yamada et al., 2003). 
 
A number of focal adhesion components are directly involved in the processes of fibrillar adhesion 
formation and FN fibrillogenesis. Talin is one of the earliest activators of β1 integrins, and if prevented 
from binding the intracellular domain of integrin β1, both integrin activation and FN fibril formation is 
diminished (Green et al., 2009). Cells lacking FAK in focal adhesions fail to translocate integrin-bound 
FN and other focal adhesion proteins along the actin fibres in fibrillar adhesions (Ilić et al., 2004). Src 
is another central kinase of focal adhesion dynamics, and cells lacking Src also show a reduced ability 
to initiate FN fibrillogenesis (Wierzbicka-Patynowski and Schwarzbauer, 2002). Furthermore, the 
pharmacological inhibition of Src after FN matrix formation shows that Src is required to maintain a 
FN matrix (Wierzbicka-Patynowski et al., 2007).  
4.3.3.2 Lateral self-association of FN molecules drives FN fibrillogenesis 
Of fundamental importance to FN fibrillogenesis, and thus FN function, is the ability of FN 
molecules, once partially extended, to associate laterally with one another through internal FN-binding 
domains. Lateral self-association of FN is the driving force behind the propagation of FN 
fibrillogenesis and is facilitated by the clustering of FN-bound integrins, which increases the local 
concentration of FN (fig. 4.11 C and D).  
The earliest approaches to identify the sequences within FN responsible for self-association relied 
on the ability of exogenous (purified and recombinant) FN to become incorporated into a cell-derived 
matrix, then systematically assaying the ability of a given truncated segment of recombinant FN to do 
the same (Hayman and Ruoslahti, 1979; McKeown-Longo and Mosher, 1983; Millis et al., 1985; 
Chernousov et al., 1987; Guan et al., 1990). Approaches based on affinity chromatography and solid-
phase binding assays with proteolytic FN fragments, recombinant truncated FN polypeptides and 
blocking antibodies (i.e., monoclonal antibodies L8 or 9D2 (Chernousov et al., 1987; Chernousov et 
al., 1991)) that bound FN, but did not affect binding of FN by integrin α5β1, led to the identification 
of an essential self-association site, a 70kDa region within N-terminal FNI1-5 termed the assembly 
domain (McKeown-Longo and Mosher, 1983; McKeown-Longo and Mosher, 1985; Chernousov et al., 
1985; McDonald et al., 1987; Allio and McKeown-Longo, 1988; Quade and McDonald, 1988; Barry 
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and Mosher, 1989). The requirement for FN-FN interactions in FN fibrillogenesis was later confirmed 
with experimental setups studying de novo assembly of recombinant FN fragments expressed and 
assembled by mammalian cells (Schwarzbauer, 1991). 
The 70kDa N-terminal FNI1-5 assembly domain is recognised by a multitude of sites within the 
more C-terminal FNIII repeats. These FN-binding sites are cryptic in the native globular state of FN 
and require extension to become available to participate in intermolecular interaction. The FN 
assembly domain has been shown to interact with sites in FNIII1 (Hocking et al., 1994), FNIII2 
(Aguirre et al., 1994; Sechler et al., 2001), FNIII4-5 (HepIII) (Maqueda et al., 2007), FNIII10 (Hocking et 
al., 1996) and FNIII12-14 (HepII) (Bultmann et al., 1998). As these binding sites are hidden in the 
soluble globular form of native FN, they could only be identified experimentally through the partial 
denaturation of FN in vitro. In vivo, the availability of cryptic FN-binding domains requires 
conformational changes imposed by forces generated by the actin-cytoskeleton in response to integrin 
activation. 
FN recognition sites within the FN subunit are hydrophobic stretches that lie buried in the globular 
native state of FN, and which, upon extension, become exposed in a thermodynamically unfavourable 
state. Thus, hydrophobic domains in semi-extended FN molecules would be thermodynamically driven 
to interact with each other. The extent of intermolecular alignment through lateral association depends 
on the number of FN-binding sites available as extension progresses. Thus, as FN becomes extended, 
it transitions from a globular form, where hydrophobic domains are sheltered from the water-based 
milieu, to an extended state that allows the hydrophobic domains to rapidly self-associate laterally 
among each other into multimeric fibrils. As to whether each individual FN-binding site is required 
and becomes occupied during fibrillogenesis, there appears to be substantial overlap in the interaction 
profile of the FN-binding domains. Not all of the above-mentioned binding sites are essential for 
fibrillogenesis, but their abundance would stabilise newly formed fibrils simply by lowering the rate of 
dissociation of FN subunits or by providing a means of controlling fibril length. Increasing the 
numbers of occupied FN-FN bonds along the length of the molecule would also strengthen the 
matrix, prevent breakage of the matrix in response to force and reduce the ease by which cells can 
detach from the ECM by ECM fibril breakage (Engler et al., 2009). 
This combination of binding sites allows end-to-end elongation of FN as well as lateral growth of 
thin FN fibrils into bundles that possess extraordinary flexibility and elasticity (Klotzsch et al., 2009). 
As the matrix matures and fibrils grow in thickness and length, FN fibrils achieve a level of cross-
linking that renders the matrix resistant to solubilisation in a detergent like sodium deoxycholate 
(DOC) (Choi and Hynes, 1979). Reaching the DOC-insoluble state is biochemical feature of FN that 
endows the ECM of a mature cell culture or tissue with physical stability. Also, DOC fractionation 
assays have long been the gold standard for assessing the degree of chemical cross-linking within a FN 
matrix (Pankov and Yamada, 2004). The insolubility of FN fibrils reflects the ability of FN to interact 
with itself, but the nature of these interactions has been uncertain. One possibility is that FN cross-
linking bonds are covalent in nature and perhaps arise from disulfide exchange between FN molecules, 
which was plausible given that FN has many intra-chain disulfide bonds and putative protein disulfide 
PhD Thesis - Josefine Gibson  Introduction 
 
 30 
isomerase activity (Chen and Mosher, 1996; Langenbach and Sottile, 1999). However, a more recent 
study concluded that FN matrix DOC-insolubility is non-covalent in nature, but is strengthened by the 
shear number of non-covalent interactions that take place between FN molecules (Ohashi and 
Erickson, 2009).  
4.3.3.3 The requirement for FN dimerisation in FN fibrillogenesis  
More than two decades ago, Dr. Schwarzbauer published the results of experiments that were 
designed to identify the sites within FN involved in de novo FN fibrillogenesis and matrix formation 
(Schwarzbauer, 1991). Recombinant FN polypeptides representing defined segments of FN were 
expressed in mammalian cells and assayed for incorporation into a DOC-insoluble cell matrix fraction 
and for the formation of fibrils at the cell surface, as detected by immunofluorescence microscopy 
(Schwarzbauer, 1991). In one experiment, a recombinant fragment of FN lacking the C-terminal 
dimerisation motif was expressed in a mammalian cell culture system and thus probed for its ability to 
undergo de novo fibrillogenesis. This construct resulted in the synthesis and secretion of a form of FN 
that could not dimerise and which failed to assemble into a fibrillar matrix upon secretion. The 
conclusion was that dimerisation mediated by the C-terminal interchain disulfide bonds is essential for 
the conversion of FN into a fibrillar DOC-insoluble form. No earlier study had reported a requirement 
for the dimerisation motif for de novo FN fibrillogenesis, for previous experimental setups were limited 
to studying the ability of proteolytic fragments of FN devoid of C-terminal cysteines to become 
incorporated into pre-assembled matrices (Chernousov et al., 1985; McKeown-Longo and Mosher, 
1985; Quade and McDonald, 1988). With both biochemical and immunocytochemical approaches, Dr. 
Schwarzbauer reported the minimum domain requirements for FN fibrillogenesis, which included the 
70kDa N-terminal FNI1-5 assembly domain (described earlier) and the C-terminal region containing the 
dimerisation motif (Schwarzbauer, 1991). These minimum domain requirements were soon to be 
confirmed by other reports (Ichihara-Tanaka et al., 1992). 
This finding laid the foundation for current models describing FN fibrillogenesis, and it is now 
widely accepted that the dimerisation motif at the C-terminus of FN is essential for the ability of FN to 
undergo fibrillogenesis. 
4.3.4 Fibrillar FN is a master scaffolding protein of the ECM  
As an extracellular ligand of a significant number of integrins, FN clearly has a prominent role as an 
adhesive substrate for cells. Yet the activity of FN goes beyond that of cell adhesion, owing to a variety 
of domains along the length of the FN molecule that endow it with the ability to interact with other 
ECM proteins and proteoglycans. FN is a very early fibrillar component of the ECM, and during the 
early steps of ECM build-up, the organisation of FN fbirls is often found to first precede and then co-
localise with late ECM components. Observations like these gave the impression that FN could guide 
the organisation of the ECM, and indeed, it is now widely accepted that FN regulates the initial and 
continuous deposition and stability of several other ECM components, including ECM-associated 
growth factors Include Sottile and Hocking 2002 (Dallas et al., 2006). 
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A number of ECM proteins depend on FN, directly or indirectly, for their incorporation into the 
ECM. Binding domains within the N-terminal FNI1-5 allow FN to interact with various extracellular 
proteins. As examples, the ability of this region of pFN to interact with hepatocyte-derived plasma 
fibrinogen and fibrin clots at a site of vessel injury underlies the role of FN in hemostasis and 
stabilisation of a blood coagulation (Pereira et al., 2002; Ni et al., 2003). Efficient blood clots consist of 
polymerized fibrin that become covalently cross-linked to FN via FNI1-5 by factor XIII 
transglutaminase (Mosher, 1975; Fibronectin, 1989; Hynes, 1990). A stretch of consecutive FNI 
modules interrupted by two FNII modules comprise a collagen/gelatin binding domain of FN which 
underlies the ability of FN to organise collagen fibrils; indeed, collagen-I and -III fibril deposition has 
been shown to depend on the presence of fibrillar FN (McDonald et al., 1982; Sottile and Hocking, 
2002; Velling et al., 2002; Li et al., 2003; Kadler et al., 2008). The same is true for thrombospondin-1; 
conversion of thrombospondin-1 into fibrils takes place only in the presence of FN fibrils (Sottile and 
Hocking, 2002). The incorporation of latent TGF-β binding protein (LTBP) into the ECM at early 
stages of ECM assembly is dependent on direct interactions between FN and LTBP-1 (Dallas et al., 
2005; Koli et al., 2005), and at later stages of ECM assembly, fibrillin associates with and stabilises 
these LTBP fibrils (Massam-Wu et al., 2010). Fibrillin, too, interacts with FN, and fibrils of fibrillin co-
localise with and strictly depend on FN fibrils at early stages of ECM formation (Sabatier et al., 2009). 
The organisation of fibulin into the ECM is also dependent on a preassembled FN matrix (Roman and 
McDonald, 1993; Godyna et al., 1995) and tenascin C is incorporated into a FN matrix by directly 
binding FN (Ingham et al., 2004a) and via perlecan binding to FN (Chung and Erickson, 1997). Even 
gram-positive cocci strain of bacteria, such as Streptococcus aureus and Streptococcus pyogenes, have evolved 
FN-binding proteins that recognize the FNI1-5 domain and exploit this interaction in the process of 
infection (Ingham et al., 2004b; Schwarz-Linek et al., 2006; Atkin et al., 2010). 
4.3.5 FN regulates growth factor availability  
As part of the ECM, FN has effects beyond providing structural support to cells and tissues. An 
important function of ECM in general, and FN specifically, is to bind, store and present growth 
factors. A large number of growth factors are released into the extracellular space and target a 
particular cell type that displays the cognate receptor. To prevent diffusion and to regulate the timing, 
dosage and mode of growth factor bioavailability, numerous growth factors become immobilised in 
the extracellular space through binding to specific components of the ECM. As such, the ECM 
functions as a solid-state growth factor depot for essential and potent growth factors, such as FGF, 
hepatocyte growth factor (HGF), TGF-β, bone morphogenic protein (BMP) and VEGF-A 
(Flaumenhaft and Rifkin, 1992; Taipale and Keski-Oja, 1997; Gregory et al., 2005; Rahman et al., 2005; 
Wijelath et al., 2006). Furthermore, the binding of growth factors to the ECM is perceived as a means 
to establish gradients of growth factors; such gradients are very important in patterning developmental 
processes, such as angiogenesis (Ruhrberg et al., 2002). In some cases, such as for FGF, the binding of 
a growth factor to the ECM is even a prerequisite for activating its cognate receptor (Goetz and 
Mohammadi, 2013). A group of growth factors (e.g. FGF and VEGF-A) bind heparin and heparan 
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sulphate, glycosaminoglycan moieties found on several proteoglycans of the ECM. Other growth 
factors bind to ECM proteins directly, and here there is growing evidence that FN plays an important 
part. While some growth factors are secreted in an active state and become sequestered by the ECM to 
prevent them from diffusing and activating their cognate receptor, other growth factors are secreted in 
an inactive state, and their incorporation into the ECM is a critical step of their activation mechanism. 
The spatial and temporal release ensures the correct order of events during tissue morphogenesis and 
repair. 
Various modes of growth factor release have been described; they are all complex and multi-
faceted, and the ECM can be either a passive or an active participant of the release mechanism, i.e. 
while some growth factors can be released simply by the degradation of ECM, other mechanisms 
employ specific properties of the ECM. Of particular interest to the topics of this thesis are growth 
factors whose storage and release requires FN, and so the following chapters serve to introduce these 
aspects of VEGF-A and TGF-β in greater detail. 
4.3.5.1 VEGF  
VEGF-A is a key regulator of blood vessel growth and is both absolutely critical for vascular 
development and a principle regulator of pathological angiogenesis. VEGF-A promotes vascular 
morphogenesis by activating the VEGF receptor 2 (VEGFR2) tyrosine kinase expressed by endothelial 
cells. The characteristic tree-like patterning of vessels is orchestrated by gradients of soluble and 
insoluble VEGF-A. The ECM helps to shape these gradients by providing a solid-state binding 
platform that regulates VEGF-A diffusion (Ruhrberg et al., 2002; Ruhrberg, 2003). While VEGF-A 
has long been known to bind heparan sulfates expressed on cell surfaces or on heparan sulphate 
proteoglycans in the ECM, it is becoming increasingly clear that FN has an important function in 
promoting sprouting angiogenesis by facilitating the deposition of VEGF-A into the extracellular 
space. 
The single VEGF-A gene transcript in mammals undergoes extensive alternative splicing to 
generate several isoforms; what differs among the most common of these isoforms is the presence or 
absence of two heparin-binding domains that enable VEGF-A to interact with heparan sulfate (Park et 
al., 1993). In mouse, the VEGF-A120 isoform (VEGF-A121 in human) lacks both heparin-binding 
domains and is freely diffusible in a heparin-containing environment. VEGF-A164 (VEGF-A165 in 
human) retains one heparin-binding domain and has intermediate affinity for heparin-based substrates, 
while VEGF-A188 (VEGF-A189 in human) contains both heparin-binding sites and is fully retained on 
heparin-containing proteoglycans expressed on the cell surface or in the ECM. The spatial restriction 
in expression and differential localisation of heparin-binding forms of VEGF-A is key to establishing 
the VEGF-A gradients that guide blood vessel branching (Ruhrberg et al., 2002; Ruhrberg, 2003; 
Gerhardt et al., 2003) (fig. 4.12). 
Two VEGF-A-binding domains have been described in FN. One binding site is located within N-
terminal first nine FNI and the only two FNII repeats and includes a heparin-binding site I (HepI) 
(Wijelath et al., 2002). The second VEGF-A binding site was found within a second heparin-binding 
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site, HepII, in FNIII13-14 (Barkalow and Schwarzbauer, 1991; Wijelath et al., 2002). The interaction of 
VEGF-A with FN influences integrin α5β1-VEGFR2 crosstalk and the endothelial cell response to 
VEGF-A (Wijelath et al., 2002; Wijelath et al., 2006). This crosstalk requires intact FN containing both 
the VEGF-binding site in FNIII13-14 and the integrin-binding site in FNIII9-10, which in turn reflects a 
need for juxtapositioning of integrin and VEGFR2 (Wijelath et al., 2006). Crosstalk between integrins 
and VEGFR is regarded as indispensable for the regulation of angiogenic processes (Byzova et al., 
2000; Wang et al., 2001b; Podar et al., 2002; De et al., 2005) remove podar – wrong cell type. Whether 
the heparin-binding sites in VEGF are important for this interaction, or whether there is an 
independent FN-binding site in VEGF-A that can be included or excluded by alternative splicing?? 
awaits investigation. Not only does this interaction enhance the effect of VEGF-A on endothelial cells 
in culture (Wijelath et al., 2002)(Wijelath et al., 2006) merge refs, the VEGF-FN complex appears to 
have strong implications in vivo. Thrombin-activated platelets secrete VEGF-A pre-bound to FN, 
which could be significant with regards to neovascularisation during wound healing (Wijelath et al., 
2006). In the mouse retina, FN cooperates with heparan sulphate proteoglycans in binding VEGF-A 
to promote directional migration of endothelial tip-cells and expansion of the retinal vasculature 
(Stenzel et al., 2011). The functional implications of the interaction of VEGF-A with FN will be 
addressed in a subsequent chapter (4.4.2.4). 
4.3.5.2 TGF-β  
The cytokine TGF-β has evolved a particularly interesting mode of storage because immobilisation 
of latent TGF-β in the ECM depends on the presence of fibrillar FN. TGF-β 1, -2 and -3 isoforms are 
prototypes of the large, multi-potent TGF- β family of secreted cytokines that bind and activate 
membrane-bound TGF-β receptor serine/threonine kinase signalling complexes I and II (TGF-βR-I 
and –II) to regulate cell growth, inflammation, matrix synthesis and apoptosis (Taipale et al., 1998). In 
this signalling complex, ligand binding to TGF-βR-II phosphorylates and thereby activates the TGF-
βRI, which propagates signals from the plasma membrane to the nuclus via the SMAD (a portmanteau 
of the names for the homologous Drosophila protein, mothers against decapentaplegic (MAD) and the 
Caenorhabditis elegans protein SMA (from gene sma for small body size)) family of proteins. In most cell 
types, receptor-regulated SMADs (R-SMAD; SMAD2, SMAD3, SMAD1, SMAD5 and SMAD8) are 
specifically phosphorylated in response to TGF-β R-I activation. Upon phosphorylation, they associate 
with the common mediator SMAD4 (co-SMAD4) and translocate into the nucleus to facilitate the 
transcriptional activation of TGF-β target genes. Among other major morphogeneic processes, the 
TGF-β family proteins are involved in cardiovascular development and hematopoiesis in the embryo 
as well as adult tissue homeostasis (ten Dijke and Arthur, 2007). 
Most cell types secrete TGF-β, which is synthesised as a homo-dimeric pro-protein (fig. 4.12). The 
dimeric pro-peptide, also known as latency associated peptide (LAP), undergoes cleavage by furin 
convertase, but remains non-covalently associated with mature TGF-β, and, as the name implies, 
renders the mature TGF-β latent by preventing it from binding TGF-β receptors (Lawrence et al., 
1984; Dubois et al., 1995). The complex formed through association of mature TGF-β and LAP is 
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referred to as the small latent complex (SLC). During synthesis, the SLC becomes covalently associated 
with an ECM protein called latent TGF-β binding protein (LTBP) through disulfide bonds between 
cysteines in LAP and LTBP (Miyazono et al., 1991; Gleizes et al., 1996; Saharinen et al., 1996; 
Saharinen and Keski-Oja, 2000). This ternary complex is commonly referred to as the large latency 
complex (LLC). In essence, LTBP functions as a chaperone of TGF-β, serving three important roles 
by (i) facilitating the secretion of the SLC, (ii) targeting the SLC to the ECM and (iii) keeping mature 
TGF-β in inactive state (Miyazono et al., 1991; Taipale et al., 1994; Rifkin, 2005). 
 
Figure 4.12. The TGF-β large latent complex, comprising TGF-β, LAP and LTBP. TGF-β 
and its propeptide are non-covalently associated, while LAP and covalently linked to LTBP 
via disulfide bonds. LAP contains two RGD motifs. LTBP is cross-linked to other ECM 
components, such as FN and fibrillin, through transglutaminase-generated isopeptide bonds. 
In FN, this involves the N-terminal 70kDa fragment. Adapted from (Annes et al., 2004). 
 
The LTBP proteins are members of the LTBP/fibrillin family of extracellular proteins, which 
comprises fibrillin-1, -2 and 3, as well as LTBP-1, -2, -3 and -4 (Ramirez and Pereira, 1999). The 
LTBPs have distinct binding specificities for TGF-β isoform pro-peptides; LTBP-1 and -3 are the 
most prominent in their binding to all three TGF-β pro-peptide isoforms, whereas LTBP-4 bind only 
weakly to LAP1/TGF-β1 and LTBP-2 fails completely to bind any of the LAP1/TGF-β1 isoforms 
(Saharinen and Keski-Oja, 2000) (fig 4.13). Mice homozygous for a knock-in mutation that disrupts 
the association of LAP1 with LTBP show traits similar to the TGF-β1 knockout phenotype 
(Yoshinaga et al., 2008). 
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Figure 4.13. A schematic illustration of LTBP isoforms and comparison with part of the 
fibrillin-1 structure. On the right, the relative binding affinities of cloned LTBPs for TGF-β,  
where LTBP-1 and -3 are found to bind all LAP-TGF-β isoforms and LTBP-4 binds only 
LAP1-TGF-β1. Adapted from (Rifkin, 2005). 
 
The interaction of LTBPs and LLC with ECM is essential in maintaining tissue homeostasis; an 
inability to store the LLC in the ECM may result in excess LLC, which can interact with latent TGF-β 
activators that are normally separated from sequestered LLC (Neptune et al., 2003). LTBPs become 
incorporated into the ECM through covalent bond formation involving one or several 8 cysteine 
repeats (8-cys repeat) (Nunes et al., 1997; Unsöld et al., 2001). This covalent association with the ECM 
involves a glutamine-lysine isopeptide bond in the 8-cys repeat near the N-terminus of LTBP that is 
catalysed by tissue transglutaminase (Nunes et al., 1997). A number of studies have investigated ECM 
binding partners of the LTBPs and there is a general agreement that direct binding of LTPB with 
fibrillin or fibronectin provides two potential modes for LTBP to interact with the ECM(Dallas et al., 
2005; Taipale et al., 1996; Kantola et al., 2008) (Isogai et al., 2003; Vehviläinen et al., 2009; Massam-Wu 
et al., 2010). A recent systematic approach to understanding the contributions of fibrillin-1, -2 and 
fibronectin to LTBP deposition into the ECM in vivo has demonstrated that while LTBP-1 association 
with the ECM relies on the presence of a fibrillar FN network, LTBP-3 and -4 rely on fibrillin-1 for 
their incorporation into the ECM (Zilberberg et al., 2012). Interestingly, fibrillin assembly into the 
ECM has also been shown to depend on FN (Kinsey et al., 2008; Sabatier et al., 2009). These results 
collectively build a scenario in which fibrillar FN is at centre stage for the incorportation of LTBP and 
LLC into the ECM (Zilberberg et al., 2012). Heparin-binding domains in LTBP-1 and LTBP-4 have 
been shown to be critical for their deposition into the ECM (Chen et al., 2007; Kantola et al., 2008), 
suggesting that heparan sulfate proteoglycans may play a critical role in controlling the association of 
LTBP with FN and subsequent deposition of LTBP into the ECM.  
The activity of latent TGF-β activity is governed by the release of TGF-β from latency. Several 
diverse mechanisms have been described for the process of latent TGF-β activation. Denaturing 
conditions, such as heat, low pH, enzymatic digestion and detergents have proven efficient for TGF-β 
release in in vitro assays (Miyazono and Heldin, 1989; Brown et al., 1990). TGF-β is also reported to 
undergo activation when exposed to reactive oxygen species or irradiation (Barcellos-Hoff et al., 1994; 
Barcellos-Hoff and Dix, 1996). The activation of TGF-β in cell culture is achieved by proteolytic 
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cleavage of LAP by plasmin and other proteases (Taipale et al., 1994; Yu and Stamenkovic, 2000; Ge 
and Greenspan, 2006). Thrombospondin-1 has been identified as a physiological regulator of latent 
TGF-β activation by binding LAP and inducing conformational changes that reduce its affinity for 
TGF-β and thereby enable TGF-β to interact with its cognate receptor (Crawford et al., 1998; Ribeiro 
et al., 1999). Perhaps of greatest physiological relevance is integrin-mediated activation of TGF-β 
(Yang et al., 2007; Wipff and Hinz, 2008). Many of the αV integrins bind RGD motifs present both in 
LAP-1 and -3, and integrins αVβ3, αVβ5, αVβ6 and αVβ8 have been shown to release and activate 
TGF-β in cell culture experiments (Munger et al., 1999; Annes et al., 2002; Mu et al., 2002; 
Fjellbirkeland et al., 2003; Annes et al., 2004). The physiological relevance of αVβ6 and αVβ8 integrin-
mediated TGF-β activation by binding LAP in vivo is supported by the fact that mice lacking αV, β6 or 
β8 or possessing a LAPRGE/RGE mutation phenocopy important aspects of TGF-β1 and TGF-β3 
knockout mice (Shull et al., 1992; Dickson et al., 1995; Kaartinen et al., 1995; Munger et al., 1999; Zhu 
et al., 2002; Yang et al., 2007; Aluwihare et al., 2009). 
Integrins are proposed to facilitate latent TGF-β activation by either of two distinct mechanisms. In 
one model, integrin αVβ8 bound to the LLC via LAP recruits trans-membrane type 1 matrix 
metalloproteinase (MT1-MMP) to cleave LAP and liberate TGF-β (Araya et al., 2006; Mu et al., 2002). 
A second mechanism of integrin-mediated latent TGF-β release has been demonstrated for αVβ5, 
αVβ6 and αVβ8 and is independent of proteases in that it relies on the role of integrins as mechano-
transducers to transmit traction generated by the contractile actin-myosin machinery to LAP to 
mechanically pry apart the LLC and release TGF-β (Munger et al., 1999; Annes et al., 2004; Wipff et 
al., 2007). Analysis of the level of mechanical force that is required to induce the conformational 
changes in the latent complex that release TGF-β1 has demonstrated that TGF-β1 activation can be 
achieved by application of mechanical force in the order of magnitude of what can be transmitted by 
single integrins (Buscemi et al., 2011). 
4.3.6 FN in early vertebrate development and morphogenesis 
Given the multitude of functions involving FN, it comes as no surprise that a variety of 
morphological events in vertebrate development rely on FN, and that ultimately, FN is an absolute 
requirement for vertebrate survival. This is made explicitly clear by the embryonic lethality of fish, 
frogs and mice carrying mutations that disrupt FN expression. While quite a few ECM molecules, such 
as laminins and collagens, arose early in evolution and are conserved from fly to human, FN evolved in 
the vertebrate phylum and thus coincided with the development of an endothelial-lined cardiovascular 
system (Hynes and Zhao, 2000). Indeed, the embryonic lethality of these vertebrate model organisms 
is to a great extent related to defects in the developing cardiovascular system. However, FN expression 
and function is certainly not restricted to the vascular system. In vertebrates, FN is an abundant 
component of ECM in a variety of embryonic tissues where it generally serves as a provisional guide to 
support cellular events and maintain borders in the developing vertebrate embryos, as well as in adult 
tissues where it serves as a provisional matrix in the healing wound.  
PhD Thesis - Josefine Gibson  Introduction 
 
 37 
Vertebrate embryos with disrupted FN expression die during gastrulation with a number of defects. 
Much of our understanding of FN functions during embryonic development comes from genetic 
knockout experiments in mouse, morpholino experiments in zebrafish and the use of function-
blocking antibodies in frog (George et al., 1993; Georges‐Labouesse et al., 1996; George et al., 1997; 
Marsden and DeSimone, 2001; Davidson et al., 2002; Trinh and Stainier, 2004b; Davidson et al., 2006). 
FN is expressed at early stages of vertebrate embryogenesis, and examination of both frog and fish 
embryos show that FN is assembled into an elaborate network before gastrulation movements even 
begin (Critchley et al., 1979; Duband and Thiery, 1982; Sanders, 1982; Boucaut and Darribere, 1983; 
Lee et al., 1984). Fibrillar FN is primarily depositied in the endodermal and ectodermal basal surfaces 
in the chick embryo, and in frog embryos fibrillar FN is found along the blastocoel roof, where it is 
has been shown to serve as a migration platform for the mesoderm (Boucaut et al., 1984a; Boucaut et 
al., 1984b; Brown and Sanders, 1991; Winklbauer and Keller, 1996). 
In general, inactivation of the Fn1 gene permits partial progression through gastrulation, and the 
absence of FN does not affect the gastrulation movements that give rise to the three germ layers, the 
endoderm, mesoderm and ectoderm. Neither does the absence of FN affect the specification of the 
various mesoderm regions (axial, paraxial/presomitic or lateral mesoderm). Likewise, neither the 
timing and location of induction of mesodermal lineages, such as the notochord, somites and heart, 
nor the ability of the precursor cells of these lineages to migrate, depend on the presence of FN 
protein (Georges‐Labouesse et al., 1996; George et al., 1997; Trinh and Stainier, 2004b; Davidson et 
al., 2006). Later events, such as migration of neural crest cells to their final destinations is also 
independent of FN (Mittal et al., 2010). However, despite apparent correct cell fate specification, 
differentiation and migration of precursors in the absence of FN, the correct morphogenesis of the 
structures they will assemble ultimately relies on the presence of FN protein. For regardless of species, 
the consequences of disrupting the expression of FN are that somite precursors will fail to condense 
into somites (Georges-Labouesse et al., 1996; Jülich et al., 2005; Koshida et al., 2005), the notochord 
precursors will fail to form a notochord (Georges‐Labouesse et al., 1996) and the cardiac precursors 
will fail to form a functional heart (George et al., 1997). 
Elegant work in re-investigating the FN knockout mouse has revealed that FN is required as early 
as during morphogenesis of the node, which takes place at the tip of the primitive streak, and for the 
subsequent establishment of left-right asymmetry in the embryonic body plan (Pulina et al., 2011). FN 
protein localises to the basal surface of the ventral node, and is speculated to be important for the 
proper orientation and vertical intercalation of nodal cells. In the absence of FN, cells within the node 
fail to arrange into two well-organised layers and instead become aberrantly oriented, which gives the 
node a disrupted, narrow and flat appearance. Absence of FN also renders the node cells incapable of 
creating the leftward nodal flow (Pulina et al., 2011), which represents the very first symmetry-breaking 
event in the mouse embryo. Left-right asymmetry is maintained by barriers of morphogens established 
at the embryonic midline and by the notochord, and this recent report by Astrof and colleagues 
suggests that FN specifically regulates the expression of Lefty1/2 through Nodal signalling and 
activation of SMADs 2/3 at the floor plate (Pulina et al., 2011). 
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Closer examination of the morphogenesis defects in the frog model showed that FN plays subtle, 
but important roles in cellular activity during gastrulation. FN is required to establish cell adhesion and 
cell polarity, which are key processes underlying the major cell rearrangements of gastrulation 
(Marsden and DeSimone, 2001). Interaction between FN and integrins modulates cadherin-dependent 
cell-cell adhesion, which in turn influences cell intercalation (Marsden and DeSimone, 2003). Fibrillar 
FN is required to establish the elongate shape of migrating cells seen in wild type embryos and to 
polarise actin-rich protrusions of cells in the gastrulating embryo, all of which is essential to axial 
extension (Davidson et al., 2006). One speculation is that the density of FN fibrils maintains a level of 
stiffness and rigidity of the tissue, which is important for convergence and extension (Moore et al., 
1995).  
New light was recently shed on the role of FN in early lineage specification. It was recently shown 
that FN in cell culture experiments plays a role in the ability of endoderm to induce mesoderm 
formation through a FN/β1 integrin/Wnt/β-catenin signalling cascade (Cheng et al., 2013). FN, along 
with known diffusible factors, promotes the emergence of Brachyury positive mesoderm (Brachyury is 
a T-box-containing transcription factor expressed in the primitive streak and early mesoderm and one 
of the earliest lineage markers of mesodermal precursors (Wilkinson et al., 1990; Kispert and 
Herrmann, 1994; Inman and Downs, 2006)). In an integrin β1/Wnt/β-catenin axis, FN biases the 
mesoderm towards cardiac mesoderm (Cheng et al., 2013).  
ECM formation and remodelling is also important as the embryo transitions into stages of 
organogenesis. Somite formation is a critical event during development and occurs as the paraxial 
mesoderm undergoes mesechymal-to-epithelial transition and condenses into epithelialised structures. 
As previously mentioned, the FN knockout mouse embryos lack somites (George et al., 1993). From 
analyses of the zebrafish FN null mutant (natter) and frog embryos injected with a dominant negative 
form of FAK (FAK-related nonkinase), it is known that FN plays both a structural and morphogenetic 
role in specifying domains of mesoderm during gastrulation. During somitogenesis in zebrafish, 
integrin α5 and FAK activation (pFAKY397) drives the accumulation of FN at the borders of newly 
formed somites, and this, in cooperation with other local signalling systems such as the Eph-Ephrin 
system, both establishes and maintains somite boundaries that stabilise the epithelialisation of the 
somites (Jülich et al., 2005; Koshida et al., 2005; Kragtorp and Miller, 2006). 
A number of organs (lung, salivary gland, kidney) are formed during embryonic development by 
epithelial branching, and basement membrane remodelling is an important feature of branching 
morphogenesis. Branching morphogenesis entails repetitive formations of clefts and buds. Cleft 
formation requires remodelling of both epithelia and indentation of the basement membrane. During 
the development of salivary glands, transient expression and fibrillar deposition of FN in the cleft has 
been found to promote cleft formation; while FN promotes the interaction of the cell with the ECM, 
its presence in the cleft was found to alleviate cell-cell interactions by down-regulating E-cadherin in 
the epithelium (Sakai et al., 2003).  
Gene knock-out studies in mice have shown that each FN-binding integrin has a unique function, 
but only integrin α5 knock-out gives rise to phenotypes reminiscent of the total FN knock-out mouse 
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(George et al., 1993; Georges‐Labouesse et al., 1996; George et al., 1997); all embryos deficient in 
integrin α5 suffer defects in mesoderm-derived structures in both extra-embryonic and embryonic 
structures such as vasculature, heart and somites that cause lethality at E9.5-10. This strongly suggests 
that integrin α5β1 mediates the early functions of FN during embryogenesis. Yet, the loss of integrin 
α5 does not fully account for the FN knock-out phenotype and implies that other FN-binding 
integrins compensate, if only to some extent, for the loss of integrin α5β1. Integrin αVβ3 is another 
highly recognised FN-binding integrin, and genetic studies of αV integrin knock-out mice showed that 
80% of all embryos deficient in αV integrins show placental defects and die around E10.5, while the 
remaining 20% survive until birth, but die shortly after with several defects, most notably intracerebral 
hemorrhage (Bader et al., 1998). The incomplete embryonic lethality most likely reflects the 
promiscuity of αV integrins, both for their β subunit and their extracellular ligand. Integrin αVβ3 
alone, which binds FN, also interacts with fibrinogen, fibrillin, LAP-TGF−β, von Willebrand factor, 
vitronectin, osteopontin, tenascin, PECAM-1 and thrombospondin, while other αV integrins bind an 
equally wide range of ligands (Humphries, 2006).  Interestingly, the compound knock-out of α5 and 
αV integrins showed synergies in their phenotypic defects, causing lethality at, or even slightly earlier 
than, the developmental stage of FN knock-out embryos, suggesting cooperative functions of these 
FN-binding integrins during mesoderm development (Yang et al., 1999). Other integrin knock-out 
mice show phenotypes at later developmental stages than the FN knock-out and α5/αV integrin 
double knock-out mouse, which indicates that the ability of these integrins to interact with FN and 
mediate functions of FN is not essential during development and/or that these integrins primarily rely 
on other ligands. Embryos lacking FN-binding α4 integrins are unable to undergo chorio-allantoic 
fusion and die between E10-12 (Yang et al., 1995) and mice that are deficient in FN-binding α8 
integrins develop defects which cause lethality at or shortly after birth remove Kreidberg (alpha3 
study) (Kreidberg et al., 1996; Müller et al., 1997). Integrin αIIbβ3 is a platelet-specific FN-binding 
integrin, and its ability to bind FN is essential in blood homeostasis and thrombus formation in adult 
stages of life. 
4.4 Cardiovascular development in the mouse 
4.4.1 Cardiogenesis 
The heart is the first organ to form in vertebrate embryos, and it is vital for the distribution of 
blood-bourne oxygen, nutrients and waste products throughout the developing embryo. The heart’s 
purpose as a central pump relies on the contractile nature of its principle component, the myocardium. 
The myocardial progenitor cells are derived from the epiblast and ingress through the primitive streak, 
along with head mesoderm and foregut endoderm, during gastrulation between E6.5 and E7.5. 
Although the morphogenetic process of gastrulation plays no role in cardiac specification, it serves to 
coordinate the spatial and temporal arrival of these cardiac precursor cells at the primary heart fields, 
which are two bilateral regions of splanchnic mesoderm on both sides of the embryonic midline that 
are specified shortly after gastrulation and fated to form the myocardium by the late primitive streak 
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stage (Tam et al., 1997). The two heart fields later converge at the embryonic midline to form the 
cardiac crescent just below the cranial parts of the embryo (Kaufman and Navaratnam, 1981; DeRuiter 
et al., 1992) (fig. 4.14 A and B).  
Steps towards shaping the heart are induced by factors secreted from the surrounding endoderm 
(e.g. gut endoderm). In response to inductive signals, the cardiac crescent expresses several 
transcriptional regulatory genes of the cardiac programme, such as Mesp1, Nkx2-5, Gata4 and 
Mef2b/c (Lints et al., 1993; Edmondson et al., 1994; Heikinheimo et al., 1994) that induce the cardiac 
precursors to contribute to the three main cardiac tissues; endocardium, myocardium and pericardium. 
First, the formation of the intra-embryonic coelom introduces a lumen that spatially segregates the 
cardiac precursors into heart mesoderm on the ventral side of the lumen and pericardial mesoderm on 
the dorsal side. By E8.0, the heart mesoderm will undergo a lineage split to give rise to the 
myocardium and the endocardium which spatially orient themselves into a hollow tube structure; the 
endocardium will form the lining of the heart tube and the myocardium will become the muscular layer 
of the heart tube (fig 4.14 C and D).  
By E8.5, the primitive heart has elongated in the cranio-caudal axis and is a peristaltic pump that 
moves blood unidirectionally as a result of a contractions along the tube, with the inflow region 
established caudally and the outflow region cranially (Moorman et al., 1998). The transformation of the 
primary heart tube into the four-chambered heart occurs as the myocardium undergoes a complex 
programme of local differentiation and proliferation along the length of the primary heart tube. 
Simultaneously, by local regions of growth and contraction within the heart tube and in effect of forces 
exerted on the heart by surrounding tissues, the heart tube is perturbed into a rightward torsion, a 
process referred to as looping morphogenesis (Harvey, 1998; Ramasubramanian et al., 2008), during 
which the caudal region of the heart becomes displaced to the left and the outflow region loops to the 
right of the embryo (fig 4.14 E and F). Hence looping morphogenesis lays out the basic plan for the 
future heart. The mechanical properties of the heart tube tissue and the induction of intracardiac blood 
flow are key factors in promoting this stage of cardiogenesis (Hove et al., 2003; Zamir et al., 2003) 
Additional myocardial precursors arrive from the secondary heart field, which originates from the 
pharynx, to build the outflow tract (Kelly et al., 2001; Mjaatvedt et al., 2001). By E9.5, the 
atrioventricular canal is formed to delimit the atrial and ventricular regions. Endocardial cardiac 
cushion forms in both the outflow tract and the atrioventricular channel (Savolainen et al., 2009). The 
endocardial cushion is a subset of mesenchymal cells that arise from both the endocardium and neural 
crest cells migrating from the hindbrain (Jiang et al., 2000). These cells migrate into a FN-rich cardiac 
jelly and are known to deposit additional FN (Mjaatvedt et al., 1987; Ffrench-Constant and Hynes, 
1988; Roman and McDonald, 1992; Eisenberg and Markwald, 1995). Cardiac cushions will condense 
to divide the outflow tract into the aorta and the pulmonary artery, and in both the outflow tract and 
the atrioventricular canal, cardiac cushion will contribute to the major valves of the heart (aortic, 
pulmonic, tricuspid and mitral valves) and closure of the heart septum (Webb et al., 1998; Savolainen 
et al., 2009). 
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Figure 4.14. Major events in early cardiac development in the mouse embryo. Left column 
shows the early embryonic cardiac tissues, while the right column shows internal features in 
heart sections; (B) and (D) are transverse sections; (F) and (H) are longitudinal sections. 
Myocardium and progenitors are highlighted in red. (A-B) Cardiac progenitors assemble into 
the cardiac crescent extending cranio-laterally. (C-D) A linear heart tube is formed as cardiac 
progenitors move ventrally and fuse, differentiate and organise into an inner endocardial 
lining and an outer myocardial cover. Inflow occurs caudally and outflow occurs cranially. 
(E-F) During cardiac looping, the inflow region is placed dorsally and cradially above the 
developing ventricles. Endocardial cushions (EC) form in the atrioventricular (AV) canal and 
in the outflow tract to form the valves and split the outflow tract, respectively. Myocytes 
form trabeculae (T) along the inner surface of the ventricles. (G-H) By E12.5 the heart has 
been divided into left and right ventricles (LV, RV) and left and right atria (LA, RA) and 
begins to resemble the adult heart. Adapted from (Harvey, 2002).  
 
At around E9.0, the epicardium develops and surrounds the heart to provide cellular elements of 
the connective tissues and coronary vasculature. Epicardial progenitor cells originate outside the 
developing heart and migrate onto the heart through a cyst-mediated mechanism in which the 
progenitors are released from the tissue of origin as cysts. These cysts float in the fluid of the 
pericardial cavity and attach to the myocardial surface of the heart. Once attached, the cysts 
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disintegrate and the cells migrate out and flatten into the epithelial sheet of the epicardium (Komiyama 
et al., 1987; Sengbusch et al., 2002). 
Looping morphogenesis will eventually align the developing chambers according to left/right 
asymmetry and place the inflow portion of the heart, including the common atrium, dorsally and 
cranially so that it is placed above the developing ventricles by the end of E10.5 (fig 4.14 E and F). 
Chamber formation occurs through ballooning effect of chambers along the outer curvature of the 
looping heart. These chambers are characterised by trabeculated working myocardium forming a 
specialised inner muscle layer along the outer curvature, to which the endocardium adheres through 
finger-link protrusions (Christoffels et al., 2000). Trabeculated myocardium is a specialised layer of 
cardiac muscle that generates the contractile force of the heart and transforms the primary heart tube 
into a high-capacity, fast-contracting pump.  
With further looping, the outflow region becomes pushed between the developing ventricles 
ventrally (fig. 4.14 G and H), and the inflow region spans the ventricles dorsally, now resembling the 
final heart structure that will persist into adulthood. The ultimate division of the heart chambers occurs 
by septation between the left and right ventricles and left and right atria. Finally, the cardiac 
conduction system is established by a specialised cardiac muscle cells that infiltrate the cardiac tissue 
and have distinct contractile, conductive, and pace-making properties to establish the coordinated 
activation of the heart (Moorman et al., 1998). 
4.4.2 Requirement for FN in cardiogenesis 
FN appears to be a critical regulator of cardiovascular development and vascular remodelling of the 
developing embryo and in the adult. Disrupting FN expression is mice causes severe defects in the the 
heart, vasculature and somites, causing them to die by E9.5 (George et al., 1993; George et al., 1997; 
Francis et al., 2002). As already mentioned, FN is dispensable for initial specification of cardiac 
precursors, endocardial and myocardial cells. However, the precursor cells fail to undergo the 
morphogenetic processes that form the functional heart and great vessels (Francis et al., 2002). Heart 
and vessel morphogenesis requires both the ability of the endothelium to organise into tube structures, 
but also requires non-endothelial cells such as mural cells to stabilise the remodelling tissue as it 
undergoes morphogenesis. Indeed, one speculation stemming from these studies is that FN has a role 
in mediating the interaction between endothelial and peri-endothelial cells (mural cells) in the heart and 
the dorsal aorta of the mouse. 
Early studies of the WT chick embryo revealed deposits of fibrillar FN at the endoderm-mesoderm 
interface of the lateral heart-forming region (Linask and Lash, 1986). Precardiac (myocardial) cells 
encounter this fibrillar FN as they migrate along the endoderm-mesoderm interface. Levels of FN 
along the precardiac cell migratory route appeared to vary, with lowest amounts of fibrillar FN 
posterior and largest amounts anterior, where precardiac cells must stop moving. This gradient of 
fibrillar FN coincides with directional migration, i.e. haptotaxis, suggesting that precardiac cells find 
their destination by migrating along a substrate with increasing adhesiveness provided by FN. 
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During heart tube formation in zebrafish, FN is also critical for the timely migration of myocardial 
cells and their subsequent organisation at the embryonic midline to form the primitive heart tube 
(Trinh and Stainier, 2004a; Trinh and Stainier, 2004b). FN becomes deposited in the basal substratum 
around sheets of myocardial precursors and along the midline between endoderm and endocardial 
precursors (Trinh and Stainier, 2004b). The nat mutation, which stalls FN expression, allows 
myocardial specification, but the heart fails to form correctly and develops into cardia bifida because 
adherens junctions in the myocardial epithelia are not formed properly (Trinh and Stainier, 2004b). 
The interaction of the myocardium with a FN-based substratum stabilises the formation of adherens 
junctions between myocardial precursors, which in turn provides integrity to the organisation of the 
myocardial epithelia (Trinh and Stainier, 2004b). This integrity is critical to the coordinated movement 
of myocardial precursors during heart formation. 
The high expression of FN in the cardiac jelly and cushion (Mjaatvedt et al., 1987; Ffrench-
Constant and Hynes, 1988; Roman and McDonald, 1992; Eisenberg and Markwald, 1995) prompts the 
question of what function FN has in the cardiac cushion. The role of FN in cushion formation has 
been tested in chick embryos by microinjecting antibodies against FN into the cushion tissue. These 
experiments showed that FN plays a role in the migration of mesenchymal cushion cells into the 
cardiac jelly (Loeber and Runyan, 1990; Icardo et al., 1992), although FN is most likely not the only 
ECM component to modulate the activity of these mesenchymal cardiac cells (Loeber and Runyan, 
1990).  
4.4.3 Vasculogenesis and angiogenesis 
The development of blood vessels is a key step during early vertebrate development, and the ability 
of blood vessels to form and remodel after birth sustains the growth and repair of tissue throughout 
life. Dysregulation of blood vessel formation has dire consequences at early stages of development, as 
the growing embryo requires greater oxygen and nutritional supply from the blood. Consequently, 
mutations that delay or impair blood vessel formation cause embryonic lethality. 
The vascular system is a specialised network of vessels that branch in a hierarchical fashion to 
spatially accommodate all parts of the organism and to both deliver and collect nutrients, respiratory 
gases and waste products as well as transport surveying immune cells to sites of infection. The main 
components of the blood vessel wall are the endothelial cells, mural cells and the ECM that constitutes 
the vascular basement membrane. The important features of a vascular tube include apical–basal 
polarity of the endothelium, a continuous lumen, a glycocalyx, the distinct transmembrane proteins 
lining the luminal side, elaborate junction complexes at the lateral side between the lining endothelial 
cells and deposition of basement membrane at the basal, ablumenal side (Wacker and Gerhardt, 2011). 
The vascular system arises very early during development through a series of dynamic, but highly 
coordinated events, generally referred to as vasculogenesis and angiogenesis. By branching, expanding 
and pruning of vessels, the vascular bed becomes highly optimised to meet local demands. Each step is 
under tight and complex molecular regulation, and a significant part of blood vessel formation depends 
on integrins and ECM components such as FN. 
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4.4.3.1 Vasculogenesis 
Vasculogenesis is initiated in the developing embryo as FGFs secreted by the mesoderm induce the 
differentiation of hemangioblasts to give rise to the angioblast lineage (Risau and Flamme, 1995). 
Within the embryo, the very first embryonic blood vessels form as angioblasts acquire arterial or 
venous fate in the process of coalescing into the dorsal aorta and the cardinal vein, respectively. In the 
yolk sac, populations of haemangioblasts merge into primitive blood islands, from which both 
endothelial cells and cells of the hematopoietic lineages segregate. These blood islands fuse and 
remodel extensively in response to hemodynamic stimuli, oxygen levels and gradients of pro-
angiogenic growth factors, to form a primitive plexus of arterial and venous vessels. Vasculogenesis 
will ultimately accomplish the complete vascularisation of the organism. 
Initially, angioblasts fuse into an initial cord-like structure and maintain this structure through 
adhesive forces to the ECM (mediated by integrins) and neighboring cells (through adherens 
junctions). Within the endothelium, adherens junctions are composed of vascular endothelial cadherin 
(VE-cadherin), α-catenins and β-catenins and are linked to the actin cytoskeleton. The balance of cell-
ECM and cell-cell junctions is important during cell polarisation and lumen formation (Zovein et al., 
2010; Xu et al., 2011). 
Various models and mechanisms have been described for lumen formation during vasculogenesis 
(Iruela-Arispe and Davis, 2009). For various vessel types, such as the mouse embryo dorsal aorta and 
the zebrafish embryo intersegmental vessels, lumen formation occurs by lumenisation, where the 
coalesced angioblasts/EC undergo dramatic shape changes to create a lumen at the cell-cell junction 
(Blum et al., 2008; Strilić et al., 2009). 
To accommodate this lumen, the endothelial cells within the early cord must collectively determine 
polarity to establish apical and basolateral membranes. In the mouse aorta, adherens junctions 
containing VE-cadherin initially fully line the interface between what will become the apical surfaces 
between opposing endothelial cells (fig. 4.15). Integrins in the basolateral endothelial cell surface will 
mediate the interaction of the developing blood vessel with the ECM in the vascular basement 
membrane. Polarity is established in part by the activation of the Par3 (Partitioning defective 3) 
complex (consisting of Par3, Par6 and the atypical protein kinase C) (Koh et al., 2008; Zovein et al., 
2010). In vitro studies have shown that PTEN (phosphatase and tensin homolog) is subsequently 
recruited to the apical surface, where it converts PIP3 to PIP2 and thereby recruits Cdc42 to promote 
the cytoskeletal rearrangements that assist in lumen formation (Koh et al., 2008; Kesavan et al., 2009). 
VE-cadherin probably play multiple roles in defining the apical surface and driving lumen 
expansion. It has been shown to drive the accumulation of negatively charged CD34 sialomucin 
glycoproteins (CD34 and podocalyxin (PODXL). First, CD34 sialomucins were shown to participate 
in directing the cytoskeletal events that underly changes in cell shape with the induction of apical/basal 
polarity and lumenisation by integrating with the F-actin cytoskeleton through phosphorylated ERM 
adaptor protein moesin. Moesin requires PKC for phosphorylation, and hence both the recruitment 
and phosphorylation of moesin at the apical membrane could be related to the activation and 
localisation of the PCK-containing Par3 complex (Bretscher et al., 2002; Strilić et al., 2009; Wang et al., 
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2010). A follow-up study demonstrated that in addition to participating in cytoskeletal remodelling 
events, the enrichment of sialomucin gives rise to an accumulation of negative charge on opposing 
membranes that serves to electrostatically repel apical membranes away from each other and thereby 
initiate the expansion of the extracellular space (Nielsen and McNagny, 2008; Strilić et al., 2010). VE-
cadherin has also been shown to influence the contractility of the F-actin cytoskeleton in endothelial 
cells during lumen formation. Via β-catenin, plakoglobin and α-catenin, VE-cadherin becomes linked 
to the F-actin-cytoskeleton. Through its interaction with p120, a RhoA GDI, VE-cadherin is thought 
to fine-tune the regulation of the RhoA pathway. To form a tube of an appropriate diameter, 
endothelial cells acquire a stretched, flattened morphology. This change in shape is driven by an 
enrichment of MLC phosphorylation and NMII-driven actomyosin contractility at the apical 
membrane, which is triggered by VEGF-A-induced ROCK activation (Strilić et al., 2009).  
 
 
Figure 4.15. A diagrammatic representation of early endothelial cell polarisation events 
leading up to vascular lumen formation of an endothelial cord. Two opposing endothelial 
cells within a cord are shown in cross-section. (A) Junctional proteins line what is to become 
the apical surfaces of opposing endothelial cells. Activation of the Par3 polarity complex 
downstream of active β1 integrins on the basolateral surface promotes the deposition of PIP2 
in the apical plasma membrane, which in turn recruits Cdc42 to drive the exocytosis of 
vesicles containing negatively charged CD34 sialomucins at the apical surface that will repel 
the surfaces. (B) VE-cadherin translocates to the apical-basolateral borders, and both VE-
cadherin and CD34 siamomucins become linked to the F-actin cytoskeleton. Adapted from 
(Zeeb et al., 2010). 
 
4.4.3.2 Angiogenesis 
The remodelling of the early primitive plexus of newly lumenised blood vessels into a functional 
hierarchy of branched vessels requires extensive morphological events, which are collectively referred 
to as angiogenesis (Risau, 1997). Angiogenic sprouting from the dorsal aorta, cardinal vein and vessels 
of the vascular plexus underlies much of this hierarchy of arteries, arterioles, capillary beds, venules 
and veins. VEGF-A induces many distinct aspects of endothelial cell behaviour during sprouting 
angiogenesis, including endothelial proliferation, migration, differentiation and survival. In the early 
postnatal retina, for example, VEGF-A induces angiogenic sprouting by guiding filopodial extension 
from specialised endothelial cells, called tip cells, situated at the tips of the vascular sprouts (Gerhardt 
et al., 2003). Growth of an angiogenic sprout occurs as a tip cell expresses proteases, including MMPs 
and MT-MMPs, to digest the surrounding basement membrane and allow outgrowth from the pre-
existing vessel (Pepper, 2001; Chun et al., 2004). Tip cells are followed by proliferating stalk cells, 
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which form the base of the angiogenic sprout and are both far less motile and extend far fewer 
filopodia than tip cells (Gerhardt et al., 2003). The shape of an angiogenic sprout is determined by the 
weight of tip cell migration against stalk cell proliferation, which in turn is dictated by both the 
expression pattern of VEGFR types (VEGFR-1, -2 and -3) as well as gradients of VEGF-A (Gerhardt 
and Betsholtz, 2005). The molecular signature underlying the functional differences between tip and 
stalk cells is based on a delta-like4-(Dll4-) and Notch-mediated lateral inhibition mechanism in which 
VEGF-A induces Dll4 expression in the tip cell, which in turn induces Notch signal activation in the 
neighboring stalk cell. Notch activation in stalk cells downregulates the expression of VEGFR-2 and 
thereby their response of the stalk cell to the VEGF-A gradient (Hellström et al., 2007; Leslie et al., 
2007; Lobov et al., 2007; Roca and Adams, 2007; Siekmann and Lawson, 2007; Suchting et al., 2007). 
Newly formed vessel sprouts will anastamose and form new lumens, thereby opening new sites of 
blood flow. 
Although there is an absolute requirement for all known VEGFR types for vascular development, a 
differential expression pattern of VEGFR types on tip and stalk cells fine tunes the effect of VEGF-A 
on the angiogenic sprout. While tip cells express VEGFR-2 and VEGFR-3, which are both potent 
receptor tyrosine kinases and signal transducers, stalk cells express and secrete a soluble form of 
VEGFR-1, which serves as a decoy receptor that sequesters soluble VEGF-A (Chappell et al., 2009). 
Soluble VEGFR-1 secreted at the base of the angiogenic sprout modulates the local VEGF-A gradient 
to promote sprouting away from the stalk and prevents the new sprout from fusing with the vessel it 
originated from (Chappell et al., 2009). 
 
 
 
Figure 4.16. Cellular mechanisms that pattern vascular sprouting. The sequential steps from 
left to right illustrate the induction of a tip cell (green) and the extension of a vascular sprout 
towards along a gradient of VEGF-A (orange) through migration of the tip cell and polarised 
proliferation of the stalk cells (white). The steepness of the VEGF-A gradient determines the 
efficiency of the sprouting, such that a steep VEGF-A gradient promotes long and directed 
filopodial extension and fast migration in the tip cell (A) and a weak VEGF-A gradient 
results in undirected extension of short filopodia extension and slow migration of the tip cell, 
while stalk cells proliferate more in response to more abundant VEGF-A, but in an 
unpolarised manner, causing vessel dilation. Adapted from (Gerhardt, 2008).  
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VEGF-A gradients are established through a combination of secreted VEGF-A isoforms that differ 
in their ability to become immobilised by the ECM. Through alternative splicing, VEGF-A either lacks 
or acquires heparin-binding domains; those VEGF-A isoforms that lack heparin-binding domains are 
freely diffusible, while others are bound by ECM or cell surface heparan sulfates upon secretion and 
cannot diffuse far from the cellular source (Ruhrberg, 2003; Gerhardt, 2008). A steep VEGF-A 
gradient is key to polarising the endothelial tip cell and promoting long, directed filopodia extension 
towards higher VEGF-A concentration (fig. 4.16 A). In the mouse retina, heparan-sulfate 
proteoglycans cooperate with FN in binding and storing VEGF-A secreted by astrocytes to promote 
directional filopodial extension and migration of the endothelial tip cells and guide the radial expansion 
of the retinal vasculature (Stenzel et al., 2011). If a sharp gradient of VEGF-A fails to form, tip cells 
will extend short filopodia in all directions and migrate slower, while stalk cells will proliferate due to 
the abundant VEGF-A and cause vessel dilation and hypertrophy (fig. 4.16 B).  
Following the establishment of the basic capillary plexus of vessels through sprouting angiogenesis, 
the distribution of vessels is optimised to meet the local demand of the tissue. To this end vessels 
undergo splitting and growth in situ through a process termed intussusceptive angiogenesis. This mode 
of angiogenesis remodels the plexus into a tree-like arrangement. Intussusceptive angiogenesis is 
intiated as opposing endothelial cells of the same vessel walls protrude into the lumen and establish 
interendothelial contact in the form of transvascular pillars. Perforation and expansion of these pillars 
splits a single vessel in two (Burri et al., 2004). Both the sprouting and intussusceptive modes of 
angiogenesis are depicted in figure 4.17. 
Vessel remodelling, maturation and stabilisation are critically dependent on both the deposition of 
ECM into the vascular basement membrane (Iruela-Arispe et al., 1991a; Iruela-Arispe et al., 1991b) and 
the acquisition of mural cell coverage of the newly formed blood vessel (Darland et al., 2003; Gerhardt 
and Betsholtz, 2003). Depending on the type and function of the blood vessel, mural cells differ in 
number, type, origin and organisation. The type of mural cell that associates with newly formed vessels 
and microvessels in general, such as arterioles and venules, is referred to as a pericyte. Those mural 
cells that line larger vessels, such as arteries and veins, are called vascular smooth muscle cells (vSMCs). 
Mural cells are generally contractile, owing to the expression of contractile filaments such as α-smooth 
muscle actin (α-SMA) and desmin. They use long cytoplasmic processes to wrap themselves around 
the abluminal surface of an endothelial cell-lined vascular tube. Mural cells originate from various 
embryonic tissues (Gerhardt and Betsholtz, 2003), such as the neural crest (Bergwerff et al., 1998; 
Etchevers et al., 2002), the coronary vessels of the heart (Vrancken Peeters et al., 1999) or 
mesenchymal cells surrounding the dorsal aorta (Drake et al., 1998; Hungerford and Little, 1999). 
Mesenchymal cells associate with the sprouting endothelium by responding to a chemotactic gradient 
of PDGF-BB secreted by the sprouting endothelium (Hellström et al., 1999; Enge et al., 2002; 
Abramsson et al., 2003), after which they progressively differentiate into mural cells. Although still 
little is known about the mechanisms by which these two cell types associate with each other during 
developmental vascularisation, integrin α4β1 expression on the endothelium and VCAM-1 expression 
by proliferating mural cells is thought to mediate their close intercellular adhesion and is critical for the 
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survival of both endothelial cells and mural cells (Garmy-Susini et al., 2005). Pericytes help to stabilise 
the newly formed vasculature by contributing to the vascular basement membrane, either by secreting 
ECM proteins themselves and/or by stimulating the endothelium to secrete ECM proteins, such as 
FN, nidogen, perlecan and laminin isoforms (Mandarino et al., 1993; Stratman et al., 2009; Turlo et al., 
2012). Pericytes are particular in that they embed themselves within the basement membrane of 
microvessels and are thought to interact with the endothelium through paracrine signalling and by 
direct physical contact at gap junctions and adhesion plaques shared with endothelial cells (Rucker et 
al., 2000). Functions of pericytes include ensuring the survival of the endothelium by secreting growth 
factors like VEGF-A (Shepro and Morel, 1993; Darland et al., 2003), regulating the capillary diameter 
of newly formed vessels by controlling endothelial proliferation (Orlidge and D’Amore, 1987; Hirschi 
et al., 1999; Hellström et al., 2001) and controlling lumen morphology (Hellström et al., 2001), which is 
how pericytes influence the flow of blood. The absence of pericytes correlates with endothelial 
hyperplasia, increased capillary diameter, abnormal EC shape and ultrastructure, changed cellular 
distribution of certain junctional proteins, and morphological signs of increased endothelial 
permeability (Hellström et al., 2001). 
TGF-β is implicated in the maturation of new vessels by acting on both endothelium and pericytes 
(ten Dijke and Arthur, 2007) (fig 4.17). Both endothelial cells and pericytes produce latent TGF-β, 
which is stored in the vascular basement membrane. Results from in vitro studies implicate that the 
activation of the latent TGF-β may require the presence of both cells and their cell-cell adhesion via 
direct physical contact at gap junctions or adhesion plaques (Antonelli-Orlidge et al., 1989; Sato and 
Rifkin, 1989; Sato et al., 1990; Ding et al., 2004). 
 
PhD Thesis - Josefine Gibson  Introduction 
 
 49 
 
Figure 4.17. TGF-β signalling in blood vessel development. Vasculogenesis is not dependent 
on TGF-β. However, the progression of the primitive vascular plexus into a remodelled state 
by angiogenesis is blocked in the absence of TGF-β signalling components. Latent TGF-β is 
stored in the vascular basement membrane and requires juxtapositioning of mesenchymal cell 
and endothelial cell. Mesenchymal cells are recruited to the remodelling vasculature through 
PDGF gradients. TGF-β induces vSMC differentiation and regulates the angiogenic activity 
of the remodelled vasculature. Adapted from (ten Dijke and Arthur, 2007). 
 
Endothelial cells promote paracrine TGF-β signalling to neighbouring mesenchymal cells to 
promote their differentiation to pericytes or vSMCs (Chen and Lechleider, 2004; Ding et al., 2004; 
Hirschi et al., 2003). The effects of TGF-β on the endothelium are far less clear. Both pro- and anti-
angiogenic properties have been ascribed to TGF-β. Endothelial cells express high amounts of TGF-β 
during embryogenesis (Akhurst et al., 1990), but in vitro studies show that the response of endothelial 
cells to TGF-β is contextual, dose-dependent and biphasic (Pepper, 1997) (fig 4.18). This biphasic 
dose-response curve of TGF-β on endothelial cell migration may be attributable to the fact that 
endothelial cells express two distinct TGF-β type I receptors (ALK1 and ALK5) that respond to 
different concentrations of TGF-β, utilise different co-receptors (e.g. endoglin promotes TGF-β-
activation of ALK1, specifically (Lebrin et al., 2004)) and phosphorylate specific sets of SMAD 
proteins, which in turn elict distinct genetic programmes (Goumans et al., 2002). Therefore, whether 
TGF-β promotes endothelial cell proliferation, migration and tube elongation, i.e. features of the active 
phase of angiogenesis, or whether TGF-β puts endothelial cells in a quiescent state depends on the 
balance in the activation of ALK1 and ALK5.  
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Figure 4.18. The biphasic effect of TGF-β on VEGF-induced angiogenesis in vitro. Total 
additive length of invading cell cords of bovine microvascular endothelial cells grown on the 
surface of three-dimensional collagen gels and treated with VEGF-A and TGF-β. TGF-β 
has a positive effect on VEGF-induced invasion of collagen gels, but has an inhibitory effect 
on VEGF-induced invasion at high concentrations. Adapted from (Pepper, 1997). 
 
4.4.4 Role of integrins in blood vessel formation and remodelling 
Endothelial cells express a range of integrin heterodimers, which in turn facilitate the interaction 
with a number of ECM proteins to coordinate the cytoskeletal rearrangements underlying endothelial 
morphogenesis, sprouting, vacuole and lumen formation during vasculogenesis and angiogenesis 
(Avraamides et al., 2008). 
While there is substantial evidence that endothelial cell-ECM adhesions containing β1 integrins are 
generally required to establish a functional vascular bed (Drake et al., 1992; Carlson et al., 2008; Lei et 
al., 2008; Tanjore et al., 2008; Zovein et al., 2010), β1 integrins play a key mechanistic role in shaping 
the endothelial cytoskeleton, orchestrating vascular morphogenesis during EC polarisation, expansion 
of the arterial lumens as well as guiding the processes that define branching points and arterial-venous 
borders (Zovein et al., 2010). 
In the mouse arterial endothelium, β1 integrins are predominantly found on the basal membrane 
and anchors the endothelium to the basement membrane and mesenchyme (Xu et al., 2011). From 
here, β1 integrins regulate endothelial cell polarity by inducing the activation of the Par3 complex, a 
well-documented determinant in cell polarity (Suzuki and Ohno, 2006; Zovein et al., 2010) that 
localises with β1 integrins at the endothelial basal membrane (Zovein et al., 2010). β1 integrins help to 
promote lumen formation by regulating the expression levels of junction proteins, such as VE-
cadherin and PECAM-1 (Zovein et al., 2010), and driving these and other junction proteins (such as 
claudin 5 and CD99) to the lateral membranes of the lumenised vessels, where they build adherens 
junctions and stabilise EC-EC contacts (Zovein et al., 2010). β1 integrins are involved in promoting 
lumenisation by promoting the apical localisation of the CD34 sialomucin glycoprotein, PODXL 
(Zovein et al., 2010). The rapid expansion of an ECM-free luminal space between apical surfaces 
depends on the formation and coalescence of pinocytic intracellular vacuoles at the apical surface of 
endothelial cells. Intracellular vacuole formation and membrane targeting in endothelial cells are driven 
by integrin signalling and both Ccd42 and Rac1 GTPase-dependent modifications of the actin 
cytoskeleton (Folkman and Haudenschild, 1980; Bayless and Davis, 2002; Davis and Bayless, 2003; 
PhD Thesis - Josefine Gibson  Introduction 
 
 51 
Downs, 2003; Davis et al., 2007; Koh et al., 2008) (fig. 4.19). The importance of vacuole delivery to an 
intercellular lumen has been confirmed in vivo with two-photon live imaging studies in zebrafish 
(Kamei et al., 2006), although this mode of lumen expansion is disputed by other observations (Blum 
et al., 2008). However, when β1 integrins are deleted from the arterial endothelium, endothelial cells 
tend to accumulate vacuoles intracellularly (Zovein et al., 2010). This confirms that once intracellular 
vacuoles form, β1 integrins are required to promote their directional transport to, and fusion with, the 
apical plasma membrane to expand the lumen. 
 
 
Figure 4.19. Schematic diagram illustrating the role of integrin β1 subunit in promoting 
lumen formation. The activation of b1 integrins on the basolateral surface of the 
endothelium induces the expression of Par3, which will direct the formation of vacuoles and 
their fusion with the apical surface. The expansion of the lumen is associated with the 
redistribution of junctional proteins, such as VE-cadherin, and changes in cell shape caused 
by remodelling of the actin cytoskeleton. Adapted from (Zovein et al., 2010). 
 
There is also an essential requirement for β1 integrins in the assembly of vascular ECM by mural 
cells. An example is that of vSMCs that line the aorta during embryonic development; here, β1 
integrins are not required for smooth muscle cell proliferation, migration or differentiation, but rather 
specifically required for aortic arch remodelling and for the assembly of ECM proteins within the 
vessel wall (Turlo et al., 2012). 
While it is clear that β1 integrins are strong players in developmental angiogenesis, it is far less clear 
which α integrins are involved. The complete knockout of α4 integrins in mouse (α4β1 and α4β7, 
which both bind CS1 regions present in specific isoforms of FN and VCAM1) causes embryonic 
lethality at E10.5-11.5 due to defective chorio-allantoic fusion and defects in both epicardium and 
coronary vessels causing cardiac hemorrhage (Yang et al., 1995; Sengbusch et al., 2002). Integrin α4β1 
is thought to promote endothelial motility and transient association of the endothelium with pericytes 
in a manner that underlines the survival of both cell types during angiogenesis (Garmy-Susini et al., 
2005). Indeed, α4 knock-out embryos show dilated cranial vessels due to ineffective mural cell 
coverage (Grazioli et al., 2006). The endothelial-specific knock-out of integrin α4 integrins, however, 
does not cause any vascular defect, and these mice are viable (Priestley et al., 2007), suggesting that the 
main requirement for α4 integrins lies in non-endothelial cells. The deletion of integrin α9β1, which 
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binds osteopontin, tenascin C, VCAM-1, either constitutively or specifically in the endothelium, gives 
rise to lymphatic defects (interestingly, α9β1 also binds lymphangiogenic VEGF-C and VEGF-D 
(Vlahakis et al., 2005)), which ultimately causes cyclothorax and lethality at a postnatal stage (Huang et 
al., 2000b; Bazigou et al., 2009). 
The major FN receptors in endothelial cells are the α5β1 and αVβ3 integrins, and considerable 
effort is still being made to elucidate the functional contributions of α5 and αV integrins in vascular 
formation and function. The role of αV integrins (of which αVβ3 and αVβ5 are FN receptors) in 
developmental and pathological angiogenesis has been addressed in vivo with both pharmacological and 
genetic tools. Early characterisations pointing to a pro-angiogenic function of αV integrins originate 
from reports showing that αV integrin expression in the endothelium becomes upregulated in tumour 
vessels or in a normal vasculature upon treatment with angiogenic growth factors (Brooks et al., 
1994b) and are required to support angiogenic growth factor-induced angiogenesis, both under 
physiological and pathological (tumour) conditions in vivo (Brooks et al., 1994a; Brooks et al., 1994b; 
Friedlander et al., 1995; Friedlander et al., 1996; Hammes et al., 1996). Studies with agonists and 
antagonists specific for integrin αVβ3 indicate that integrin αVβ3 sustains neovascularisation by 
promoting endothelial cell survival, e.g. by activating the MAP kinase, FAK and Src signalling 
pathways (Eliceiri et al., 1998), inhibiting p53 activity, decreasing expression of the cell cyle inhibitor 
p21WAF1/CIP1 and suppressing the bax cell death pathway (Strömblad et al., 1996). Generally, results 
from studies of integrin antagonists indicate that αV integrins promote angiogenesis. 
However, genetic experiments show that αV integrins are only remotely involved in vascular 
development. For example, mice that are genetically depleted of all αV integrins (i.e. αVβ1, αVβ3, 
αVβ5, αVβ6 and αVβ8) develop blood vessels (Bader et al., 1998); all αV knockout embryos develop 
normally until E9.5, and 20% of these embryos survive until birth. The remaining 80% of αV 
knockouts die of placental defects around E10.5-11.5. Those mice that do survive until birth ultimately 
die of cleft palates and brain hemorrhage, stemming from distended and leaky blood vessels (Bader et 
al., 1998). Thus, αV integrins seem to be involved in development of blood vessels in specific tissues 
such as placenta and brain. The Tie2-Cre mediated αV integrin knockout in endothelium, however, 
shows no detectable vascular defects, whereas αV integrin knockout in neural cells, such as glia, 
showed that αV integrins in cells associated with the endothelium are necessary to support cerebral 
vascular development (McCarty et al., 2005). This phenotype has been attributed to the loss of integrin 
αVβ8 since β8 integrin knockout mice most closely resemble the αV integrin knockout (Zhu et al., 
2002). Interestingly, the brain hemorrhage phenotype of αV knockouts has been linked to an inability 
of astrocytes associated with the brain vasculature to induce αVβ8-mediated TGF-β activation 
(McCarty et al., 2002; Cambier et al., 2005; McCarty et al., 2005). 
Hence there is a discrepancy in the reported functions of αV integrins in physiological and 
pathological blood vessel formation. While results from studies of integrin antagonists indicate that 
αVβ3 integrin promotes angiogenesis, genetic deletion studies generally suggest that αV integrins are 
not critical for neovessel formation and might even be negative regulators of angiogenesis given that 
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αV integrin knockout gives rise to such large and dilated vessels. One view on this discrepancy is that 
αV integrins can act both as positive and negative regulators of angiogenesis in different phases of 
angiogenesis and depending on environmental context (Hynes, 2002a). According to the model in 
which integrin αVβ3 acts as a negative regulator of angiogenesis, the engagement of the αV integrins 
by pharmacological agonists (e.g. monoclonal antibodies or RGD motif-containing peptides) would 
activate their negative regulatory functions in tissue and supress tumour angiogenesis. In turn, 
genetically or pharmacologically ablating integrin αV function during development would disturb an 
angiogenic regulatory mechanism and allow angiogenesis to occur at an accelerated rate, forming 
largely defective blood vessels that could support tumour growth. One mechanism for achieving anti-
angiogenic activity would be for integrin αVβ3 to bind, and thereby localise, antiangiogenic 
thrombospondin (TSP-1 and -2) to relevant sites during vessel development (Jiménez et al., 2000; 
Lawler, 2000; Adams, 2001; Rodriguez-Manzaneque et al., 2001). Integrin αVβ3 has also been 
implicated in either generating or binding and mediating the anti-angiogenic effects of specific 
proteolytic ECM fragments, such as tumstatin (Brooks et al., 1998; Maeshima et al., 2000; Petitclerc et 
al., 2000; Rehn et al., 2001; Tarui et al., 2001). Another mode of anti-angiogenic regulation could stem 
from the ability of integrin αVβ3 to regulate and maintain low VEGFR2 expression in endothelium 
once the vasculature has formed, creating a negative feedback mechanism of angiogenesis (Reynolds et 
al., 2002). The role of integrins in regulating apoptosis represents yet another way of regulating 
angiogenesis. It is widely accepted that integrin-mediated adhesion to the ECM creates an intracellular 
pro-survival signal (deleted because references does not mention sigaling pathways) and forms the 
basis of anchorage-dependent survival (Meredith et al., 1993). A more recent model proposes that 
integrins in an unligated or antagonised state actively induce apoptosis by recruiting caspase-8. Such an 
“integrin-mediated death” model applied to integrin αVβ3 in the endothelium could account for the 
enhanced angiogenesis in tissue lacking integrin αVβ3 (Cheresh and Stupack, 2002).  
A characteristic trait of both physiological and pathological angiogenesis is the enhanced expression 
of integrin α5β1 and its ligand FN (Kim et al., 2000; Muether et al., 2007), and administrating blocking 
antibodies or peptides that block the interaction of integrin α5β1 with FN suppresses angiogenesis 
(Kim et al., 2000). In full agreement with such blocking experiments, genetic ablation of integrin α5 
creates a lethal phenotype dominated by vascular defects (Yang et al., 1993). The expression of integrin 
α5β1 also becomes induced in endothelium in response to angiogenic growth factors such as FGF-2, 
IL-8 and Del-1 remove kim – no mention of GF-induced integrin expression (Kim et al., 2000; 
Boudreau and Varner, 2004). Although these data unanimously establish integrin α5β1 as a pro-
angiogenic integrin, they could not clarify how the endothelium specifically uses integrin α5β1. To this 
end, a recent report describes the endothelial-specific (Tie2-Cre-mediated) α5 integrin knockout 
mouse as viable and lacking any obvious phenotype (van der Flier et al., 2010). To address a possible 
functional compensation by αV integrins in the conditional integrin α5 knockout mouse, the same 
author group generated endothelial-specific α5/αV compound knockout mice (van der Flier et al., 
2010). This model revealed that mice lacking α5 and αV integrin expression in the endothelium still 
show, to a large extent, vascular morphogenesis through formation of vascular plexi, large vessels and 
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the heart by mid-gestation. However, around mid-gestation (i.e. E11.5 onwards), the expression and 
cooperation of these integrins becomes crucial for the remodelling of the branchial arch arteries and 
vascular structures derived from these arteries. It is very interesting that a few of these compound 
conditional knockout mice are reported to complete development and survive to adulthood. Whatever 
function integrin α5β1 might have in the endothelium, it is likely that integrin α5β1 and FN also play 
an important part in pericytes and/or smooth muscle cells that support the growing vasculature. 
4.4.5 Role of FN in blood vessel formation and remodelling 
The ECM that supports the developing vasculature is dynamic, and multiple integrins participate in 
vascular morphogenesis, depending on the ECM context in which the vasculature is remodelling. The 
composition of the vascular ECM changes as the endothelium progresses through vasculogenesis and 
angiogenesis. During development, new vessels arise from endothelial cells proliferating, migrating and 
sprouting within a FN-rich matrix, while mature vessels are associated with a sheet-like basement 
membrane containing laminins, collagen IV and heparan sulphate proteoglycans (Risau and Lemmon, 
1988). The supporting role of FN in blood vessel formation is illustrated by the phenotype of FN-null 
embryoid bodies; they contain PECAM-1-positive endothelial cells, but these endothelial cells do not 
organise into islands or form vascular structures (Francis et al., 2002). During development, the 
abundance of FN associated with sprouting vessels is complemented by high expression of FN-
binding integrin α5β1 in the endothelium (Goh et al., 1997; Francis et al., 2002). In adult tissues, where 
collagen expression around blood vessels becomes more prominent, collagen receptors α1β1 and 
α2β1 are likely to be more important in maintaining vascular stability (Davis and Camarillo, 1996; 
Senger et al., 2002; Perruzzi et al., 2003). Injured adult tissue undergoing the process of wound healing 
shows a marked, but temporary increase in the deposition of FN while the endothelium grows and 
sprouts into the healing tissue (Clark et al., 1982). In this case both FN-binding integrins and collagen-
binding integrins play important roles (Davis and Senger, 2005). In various pathological instances, such 
as in a hypoxic central nervous system, the expression of FN is induced on angiogenic vessels with 
concomitant expression of FN-binding integrins α5 and αV (Li et al., 2012). There is also strong 
evidence that FN is deposited around new blood vessels forming in tumours and enhances tumour 
angiogenesis, which in turn contributes to tumour growth in vivo (Kim et al., 2000).  
There is a complex pattern of interaction among integrins, ECM and growth factor receptors 
throughout vasculogenesis and angiogenesis. Signals stemming from anchorage of endothelial cells to 
the ECM by integrins is important for both the survival and proliferation of endothelial cells, in part 
through activation of the mitogen-activated protein kinase (MAPK) signalling pathway, by promoting 
cell cycle progression and by preventing apoptosis (Eliceiri et al., 1998; Short et al., 1998; Aoudjit and 
Vuori, 2001). On a cellular level, FN has been shown to regulate endothelial cell migration by 
promoting the β1 integrin and Src-dependent phosphorylation of FGFR at tyrosines 653/654 and 766 
(Zou et al., 2012). Integrins and the ECM also facilitate the chemotactic migration of sprouting 
endothelial cells in response to gradients of angiogenic growth factors (e.g. VEGF-A) (Dejana et al., 
1985; Ruhrberg et al., 2002; Senger et al., 2002; Wijelath et al., 2006), and it is likely that sprouting 
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angiogenesis relies on both chemotactic gradients of angiogenic growth factors and haptotactic 
gradients of ECM.  
The requirement for fibrillar FN in angiogenesis has been addressed with endothelial cell 
tubulogenesis assays in three-dimensional fibrin gels (Zhou et al., 2008). To test the consequence of 
preventing FN fibrillogenesis by the embedded endothelial cells, the authors of this study used a 49-
mer peptide (termed the functional upstream domain, or FUD) derived from the Streptococcus pyogenes 
adhesion F1 protein, which binds directly to the N-terminal assembly domain of FN and thereby 
prevents self-association of FN, but does not block the binding of integrin α5β1 to the cell-binding 
RGD motif in FN (Tomasini-Johansson et al., 2001). Without affecting apoptosis, the presence of this 
peptide ablated the ability of the endothelial cells to construct a pericellular fibrillar FN matrix and also 
blocked their migratory and proliferative preparation to transition into tubular structures (Zhou et al., 
2008). While the absence of fibrillar FN did not affect phosphorylation of MAPKs (ERK1 and 2), it 
disrupted the organisation of the actin cytoskeleton and attenuated the ability of the endothelial cells to 
exert myosin-dependent traction forces on their three-dimensional environment (Zhou et al., 2008).   
From work dealing with alternatively spliced variants of FN in various vertebrate model organisms, 
it has become clear that the extra domains EIIIA and EIIIB are instrumental in forming a fully 
functional cardiovascular system. The expression of alternatively spliced variants of FN containing 
exons EIIIA and EIIIB is a hallmark of the developing vasculature. EIIIA- and EIIIB-containing FN 
is amply expressed around new vessels that form both during embryonic development and wound 
healing as well as during pathological events that require vascular remodelling, such as tumour 
development and artherosclerosis. Yet these alternatively spliced isoforms are silenced in the quiescent 
vasculature (Ffrench-Constant and Hynes, 1989; Ffrench-Constant et al., 1989; Oyama et al., 1989; 
Castellani et al., 2002; Peters et al., 2002; Astrof et al., 2004; Matter et al., 2004). Deletion of both the 
EIIIA- and EIIIB-containing splice variants in the mouse does not affect FN expression level, but 
clearly affects FN function as these embryos die around E10.5 with vascular defects of the placenta, 
yolk sac and heart (Astrof et al., 2007). 
A more recent study addresses the functions of FN in mouse retinal angiogenesis (Stenzel et al., 
2011). In the retina, astrocytes enter from the optic nerve and form a network that expands radially 
towards the periphery of the retina. Astrocytes respond to hypoxia in this avascular tissue by 
expressing and establishing a gradient of VEGF-A. Endothelial tip cells expressing high levels of 
VEGFR2 extend filopodia and migrate towards the gradient of VEGF-A laid down by the astrocytic 
network (Stone et al., 1995; Ruhrberg et al., 2002; Gerhardt et al., 2003). Retinal astrocytes also secrete 
FN ahead of growing vessels and thereby deposit a field of FN to guide the growing vascualture (Jiang 
et al., 1994; Uemura et al., 2006; Stenzel et al., 2011). 
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Figure 4.20. Schematic model of astrocytic VEGF-FN interaction regulating vessel migration. 
In the mouse retina, astrocytes migrating ahead of the growing vasculature assemble a 
fibrillar FN matrix. Integrins exprsesed on endothelial tip-cell filopodia mediate adhesion to 
the FN matrix and allow filopodial alignment along the astrocyte network. However the 
ability of integrins to interact with FN is not crucial to the expansion of the vascular network. 
Astrocytes also secrete VEGF-A, which is stored by FN. The astrocyte-derived FN 
establishes VEGF-A gradients that regulate filopodial extension and migration of tip cells as 
well as polarised proliferation of stalk cells during sprouting angiogenesis. Without astrocytic 
FN, the VEGF-A gradient becomes diffuse, and vascular expansion is disrupted. Adapted 
from (Stenzel et al., 2011). 
 
Genetic studies showed that astrocytic FN plays a role in retinal angiogenesis by regulating vessel 
extension towards the retinal periphery (fig. 4.21); loss of astrocytic FN results in increased number of 
filopodia, increased number of vessel branch points and increased vessel diameter whereas the 
migration and expansion of vessels towards the periphery is diminished (Stenzel et al., 2011). These 
findings indicated that astrocytic FN promotes tip-cell migration and filopodial elongation. 
Interestingly, these functions of FN are to a large extent independent of integrin binding to FN. While 
the abilty of endothelial integrins to interact with FNRGD does affect filopodial alignment and 
stabilisation, and the authors speculate that the altered fibril complexity of FNRGE versus FNRGD could 
compromise filopodial interactions with astrocytic FN, preventing integrin ligation of FN does not 
overwhelmingly affect radial expansion of the retinal vasculature (Stenzel et al., 2011). Rather, it is the 
abilty of FN to bind VEGF-A (Wijelath et al., 2002; Wijelath et al., 2006) that has the greatest 
implications for retinal angiogenesis, and the effects of deleting astrocytic FN can be explained by an 
inability to store and establish gradients of VEGF-A and a consequent reduction in VEGFR2-
mediated stimulation of endothelial migration (Stenzel et al., 2011) (fig. 4.20). Hence, in the retinal 
vasculature, FN has both integrin-dependent and –independent functions in promoting angiogenesis. 
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5 AIM OF THIS STUDY 
 
Fibronectin is deposited into the extracellular matrix and secreted into the plasma in a dimerised 
form. The reported requirement for FN dimerisation to promote FN fibrillogenesis, and hence FN 
function, is based on past studies that examined the cell-mediated deposition of truncated FN peptide 
fragments. The overall aim of this PhD project was to characterise the function of the FN dimerisation 
motif with in vivo and in vitro tools. The strategy was to address the requirement for FN dimerisation 
with a mouse model carrying mutant FN alleles in which the two critical cysteine residues of the 
dimerisation motif were mutatated to serines residues (FNCC>SS/CC>SS).  
More specifically, the first aim of this study was to address the requirement for FN dimerisation in 
FN fibrillogenesis, i.e. fibril matrix assembly. The second aim of this study was to understand the 
implications of preventing FN dimerisation in integrin function during mouse development. Finally, 
this study was aimed to understand the contribution of dimerised FN for the ability of the extracellular 
matrix to regulate growth factor bioavailabilty. 
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6 PREFACE 
 
 A few of the figures presented in this thesis have been adopted from the PhD thesis of Dr. M. 
Leiss (2009), who performed his thesis work in the laboratory of Dr. Reinhard Fässler and whose 
thesis work laid a foundation for this current PhD project. They are important for the understanding 
of the experimental design of this project and are clearly labelled in figure legends.  
 Dr. Julien Polleux and Dr. Kyle Legate assisted with preparation towards and performance of 
AFM experiments, respectively. 
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7 MATERIALS AND METHODS 
 
7.1 Chemicals 
The chemicals used in this work were acquired from AppliChem (Darmstadt, Germany), Carl Roth 
GmbH (Karlsruhe, Germany), Eurofins MWG Operon (Ebersberg, Germany), Merck (Darmstadt, 
Germany), Sigma Aldrich (Munich, Germany), Serva (Heidelberg, Germany) and Roche Diagnostics 
GmbH (Mannheim, Germany). 
7.2 Mice 
The mice used in this study were hosted by the animal facility of the Max Planck Institute of 
Biochemistry (Martinsried, Germany). The FN+/CC>SS knockin mouse strain was back-crossed for at 
least seven generations with C57BL6. 
The FNfl/fl strain (Sakai et al., 2001) was crossed with the Mx1Cre mouse strain (Kühn et al., 1995; 
Schneider et al., 2003). The FNfl/fl Mx1Cre mouse strain was maintained on a 129Sv genetic 
background.  
FNfl/CC>SSMx1Cre and control FNfl/+Mx1Cre mice were generally made by crossing FNfl/flMx1Cre 
mice with FN+/CC>SS mice. Deletion of the floxed FN allele was induced in 4–5-wk-old mice by 3 
intraperitoneal injections of 250 µg polyinosinic:polycytidylic acid pI:C at 2-day intervals (Kühn et al., 
1995). For experiments, mice were used at least 1 month after pI:C injection. 
Mice were weaned and ear-tagged at 3-4 weeks of age. DNA for genotyping PCR was prepared 
from lysed tail biopsies and purified by isopropanol precipitation. Genotyping was accomplished by 
polymerase chain reaction (PCR) analysis of tail biopsy DNA, using oligonucleotides (Eurofins MWG 
Operon) listed in table 5.1. PCRs were performed in a 25µl volume according to Metabion Taq 
instructions. The relevant thermo-cycle conditions are listed in table 5.2.  
• Tail lysis buffer: 100 mM Tris pH8.0, 5mM EDTA, 0.2% w/v SDS, 200 mM NaCl 
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Table 7. 1 Oligonucleotide sequences for genotyping PCR. 
Application 5' - 3' sequence Primer name Product size  
GTG GAG ATT TGT GTC ACA GGT G Rb2 
FNCC>SS 
CGG GAT CCG CTC ATG AAC AAA GCA GAC AGC Fb (HpaI BamHIF) 
FN+ 202 bp 
Deleted Neo 298 bp 
GTA CTG TCC CAT ATA AGC CTC TG mFn E1f1 
FNfl 
CTG AGC ATC TTG AGT GGA TGG GA mFn E1r2 
FN fl 300 bp 
FN+ 250 bp 
GCC TGC ATT ACC GGT CGA TGC AAC GA Cre1 
Cre 
GTG GCA GAT GGC GCG GCA ACA CCA TT Cre2 
720 bp 
 
 
Table 7. 2 Genotyping PCR programmes. 
Gene Temperature Time # of cycles 
95°C 3 min 1x 
95°C 30 sec 
58°C 30 sec 
72°C 30 sec 
5x 
95°C 30 sec 
62°C 30 sec 
72°C 30 sec 
28x 
FNCC>SS 
4°C pause  
95°C 3 min 1x 
95°C 30 sec 
61°C 30 sec 
72°C 45 sec 
35x 
72°C 3 min 1x 
FNfl 
4°C pause  
95°C 5 min 1x 
95°C 45 sec 
61°C 45 sec 
72°C 1 min 
35x 
72°C 5min 1x 
Cre 
4°C pause  
 
7.2.1 Mouse breeding 
Crosses were initiated between males and females once 8 weeks of age. For timed matings, a male 
and a female mouse were joined overnight. The presence of a female vaginal plug the next morning 
was taken as successful mating, and this time point was set as E0.5. 
7.2.2 Dissection of mouse embryos 
To analyse the features of the recessive embryonic lethal phenotype, embryos were harvested and 
dissected at indicated days of gestation. Dissected uteri were transferred to ice-cold PBS, and each 
embryo was separated from decidual tissue, yolk sac and amnion. Embryos and yolk sacs were 
preserved for analysis. A small piece of the yolk sac or embryo tail bud was sampled for genotyping 
purpose. Embryos and yolk sacs were fixed in a fixative that was compatible with the subsequent 
immunological staining.  
PhD Thesis - Josefine Gibson  Materials and Methods 
 
 61 
• PBS: 137 mM NaCl, 2.7 mM KCl, 1.4 mM KH2PO4, 10mM Na2HPO4 
7.3 Whole mount stainings of embryos and yolk sacs 
7.3.1 Critical buffers 
• Dent’s fixative: 80% MeOH, 20% DMSO 
• MEMFA: 2mM EGTA, 1mM MgSO4, 3.7% PFA in 0.1 M MOPS, pH7.4 
• TBS: 0.1M Tris-HCL pH7.5, 0.15M NaCl 
7.3.2 Whole mount immunofluorescence staining 
Staged embryos and yolk sacs were fixed overnight at 4°C with gentle agitation in Dent’s fixative or 
MEMFA, depending on the antibody (5.5). Tissues that had been fixed in MEMFA were subsequently 
dehydrated in 100% MeOH. All tissues were sequentially rehydrated in MeOH/TBS solutions with 
decreasing MeOH concentration (75%, 50%, 25% (v/v) MeOH/H2O, for 20 minutes each) at room 
temperature. Rehydrated embryos were blocked in 5% (v/v) normal goat serum/2% (w/v) BSA/TBS 
for 3 hours at room temperature with agitation. Primary antibody (diluted in 5% (v/v) normal goat 
serum/2% (w/v) BSA/TBS) was applied for incubation for a minimum of 24 hours at 4°C with 
agitation. To wash away excess primary antibody, tissues were washed extensively for a minimum of 3x 
1 hour in 0.05% (v/v) Tween-20/TBS. Rinsed tissues were re-blocked in 2% (w/v) BSA/TBS for 3 
hours at room temperature with agitation. Fluorophore-conjugated secondary antibody (diluted 1:300 
in 2% (w/v) BSA/0.05% (v/v) Tween-20/TBS) was applied for overnight incubation in the dark at 
4°C with agitation. To wash away excess secondary antibody, tissues were extensively washed in 0.05% 
(v/v) Tween-20/TBS for a minimum of 4x 1 hour in the dark at room temperature with agitation, 
followed by 1 hour in 0.05% (v/v) Tween-20/TBS containing 6-Diamidino-2-phenylindole (DAPI) to 
stain nuclei. Tissues were mounted onto a glass microscope slide (Thermo Scientific) in Elvanol 
(Roth).  
7.3.3 Whole mount diaminobenzidine (DAB) staining 
Staged embryos and were fixed overnight at 4°C with gentle agitation in Dent’s fixative. Tissues 
were transferred to 3% (v/v) H2O2/MeOH solution at room temperature for 1 hour with gentle 
agitation to quench endogenous peroxidase activity. Tissues were sequentially rehydrated in 
MeOH/PBS solutions with decreasing MeOH concentration (75%, 50%, 25% (v/v) MeOH/H2O, for 
20 minutes each) at room temperature. Rehydrated embryos were blocked in 2% (w/v) skim milk 
powder/0.1% (v/v) Triton-X100/PBS for 2x 1 hour at room temperature with gentle agitation. 
Primary antibody (diluted in 2% (w/v) skim milk powder/0.1% (v/v) Triton-X100/PBS) was applied 
for incubation at 4°C for minimum 24 hours. Tissues were washed extensively in 2% (w/v) skim milk 
powder/0.1% (v/v) Triton-X100/PBS, first 2x 1 hour at 4°C, then 3x 1 hour at room temperature. 
Horse radish peroxidase (HRP)-conjugated secondary antibody (1:200 diluted in 2% (w/v) skim milk 
powder/0.1% (v/v) Triton-X100/PBS) was applied for overnight incubation at 4°C. Tissues were 
washed extensively in 2% (w/v) skim milk powder/0.1% (v/v) Triton-X100/PBS, first 2x 1 hour at 
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4°C then 3x 1 hour at room temperature followed by washes in 0.2% (w/v) BSA/0.1% (v/v) Triton-
X100/PBS for 20 minutes at room temperature. Tissues were incubated in 0.3 mg/ml DAB in 0.2% 
BSA (w/v)/0.1% (v/v) Triton-X100/PBS for 20-40 mininutes at room temperature. To develop the 
histochemical signal, H2O2 was added to 0.03% (v/v) for 5-15 minutes, during which time the 
HRP-catalysed deposition of brown precipitate would occur where antibody is bound to antigen. 
When sufficient signal was obtained, the reaction was stopped by rinsing tissues extensively in 
0.2% (w/v) BSA/0.1% (v/v) Triton-X100/PBS. To clarify the tissues for imaging, they were 
sequentially dehydrated in MeOH/PBS solutions with increasing MeOH concentration (25%, 50%, 
75% (v/v) MeOH/H2O, for 20 min each) at room temperature. Then tissues were transferred to a 
clearing solution consisting of a benzyl alcohol and benzyl benzoate (1:2) for 20 minutes. Tissues were 
kept in clearing solution for imaging. 
7.4 Embryo histology 
7.4.1 Paraffin sectioning 
In preparation for paraffin sectioning, embryos and yolk sacs were fixed in 4%PFA/PBS at 4°C 
with gentle agitation. For embryos at or younger than E9.5, fixation time was 1 hour. If older than 
E9.5, embryos were fixed for 3 hours. Tissues were sequentially dehydrated in EtOH/PBS with 
increasing EtOH concentrations (70%, 80%, 90%, 95% and 100% (v/v) EtOH/H2O for 20 minutes 
each) at room temperature. Once fully dehydrated, the tissues were incubated in 100% EtOH for 6x 1 
hour at room temperature with gentle agitation. Then tissues were transferred to 100% butanol and 
incubated at ascending temperature, i.e. 1 hour at 35°C, 1 hour at 40°C and 1 hour at 45°C. Finally 
tissue were transferred to melted paraffin at 60°C for 4 hours and transferred into fresh melted 
paraffin after the first and second hour. Next, tissues were embedded in a paraffin block using an 
embedding machine (Shandon, HistoCentre 2). Paraffin sections were cut at 8 µm thickness on a 
microtome (Microm, Vacutome HM5000M) and dry-mounted onto glass microscope slides. Warm 
water (37°C) was applied to the sections, and slides were kept on a warm surface until the sections had 
smoothend out before removing the water and drying the paraffin sections at 37°C overnight. 
7.4.2 Cryo-sectioning 
In preparation of cryo-sectioning, embryos and yolk sacs were fixed overnight in 4% (w/v) 
PFA/PBS at 4°C with gentle agitation. Tissues were incubated in increasing concentrations of sucrose 
(0.5%, 1%, 2%, 5%, 10%, 20% (v/v) sucrose/PBS, for 1 hour each, or until tissue reaches the density 
of the sucrose solution). Tissues were transferred to a mixture of 20% sucrose and Cryomatrix 
(Thermo Scientific) (1:1) for a 20-minute incubation before embedding tissue in Cryomatrix in a 
cryomold (Sakura, Tissue-Tek). Tissues were kept in cryomatrix for 1 hour at room temperature before 
freezing the tissue in the Cryomatrix on dry ice. Cryosections were cut at 10 µm thickness on a 
cryotome kept at -18°C. The cryosections were transferred to glass microscope slides and dried for a 
minimum of 20 minutes at room temperature before being stored away for later use at -80°C. 
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7.4.3 Haematoxylin and eosin (H&E) staining of tissue sections 
H&E staining was performed to highlight morphological features of embryonic and 
extraembryonic tissues in effect of a blue nuclear staining by hemalum (a complex formed from 
aluminum ions and hematein, an oxidation product of haematoxylin) followed by a pink staining of 
cytoplasm and extracellular matrix by Eosin G. H&E stainings were performed on cryosections. To 
prepare cryosections for H&E staining, the cryomatrix was rinsed away from the tissue section 
through washes in destilled water 2x 3 minutes. Next, the slides were stained for 1 minute in a 
Hematoxylin solution (Merck, diluted 1:5 in distilled water), followed by continuous rinsing of the 
slides. Next the slides were stained for 1 minute in Eosin G solution (Merck). When complete, the 
excess eosin was washed away with distilled water. Tissue sections were mounted under dehydrated 
conditions, which involved sequentially dehydrating the sections in increasing concentrations of EtOH 
(70%, 80%, 90%, 95% and 100% (v/v) EtOH/H2O for 1 minute each) before moutning sections in 
Entellan (Merck). 
7.4.4 Immunofluoresence stainings of tissue sections 
Both paraffin sections and cryosections of embryonic tissue were used for immunofluorescence 
stainings. 
To prepare paraffin sections for immunofluorescence stainings, sections were deparaffinised and 
rehydrated. Sections were processed sequentially in xylene (3x 5 minutes), 100% EtOH (2x 10 
minutes), 95% (v/v) EtOH/H2O (2x 10 minutes) and were then sequentially rehydrated in decreasing 
concentrations of EtOH (90%, 80%, 70%, 60%, 50% (v/v) EtOH/H2O for 1 minute each) at room 
temperature. Sections were washed in water 2x 5 minutes at room temperature. Primary antibodies 
used here required antigen unmasking of paraffin sections, in which case either 1mM ETDA pH8.0 or 
10mM citrate buffer pH6.0 in combination with heat was applied to tissue sections. Sections were 
brought to 95°C in 1mM ETDA pH8.0 or 10 mM citrate buffer pH6.0, followed by 15 minutes at sub-
boiling temperature. Following 10 minutes cooling time, sections were washed in distilled water for 3x 
5 minutes. 
To prepare embryonic cryo-sections for immunofluorescence staining, slides were air-dried for 30 
minutes and washed in PBS for 3x 5 minutes.  
To prepare tissue sections for stainings, tissue sections were permeablised in 0.1% (v/v) Tween-
20/TBS for 5 minutes and blocked in 5% (v/v) normal goat serum/2% (w/v) BSA/0.1% (v/v) 
Tween-20/TBS for 1 hour at room temperature. Blocking solution was replaced with primary antibody 
solution (diluted in 5% (v/v) normal goat serum/2% (w/v) BSA/0.1% (v/v) Tween-20/TBS) and 
incubated with sections overnight at 4°C. Sections were washed in 0.1% (v/v) Tween-20/TBS 3x 5 
minutes and fluorophore-conjugated secondary antibody (diluted 1:300 in 0.1% (v/v) Tween-20/TBS) 
was applied for 1 hour in the dark at room temperature. Excess secondary antibody was removed 
through washes with 0.1% (v/v) Tween-20/TBS for 2x 5 minutes, followed by a 5-minute incubation 
with DAPI diluted in 0.1% (v/v) Tween-20/TBS before sections were mounted in Elvanol. 
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7.4.5 DAB staining of tissue sections 
To prepare embryonic paraffin sections for DAB stainings, sections were deparaffinised and 
rehydrated essentially as described in 5.3.4. Once fully rehydrated, sections were incubated in 3% (v/v) 
H2O2/water for 10 minutes at room temperature to quench endogenous peroxidase activity. Tissues 
were blocked in 5% (v/v) normal goat serum/0.1% (v/v) Tween-20/PBS for 1 hour at room 
temperature and primary antibody (diluted in 5% (v/v) normal goat serum/0.1% (v/v) Tween-
20/PBS) was applied for overnight incubation at 4°C. Excess primary antibody was washed off 
sections with 0.1% (v/v) Tween-20/PBS for 3x 5 minutes, and HRP-conjugated secondary antibody 
(diluted 1:300 in 0.1% (v/v) Tween-20/PBS) was applied for 1 hour at room temperature. Thereafter, 
sections were washed in 0.1% (v/v) Tween-20/PBS and processed for the HRP-catalysed DAB 
reaction by immersing sections in a solution of 0.05% (w/v) DAB/0.015% (v/v) H2O2/Tris pH7.6 for 
2-10 minutes, during which HRP-catalysed deposition of brown precipitate would occur where 
antibody is bound to antigen. The reaction was quenched in water and sections were counterstained 
with haematoxylin (diluted 1:5 in distilled water) for 2 minutes. After rinsing off excess haematoxylin, 
tissue sections sequentially dehydrating in increasing concentrations of EtOH (70%, 80%, 90%, 95% 
and 100% (v/v) EtOH/H2O for 1 minute each) and mounted in Entellan. 
7.5 Immunofluorescence staining of adherent cells and ECM in culture 
For immunofluorescence staining of adherent cells and the ECM they deposit, cells were seeded 
onto glass coverslips contained in plates or onto LabTek chamber slides (Nunc). All surfaces were 
precoated with LM-111 at 5µg/mL in PBS prior to seeding cells at a density of 2-10 x 103 cells/cm2. 
To prepare for immunofluorescence staining, cultures were rinsed in PBS and fixed in 4% PFA/PBS 
at 4°C for 10 minutes. Fixed cultures were rinsed in PBS for 3x 5 minutes and incubated in 2% (w/v) 
BSA/PBS for 1 hour at room temperature. The blocked cultures were incubated in primary antibody 
(diluted in 2% (w/v) BSA/PBS) overnight at 4°C. Excess primary antibody was washed away with PBS 
for 3x 5 minutes and fluorophore-conjugated secondary antibody (diluted 1:1000 in PBS) was applied 
for 1 hour at room temperature. Further washing in PBS for 3x 5 minutes removed secondary 
antibody. DAPI staining was performed for 5 minutes at room temperature. Thereafter, cultures were 
mouted in Elvanol.  
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7.6 Antibodies 
Table 7. 3 Primary and secondary antibodies 
Dilutions Antibody Company Cat. # Species 
IF/IHC WB IP 
Requirements 
Endomucin Santa Cruz Sc-53941 rat 1:300 - -  
PECAM-1 PharMingen 01951D rat 1:300 - - IF: Fix in Dent’s 
pFAKY397 Biosource 44-624G rabbit - 1:1000 - WB: 1% BSA 
FAK Abcam ab71563 rabbit - 1:1000 - WB: 1% BSA 
FN Millipore ab2033 rabbit 1:300 1:5000 - WB: 1% BSA 
pMLC2 Cell Signaling 3675L mouse - 1:1000 - WB: 1% BSA 
MLC2 Santa Cruz sc-15370 rabbit - 1:1000 - WB: 1% BSA 
GAPDH Calbiochem CB1001 mouse - 1:1000 - WB: 1% BSA 
β-actin Sigma A5441-2ML mouse - 1:1000 - WB: 1% BSA 
α5 integrin Cell Signaling 4705 rat 1:50  -  
4G10 Axel Ullrich  mouse - 1:12000 - WB: 1% BSA 
LTBP-1 Heldin/ Rifkin pAb 8579 rabbit 1:300 1:200 -  
pSMAD2 Millipore ab3849 rabbit -  - WB: 1% BSA 
SMAD2/3 Santa Cruz sc-8332 rabbit - 1:1000 - WB: 1% BSA 
pSMAD1/5/8 Cell Signaling 9511 rabbit - 1:1000 - IF: Fix in MEMFA WB: 1% BSA 
SMAD5 Calbiochem st1104 rabbit - 1:1000 - WB: 1% BSA 
Phalloidin Alexa488 Molecular Probes A12379  1:300 - -  
α-SMA-Cy3 Sigma C6198 mouse 1:400 - -  
VEGFR2 Cell Signaling 2479 rabbit 1:200 - 1:100  
Anti-mouse HRP BioRad 170-6516 goat - 1:10000 -  
Anti-rabbit HRP BioRad 170-6515 goat - 1:10000 -  
Anti-rat HRP    1:300 - -  
Anti-rabbit Alexa 488 Invitrogen A11008 goat 1:1000 - -  
Anti-rabbit Alexa 546 Invitrogen A11010 goat 1:1000 - -  
Anti-rat Alexa 488 Life Technologies A21208 goat 1:1000 - -  
Anti-rat Alexa 546 Invitrogen A11081 goat 1:1000 - -  
 
All primary and secondary antibodies used for western blot analysis were diluted in 1% BSA/0.5% 
tween-20/TBS. 
6-Diamidino-2-phenylindole (DAPI) was used at 1:10000 dilution in PBS 
7.7 Microscopy 
7.7.1 Fluorescence microscopy 
Confocal images of immunofluorescence stainings were acquired on a Leica SP5 confocal 
microscope using either a ×40 (oil), ×100 (oil) or ×10 (dry) objective. Fluorescence images were 
acquired on a Zeiss Apotome microscope with a ×20 dry objective. 
7.7.2 Light microscopy 
Light images of histological sections were taken using a Zeiss Axioskop light microscope equipped 
with a ×10 objective (Zeiss, Plan-NEOFLUAR) and a LCD camera (Leica, DCC500). 
Time-lapse bright-field movies of migrating cells on decellularised ECM platforms were recorded at 
5-minute intervals using an inverted Zeiss Axiovert 40 microscope equipped with a ×10 objective and 
a PAL cameras (Prosilica), which was triggered by custom-made software (SVS Visitek). 
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7.8 Cell culture methods 
7.8.1 Cell lines 
FNCC>SS/CC>SS and WT control mouse embryonic fibroblasts (MEFs) were described in the PhD 
thesis of Dr. Michael Leiss. Briefly, these fibroblasts were isolated from E9.5 FNCC>SS/CC>SS or WT 
embryos and immortalised through multiple rounds of retroviral transfection with the simian virus 40 
large T antigen. These MEFs were either used as mixed populations (i.e. no clonal selection) or as 
clonal cell lines, which were isolated by limited dilution and characterised by FACS analysis of integrin 
expression.  
FN-/- MEFs were described by Sakai et al. 2001. Briefly, these fibroblasts were prepared by isolating 
MEFs from FNflox/flox mouse embryos at E13.5 (Sakai et al., 2001). The floxed FN gene was deleted by 
transfecting MEFs with Cre-transducing adenovirus. The deletion of floxed FN alleles was confirmed 
by PCR. 
Both the CHO cells stably transfected with the β6 integrin subunit (CHO-β6) (Annes et al., 2004) 
and the mink lung epithelial cells (MLEC) transfected with the reporter construct p800neoLuc (Abe et 
al., 1994) were kind gifts from Dr. Daniel Rifkin. Both of these cell lines were cultured in the presence 
of neomycin (PAA). 
All cells were maintained in DMEM (Gibco) supplemented with 5% (v/v) heat-inactivated fetal 
bovine serum (FBS) and 1x penicillin/streptomycin supplement, unless otherwise stated. Cell 
passaging was done by incubating cultures in 1x Trypsin – EDTA for 2 minutes at 37°C and 
resuspending cells in fresh medium. 
For all cell biological assays, cells were cultured in media supplemented with 0.5-2% FBS depleted 
of FN by affinity purification with gelatin sepharose 4b (GE Healthcare Life Sciences). To compensate 
for the very low serum levels, cells were cultured in a home-blended “serum replacement medium”, 
consisting of DMEM, AIM-V (Gibco), RPMI 1640 (Gibco) and non-essential amino acids (Gibco) at 
47.5: 47.5: 5: 1 ratio.  
7.8.2 Plasma preparation from mouse whole blood 
Plasma was prepared from whole blood of pI:C-treated FNfl/CC>SSMx1Cre and control 
FNfl/+Mx1Cre mice for cell culture purposes. Whole blood was collected by retro-orbital bleeding into 
tubes containing 0.5M EDTA to prevent platelet activation. To isolate plasma, the blood samples were 
centrifuged at 3000 x g for 20 minutes at 4°C. The low density top layer of clear plasma was collected 
and centrifuged again at 3000 x g for 20 minutes at 4°C. Clarified plasma was collected and stored at -
20°C.  
Plasma from multiple mice of the same genotype was pooled and used to supplement normal 
DMEM growth media at 5% (v/v). Growth media containing mouse plasma was sterile-filtered before 
use. 
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7.8.3 Preparation of MEF-derived decellularised ECM platforms 
MEF-derived ECM was decellularised in one of two different ways, depending on the application.  
ECM platforms that were used for analysis of cell signalling and migration were generated by 
seeding FNCC>SS/CC>SS and WT MEFs at 31 x 103 cells/cm2 onto a gelatin-coated 35-mm culture dish 
and incubating cells in serum replacement medium supplemented with 0.5% (v/v) FN-depleted FBS 
for 3 days to allow the deposition of ECM. Cultures were rinsed with PBS and cells were selectively 
detached from the cell culture plate with EDTA-based cell extraction buffer at 37°C for 2 hours. 
Subsequent rinses in PBS rendered the dishes free of rounded cells. To monitor the quality of the 
decellularised ECM platforms, EDTA-treated decellularised ECM was prepared on LM111-coated 
LabTek chamber slides to enable immunofluorescence staining of FN and detection of residual cells by 
nuclear staining with DAPI.  
ECM platforms that were used for analysis of mechanical properties by atomic force microscopy 
analysis were generated by seeding FNCC>SS/CC>SS and WT MEFs at 10 x 103 cells/cm2 onto 22-mm 
coverslips covalently coated with a monolayer of WT fibronectin as described elsewhere (Prewitz et al, 
2013). Cultures were kept for ten days with daily changes of serum replacement medium supplemented 
with 2% (v/v) FN-depleted FBS. ECMs were decellularised by treatment with a detergent-based cell 
extraction buffer for 5 minutes at 37°C with gentle agitation, followed by treatment with DNAse 
(AppliChem; 0.1 mg/ml in DNase buffer containing 40 mM Tris pH7.4, 10 mM NaCl, 6 mM MgCl2 
and 1 mM CaCl2). Decellularized matrices were rinsed and maintained in PBS at room temperature and 
probed immediately. The quality of the decellularised and anchored ECM platforms was monitored by 
fixing the decellularised ECM and carrying out an immunofluorescence staining of FN and detection 
of residual cells by nuclear staining with DAPI. 
• EDTA-based cell extraction buffer: 20 mM EDTA in PBS 
• Detergent-based cell extraction buffer: 20 mM ammonium hydroxide and 0.5% (v/v) Triton X-
100 in PBS 
7.8.4 Cell signalling assays on ECM platforms 
To test the effect of FNCC>SS on selected cell signalling pathways downstream of integrin outside-in 
signalling, FN-/- fibroblasts were starved overnight and put into suspension at 37°C for 1 hour to 
essentially inactivate all signalling pathways related to cell adhesion. The starved, suspended FN-/- 
fibroblasts were seeded onto decellularised ECM platforms derived from either FNCC>SS/CC>SS or WT 
MEFs at equal cell densities in DMEM. FN-/- fibroblasts were incubated on the ECM platforms for 30 
minutes, allowing cells to attach to the ECM and initiate integrins signalling.  The media was aspirated, 
cells were gently rinsed and then lysed in cell lysis (RIPA; 7.9.1) buffer for subsequent detection of 
signalling activity by SDS-PAGE and western blot analysis. 
7.8.5 Cell migration assays on ECM platforms 
To test migration speed of FN-/- fibroblasts on ECM platforms containing either FNCC>SS or WT 
FN, FN-/- fibroblasts were starved overnight and seeded onto decellularised ECM platforms derived 
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from either FNCC>SS/CC>SS or WT MEFs (2 x 103 cells/cm2). FN-/- fibroblasts were incubated for 1 
hour before migration was stimulated by adding recombinant human PDGF-BB (Preprotech) to the 
culture medium at a final concentration of 50 ng/ml. Still images of fibroblasts were acquired for 12 
hours at 5 minutes intervals. Single migrating fibroblasts were tracked and migration speeds were 
calculated using 64-bit ImageJ 1.47 with the MBF ‘ImageJ for Microscopy’ plugin Chemotaxis and 
Migration Tool installed. 
7.8.6 Atomic force microscopy (AFM) of ECM platforms 
The stiffness of decellularised ECM platforms derived from either FNCC>SS/CC>SS or WT MEFs was 
determined using a tipless silicon nitride cantilever with a nominal spring constant of 0.01 N/m 
(MLCT-O10, Veeco), functionalized by attaching a 20 µm glass bead (Kisker Biotech, Germany) using 
a two-component epoxy. Coverslips containing ECM were mounted onto the stage of a Zeiss Axiovert 
200 M and force spectroscopy was conducted using a NanoWizard II together with a CellHesion 
module (JPK Instruments). Cantilevers were blocked with 100% FBS and calibrated by the thermal 
noise method prior to measurements. Force-distance curves were recorded in closed loop mode at an 
approach and retract velocity of 0.5 µm/s until a trigger force of 500pN was reached, and retracted to 
3 µm. 
Young’s moduli were determined by fitting the approach curve using the Hertz model within the 
JPK analysis software. 
7.8.7 TGF-β  bioassays 
The MLEC cell line is a sensitive tool to assay the amount of active TGF-β in a conditioned 
medium. The MLEC cell line is stably transfected with a luciferase gene fused to the promoter of 
plasminogen activator inhibitor 1 (PAI-1), which is a prominent gene target downstream of the TGF-
β/SMAD signalling pathway. In this project, the MLEC cell line was used to assay the levels of latent 
TGF-β deposited into the ECM as well as the ability of CHO-β6 cells to activate latent TGF-β. All 
assays involving MLEC reporter lines were performed in 96-well plate format. 
To test the deposition of latent TGF-β into ECM containing either FNCC>SS or WT FN, ECM was 
generated by seeding FNCC>SS/CC>SS and WT MEFs into 24-well plates, 40 x 103 cells/well, and 
culturing them in serum replacement medium supplemented with 0.5% (v/v) FN-depleted FBS. 48 
hours later, the cultures were rinsed in PBS and MEFs were selectively detached from the cell culture 
plate with 20 mM EDTA/PBS at 37°C for 2 hours. The decellularised matrices were covered in fresh 
serum replacement medium, and through a heat-activating treatment at 80°C for 10 minutes the total 
latent TGF-β was released into the medium in an active form. This conditioned medium containing 
active TGF-β was cooled and incubated with a MLEC monolayer for 16 hours and luciferase activity 
in MLEC monocultures was assayed with Bright-GloTM Luciferase Assay System (Promega) on a 
GloMaxTM luminometer. 
To test the ability of CHO-β6 cells to activate latent TGF-β deposited into ECM containing either 
FNCC>SS or WT FN, ECM was generated by seeding FNCC>SS/CC>SS and WT MEFs into 96-well plates, 
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10 x 103 cells/well, and culturing them in serum replacement medium supplemented with 0.5% (v/v) 
FN-depleted FBS. 48 hours later, the cultures were rinsed in PBS and MEFs were selectively detached 
from the cell culture plate with 20 mM EDTA/PBS at 37°C for 2 hours. The decellularised matrices 
were rinsed with PBS, and a co-culture of CHO-β6 cells (2 x 104 cells per well) and MLEC reporter 
cells (1.5 x 104 cells per well, giving a final volume of 100 µl) were plated onto the decellularised ECM 
in DMEM. A TGF-β neutralizing antibody (1D11; 15 µg/ml) or an αVβ6-blocking antibody (10D5; 
20 µg/ml) was added to the co-culture wells as indicated. The MLEC and CHO-β6 co-cultures were 
incubated for 24 hours. Luciferase activity in MLEC/CHO-β6 co-cultures was assayed with Bright-
GloTM Luciferase Assay System (Promega) on a GloMaxTM luminometer. 
7.9 Biochemical methods 
7.9.1 Preparation of total protein lysates from embryonic tissues and cell cultures 
For preparation of total protein lysates from embryonic tissues, dissected embryos and yolk sacs 
were either snap-frozen in liquid N2 and stored prior to lysis or processed immediately upon dissection 
by lysis in cell lysis buffer. Single E9.5 embryos or yolk sacs were lysed directly in 50 µl 1x Laemmli 
sample buffer. Complete tissue disintegration was achieved by pipetting rigorously and incubation on 
rotating wheel for 30 minutes at 4°C. Debris was collected by centrifugation at 15,000 x g for 5 
minutes at 4°C. The concentration of soluble protein was determined with the BCA assay kit (Pierce) 
and spectrophotometric absorbance at 562 nanometre. Lysates were analysed by SDS-PAGE and 
western blotting. 
For preparation of total protein lysates from cell cultures, the cultures were initially rinsed twice in 
ice-cold PBS. Cells were lysed in cell lysis (RIPA) buffer for 5 minutes on ice, and using a cell scraper 
the lysate was collected and lysis was continued by incubation on a rotating wheel for 30 minutes at 
4°C. Cellular debris was collected by centrifugation at 15,000 x g for 10 minutes at 4°C. The 
concentration of soluble protein was determined with the BCA assay kit (Pierce) and 
spectrophotometric absorbance at 562 nanometre. Lysates were analysed by SDS-PAGE and western 
blotting. 
• 4x Laemmli sample buffer: 2% (w/v) SDS, 10% (v/v) glycerol, 0.01% (w/v) bromphenol blue in 
62.5 mM Tris-HCl pH 6.8 (+ 300 mM β-mercaptoethanol for a reducing Laemmli sample buffer) 
• Cell lysis (RIPA) buffer: 150 mM NaCl, 1 mM EDTA, 1% (w/v) Na-deoxycholate, 0.1% (w/v) 
SDS, 1% (v/v) Triton X-100, 1mM PMSF, 10 mM NaF, 1 mM Na3VO4 in 50 mM Tris-HCl pH 
7.4 and futher supplemented with protease inhibitor cocktail (Roche). 
7.9.2 Na-deoxycholate (DOC) fractionation of the FN matrix 
The quantification of FN matrix assembly by DOC fractionation was performed as described by 
Pankov and Yamada (Pankov and Yamada, 2004) and based on the work of McKeown-Longo and 
Mosher (McKeown-Longo and Mosher, 1983). Briefly, WT and FNCC>SS/CC>SS MEFs were seeded in 
gelatin-coated 35-mm dishes at approximately 90% confluency (i.e. 250 x 103 cells/well) in serum 
replacement medium containing 0.5% (v/v) FN-depleted FBS. After 48 hours in a tissue culture 
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incubator, the medium was aspirated and cells were washed three times in ice-cold PBS. Cells and 
ECM were lysed in 0.5 ml DOC extraction buffer for 5 minutes on ice, and the lysates were collected 
with a cell scraper. The lysate was passed through a 23-G needle attached to a 1-ml syringe to reduce 
viscosity and allow sedimentation of small, insoluble matrix aggregates during centrifugation. Lysates 
were centrifuged at 20,000 x g for 20 minutes at 4°C to pellet the DOC insoluble fraction. 
A 100 µl aliquot of the supernatant (DOC soluble fraction) was transferred to a fresh tube, mixed 
with 100 µl 2 x Laemmli sample buffer and heated at 95°C for 5 minutes. The remaining supernatant 
was removed and the DOC insoluble pellet was washed extensively in 100 µl DOC extraction buffer 
before sedimentation by centrifugation at 20,000 x g for 10 minutes at 4°C. All supernatant was 
removed and the DOC insoluble pellet was dissolved in 50 µl 2x Laemmli sample buffer. DOC soluble 
and insoluble fractions were analysed by SDS-PAGE and western blotting. 
• DOC extraction buffer: 1% (w/v) DOC, 20 mM Tris-HCl pH 8.5, 2 mM EDTA, 1 x protease 
inhibitor cocktail (Roche), 1 x phosphatase inhibitor cocktails 2 & 3 (Sigma Aldrich).  
7.9.3 Immunoprecipitation of VEGFR2 
Immunoprecipitation of VEGFR2 was performed in order to concentrate the protein from 
embryonic and yolk sac lysates and subsequently monitor the extent of VEGFR2 phosphorylation at 
specific tyrosine residues. E9.5 embryos and yolk sacs (7 of each) were pooled in 300 µl cell lysis 
buffer containing protease and phosphatase inhibitors. The lysates were passed through a 23-G needle 
attached to a 1-ml syringe to shear DNA, and lysis was completed under rotary agitation for an 
additional 30 minutes at 4°C. Insoluble protein and debris was sedimented by centrifugation at 15,000 
x g for 10 minutes at 4°C. The concentration of soluble protein was determined with the BCA assay 
kit. The lysate volumes were adjusted to appropriate concentrations such that embryo lysates contained 
250 µg and yolk sac lysates contained 150 µg. Lysates were pre-cleared with 20 µl Protein G Sepharose 
beads (Sigma) under rotary agitation for 30 minutes at 4°C, in order to reduce unspecific binding of 
proteins to the Protein G Sepharose beads in subsequent steps. To the pre-cleared lysates, VEGR2 
rabbit mAb was added for overnight incubation under rotary agitation at 4°C. After the antibody 
incubation, 20 µl Protein G Sepharose beads were added and the lysate-antibody-bead mix was 
incubated under rotary agitation for 4 hours at 4°C. Next, the Protein G Sepharose beads were 
sedimented and the lysate was removed. After multiple rounds of washes in cell lysis buffer, VEGFR2 
was eluted from the Protein G Sepharose beads with 50 µl 2x Laemmli sample buffer and heating to 
95°C for 5 minutes. Lysates were analysed by SDS-PAGE and western blotting. 
7.9.4 SDS-polyacrylamide gel electrophoresis (SDS-PAGE) and western blotting 
Total protein lysates were adjusted in protein concentration and resolved on Tris-glycine gels (8%-
12% resolving acrylamide gels, depending on application) by SDS-PAGE in SDS running buffer at 
constant 100 volts. Once resolved, the proteins were transferred onto PVDF membrane (Millipore) by 
wet transfer in Towbin buffer at constrant 50 milliampere overnight at 4°C. PVDF membranes were 
air dried and subsequently immersed in primary antibody (diluted in 1% bovine serum albumin/0.1% 
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Tween-20/TBS) for overnight incubation at 4°C. After multiple washes in 0.1% Tween-20/TBS, 
membranes were incubated in HRP-conjugated secondary antibody (diluted in 1% (w/v) bovine serum 
albumin/0.1% (v/v) Tween-20/TBS) for 1 hour at room temperature. Following multiple washes in 
0.1% (v/v) Tween-20, protein bands were detected using enhanced chemiluminescence reagents (ECL, 
Millipore). Where necessary, PVDF membranes were stripped of antibodies using a mild stripping 
buffer for 2x 10 minutes at room temperature followed by extensive washing in 0.1% (v/v) Tween-
20/TBS. PVDF membranes were air-dried prior to any further antibody incubation. 
• SDS running buffer: 25 mM Tris, 192 mM glycine, 0.1% (w/v) SDS 
• Towbin buffer: 25 mM Tris, 192 mM glycine, 10% (v/v) MeOH 
• Mild stripping buffer: 1% SDS (w/v), 25 mM glycine pH 2 
7.10 Real-time PCR (RT-PCR) 
Total cellular RNA was isolated using RNeasy Mini kit (Qiagen). RNA concentration and purity 
were determined spectrophotometrically on Nanodrop equipment. 5 µg of RNA was reverse 
transcribed to cDNA using a blend of oligo(dT) and random hexamer primers provided as part of the 
iScript cDNA Synthesis Kit (BioRad). 
The reaction mixes for RT-PCR were prepared with the cDNA template, oligonucleotides designed 
with IDT PrimerQuest (table 5.4) and the iQTM SYBR Green supermix (BioRad). A 3-step RT-PCR 
protocol with a melting curve step was executed in an iCycler thermocycler (BioRad) (table 5.5). 
The specificity of the amplified product was verified both by analysis of the melt curve and by agarose 
gel analysis of the amplified products. For the relative quantification of gene expression, the threshold 
cycle (CT) values for genes of interest were internally normalised to that of GAPDH. These relative CT 
values formed the basis for the quantitative comparison of WT and FNCC>SS/CC>SS samples. 
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Table 7.4 Oligonucleotide sequences for RT-PCR 
Gene 5' - 3' sequence Primer name 
GTG GAG ATT TGT GTC ACA GGT G FN1 forward 
FN 
CGG GAT CCG CTC ATG AAC AAA GCA GAC AGC FN1 reverse 
AGC TGA ACT CGG AGT CTG AAG TCG ID1 forward 
Id1 
TTT CCT CTT GCC TCC TGA AGG GCT ID1 reverse 
TTC AGT GGC CAA TGG AAG ACT CCT PAI1 forward 
PAI-1/Serpine1 
GTG GCA GAT GGC GCG GCA ACA CCA TT PAI1 reverse 
TCC TGC ACC ACC ACC TGC TTA GAPDH forward 
GAPDH 
TGG ATG CAG GGA TGA TGT TCT GG GAPDH reverse 
 
Table 7.5 3-step RT-PCR protocol with melting curve 
Cycling step Temperature Hold time (min:sec) # of cycles 
Initial denaturation  
and enzyme activation 
95°C 3:00 1 
Denaturing 95°C 0:15 
Annealing 65°C 0:30 
Extension 72°C 0:30 
40 
Melt curve 55-95°C 
(in 0.5°C increments) 
0:10-0:30 1 
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8 RESULTS 
 
8.1 Targeted disruption of the FN dimerisation motif in v ivo  
All murine and human isoforms of FN are secreted as dimers. Dimerisation of FN molecules is 
mediated by a dimerisation motif that consists of a pair of closely positioned cysteines at the C-
terminus of each FN molecule. It has become widely accepted that FN dimerisation is one of a few 
criteria for FN to undergo de novo fibrillogenesis. However, the current study is the first to address 
the function of FN dimerisation in vivo with a mouse model carrying mutations in the dimerisation 
motif of the Mus musculus Fn1 gene that are designed to prevent FN dimerisation. Consequently, this 
mouse expresses only a monomeric form of FN. The strategy behind this approach to monomerise all 
FN was to replace the two critical C-terminal cysteine residues of the dimerisation motif with serines 
by site-directed mutagenesis, i.e. FNCC>SS (fig. 8.1) and to introduce this mutation into the mouse 
germline by homologous recombination technology. The FNCC>SS knock-in mouse was generated by 
Drs. Reinhard Fässler and Takao Sakai prior to the initiation of this PhD project. 
 
 
Fig 8.1. Site-directed mutagenesis of cysteine residues to serine residues in FN to create 
FNCC>SS. 
 
To generate the FNCC>SS knock-in targeting construct, a fragment of FN containing exon 44 and 45 
was cloned into a pKS vector, and site-directed mutagenesis of Cys-encoding codons TGC to TCC 
was performed to achieve the substitution of C2458 and C2462 with serine residues within exon 45. In 
addition to the amino acid substitutions, a loxP-flanked neomycin resistance cassette (NeoR) was 
inserted into intron 44 to allow for positive selection of ES clones that had genomically incorporated 
the targeting construct by homologous recombination (fig 8.2 A). The targeting construct FNCC>SS NeoR 
was introduced to 129/Sv mouse-derived embryonic stem (ES) cells through electroporation. Among 
the neomycin-resistant ES cells, those carrying correct gene targeting were identified byBamHI 
restriction enzyme digestion and subsequent Southern blotting of ES cell DNA. A 5’ external probe to 
distinguish between fragments of a WT allele (12.9 kbp) and a targeted allele (8.8 kpb) (fig 8.2 B). To 
generate heterozygous mice (FNCC>SS/+), ES cell clones carrying FNCC>SS NeoR were injected into 
blastocysts, and these blastocysts were transferred to C57Bl/6 recipient females. Chimeric offspring 
PhD Thesis - Josefine Gibson  Results 
 
 74 
were identified by coat colour, and chimeric males were crossed to C57Bl6 females. Germ-line 
transmission was confirmed if offspring were found to contain FNCC>SS/+ NeoR mice, as validated by 
Southern blot analysis of tail biopsy DNA, following the same validation concept as described above 
for ES cells (fig 8.2 C). The neomycin selection cassette was removed by crossing FNCC>SS/+ NeoR males 
with deleter-Cre C57Bl/6 females. Both the deletion of neomycin selection cassette by Cre 
recombinase and the presence of a WT or targeted allele in FNCC>SS/+ mice was validated by PCR of 
tail tip DNA. Here, the PCR analysis was designed to detect and distinguish between FNCC>SS/+ Neo 
(342bp), FNCC>SS/+ (298 bp) and FN+/+ (202 bp) (fig. 8.2 D, E).  
 
 
Fig 8.2. Genetic targeting of the dimerisation motif in FN. (A) Schematic representation of 
the FN-monomer (FNCC>SS) knock-in strategy. The targeting vector FNCC>SS neo contains the 
loxP flanked neomycin cassette and the mutated exon 45 (**). Homologous recombination in 
ES cells results in the depicted targeted allele. The removal of the neo selection cassette from 
the targeted allele was performed by intercrossing FNCC>SS neo/+ heterozygous mice with a 
deleter-Cre recombinase mouse strain. Probe indicates the binding position of the external 
probe used in southern blotting. Restriction sites: B, BamHI; S, SpeI; RV, EcoRV. (B-C) 
Confirmation of the FNCC>SS mutation in ES cells (B) and mice (C) by southern blot analysis 
of genomic DNA. DNA was hybridized with an external probe after BamHI digestion. 
Successful insertion of the targeting vector changes the size of WT genomic DNA fragment 
of 12.9 kbp to 8.8 kbp, and heterozygous FNCC>SS/+ mice contain both the WT (12.9 kbp) 
and the targeted allele (8.8 kbp). (D-E) Genotyping PCR of tail DNA. Primers were designed 
to distinguish between a 202 bp WT allele and a 298 bp targeted allele (FNCC>SS), from which 
the neo sequence had been removed by deleter-Cre (D). PCR products were resolved by 
electrophoresis on an agarose gel containing ethidium bromide (E). This dataset was 
obtained by Dr. Takao Sakai. 
 
FNCC>SS/+ mice were viable and fertile. To monitor weight development among heterozygotes and 
control littermates, all were weighed at weasning age. This analysis showed that heterozygotes are of 
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normal weight and thus apparently indistinguishable from WT littermates (fig. 8.3). To generate mice 
homozygous for the FNCC>SS knock-in, intercrossings of heterozygous FNCC>SS/+ mice were 
performed. 
 
 
Fig 8.3. Weight distribution of WT and FNCC>SS/+ (HET) male and female mice at weaning 
age (postnatal day 21). 
 
8.2 Phenotypic analysis of the FNCC>SS/CC>SS mouse 
FNCC>SS/+ mice were intercrossed to generate FNCC>SS/CC>SS mice. As indicated in table 8.1, among 
the large number of progeny of FNCC>SS/+ intercrossings that were genotyped at weaning age (21 days 
postnatal), none were FNCC>SS/CC>SS homozygous mutant. 
To estimate the age at which FNCC>SS/CC>SS die off, timed matings were initiated between FNCC>SS/+ 
mice and embryos were collected at specific developmental stages. Among embryos collected between 
E8.5 and E10.5, we found WT, FNCC>SS/+ and FNCC>SS/CC>SS embryos at normal Mendelian ratios, i.e. 
1:2:1, respectively. However, the proportion of FNCC>SS/CC>SS embryos was found to decline between 
E9.5 and E11.5, such that by E11.5, the representation of FNCC>SS/CC>SS embryos within a litter was 
drastically reduced to ca. 2.5%. Of the twenty-seven embryos recovered at E12.5, none were 
homozygous for the FNCC>SS knock in mutation. With this, we concluded that the FNCC>SS knock-in is 
a recessive embryonic lethal mutation. 
 
 
Table 8.1: Genotypes of offspring from intercrosses of FNCC>SS/+ heterozygous mice. The 
normal Mendelian ratio of 1 WT: 2 FNCC>SS/+: 1 FNCC>SS/CC>SS was observed for embryos 
collected between E8.5 to E10.5. Homozygous mutants (FNCC>SS/CC>SS) were never 
identified after E11.5, indicating that lethality commences between E10.5 and E11.5. Dr. 
Michael Leiss contributed to this dataset. 
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The cause of embryonic lethality was examined in close detail. Inspection of embryos recovered 
between E8.5 and E10.5 revealed that all FNCC>SS/CC>SS embryos proceed well beyond the egg cylinder 
stage and the early stages of gastrulation and reach the early stages of organogenesis. At E8.5, 
FNCC>SS/CC>SS embryos were morphologically indistinguishable from WT (fig. 8.4 A and B) and 
heterozygous littermates (not shown). This specifically refers to finding that FNCC>SS/CC>SS embryos 
showed a proper head fold and were proceeding through somitogenesis at comparable rates, showing 
6-12 somite pairs at the time of dissection. FNCC>SS/CC>SS embryos showed normal length and 
curvature along the anterior-posterior axis. Likewise, the neural tube of FNCC>SS/CC>SS embryos 
appeared normal. The heart of FNCC>SS/CC>SS embryos was normally enclosed by the body wall and the 
heart tube was producing regular contractions at the time of dissection. At the embryonic posterior, 
both FNCC>SS/CC>SS and WT embryos had developed an allantois that either had made or was in the 
process of making contact with the chorion at the base of the placenta, in preparation of forming the 
placental blood vessels and building the umbilical cord. 
The mutant phenotype became apparent at E9.5, with several anomalies, albeit at various degrees 
of severity (fig. 8.4 C). Although most FNCC>SS/CC>SS embryos had successfully turned into the fetal 
position, they began to exhibit a general delay in growth; the head region was small and posterior 
region was short compared to WT littermates. Whereas WT embryos at E9.5 had developed up to 24 
somite pairs, the FNCC>SS/CC>SS embryos were rarely found to have more than 20 somite pairs. At this 
embryonic stage, WT embryos had always developed the first, second and third pair of pharyngeal 
arches, while FNCC>SS/CC>SS embryos typically only develop the first pair of pharyngeal archs 
(occasionally a second pair). These are vascularised anlage that arise from the aortic sac, extend 
ventrally from the dorsal aorta to meet at the midline and will give rise to several major arteries. 
FNCC>SS/CC>SS embryos had an overall anaemic appearance with only trace amounts of blood in the 
dorsal aorta, heart and in the general circulation, suggesting vascular or hematopoietic malfunction. 
Although the heart still maintained regular contractions in E9.5 FNCC>SS/CC>SS embryos, the heart 
appeared under-developed and lacked features of a looped and segmented cardiac tube. Most striking 
at this stage of development was the appearance of an enlarged pericardial sac surrounding the 
FNCC>SS/CC>SS cardiac tube. The pericardial sac is a fibrous sac surrounding the heart, and under 
normal WT circumstances it contains only little fluid. This swelling of the pericardium seen in 
FNCC>SS/CC>SS embryos is strongly indicative of accumulating plasma, i.e. oedema, arising from leaky 
vessels and/or insufficient cardiac output from the under-developed heart. 
Of those FNCC>SS/CC>SS embryos that advanced to E10.5, many showed signs of deterioration and 
were very fragile (fig. 8.4 D). The major phenotypic features seen in younger FNCC>SS/CC>SS embryos, 
such as anaemia and oedema, had only become more severe by E10.5. Also, the allantoic mesoderm of 
most FNCC>SS/CC>SS embryo had failed to establish the umbilical vasculature (not shown), despite the 
fact that at E8.5, the allantois of all FNCC>SS/CC>SS embryos examined had grown and appeared to have 
fused with the chorion. Where chorioallantoic fusion had occurred, the allantois often appeared 
constricted, while the base of these allantois often appeared swollen and oedemic. Brain, somite and 
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pharyngeal arch development had stalled, and there were no sign of forelimb development to the 
extent seen in WT littermates. 
 
 
Figure 8.4. Whole mount presentation of WT and FNCC>SS/CC>SS embryos between E8.5 and 
E10.5. (A) Lateral view of E8.5 WT and FNCC>SS/CC>SS embryos. (B) Dorsal view of E8.5 
WT and FNCC>SS/CC>SS embryos. Insets show magnified view of somites, 6 pairs in both 
embryos. (C) Lateral view of E9.5 WT and FNCC>SS/CC>SS embryos. (D) Lateral view of 
E10.5 WT and FNCC>SS/CC>SS embryos. al, allantois; DA, dorsal aorta; FL, forelimb, Hd, 
head; H, heart, NT, neural tube; OPP, optic pit; OP otic pit; PA, pharyngeal arch; S, somites. 
Scale bar: (A-C) 500 µm; (D) 1 mm. This dataset was obtained by Dr. Michael Leiss.  
 
8.2.1 Extraembryonic vascular defects 
Morphologically abnormal FNCC>SS/CC>SS embryos also exhibited defects in the development of the 
vasculature in extra-embryonic tissues, such as the yolk sac and the placenta. A striking, but typical, 
phenotypic feature of FNCC>SS/CC>SS yolk sacs between E9.5 and E10.5 was a blistered and anaemic 
appearance of the yolk sac surface revealed to stem from an unusual swelling of a highly primitive 
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vascular plexus (fig. 8.5).  The primitive blood vessels were devoid of blood, yet small amounts of 
blood were often found to have accumulated within the exocoelomic cavity. Although the presence of 
blood indicates that hematopoiesis must have occured within the blood islands of FNCC>SS/CC>SS yolk 
sacs, the blood leakage into the exocoelomic cavity suggests that the dilated vessels of the 
FNCC>SS/CC>SS yolk are inappropriately permeable to erythrocytes and other blood components. This 
inevitably is associated with the deficiency of erythrocytes within the embryonic circulation and 
explains the anaemic appearance of the FNCC>SS/CC>SS embryo. Overall, these findings demonstrate that 
FNCC>SS does not support yolk sac angiogenesis and that FN dimers are required for ensuring the 
integrity of the yolk sac vasculature. 
 
 
Figure 8.5. Abnormal vascular development in FNCC>SS/CC>SS yolk sac. Gross morphology of 
whole-mount yolk sacs of FNCC>SS/CC>SS embryos is compared to that of WT littermates at 
late E9.5. FNCC>SS/CC>SS yolk sacs exhibit severe defects in vascular development. 
Arrowheads show a defined and organized vessel structure in the WT yolk sac (left), whereas 
the FNCC>SS/CC>SS yolk sac contains a primitive vascular plexus of dilated blood vessels that 
leak into the yolk sac tissue. H, heart; P, placenta; VP, vascular plexus; VV, vitelline vessel; 
YS, yolk sac. * denotes oedema within the pericardium surrounding cardiac tissue in 
FNCC>SS/CC>SS embryos. Scale bar 500 µm. 
 
Vascular development in the FNCC>SS/CC>SS yolk sacs was examined in closer detail by visualising 
vessels with an antibody specific for PECAM-1. First, I compared the vascular plexus of E8.5 yolk sacs 
of WT and FNCC>SS/CC>SS embryos and found that at this stage all yolk sacs were of comparable size 
and showed similar characteristics of a primitive plexus of vessels with uniform diameter and 
extending throughout the entire yolk sac (fig. 8.6 A). Hence vasculogenesis occurs normally in 
FNCC>SS/CC>SS yolk sacs. 
Next I compared yolk sacs from E9.5 embryos. At this stage, a WT yolk sac vasculature will have 
undergone substantial remodelling to build a hierarchy of highly branched large and small calibre 
vessels. However, the vasculature of FNCC>SS/CC>SS yolk sacs had failed to undergo the same 
remodelling programme and therefore lacks any hierarchical organisation and branching of vessels (fig. 
8.6 B). 
Futher histological analysis of E9.5 yolk sac sections demonstrated that FNCC>SS/CC>SS yolk sacs 
have abnormally large vessel lumens (fig. 8.6 C), explaining the blistered gross-morphological 
appearance of FNCC>SS/CC>SS yolk sacs. Large vascular lumens in the yolk sac have been described 
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before and are often interpreted as deriving from defective cell-matrix adhesion resulting in weak 
attachment between the extra-embryonic endoderm and mesoderm layers of the yolk sac. Consistent 
with this interpretation, large lumens were described for yolk sacs of both FN knock-out (George et 
al., 1993; George et al., 1997) and integrin α5 knock-out mice (Yang et al., 1993), but have also been 
described for mutant mice lacking diverse growth factor signals such as TGF-β1 (Larsson et al., 2001) 
and VEGF-A (Carmeliet et al., 1996). Together these findings suggest defects in the complex interplay 
of growth factor- and cell adhesion-mediated vascular remodelling in the FNCC>SS/CC>SS mouse.  
 
 
Figure 8.6. Defective remodelling of the primitive vascular plexus in FNCC>SS/CC>SS yolk sacs. 
Flat-mounted WT and FNCC>SS/CC>SS yolk sacs at (A) E8.5 and (B) E9.5 were 
immunostained with an antibody against PECAM-1. (C) Cryo-sections of WT and 
FNCC>SS/CC>SS yolk sac at E9.5 stained by H&E. BC, blood cell; E, extraembryonic 
endoderm; M, extraembryonic mesoderm. Scale bars: (A) 100 µm, (B) 200 µm, (C) 100 µm. 
 
8.2.2 Distribution of mural cell within the FNCC>SS/CC>SS yolk sac primitive vascular plexus 
Although vasculogenesis does not depend on mural cells, the subsequent survival, remodelling and 
stabilisation of remodelled vessels (i.e. angiogenesis) relies strongly on the short-range signalling 
between mural cells and endothelium (Abramsson et al., 2003) Also add Lindahl et al 1997a. 
FNCC>SS/CC>SS yolk sac vasculatures show clear signs of stalling their development at the remodelling 
stage, and therefore I investigated the extent of mural cell differentiation and investment of yolk sac 
blood vessels.  
Using α-smooth muscle actin (α-SMA) as a marker for mural cells, WT yolk sacs were found to 
contain mural cells associating with the underlying endothelium according to vessel calibre; high-
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calibre vessels were associated with a high density of mural cells whereas low-calibre capillaries showed 
more sparse association with mural cells (fig. 8.7 A). In FNCC>SS/CC>SS yolk sacs, α-SMA-positive mural 
cells were present in the vascular plexi, but in contrast to WT yolk sacs, these mural cells were highly 
abundant and distributed randomly across the entire plexus.  
 
 
Figure 8.7. Abnormal distribution of mural cells within the vasculature of FNCC>SS/CC>SS yolk 
sac. (A) Flat-mounted WT and FNCC>SS/CC>SS yolk sacs at E9.5 were immunostained with 
antibodies against PECAM-1 (green) and α-SMA (red), and nuclei were stained with DAPI 
(blue). (B) Cryo-sections of WT and FNCC>SS/CC>SS yolk sacs at E9.5 were immunostained with 
antibodies against PECAM-1 (green) and α-SMA (red), and nuclei were stained with DAPI 
(blue). MC, mural cell; EC, endothelial cell; M, extraembryonic mesoderm; E, extraembryonic 
endoderm. Scale bar: 100 µm. 
 
The association of mural cells with the endothelium was also examined in histological sections of 
E9.5 yolk sacs. Cross-sections of WT yolk sacs showed an intimate association between mural cells and 
the endothelium surrounding narrow lumens (fig. 8.7 B). Most fields of FNCC>SS/CC>SS yolk sac cross 
sections revealed abnormally large lumens that were fully lined with endothelium, but only sparsely 
lined by mural cells. The majority of α-SMA-positive mural cells appeared to be associated with the 
extraembryonic mesoderm, and those that were found lining the vessel appeared correctly associated 
with the endothelium. While these data unanimously indicate that the FNCC>SS/CC>SS endothelium 
supports both the recruitment of mesenchymal cells and their differentiation into α-SMA-positive 
mural cells, where else the functional defect lies remains unclear. The random distribution of mural 
cells along the FNCC>SS/CC>SS yolk sac endothelium appears to reflect the lack of vascular hierarchy 
within the underlying endothelium and suggests that the failure of the primitive plexus to remodel 
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primarily relates to an endothelial cell-autonomous defect. However, an inability of mural cells to 
migrate and align correctly with the endothelium could also abrogate the pro-angiogenic paracrine 
signalling events between endothelial cells and mural cells and thereby stall angiogenesis. Given that 
FN is a prominent component of the vascular basement membrane shared between endothelial cells 
and mural cells, it is possible that FNCC>SS impairs the alignment and paracrine signalling between 
endothelium and mural cells. 
8.2.3 Placentation defects in FNCC>SS/CC>SS embryos  
Placental development is accompanied by chorioallantoic fusion, vascular growth from the allantoic 
mesoderm and vascular infiltration of the placenta. As shown earlier, the majority of both 
FNCC>SS/CC>SS and WT embryos alike had built an allantois that appeared to have made contact to the 
chorion between E8.5 and E9.5. Normally, just hours after chorioallantoic fusion, embryonic vessels 
develop from the allantoic mesoderm and sprout into the placenta to establish the embryonic 
components of the placental vascular network. By E10.5, these embryonic vessels will have formed 
finger like projections into the placental labyrinth layer (Rossant and Cross, 2001). Indeed this was 
evident for WT placenta sectioned parasagitally and immunostained against endomucin (fig. 8.8). In 
contrast, immunohistochemical analysis of FNCC>SS/CC>SS placental tissue revealed a complete failure of 
embryonic vessels to emerge from the allantois to penetrate the chorion and sprout into the maternal 
labyrinthine layer of the placenta. This finding could explain the cause of the abnormal appearance of 
the allantoic tissue at E10.5. 
 
 
Figure 8.8. Placental vascularisation defects in FNCC>SS/CC>SS embryos. Histological cross-
sections of E10.5 placental tissue were stained with an antibody against endomucin. c, 
chorion; ev, embryonic vessel; ll, labyrinthine layer. Scale bar 100 µm. This dataset was 
obtained by Dr. Michael Leiss. 
 
In response to failing to establish circulation between embryonic and maternal tissue, the allantoic 
tissue begins to regress and degenerate, while plasma originating from the embryo accumulates at the 
base of the allantois and causes oedema. Without intermingling of embryonic and maternal vessels, 
there can be no exchange of waste products or nutrients to support the growth of the embryo. Thus 
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placental insufficiency caused by inefficient vascularisation is a plausible cause of lethality in 
FNCC>SS/CC>SS embryos.  
8.2.4 Embryonic vascular remodelling defects 
To investigate the vascular infrastructure of E9.5 FNCC>SS/CC>SS embryos, the embryo proper was 
examined by detecting vessels with an antibody against endomucin. A striking feature of the 
FNCC>SS/CC>SS embryos at E9.5 was the weak antigenicity for endomucin antibody in the cranial tissue, 
indicating a paucity of cranial vessels in a region where the WT littermate otherwise show dense, 
clearly patterned and elaborate networks of endomucin-positive blood vessels (fig. 8.9). In 
FNCC>SS/CC>SS embryos blood vessels in appear constricted and chaotically arranged, in contrast to the 
hierarchical arrangement of branching vessels in the head of WT embryos. Beyond the head region, 
the endomucin staining highlights the vascular lining of the dorsal aorta and pharyngeal arches. Again, 
these vascular structures were found to appear narrow in FNCC>SS/CC>SS embryos, which would 
obstruct the flow of blood to the tissues they supply. 
 
 
Figure 8.9. Abnormal vascular patterning in the FNCC>SS/CC>SS embryo proper. Whole mount 
E9.5 WT and FNCC>SS/CC>SS embryos were immunohistochemically stained with an antibody 
against endomucin. The dotted line outlines the dorsal aorta and pharyngeal arteries, which 
are well-defined in WT embryos, but appear constricted in FNCC>SS/CC>SS embryos. DA, 
dorsal aorta H, head; OP, optic pit; PA, pharyngeal artery. Scale bar: 250 µm. These data 
were obtained by Dr. Michael Leiss. 
 
Similar traits of immature vascular development and defective vascular interconnections emerged 
from whole mount immunostainings of the vasculature in the trunk region of E9.5 FNCC>SS/CC>SS 
embryos stained with antibodies against PECAM-1 (fig. 8.10). WT embryos at E9.5 showed an 
extensive vascular network infiltrating the entire trunk and tail region. Vessels were found to sprout 
from the dorsal aorta into the intersomitic regions and emerge on the dorsal side of the somites where 
they anastamose. Compared to WT littermates, the blood vessels appeared scarce throughout the 
entire trunk and tail region of FNCC>SS/CC>SS embryos. Similar to the endomucin stainings above, 
PECAM-1 stainings outlined a very thin dorsal aorta and pharyngeal arch arteries, and particularly 
striking was the deficiency in sprouting of intersomitic vessels from the dorsal aorta into the 
intersomitic region. 
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I assessed the presence of myocardial tissue in E9.5 embryos by whole mount immunostaining of 
α−SMA, which is a prominent intracellular component of the contractile myocardium (fig. 8.10). Both 
WT and FNCC>SS/CC>SS embryonic hearts showed prominent α−SMA-positive myocardium encasing 
the endocardium, but highlighted striking differences in the size and shape of the FNCC>SS/CC>SS heart 
tube.  
 
 
Figure 8.10. Lack of vascular expansion throughout FNCC>SS/CC>SS embryos. Confocal 
immunofluorescence images of whole mount E9.5 WT and FNCC>SS/CC>SS embryos stained 
with antibodies against PECAM-1 (green) and αSMA (red). DA, dorsal aorta; ISV, 
intersomitic vessel; OP, otic placode; PA, pharyngeal arch arteries; S, somite. Scale bar 500 
µm. 
 
8.2.5 FNCC>SS/CC>SS embryos develop cardiac defects 
The enlarged pericardial sacs, heart oedema and signs of a growth defect of the myocardium shown 
earlier suggested a failure of the FNCC>SS/CC>SS primitive heart tube to elongate and undergo looping 
morphogenesis. This prompted me to examine how FNCC>SS distorts endocardial morphogenesis. 
Endocardial morphology in E9.5 WT and FNCC>SS/CC>SS embryos was analysed by immuno-staining 
with an antibody against PECAM-1. At E9.5, the WT heart tube had proceeded through rightward 
looping morphogenesis to bring the segments of the heart tube close to their final topographical 
position whereas the endocardial morphology of FNCC>SS/CC>SS embryos was severely distorted (fig. 
8.11 A). The degree of distortion varied among FNCC>SS/CC>SS embryos, but in all cases observed the 
endocardium curvature appeared irregular and the endocardial heart tube was both stunted and had 
failed to complete rightward looping morphogenesis. Immuno-histological analysis of E9.5 embryonic 
hearts sectioned in transverse and stained with antibodies against PECAM-1 demonstrated an inability 
of the FNCC>SS/CC>SS endocardium to extend and interact with the surrounding myocardium (here 
indicated by DAPI stain) (fig. 8.11 B).  
Although these structurally deformed heart tubes in FNCC>SS/CC>SS embryos appeared to have 
adequate ample myocardial coverage (cf. fig. 8.10) and were showing regular contractions at the time of 
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dissection, the failure to undergo looping morphogenesis is likely to affects the ability of the mutant 
heart to establish and maintain a sufficient level of blood circulation as the embryos grow. 
Interestingly, very recent work has shown that vascular remodeling in the mouse yolk sac is secondarily 
affected when cardiac function and proper circulation is reduced or absent (Lucitti et al., 2007). This 
raises the possibility that blood vessel remodelling defects in FNCC>SS/CC>SS embryos is a secondary 
effect of the malformed cardiac tissue and a lack of hemodynamic force. 
While such cardiac remodelling defects could relate to a number of faulty mechanisms, such as a 
general left/right asymmetry abnormality in FNCC>SS/CC>SS embryos, ventral closure defects or even 
deficiencies in the lateral plate mesoderm.  
 
 
Figure 8.11. Failure in cardiac looping morphogenesis in FNCC>SS/CC>SS embryos. (A) 
Confocal images of whole mount E9.5 WT and FNCC>SS/CC>SS endocardiac tissue from a 
parasastained with an antibody against PECAM-1. The dotted line outlines the endocardium. 
(B) Immunofluorescence images of paraffin sectioned E9.5 WT and FNCC>SS/CC>SS embryos 
that were stained with an antibody against PECAM-1 (green) and DAPI (blue) for nuclei. * 
indicates point of contact between endocardium (green) and myocardium (blue), of which 
there are only a few in FNCC>SS/CC>SS cardiac tissue. DA, dorsal aorta; E, endocardium; M, 
myocardium; NT, neural tube. Scale bar 200µm. 
 
8.2.6 Misoriented and deformed myotomal myocytes in FNCC>SS/CC>SS embryos  
Although malformations in the cardiovascular system are prominent features of the FNCC>SS/CC>SS 
embryos and likely to be the cause of embryonic lethality, the developmental defects caused by the 
FNCC>SS knock-in mutation are not restricted to the cardiovascular system. For example, α-SMA-
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immunostaining of whole mount E9.5 embryos revealed a striking difference in the organisation of 
myotomal cells within the somites. WT embryos showed clusters of fully aligned α-SMA-positive cells 
that were stretched and elongated through what appeared to be attachments to the intersegmental 
borders. In stark contrast, α-SMA-positive myotomal cells in FNCC>SS/CC>SS embryos were strongly 
reduced in numbers and found to populate only the anterior-most somites (fig. 8.12). 
 
 
Figure 8.12. Abnormal number and orientation of α-SMA-positive myocytes residing in the 
somites. Confocal immunofluorescence images of a parasagittal view on whole-mount E9.5 
WT and FNCC>SS/CC>SS embryos, stained with antibodies against PECAM-1 (green) and α-
SMA (red). Nuclei are stained with DAPI (blue). Paired images compare tissue at the 
anterior-most somite level. A, anterior; D, dorsal; isv, intersomitic vessel; m, myotomal 
myocyte; P, posterior; s, somite; V, ventral. Scale bar 100 µm. Experiments of this type was 
performed on at least 3 indiviual embryos. 
 
The myotome is a segmented, transitory muscle that forms within the somite and transitions into 
the epaxial and hypaxial muscles (deep back muscles) of the adult vertebrate organism (Deries et al., 
2010). Myotomal myocytes differentiate from myoblasts and elongate to span the length of each 
somite in parallel to the anterior-posterior axis of the embryo by attaching to the intersegmental 
boundary of the somite. The unusually low number of myotomal myocytes in FNCC>SS/CC>SS embryos 
suggests an inability of dermomyotomal myoblasts to differentiate into myocytes. The misorientation 
and misalignment, in turn, suggest an inability of the myotomal myocytes to sense the alignment of 
neighboring myocytes and/or attach to the intersegmental boundary. These myotomal myocyte defects 
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are accompanied by their rounding up and disintegration in an anoikis-like manner. Such an 
attachment defect could reflect a failure of monomerised FNCC>SS matrix to support myocyte 
attachment due to mechanical flaws of the matrix, which is a theme that will be explored futher. 
 
8.3 Characterisation of FN expression and distribution in FNCC>SS/CC>SS embryos 
To begin understanding the cellular and molecular consequences of preventing FN dimerisation, an 
analysis of FN expression, distribution and assembly was performed in WT and FNCC>SS/CC>SS 
embryos. The expression level of FN in WT and FNCC>SS/CC>SS littermate embryos was determined by 
real time quantitiative PCR (RT-qPCR) analysis of cDNA isolated from single E8.5 yolk sacs. Here, 
WT and FNCC>SS/CC>SS littermates were found to have comparable levels of FN transcript (fig. 8.13 A).  
 
 
Figure 8.13. FN expression and synthesis in WT and FNCC>SS/CC>SS tissue. (A) RT-PCR 
analysis of FN gene expression based on cDNA prepared from individual E8.5 WT (n=3) 
and FNCC>SS/CC>SS (n=4) yolk sacs. Error bars represent standard deviation. (B) Non-
reducing SDS-PAGE and western blot analysis of total FN in single E9.5 WT, FN+/CC>SS 
and FNCC>SS/CC>SS embryo lysates. di, dimeric FN; mo, monomeric FN. Data shown in (B) 
was obtained by Dr. Michael Leiss. 
 
Both the total levels and molecular weight distribution of non-reduced FN protein isolated from 
WT and FNCC>SS/CC>SS embryos was analysed by western blotting. Single E8.5 embryo lysates were 
resolved by SDS-PAGE under non-reducing conditions to preserve disulfide-mediated dimers, when 
present. Western blot analysis showed that total FN protein levels were comparable between WT and 
FNCC>SS/CC>SS embryos. Furthermore, while WT embryos accumulated mainly a high molecular weight 
form of FN (i.e., greater than 400 kDa), representing the dimeric form of FN, the FN isolated from 
FNCC>SS/CC>SS embryos was exclusively of a low molecular weight form (i.e., ca. 250 kDa), which 
represents monomeric FN (fig. 8.13 B).  
The distribution of FN in WT and FNCC>SS/CC>SS embryos was analysed by histological analysis of 
E9.5 embryo parasagittal sections stained with antibodies against FN. In both WT and FNCC>SS/CC>SS 
embryos, FN is abundant in the majority of tissues, including the head mesenchyme, endocardium, 
intersomitic regions and pre-somitic mesoderm. Hence, the monomerised form of FN is expressed 
and distributed normally throughout the FNCC>SS/CC>SS embryo (fig 8.14). 
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Figure 8.14. Distribution of FN in E9.5 WT and FNCC>SS/CC>SS embryos. 
Immunofluorescent images of parasagittal embryo paraffin sections stained with antibody 
against FN (green). Nuclei are stained by DAPI (blue). H, head mesenchyme; E, 
endocardium; ISR, intersomitic region; PSM, presomitic mesoderm. Scale bar 500 µm. These 
data were obtained by Dr. Michael Leiss. 
 
Given the striking vascular remodelling defects of the yolk sac, I also examined the distribution of 
FN in histological sections of E9.5 WT and FNCC>SS/CC>SS yolk sacs. Cross-sections contained FN in 
the basement membrane between endothelium and mural cells and showed little difference in the 
amounts or distribution of FN between WT and FNCC>SS/CC>SS yolk sacs (fig. 8.15).  
 
 
Figure 8.15. Distribution of FN in E9.5 WT and FNCC>SS/CC>SS yolk sacs. 
Immunofluorescence images of yolk sac cryosections stained with antibody against FN 
(green). Nuclei are stained by DAPI (blue). EE, extraembryonic endoderm; EM, 
extraembryonic mesoderm. Scale bar 50 µm. 
 
PhD Thesis - Josefine Gibson  Results 
 
 88 
Having found normal patterns of expression and distribution of FN in FNCC>SS/CC>SS embryos and 
yolk sacs, I asked whether the monomeric form of FN in FNCC>SS/CC>SS embryos was present in a 
fibrillar form. Studies from other labs have concluded that if FN is prevented from dimerising, it 
cannot undergo de novo fibrillogenesis and is therefore not deposited in a fibrillar form 
(Schwarzbauer, 1991). The fact that FNCC>SS/CC>SS embryos survive longer than FN knock-out mice 
suggests that the FNCC>SS deposited in embryonic tissues could retain some functions that relate to its 
fibrillar state. To investigate the fibrillar state of FN in WT and FNCC>SS/CC>SS tissue, E9.5 embryos 
were stained with an antibody against FN and examined as whole-mounts by confocal microscopy.  
Representative images of FN in comparable regions of somite and cranial tissue demonstrate the 
fibrillar nature of FN in WT and FNCC>SS/CC>SS (fig. 8.16 A). All embryonic tissues unanimously 
revealed that FN in FNCC>SS/CC>SS embryos is present in a fibrillar form. This is the first demonstration 
that FN that is prevented from dimerising can undergo de novo fibrillogenesis and that FN 
fibrillogenesis does not strictly require FN dimerisation.  
When compared to the FN fibrillar matrix in corresponding tissues of WT embryos, subtle 
morphological differences in the fibrillar character of FN in FNCC>SS/CC>SS embryos are noticed. In 
FNCC>SS/CC>SS embryos, FN fibrils appear both structurally less compact and mostly shorter than fibrils 
of WT FN. To quantify the distribution of FN fibril length, projections of high-magnification confocal 
z-stacks of WT and FNCC>SS/CC>SS embryonic tissue were analysed with a tracking function in ImageJ 
software. Single fibrils in z-stack projections of equal thickness were tracked manually, and the lengths 
of these traces were collected for statistical analysis. Care was taken to track fibrils that had clear 
inititation and end points within the plane of the image. To ensure an unbiased analysis, fibrils were 
tracked under blinded conditions, which meant that genotype of a given tissue was revealed only after 
the analysis. 
This fibril length analysis confirmed that FN matrix in FNCC>SS/CC>SS tissue represents a distinct 
population of fibrils that are shorter than FN fibrils in WT tissue (fig. 8.16 B). FN fibrils in WT tissue 
tend to form fibrils greater than 6-8 µm long and have a median length of 7.46 µm, while most fibrils 
of monomeric FN are less than 4-6 µm long and have a median length of 4.45 µm. Statistical analysis 
using the Wilcoxen-Mann-Whitney test, which does not assume Gaussian distribution, showed that 
this difference in fibril length is highly significant (p<0.001) (fig. 8.16 C). 
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Figure 8.16. Morphology of the FN fibrillar matrix in WT and FNCC>SS/CC>SS embryonic 
tissue. (A) Confocal immunofluorescence images of head (left column) and somite tissue 
(right column) in whole-mount E9.5 embryos stained with antibody against FN. Scale bar 50 
microns. (B) Histogram of the FN fibril length distribution in WT and FNCC>SS/CC>SS tissue. 
(C) Box and whisker plot of fibril lengths, shows that FNCC>SS fibrils are significantly shorter 
than WT FN fibrils. Grey dots indicate data points that lie outside the 75th percentile and 
clear dots indicate presumed otliers. Absolute median fibril length of WT FN=7.46 µm, and 
FNCC>SS =4.45 µm. Significance was determined by the Wilcoxen-Mann-Whitney test, *** 
p<0.001. Analysis was performed on at least three individual embryos of each genotype. 
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8.4 Biochemical and physical characterisation of the FNCC>SS matrix 
The data presented in the previous chapter established that FN deposited by FNCC>SS/CC>SS 
embryonic tissue is fibrillar, but this fibrillar monomeric FN matrix is morphologically distinct from 
WT FN matrix. The following characterisation of the monomeric FN matrix is based on in vitro, cell 
culture-based experiments with cell-derived ECM. The ability to culture cells that deposit ECM allows 
us to investigate the kinetics of FN fibrillogenesis in a way that cannot be done in vivo. ECM generated 
in culture setups also provides a means to assay the cellular response to mutant FN, which in turn 
could help us understand the effect of mutant FN on embryonic development. Some of the following 
experiments relied on mouse embryonic fibroblasts (MEFs) that were isolated from E9.5 WT and 
FNCC>SS/CC>SS embryos by Dr. Michael Leiss and described in his thesis work. Both mixed populations 
and clonal cell lines of MEFs were used to address questions related to the characterisation of FNCC>SS. 
Clonal MEFs were selected on the basis of their integrin surface expression profile, which was 
determined by fluorescence-activated cell sorting (FACS) analysis. The selection criteria for WT and 
FNCC>SS/CC>SS clones were (a) a comparable surface expression level of FN-binding integrins, (b) low 
surface levels of α4 integrins, which interact with FN in an RGD motif-independent manner, and (c) 
low levels of α2 integrins that bind laminin, collagen and thrombospondin. As such, the clones that 
were chosen for subsequent analysis had equal levels of α2, α5, α6, αV, α4, β1 and β3 integrins (fig. 
8.17 A). 
To assess the ability of the selected clones of WT and FNCC>SS/CC>SS MEFs to assemble FN, the 
MEFs were cultured in serum replacement medium supplemented with exogenous pFN at 60 nM for 2 
days. The resulting ECM was stained with antibodies against FN and integrin α5, as a molecular 
marker of fibrillar adhesions. The movement of α5β1 integrins along actin stress fibres to form 
fibrillar adhesions induces the extension of FN fibrils on the cell surface, which exposes cryptic 
binding sites within FN and allows it to associate with other FN molecules and form supramolecular 
bundles. Immunofluorescence imaging revealed the presence of long bundles of FN fibrils deposited 
in the ECM of both WT and FNCC>SS/CC>SS MEFs and that in both cultures, the FN fibrils aligned with 
streaks of α5 integrin-positive fibrillar adhesions. Importantly, these results indicate a comparable 
capacity of the FN-binding integrins expressed on the surface of WT and FNCC>SS/CC>SS MEF clones 
to assemble exogenous pFN (fig. 8.17 B). Furthermore, given that FNCC>SS/CC>SS clones assemble WT 
FN in the presence of endogenous mutant FN implies that FN derived from FNCC>SS/CC>SS MEFs does 
not have a dominant-negative effect on FN fibrillogenesis. 
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Figure 8.17. Surface integrin expression profile and FN fibrillogenesis competence of 
selected WT and FNCC>SS/CC>SS MEF clonal cell lines (A) Representative histograms of 
FACS analysis of integrins α2,  α4,  α5,  α6,  α6, β1 and β3 expression (red lines) compared 
to isotype controls (black). (B) Immunofluorescence images of WT and FNCC>SS/CC>SS MEF 
clonal cell lines, cultured in the presence of exogenous pFN (60nM), stained with antibodies 
against FN (red) and integrin α5 (green). Nuclei were stained by DAPI (blue). Scale bar 15 
µm. These data were obtained by Dr. Michael Leiss. 
 
8.4.1 FN fibrillogenesis by FNCC>SS/CC>SS mouse embryonic fibroblasts 
To determine the capacity for fibrillogenesis of endogenous FN by FNCC>SS/CC>SS MEF and to 
compare the kinetics of FN fibrillogenesis by WT and FNCC>SS/CC>SS MEF clones, I designed time-
course assays to follow the progressive deposition and assembly of FN fibrils over time. To this end, 
WT and FNCC>SS/CC>SS MEF clones were seeded on laminin111-coated glass and cultured in serum-
replacement medium supplemented with 0.5% FN-depleted FBS to avoid introducing WT pFN to the 
cultures. At defined time points ranging from eight to ninety-six hours after cell seeding, the cultures 
were fixed in 4% PFA and stained with antibodies against FN. 
A typical FN fibrillogenesis assay showed that after eight hours of culture time, both WT and 
FNCC>SS/CC>SS MEFs had initiated FN fibrillogenesis, generating a nearly complete carpet of short and 
delicate fibrils (fig. 8.18). By twenty-four hours of culture, the fibrillar morphology of FN derived from 
FNCC>SS/CC>SS MEFs remained indistinguishable from WT FN. Hence both WT and FNCC>SS/CC>SS 
MEF clones showed comparable kinetics of early fibril formation. However, after fourty-eight hours 
of culture time, WT FN fibrils had developed into long bundles, spanning multiple cell bodies and 
interconnecting with other long FN fibrils, whereas the complexity of the FN matrix derived from 
FNCC>SS/CC>SS MEFs had not changed from the previous time point such that individual FN fibrils still 
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appeared short and delicate. Over the course of the following fourty-eight hours, the WT FN matrix 
continued to evolve into a highly complex matrix of large, and heavily inter-twined bundles. In 
contrast, the FN matrix derived from FNCC>SS/CC>SS MEF cultures appeared static and failed to 
undergo any structural elongation or compaction. Hence, these data reiterate that FN lacking the C-
terminal dimerisation motif does undergo de novo fibrillogenesis. However, fibrillogenesis of 
monomeric FN beyond the early stages appears to reach a growth plateau beyond which fibrils cannot 
grow in length or thickness. 
 
 
Figure 8.18. Kinetics of FNCC>SS fibrillogenesis. Immunofluoresence images of WT and 
FNCC>SS/CC>SS MEF clonal cell lines cultured for the indicated period of time in the presence 
of 0.5% FN-depleted FBS. The FN matrix is stained with antibodies against FN and nuclei 
are stained by DAPI. Scale bar 25 µm. 
 
To exclude that a distinct morphology of the monomeric FN matrix arises due to differences in the 
total levels of FN protein deposited into the ECM, the FN content in lysatses of WT and 
FNCC>SS/CC>SS MEF cultures was analysed by western blotting. This analysis confirmed that the levels 
of FN synthesised and deposited into the matrix by WT and FNCC>SS/CC>SS MEFs was comparable (fig. 
8.19). Thus the inability of monomeric FN fibrils to grow in length and thinkness was neither related 
to the quantity of FN nor an inability of integrins expressed on the surface of FNCC>SS/CC>SS MEFs to 
induce FN fibrillogenesis.  
 
Figure 8.19. Western blot analysis of WT FN and FNCC>SS levels deposited into the ECM by a WT 
and FNCC>SS/CC>SS MEFs. Representative western blot comparing the FN content of lysates of 
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both WT and FNCC>SS/CC>SS MEF clonal cell line resolved by SDS-PAGE under reducing 
conditions. 
 
To confirm the unique features of monomeric FN fibrillogenesis and exclude possible artefacts 
derived from MEF clonal cell lines, I tested the ability of FN-/- mouse fibroblasts (Sakai et al., 2001) to 
assemble either monomeric mouse pFN or WT mouse pFN. To generate monomeric mouse pFN, 
FN+/CC>SS females were crossed with males carrying the inducible Cre recombinase transgene under the 
control of the Mx1 promoter (Mx1Cre) (Kühn et al., 1995) and both FN alleles flanked by loxP sites 
(FNfl/fl Mx1Cre). Among the offspring of this cross, I selected FNCC>SS/fl Mx1Cre test mice and FN+/fl 
Mx1Cre control mice for intraperitoneal injection of poly(I:C). This double-stranded RNA induces 
Mx1Cre expression in the liver and thus drives the excision of the floxed FN allele in hepatocytes 
(Kühn et al., 1995), while the second FN allele remains intact and is continuously expressed. Succesful 
ablation of the floxed FN allele in liver tissue upon poly(I:C) treatment was monitored by PCR (not 
shown). By western blot analysis of FN content in plasma samples, I confirmed the presence of 
exclusively pFNCC>SS or WT pFN derived from the single intact FN allele in hepatocytes after 
poly(I:C)-induced, Cre-mediated excision of the floxed FN allele. (fig. 8.20).  
 
 
Figure 8.20. Western blot analysis of FN content in plasma from FN+/fl and FNCC>SS/fl mice 
after treatment with pI:C. These are representative western blots to demonstrate the analysis 
that was routinely performed to ensure the excision of the floxed FN allele upon pI:C 
treatment. These blots show that there is no floxed (WT) FN after pI:C treatment of 
FNCC>SS/fl Mx1Cre mice. Under non-reducing conditions, WT (dimeric) FN migrates as a 
high-molecular weight protein (>400 kDa), and monomerised FNCC>SS migrates at 
approximately 250 kDa. Under reducing conditions, both WT and monomerised FN migrate 
at 250 kDa. Although plasma samples from two different FN+/fl mice were loaded onto these 
gels for analysis, one sample shows no FN, indicating a technical error in the experiment. 
 
Plasma for cell culture experiments was isolated from whole blood isolated from poly I:C-treated 
FNCC>SS/fl and FN+/fl Mx1Cre mice and pooled for use and storage. I specifically chose not to purify 
pFN from plasma to avoid artefacts that could arise from this manipulation. The pFN assembly assay 
was performed by seeding FN-/- mouse fibroblasts onto LM111-coated glass coverslips and culturing 
them in serum replacement medium supplemented with 5% (v/v) mouse plasma containing either 
pFNCC>SS or WT pFN. After two days of culture, the assembled pFN matrix was examined by 
immunostaining with antibodies against FN and integrin α5.  
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Immunofluorescence imaging showed a drastic difference between the fibrillar morphology of FN 
matrix generated with WT pFN and pFNCC>SS (fig. 8.21). WT pFN is assembled into a complex matrix 
of long and thick bundles of fibrils, whereas pFNCC>SS is assembled into very short fibrils that do not 
bundle into supramolecular structures like WT pFN fibrils do. The short fibrils within the pFNCC>SS 
matrix versus the highly complex fibrillar arrangement within a WT pFN matrix is remarkable given 
that the same cell type generated these two very different matrices. This finding implies that the 
distinct fibrillar morphology of monomeric FN is exclusively related to properties of the FN, rather 
than the cell line. Furthermore, these assembly assays of both pFN and cFN support the in vivo data 
showing that FN fibrils are shorter in FNCC>SS/CC>SS tissue ECM compared to WT ECM (fig. 8.16). 
These results unanimously show that preventing C-terminal disulfide bond-mediated dimerisation of 
FN imposes a structural limitation on the degree of fibril complexity that can be achieved once 
integrins have unfolded FN. 
 
 
Figure 8.21. Fibrillar morphology of WT pFN and pFNCC>SS as assembly by FN-/- mouse 
fibroblasts. Immunofluorescence images of FN-/- fibroblasts cultured in the presence of 
mouse plasma containing either WT pFN (from FN+/fl Mx1Cre mouse) or pFNCC>SS (from 
FNCC>SS/fl Mx1Cre mouse) for 48 hours and stained with antibodies against FN (red) and 
integrin α5 (green). Nuclei are stained by DAPI. Scale bar: 15 µm.  
 
The abnormal fibrillar morphology of FN observed in both the ECM of FNCC>SS/CC>SS MEF clones 
(fig. 8.18) as well as the pFNCC>SS matrix generated by FN-/- fibroblasts (fig. 8.21) raised the question 
whether integrin α5β1 might cluster differently within fibrillar adhesions during the assembly of 
FNCC>SS. Within the same experimental framework as used to demonstrate the fibrillar nature of 
FNCC>SS matrix, I examined the morphology of fibrillar adhesions in FN-/- cells assembling either WT 
or monomeric pFN, using integrin α5 as a marker of fibrillar adhesions (fig. 8.21). Despite the 
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dramatic differences between pFNCC>SS and WT matrices in terms of supramolecular organisation of 
FN fibrils, the α5β1-containing fibrillar adhesions in FN-/- fibroblasts showed no overt difference in 
size or cellular distribution (fig. 8.21). Such a finding indicates that the ability of integrin α5β1 to 
segregate from focal adhesions and move centripetally along stress fibres does not require FN 
dimerisation. Furthermore, the full alignment between pFNCC>SS and integrin α5β1 within fibrillar 
adhesions shows that FNCC>SS incorporates into fibrillar adhesions and becomes unfolded sufficiently 
to allow interaction with other FNCC>SS molecules and thereby form small local bundles. The 
subsequent failure of FNCC>SS to transform into complex supramolecular structures indicates that 
failure to dimerise limits the process of lateral association and fibril elongation. 
A similar approach to understanding the relationship between fibrillar adhesions and fibrillogenesis 
of FNCC>SS was taken in the clonal MEF lines depositing endogenous cFN. To this end, WT and 
FNCC>SS/CC>SS MEF clones were seeded onto LM-111-coated glass coverslips and cultured in serum 
replacement medium supplemented with FN-depleted FBS for eighteen hours to allow fibrillar 
adhesion formation and fibrillogenesis of endogenous FN. FN and integrin α5 were stained with 
antibodies to detect cFN fibrils and fibrillar adhesions, respectively, while cytoskeletal F-actin was 
stained with fluorophore-conjugated phalloidin. 
 
  
Figure 8.22. Morphology of fibrillar adhesions in WT and FNCC>SS/CC>SS MEFs. 
Immunofluorescence images of WT and FNCC>SS/CC>SS MEF clonal cell lines cultured in 
0.5% FN-depleted serum for 18 hours and stained with antibodies against FN (green) and 
integrin α5 (red). Nuclei are stained by DAPI (blue). Scale bar 15 µm. These data were 
obtained by Dr. Michael Leiss. 
 
Immunofluorescence imaging showed that WT MEF clones developed elongated and streak-like 
fibrillar adhesions in which long FN fibrils align with both integrin α5β1 and F-actin (fig. 8.22). In 
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contrast, fibrillar adhesions on FNCC>SS/CC>SS MEFs were considerably shorter, thereby closely 
resembling the short fibrils of FNCC>SS associtated with the cell surface of the FNCC>SS/CC>SS MEFs. 
Once again, the association of integrin α5β1 with FNCC>SS in FNCC>SS/CC>SS MEFs indicates that 
these integrins participate in the initial processing of FNCC>SS. The stunted appearance of fibrillar 
adhesions could suggest that FNCC>SS affects the abilty of integrin α5β1 to cluster and trigger the 
biochemical signals that activate the bundling and contractile effect of NM-II on F-actin, resulting in 
the failure to extend fibrillar adhesions. However, it is worth stressing that the discrepancy of these 
results with those of FN-/- cells cultured in the presence of pFN could relate to the fact that the WT 
and FNCC>SS/CC>SS MEF clones used in the latter experiment are essentially different cell lines. Despite 
having been selected for comparable integrin surface expression levels, we know little about how else 
these cells might differ. As such, the FN-/- cells represent a more robust system with which to evaluate 
the fibrillogenesis of normal and mutant FN.  
8.4.2 Chemical cross-linking within a FNCC>SS matrix 
The unique fibrillar morphology of both pFNCC>SS and cFNCC>SS prompted an investigation into 
the degree of intermolecular cross-linking within the FNCC>SS matrix. FN cross-linking is commonly 
addressed by assaying the fraction of total FN that remains insoluble in 1% deoxycholate (DOC), as 
described by Pankov and Yamada (Pankov and Yamada, 2004). Solubilising the ECMin 1% DOC 
fractions FN into a DOC-soluble and –insoluble fraction. While the DOC-insoluble fraction contains 
FN that, over time, has become cross-linked to the extent that it resists solubilisation in detergent, the 
DOC-soluble fraction contains only newly assembled FN that has yet to become cross-linked. Hence, 
the distribution of FN in DOC soluble and insoluble fractions reflects the degree of chemical cross-
linking within a fibrillar FN matrix. 
To perform DOC fractionation of WT FN and FNCC>SS, mixed populations of WT and 
FNCC>SS/CC>SS MEFs were seeded onto plastic culture dishes and cultured in serum replacement 
medium supplemented with 0.5% (v/v) FN-depleted FBS. After fourty-eight hours in culture, at a 
stage of fibrillogenesis where the fibrillar morphology of FNCC>SS matrices begins to differ substantially 
from that of WT FN (cf. fig. 8.18), the cultures and ECM were lysed in an extraction buffer containing 
1% DOC and essential protease inhibitors. The insoluble fractions were resolved by SDS-PAGE 
under reducing conditions, and the FN content was analysed by western blotting, using the DOC-
insoluble intermediate filament vimentin as a loading control. 
Western blot analysis of the DOC insoluble fractions showed that FN matrices derived from 
FNCC>SS/CC>SS MEFs contained only slightly less DOC-insoluble FN compared to matrices generated 
by WT MEFs. Hence, despite the stunted appearance, the degree of chemical cross-linking within the 
monomeric FN fibrils does not differ much from that of a WT FN matrix (fig. 8.23). 
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Figure 8.23. Biochemical characterisation of the WT FN and FNCC>SS fibrillar matrix. 
Western blot analysis of the DOC-insoluble fraction of FN derived from WT and 
FNCC>SS/CC>SS MEFs (mixed populations) cultured for 48 hours. This is a representative 
western blot out of three independent assays. 
 
8.4.3 Mechanical properties of ECM layers containing FNCC>SS 
An increasing body of research suggests that the mechanical properties inherent to the ECM are 
critical regulators of cell behaviour and tissue morphogenesis. The requirement of fibrillar FN for the 
deposition and stabilisation of a range of structural ECM molecules puts FN at a central position to 
dictate the compliance of an ECM. Given the short, poorly bundled and perhaps less chemically cross-
linked features of the FNCC>SS fibrillar matrix, I asked whether FNCC>SS affects the compliance of the 
ECM. 
Measuring the compliance of embryonic tissue is technically challenging. Instead, I sought to 
prepare tissue-mimetic ECM platforms derived from WT and FNCC>SS/CC>SS MEFs. To isolate stiffness 
contributions of ECM only, the ECM platforms had to be decellularised. However, decellularising 
ECM derived from FNCC>SS/CC>SS MEFs has represented a recurring technical problem in that cell 
extraction caused partial or complete ECM delamination from the culture dish, leaving inconsistent 
amounts of FNCC>SS fibrillar matrix and ECM on the dish for subsequent stiffness assays. This 
inherent instability of an ECM containing FNCC>SS was speculated to be related to mechanical 
properties of the FNCC>SS fibrillar matrix. 
A major technical advance came by adopting a novel ECM immobilisation protocol to stably 
anchor cell-derived ECM to a glass sufrace (Prewitz et al., 2013). This anchorage relied on 
immobilising a thin film of poly(octadecene-alt-maleic anhydride) (POMA) on a glass surface and 
subsequently depositing a monolayer of a commercially available form of pFN through covalent bond 
formation between reactive anhydride moieties in POMA and amino-terminated lysine residues in FN. 
Onto these FN-coated glass surfaces I seeded WT and FNCC>SS/CC>SS MEFs mixed populations and 
cultured them in serum replacement medium supplemented with 2% (v/v) FN-depleted FBS. Over the 
course of ten days, the MEFs were allowed to deposit ECM, which by virtue of the ability of FN to 
interact with multiple ECM components, such as collagen, fibrin and heparan sulfate proteoglycans, 
would become robustly anchored to the FN-coated glass and withstand decellularisation. After ten 
days of culture, MEFs were extracted from the ECM with an extraction buffer based on Triton X-100 
and ammonium hydroxide, and the cellular content of DNA was removed by treatment with DNase. 
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Figure 8.24. Anchored ECM platforms derived from WT and FNCC>SS/CC>SS MEFs. 
Immunofluorescence images of decellularised ECM generated by WT and FNCC>SS/CC>SS 
MEF (mixed populations) and covalently anchored to glass to provide stability during 
decellularisation. FN was stained with antibodies against FN. * indicate holes in the FNCC>SS 
fibrillar matrix. Scale bar 100 µm. This analysis was performed once. 
 
To monitor the quality of the decellularised MEF-derived ECM and to ensure that the anchoring of 
the ECM to the glass coverslip was beneficial, the decellularised matrices were fixed and 
immunostained with an antibody against FN. Immunofluorescence imaging of the ECM revealed 
dense carpets of fibrillar FN matrices left on the coverslips after decellularisation (fig. 8.24). ECM 
containing FNCC>SS had been stabilised by the anchoring chemistry applied during preparation and had 
maintained a morphology distinct from WT FN fibrils characterised by a fine meshwork of short 
fibrils. In some regions of the ECM, however, FNCC>SS was found to have formed a considerably 
complex fibrillar network. Despite FNCC>SS having formed fibrils longer than seen previously, the 
integrity of the matrix appeared compromised, with large holes where the long fibrils of FNCC>SS 
appear to have given in to tension maintained in the ECM upon cell extraction (indicated by * in fig. 
8.24). 
The elasticity analysis of ECM by indentation atomic force microscopy (AFM) showed that the 
ECM derived from FNCC>SS/CC>SS MEFs is significantly more compliant (mean Young’s modulus 
137.249 Pa) than ECM generated by WT MEFs (mean Young’s modulus 371.418 Pa) (fig. 8.25). Non-
coated glass surfaces were orders of magnitude stiffer than coverslips containing ECM (not shown). 
Statistical analysis by the Mann-Whitney test indicated that the difference in elasticity between ECM 
containing FNCC>SS and WT FN are significantly different. Hence FNCC>SS truely affects the 
mechanical properties of an ECM. 
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Figure 8.25. Characterisation of the mechanical properties of ECM containing WT FN and 
FNCC>SS by the indentation AFM technique. The box plot shows Young’s moduli of ECM 
derived from WT (mean Young’s modulus 371.418 Pa) and FNCC>SS/CC>SS (mean Young’s 
modulus 137.249 Pa) MEF mixed populations. Each data point represents a single 
measurement, in total n=103 (WT ECM) and n=109 (ECM containing FNCC>SS/CC>SS) 
distributed over 3 separate coverslips. ***p<0.001.  
 
8.5 Functional characterisation of FNCC>SS  
8.5.1 Cell migration on ECM layers containing FNCC>SS 
Cells sense and respond to the mechanical properties of their microenvironment, and it has long 
been recognised that substrate flexibily affects focal adhesion dynamics and cell migration and that 
substrate rigidity regulates the formation and maintenance of tissues (Pelham and Wang, 1997; Guo et 
al., 2006). Most cell types respond to a gradient in matrix stiffness by moving toward areas of stiffer 
ECM in a process termed durotaxis (Lo et al., 2000). Durotaxis is thought to be critical for 
development and wound healing, and tumor cell invasion through tissue is strongly regulated by the 
microstructural and mechanical properties of the ECM.  
In the preceding chapter, I presented indentation AFM measurements of decellularised tissue-
mimetic ECM platforms and demonstrated that ECM containing FNCC>SS is significantly more 
compliant than ECM containing WT FN.  This, and other features of the FNCC>SS matrix led to the 
hypothesis that ECM containing FNCC>SS would affect the speed of migration of cells. To test this 
hypothesis, I prepared decellularised, tissue-mimetic ECM platforms derived from WT and 
FNCC>SS/CC>SS MEFs seeded onto gelatin-coated plastic surfaces and cultured in serum replacement 
medium supplemented with 2% (v/v) FN-depleted FBS for three days. In this context, ECM 
platforms were decellularised by treatment with EDTA, which causes adherent cells to round up and 
detach from the ECM. 
To characterise the morphology of the FN fibrillar matrix in these MEF-derived, decellularised 
ECM platforms, WT and FNCC>SS/CC>SS MEF clones were seeded onto LM111-coated glass coverslips, 
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cultured and subsequently removed from the ECM with EDTA. FN in ECM with and without cells 
was immunostained with antibodies against FN. 
 
 
Figure 8.26. Characterisation of decellularised ECM derived from WT and FNCC>SS/CC>SS 
MEFs. (A) Immunofluorescence image of FN matrix generated by WT and FNCC>SS/CC>SS 
MEF clonal cell lines before and after cell extraction with EDTA. FN is stained with 
antibody against FN (green) and nuclei are stained by DAPI (blue). Scale bar: 100 µm. (B) 
Western blot analysis of FN content in lysates of decellularised ECM derived from WT and 
FNCC>SS/CC>SS MEF clonal cell lines (as shown in A). Decellularised ECM lysates were 
resolved by SDS-PAGE under reducing conditions. “no ECM” denotes a blank dish to 
demonstrate the abundance of FN after decellularisation. This analysis was performed twice. 
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Immunofluorescence images showed rather substantial changes in the fibrillar morphology upon 
EDTA-mediated decellularisation of MEFs cultured on plastic (fig. 8.26 A). In particular, the FN 
matrix derived from WT MEFs appeared to have collapsed upon cell extraction, whereas the 
morphology of FN fibrils derived from FNCC>SS/CC>SS MEFs maintained had changed very little upon 
cell extraction. The collapse of WT FN matrix upon cell removal could be due to the fact that cells 
maintain this highly complex fibrillar matrix under very high tension, and when cells are removed, this 
tension is lost and the matrix collapses. Finding that the matrix of FNCC>SS appears much less collapsed 
upon cell removal might reflect that less strain is exerted on the fibrils by FNCC>SS/CC>SS MEFs. Since 
the MEFs used here were clonal cell lines, it is not possible to say whether this differential strain is a 
response of the cell to the FN matrix or whether it is a clonal feature. 
To assess the levels of FN remaining in the decellularised ECM, I prepared lysates of decellularised 
ECM derived from WT and FNCC>SS/CC>SS MEFs. Lysates were resolved by SDS-PAGE under 
reducing conditions, and the FN content was analysed by western blotting. Western blot analysis 
showed that decellularised ECM derived from WT and FNCC>SS/CC>SS MEFs contain comparable 
amounts of FN (fig. 8.26 B). 
The decellularised ECM derived from WT and FNCC>SS/CC>SS MEFs were subsequently used as 
migration platforms for FN-/- fibroblasts. I chose FN-/- fibroblasts (Sakai et al., 2001) for these 
migration assays to eliminate the contribution of endogenous (WT) fibronectin during the analysis. 
FN-/- fibroblasts were seeded onto the decellularised ECM platforms at low density and left for one 
hour in serum replacement medium without supplemental FBS. During this hour, FN-/-fibroblasts 
attached and spread equally well on ECM containing WT FN and FNCC>SS. To induce migratory 
activity, FN-/-fibroblasts were stimulated with PDGF-BB and transferred to a brightfield microscope 
where cellular position was recorded at five min time intervals for twelve hours. Movies of migrating 
cells were compiled from the still-images of FN-/- fibroblasts. Using the Manual Tracking plugin for 
ImageJ, I tracked the migration path of individual cells, and with the ImageJ Chemotaxis Tool, I 
calculated the average speed of migration of FN-/- fibroblasts migrating on ECM containing either WT 
FN or FNCC>SS (fig. 8.27) 
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Figure 6.27. Migration analysis of FN-/- fibroblasts on ECM containing WT FN and FNCC>SS. 
Histograms indicate mean migration speed of FN-/- fibroblasts on ECM derived from WT 
and FNCC>SS/CC>SS MEF clonal cell lines. PDGF-BB was added at 50 ng/ml in serum 
replacement medium. No directionality data is provided because not all tracks were recorded 
for the same period of time. This experiment was performed four times, where n>40 cells 
per condition. 
 
Analysis of the cellular migration speeds suggested a tendency for FN-/- fibroblasts to migrate at a 
higher speed on ECM containing FNCC>SS compared to when seeded onto ECM containing WT FN 
(fig. 7.27). This, in turn, would point to an effect of FNCC>SS on adhesion stability. However, statistical 
analysis of the data set indicated that the difference in migration speeds were not statistically 
significant. 
8.5.2 Effect of FNCC>SS on outside-in integrin signalling 
Cells use their integrins and focal adhesion-associated proteins to probe and respond to the 
mechanical properties of their environment. Matrix rigidity regulates integrin function, as stiff matrices 
promote the assembly of large focal adhesions that change the cytoskeletal organisation of the cell, 
while compliant matrices only support the assembly of small dot-like structures containing integrins 
(Choquet et al., 1997; Pelham and Wang, 1997; Riveline et al., 2001; Paszek et al., 2005). As 
mechanotransducers, integrins convert mechanical input into intracellular biochemical signals by 
recruiting intracellular signalling complexes. Integrin signalling, in particular those that are triggered by 
active integrin α5β1 are crucial to developmental vasculogenesis and angiogenesis (Francis et al., 2002). 
The abnormal vascular development observed in FNCC>SS/CC>SS embryos, combined with altered 
mechanical properties of ECM deposited by FNCC>SS/CC>SS MEF mixed populations and the stunted 
appearance of fibrillar adhesions in FNCC>SS/CC>SS MEF clones, led to the hypothesis that outside-in 
signalling downstream of integrin α5β1 may be affected in FNCC>SS/CC>SS mice.  
Autophosphorylation of FAK at tyrosine residue Y397 (pFAKY397) is sensitive to both number and 
bond-strength of the interaction between integrin α5β1 and FN.  Levels of pFAKY397 thus reflect the 
mechanical tension across focal adhesions resulting from the resistance of FN to the pulling forces of 
the contractile actomyosin cytoskeleton (Shi and Boettiger, 2003; Friedland et al., 2009). Semi-
quantitative analysis of pFAKY397 levels therefore reflects not only the quantity and strength of 
interactions between integrin α5β1 and FN, but also provides an indirect cellular read-out of ECM 
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stiffness. FAK is also reported to be involved in mechanosensing during fibroblast migration (Wang et 
al., 2001a).  
First, I compared the kinetics of FAKY397 phosphorylation in WT and FNCC>SS/CC>SS MEFs in the 
process of assembling a fibrillar matrix of endogenous FN. In this assay, cellular pFAKY397 levels were 
compared as cells deposited FN into the ECM and thereby became increasingly exposed to fibrillar 
matrix containing either WT FN or FNCC>SS. The assumption here was that integrin-binding sites 
within FNCC>SS are intact, and if FNCC>SS were to have a unique effect on integrin outside-in signalling, 
it would have so exclusively in a fibrillar form with true mechanical that can be probed by integrins. 
The time points for assaying the level of pFAKY397 matched those of the FN fibrillogenesis time 
course presented earlier (cf. fig. 8.19). This allowed a correlation to be made between pFAKY397 levels 
and the complexity of the FN fibrillar matrix.  
WT and FNCC>SS/CC>SS MEF clones were seeded onto gelatin-coated culture dishes and cultured in 
serum-replacement medium supplemented with 0.5% (v/v) FN-depleted FBS. At defined time points 
after seeding, ranging from four to seventy-two hours, the cultures were lysed in the presence of 
protease and phosphatase inhibitors. Lysates were resolved by SDS-PAGE under reducing conditions, 
and both pFAKY397 and total FAK protein contents were analysed by western blotting. 
 
 
Figure 8.28. Integrin outside-in signalling through FAKY397 in WT and FNCC>SS/CC>SS 
MEFs. A representative western blot of pFAKY397, total FAK and GAPDH protein levels 
in WT and FNCC>SS/CC>SS MEFs clonal cell lines cultured in serum replacement medium 
supplemented with 0.5% FN-depleted FBS for the indicated number of hours. This assay 
was performed once. 
 
At the four hour time point, where FN fibrillogenesis has already begun and traces of small FN 
fibrils can be seen in a MEF culture, the ratio of pFAKY397 to total FAK protein in a FNCC>SS/CC>SS 
MEF culture was indistinguishable from a WT MEF culture (fig. 8.28). Over the course of the next 
seventy-two hours, there continued to be no difference in the steady state levels of pFAKY397. If the 
levels of pFAKY397 reflects the degree of integrin force coupling to the contractile actomyosin 
cytoskeleton, this lack of difference in pFAKY397 levels between WT and FNCC>SS/CC>SS MEF lysates 
suggests that the unique structural and mechanical properties of FNCC>SS do not affect integrin force 
coupling. An alternative interpretation is that both WT and FNCC>SS/CC>SS MEFs reach the same 
steady-state ratio of pFAKY397 to FAK ratio because FNCC>SS/CC>SS MEFs compensate for short 
fibrillar adhesions by generating more fibrillar adhesions, such that overall, the same number of 
integrins are activated and force-coupled to actomyosin to the same degree as in WT MEFs. 
Unfortunately, the method employed here cannot resolve such putative compensatory mechanisms.  
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In order to assay the level of pFAKY397 in a setup that mimics the three-dimensional extracellular 
environment in vivo, I adopted a setup seeding FN-/- fibroblasts onto MEF-derived, tissue-mimetic 
ECM. FN-/- fibroblasts were seeded onto ECM platforms that had been decellularised with EDTA, 
and cultured in the presence of serum replacement medium without any supplemental FBS or growth 
factors. After thirty minutes, by which time the FN-/- fibroblasts had spread on both WT and ECM 
platforms containing FNCC>SS, cells were lysed and the ratio of pFAKY397 to total FAK protein in cell 
lysates was assessed by western blot analysis. Additionaly, lysates were probed for the levels of 
pMLC2S19 and total MLC2 protein to address whether integrin signalling via ROCK/pMLC2 is 
changed in the presence of FNCC>SS. Western blot analysis showed that FN-/- fibroblasts responded 
similarly to ECM derived from WT and FNCC>SS/CC>SS MEF, resulting in no difference in the activation 
status of FAK or MLC2 (fig. 8.29 A and B, respectively).  
 
 
Figure 8.29. Integrin outside-in signalling in FN-/- fibroblasts on ECM platforms containing 
WT FN and FNCC>SS/CC>SS. Representative western blots of (A) pFAKY397, total FAK and 
GAPDH and (B) pMLC2S19, total MLC2 and β-actin protein levels in FN-/- fibroblasts 
cultured for 30 minutes on decellularised ECM generated by WT and FNCC>SS/CC>SS MEFs 
clonal cell lines. Experiments like that shown in (A) was performed three times, and the 
experiment shown in (B) was performed once. 
 
A final approach to investigating the impact of FNCC>SS on integrin outside-in signalling focused on 
comparing the levels of pFAKY397 in FNCC>SS/CC>SS embryonic and extra-embryonic tissue with that of 
WT embryonic tissues. Single E9.5 embryos or yolk sacs were lysed, and the ratios of pFAKY397 to 
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total FAK protein in embryo and yolk sac lysates were assessed by western blotting (fig. 8.30 A and B, 
respectively).  
Western blot analysis revealed a degree of natural variation in pFAKY397 to FAK in lysates of tissues 
of the same genotype. However, band densitometry of the ratios of pFAKY397 to total FAK protein 
showed that there was no significant difference in FAKY397 activation between WT and FNCC>SS/CC>SS 
tissue (fig. 8.30 C).  
 
 
Figure 8.30. Integrin outside-in signalling in WT and FNCC>SS/CC>SS embryonic and extra-
embryonic tissue. Levels of pFAKY397, FAK and GAPDH protein in lysates of single E9.5 
embryos (A) or single E9.5 yolk sacs (B). (C) Histogram shows mean ratios of pFAKY397 to 
total FAK, where n(WT embryo)=6, n(FNCC>SS/CC>SS embryo)=6; n(WT yolk sac)=2; 
n(FNCC>SS/CC>SS yolk sac)=6. Error bars represent standard deviation. This experiment was 
performed five times with different sets and numbers of embryos and yolk sacs, but the 
quantification provided in (C) accounts for the pFAKY397/FAK levels presented in (A) and 
(B).  
 
8.5.3 Effect of FNCC>SS on latent TGF-β  storage and activation 
With vascular remodelling defects in both embryonic and extra-embryonic tissue as well as 
abnormal cardiac development resulting in embryonic lethality, the FNCC>SS/CC>SS mouse also shares 
phenotypic features with mice where TGF-β signalling has been disrupted through genetic 
manipulation (Dickson et al., 1995; Oshima et al., 1996; Sanford et al., 1997; Arthur et al., 2000; Oh et 
al., 2000; Bartram et al., 2001; Stenvers et al., 2003; Jiao et al., 2006; Seki et al., 2006; Carvalho et al., 
2007; Sridurongrit et al., 2008). The phenotypic parallels between mice carrying mutations in an ECM 
component and mice with compromised growth factor signalling pathway reflects an important 
function of the ECM in regulating growth factor activity, and this relation is pivotal to tissue 
morphogenesis programmes such as cardiovascular patterninng. 
FN is a core component of the machinery regulating the bio-availability of TGF-β by immobilising 
the LTBP-1 component of LLC into the ECM (Dallas et al., 2005; Koli et al., 2005). LTBP-1 plays a 
role in a mechanism of integrin-dependent latent TGF-β activation (Annes et al., 2004), and as LTBPs 
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become anchored to FN, this puts FN at centre stage in the latent TGF-β activation mechanism. This 
led to the hypothesis that the lethal cardiovascular defects in the FNCC>SS/CC>SS mouse relate to either 
(1) an inability of FNCC>SS to support the deposition of the LLC into the ECM and/or (2) a failure of 
FNCC>SS to facilitate the integrin-dependent mechanism of latent TGF-β activation.  
The first hypothesis was addressed by investigating the deposition of LTBP-1 into an ECM 
containing FNCC>SS. WT and FNCC>SS/CC>SS MEF clones were seeded onto LM-111-coated glass 
coverslips and cultured in serum replacement medium supplemented with 0.5% (v/v) FN-depleted 
FBS. After five days, the cultures were fixed and immunostained with antibodies directed against 
LTBP-1 and FN (fig. 8.31).  
 
 
Figure 6.31. Fibrillar morphology and protein levels of LTBP-1 deposited into ECM 
containing WT FN and FNCC>SS. (A) Immunofluorescence images of five-day WT and 
FNCC>SS/CC>SS MEF clonal cell lines cultured in FN-depleted FBS and stained with 
antibodies against FN (red) and LTBP-1 (green). Nuclei were stained by DAPI (blue). Scale 
bar 25 µm. (B) Representative western blot analysis of LTBP-1 protein levels in lysates of 
five-day cultures of WT and FNCC>SS/CC>SS MEF clonal cell lines. (C) LTBP-1 protein levels 
in WT and FNCC>SS/CC>SS embryos; representative western blot analysis of the total LTBP-1 
protein levels in lysates of single E9.5 WT and FNCC>SS/CC>SS embryos. A Ponceau S staining 
of the PVDF membrane after protein transfer shows equal protein loading in the two lanes. 
These data were obtained by Dr. Michael Leiss. 
 
Consistent with a scaffolding role for FN in directing the deposition of LTBP-1 during early ECM 
formation (Dallas et al., 2005; Koli et al., 2005), immunofluorescence imaging showed a high degree of 
colocalisation and similarity in fibril structure between LTBP-1 and FN (fig. 8.31 A). In five-day-old 
ECM derived from WT MEFs, LTBP-1 appeared as bundles of long fibrils. In contrast, LTBP-1 in the 
ECM derived from FNCC>SS/CC>SS MEF appeared punctate and those fibrils that had formed were 
severely stunted and thus reminiscent of the FNCC>SS fibrillar matrix. While this result shows that 
FNCC>SS does not prevent the deposition of LTBP-1, it suggests that the fibrillar growth and 
complexity of an LTBP-1 matrix in an early ECM is limited by the structural features of the FNCC>SS 
matrix.  
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To complement these data, the total amount of LTBP-1 protein deposited into the ECM was 
assessed by western blot analysis. WT and two different FNCC>SS/CC>SS MEF clones were seeded onto 
gelatin-coated culture dishes and cultured in the presence of serum-replacement medium 
supplemented with 0.5% (v/v) FN-depleted FBS. After 5 days, protein lysates of these cultures were 
resolved by SDS-PAGE under reducing conditions and the LTBP-1 content assessed by western 
blotting. This experiment showed that only very minute decreases in total LTBP-1 protein levels 
complemented the drastic change in LTBP-1 fibril morphology (fig. 8.31 B). This indicates that the 
major effect of FNCC>SS on LTBP-1 is on the structural arrangement of its deposition into the ECM. 
The protein levels of LTBP-1 in WT and FNCC>SS/CC>SS embryonic tissue was also compared. For 
this purpose, single E9.5 embryos were lysed, and the relative content of LTBP-1 protein was assessed 
by western blotting analysis, which showed that the levels of LTBP-1 protein were comparable 
between WT and FNCC>SS/CC>SS embryo lysates (fig. 8.31C).  
The minute changes in LTBP-1 protein levels in lysates of MEF-derived ECM (fig. 8.31 B) and 
E9.5 embryo (fig. 8.31C) suggest that the levels of LLC containing latent TGF-β embedded in the 
ECM would be comparable between WT and FNCC>SS/CC>SS embryos. To test this hypothesis and 
compare the latent TGF-β storage capacity of ECM containing WT FN or FNCC>SS, FNCC>SS/CC>SS and 
WT MEFs were seeded to confluency onto gelatin-coated culture dishes and cultured for three days in 
serum replacement medium supplemented with 0.5% (v/v) FN-depleted FBS. To collect the latent 
TGF-β stored in the ECM only, MEFs were rinsed and selectively removed with EDTA. 
Decellularised ECMs in serum replacement medium were incubated at 80°C for ten minutes, causing 
all latent TGF-β stored in the ECM to be released into the conditioned medium in an active form 
(Brown et al., 1990). To assay the levels of active TGF-β present in the conditioned medium a TGF-β 
reporter cell line (mink lung epithelial cell line, MLEC) was cultured in the presence of the conditioned 
medium (Abe et al., 1994). Following incubation, the MLEC were lysed, and this lysate was assayed for 
total intracellular luciferase activity. 
Luciferase measurements reflected comparable amounts of active TGF-β in conditioned medium 
derived from heat-treated ECM derived from WT and FNCC>SS/CC>SS MEFs (fig. 8.32 A). Hence the 
fibrillar complexity of LTBP-1 and FN did not affect the capacity of the ECM to store latent TGF-β. 
The disrupted structural feature of LTBP-1 fibrils in an ECM derived from FNCC>SS/CC>SS MEFs 
also inspired the hypothesis that FNCC>SS would disrupt the ability of integrins to activate TGF-β upon 
traction. To examine whether the abnormal morphology of the LTBP-1 matrix formed in the presence 
of FNCC>SS could be associated with a change in integrin-mediated activation of latent TGF-β from the 
ECM, ECMs were generated from WT and FNCC>SS/CC>SS MEF clones seeded onto gelatin-coated 
culture dishes and cultured in serum replacement medium supplemented with 0.5% (v/v) FN-depleted 
FBS. Residing MEFs were removed from the ECM with ETDA, and a co-culture of TGF-β reporter 
MLEC and chinese hamster ovary (CHO) cells stably expressing integrin αVβ6 (CHO-β6) (Weinacker 
et al., 1994) was seeded onto the decellularised ECM. The co-culture was incubated on the 
decellularised ECM for twenty-four hours before lysing all cells and assaying intracellular luciferase 
activity. In this experimental setup, latent TGF-β stored in the ECM becomes activated by integrin 
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αVβ6, expressed by CHO-β6 cell line. Active TGF-β is released into the medium and detected by the 
TGF-β reporter MLEC, and luciferase activity in the lysates is proportional to the amount of active 
TGF-β released by integrin αVβ6. To evaluate the specific contributions to TGF-β reporter activation 
by integrin αVβ6-mediated TGF-β activation, co-cultures were cultured in the presence of αV integrin 
blocking antibody. To test the specificity of the assay, co-cultures were cultured in the presence of 
TGF-β pan-specific polyclonal antibody. 
Analysis of luciferase activity in MLEC lysates showed no statistically significant difference in the 
ability of integrin αVβ6 to activate more latent TGF-β from ECM derived from FNCC>SS/CC>SS MEFs 
compared to WT MEF (fig. 8.32 B) and hence monomerised FN does not affect the ability of integrins 
to release TGF-β from ECM. 
 
 
Figure 8.32. TGF-β storage capacity of FNCC>SS and the effect of FNCC>SS on αVβ6 integrin-
mediated latent TGF-β activation. (A) Conditioned medium of heat-treated decellularised 
ECM generated by WT and FNCC>SS/CC>SS MEF clonal cell lines was added to TGF-β 
reporter MLEC and incubated for further sixteen hours prior to detection of TGF-β-induced 
luciferase expression. Histogram shows mean luciferase activity in TGF-β reporter MLEC 
and error bars represent standard deviation. (B) Co-cultures of TGF-β reporter MLEC and 
CHO-β6 on decellularised ECM generated by WT and FNCC>SS/CC>SS MEF clonal cell lines. 
Luciferase activity in TGF-β reporter MLEC was measured twenty-four hours after seeding. 
TGF-β N.A., pan-TGF-β neutralising antibody (1D11; 15 µg/ml); αV B.A., αV blocking 
antibody (10D5; 15 µg/ml). Histogram shows mean luciferase activity in TGF-β reporter 
MLEC and error bars represent standard deviation.  RLU, relative light units. Experiments 
were performed in triplicates and performed four times. 
 
8.5.4 TGF-β  signalling in FNCC>SS/CC>SS embryos 
TGF-β is thought to play a pivotal role in driving vascular remodelling (ten Dijke and Arthur, 
2007). Although there is little mechanistic support from cell-based assays for an effect of FNCC>SS on 
either latent TGF-β storage in the ECM or on integrin-mediated latent TGF-β activation, the vascular 
remodelling defects in FNCC>SS/CC>SS embryos nevertheless called for an analysis of TGF-β receptor 
signalling in embryonic tissue.  
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SMAD phosphorylation occurs upon activation of TGF-β binding and activation of type I and type 
II receptors. Differences in the intracellular levels of phosphorylated SMAD complex therefore reflect 
the relative abundance of TGF-β ligand. In the endothelium, TGF-β activates either one of two 
distinct type I receptor/R-SMAD signalling pathways (Goumans et al., 2002). TGF-β activation of 
activin-like kinase 1 (ALK1) in the endothelium induces phosphorylation of R-SMAD1/5S463/465 
complexes, while TGF-β activation of ALK5 phosphorylates and activates R-SMAD2S465/467 
complexes. The activation of these two SMAD signalling pathways trigger different genetic responses 
that elicit opposing effects on endothelial biology; activation of the ALK5/SMAD1/5 pathway 
initiates a genetic programme that inhibits endothelial cell migration and proliferation, while activation 
of the the ALK1/SMAD2/3 triggers endothelial cell migration and proliferation (Goumans et al., 
2002). The spatial and temporal fine-tuning of angiogenic events requires a delicate balance between 
these two canonical TGF- β signalling pathways.   
To address and compare TGF- β signalling in embryonic tissue, single E9.5 embryos were lysed, 
and the ratios of pSMAD1/5/8S463/S465 to total SMAD5 protein and pSMAD2/3S465/S467 to total 
SMAD2/3 protein were assessed by western blot analysis. I found that the ratios of both 
pSMAD1/5/8S463/S465 and pSMAD2/3S465/S467 to total SMAD protein were comparable between WT 
and FNCC>SS/CC>SS embryo lysates (fig. 8.33 A and B, respectively). 
 
 
Figure 8.33. TGF-β signalling in WT and FNCC>SS/CC>SS embryonic tissue. Representative 
western blots and quantification of (A) pSMAD1/5/8S463/S465, SMAD5 and GAPDH and (B) 
pSMAD2/3S465/S467, SMAD2/3 and GAPDH protein levels in lysates of single E9.5 WT and 
FNCC>SS/CC>SS embryos. Histograms show mean ratio of pSMAD to SMAD protein levels 
for n=5 embryos of each genotype. Error bars represent standard deviation.  
 
Comparable levels of phosphorylated SMAD complexes in whole embryo lysates do not exclude 
the possibility of there being significant differences in TGF-β signalling in a minor subset of tissues. 
Upon their phosphorylation, R-SMAD complexes associate with SMAD4 and translocate to the 
nucleus, and so to compare TGF-β signalling activity in WT and FNCC>SS/CC>SS tissue, I examined the 
distribution of pSMAD-positive nuclei in WT and FNCC>SS/CC>SS embryonic tissue. Given the 
cardiovascular defects and that the endothelium is sensitive to changes in bioavailability of TGF-β, 
particular focus was given to the distribution of phosphorylated SMAD-positive nuclei in highly 
vascularised tissues such as yolk sac and heart. 
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 Embryos and yolk sacs were harvested at E9.5 and immunostained with antibodies against 
phospho-specific SMAD1/5/8S463/S465 and PECAM-1. Whole-mount and stained embryos and yolk 
sacs were imaged by confocal microscopy (fig. 8.34). 
A large proportion of the embryonic tissues were found to contain pSMAD1/5/8S463/465-positive 
nuclei, stemming not only from TGF-β signalling, but also from BMP receptor activation in both 
endothelial and non-endothelial tissues (Miyazono et al., 2005). Both PECAM-1 and the characteristic 
flattened appearance of endothelial nuclei lining a WT vessel were used to identify the 
pSMAD1/5/8S463/465-positive nuclei belonging to endothelium. In both WT and FNCC>SS/CC>SS yolk 
sacs, a fraction of the most prominent pSMAD1/5/8S463/465-positive nuclei appeared to be associated 
with the PECAM-1 stain. Although the heavily distorted appearance of the endothelium in the 
FNCC>SS/CC>SS made it difficult to faithfully identify endothelial nuclei, overall there was no indication 
that FNCC>SS/CC>SS yolk sac endothelium suffered excess or moderation of TGF-β-induced 
pSMAD1/5/8S463/465.  
In the developing cardiac tissue of both WT and FNCC>SS/CC>SS embryos, the most prominent of 
the pSMAD1/5/8S463/465-positive nuclei were associated with the PECAM-1-positive endocardium. 
Despite the compromised growth and morphology of the FNCC>SS/CC>SS endocardium, the 
endothelium appeared to contain pSMAD1/5/8S463/465-positive nuclei. This would indicate that the 
endocardial remodelling defects cannot be attributed to an absence of TGF-β signalling. Overall, there 
is no strong indication that endothelium of FNCC>SS/CC>SS tissue shows any difference in TGF-β 
signalling activity compared to WT endothelium.  
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Figure 8.34. Distribution of pSMAD1/5/8S463/S465-positive nuclei in WT and FNCC>SS/CC>SS 
embryonic tissue. Confocal immunofluorescence images of whole mount E9.5 WT and 
FNCC>SS/CC>SS embryonic tissues stained with antibodies against pSMAD1/5/8S463/S465 (red) and 
PECAM-1 (green). Nuclei are stained by DAPI (blue). (A) Dorsal view of flat-mounted yolk sac and 
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(B) parasagittal view of embryonic heart. Scale bar 50 µm. This analysis was performed once on at 
least three individual embryos/yolk sacs. 
 
A final approach to comparing the level of TGF-β signalling activity between WT and 
FNCC>SS/CC>SS embryonic tissue was undertaken through quantitative real-time PCR (RT-PCR) analysis 
of pSMAD target gene mRNA. Plasminogen activator inhibitor 1 (PAI-1) and Inhibitor of DNA 1 
(Id1) are targets genes of activated pSMAD2/3S465/467 and pSMAD1/5/8 S463/465, respectively, and thus 
implicated in generating the endothelial response to TGF-β (Goumans et al., 2002). cDNA was 
prepared from mRNA isolated from single E8.5 yolk sacs, and the transcript levels of both PAI-1 and 
Id1 were normalised to GAPDH transcript levels (fig. 8.35). Both Id1 and PAI-1 transcript levels were 
lower in FNCC>SS/CC>SS yolk sac compared to WT, and the 1.6 fold decrease in Id1 transcript level was 
statistically significant. Id1 is a target of pSMAD1/5/8S463/465, and so this suggests that TGF-β 
signalling is very mildly compromised in FNCC>SS/CC>SS yolk sac tissue. 
 
 
Figure 8.35. Expression of TGF-β/SMAD target genes in WT and FNCC>SS/CC>SS yolk sac. 
RT-PCR of cDNA that was isolated from single E8.5 WT and FNCC>SS/CC>SS yolk sacs. For 
each sample, the transcript level of the gene of interest was normalised to the transcript level 
of GAPDH. Histogram shows relative mean transcript levels of Id1 and PAI-1 for n(WT)=3 
and n(FNCC>SS/CC>SS)=4, and the mean WT relative transcript levels are set to 1. *p=0.025, 
statistically analysed by Student’s T-test. 
 
8.5.5 Effect of FNCC>SS on VEGF signalling 
The phenotype of the FNCC>SS/CC>SS mouse cannot be explained by an ECM-related defect in latent 
TGF-β storage and activation. Focusing on the vascular defect and staying with the hypothesis that 
monomeric FNCC>SS could disturb FN-mediated growth factor deposition into the ECM, I asked 
whether FNCC>SS could alter the availability of VEGF-A in FNCC>SS/CC>SS embryos. VEGF-A is a 
growth factor that becomes immobilised in the ECM, and the interaction between VEGF-A and FN is 
important for establishing the VEGF-A gradients that promote angiogenesis, for example in retinal 
angiogenesis (Stenzel et al., 2011). These observations led to the hypthesis that FNCC>SS affects 
vascular remodelling by disturbing the ability of ECM to regulate the availability of VEGF-A. 
To begin exploring the effect of FNCC>SS on the availability of VEGF-A, I compared the levels of 
VEGFR2 phosphorylation between WT and FNCC>SS/CC>SS embryonic and extraembryonic tissue. One 
approach was based on immunohistochemical analysis of phosphorylated VEGFR2 in embryonic and 
extraembryonic tissue sections. However, for technical reasons, multiple attempts to detect various 
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forms of phosphorylated VEGFR2 (pVEGFR2Y951 and pVEGFR2Y1175) failed to provide specific 
immunohistochemical signals (not shown). 
VEGFR activation was then investigated by western blot analysis. An intial attempt to detect the 
pVEGFR2Y951 in lysates of embryos or yolk sacs, either single or pooled, failed to provide single 
specific bands to allow a fair comparison of VEGFR2 activation between WT and FNCC>SS/CC>SS 
lysates (not shown). To circumvent this technical problem, I decided to compare the level of 
phosphorylated tyrosine residues (pY) in VEGFR2 immunoprecipitated from either embryo or yolk 
sac lysates.  
From lysates of either pooled embryos or yolk sacs, VEGFR2 was immunoprecipitated using a 
monoclonal VEGFR2 antibody. The VEGFR2 immunoprecipitate was resolved by SDS-PAGE, and 
the content of phospholated tyrosine residues was analysed by western blotting using the 4G10 
monoclonal antibody (fig. 8.36). 
Western blot analysis of phosphorylated tyrosine content in the immunoprecipitated VEGFR2 
showed that WT and FNCC>SS/CC>SS embryonic and yolk sac lysates contain comparable levels of 
tyrosine-phosphorylated VEGFR2 (fig. 8.36). Thus, on a global, whole tissue level, the activation status 
of VEGFR2 is the same between WT and FNCC>SS/CC>SS embryonic tissue, which suggests that the 
VEGF-A ligand availability is not affected by FNCC>SS. However, these data do not reflect whether the 
gradients of VEGF-A are intact or achieve the appropriate strength within FNCC>SS/CC>SS tissue, which 
is crucial for the correct extent of endothelial activation and vascular growth. 
 
 
Figure 8.36. VEGFR2 activation status in WT and FNCC>SS/CC>SS embryonic tissue. 
VEGFR2 was immunoprecipitated from lysates of pooled E9.5 embryos and yolk sacs (n=7 
of each) and the phospho-tyrosine content of immunoprecipitated VEGFR2 was analysed by 
western blot, using the 4G10 monoclonal antibody to detect phosphorylated tyrosine 
residues in VEGFR2. Input: the embryo and yolk sac lysates before VEGFR2 
immunoprecipitation. IP: immunoprecipitated VEGFR2. 
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9 DISCUSSION 
 
In this study, I have addressed the requirement for the dimerisation motif for FN fibrillogenesis 
and its role in FN function in vivo. With the analysis of a genetically modified mouse strain that 
exclusively expresses a form of FN that cannot dimerise, this study provides a more complete 
understanding of the requirement for FN dimers in FN fibrillogenesis. Here I provide evidence that 
dimerisation of FN is important for maintaining structural and mechanical properties of the FN matrix 
and the ECM that assembles around FN, and I demonstrate the consequences of preventing FN 
dimerisation to mouse development. 
Disruption of the FN dimerisation motif was achieved by replacing the two critical cysteines within 
the dimerisation motif with serines (FNCC>SS/CC>SS) and thereby ablating the formation of the two 
critical disulfide bonds responsible for dimersing FN (fig. 8.1 and 8.2). This mutation in FN disrupts 
embryonic development at mid-gestation and is recessive lethal around E10.5, such that the majority 
of FNCC>SS/CC>SS mice are lost by E11.5 (table 8.1). This demonstrates vital functions of FN that rely 
on properties unique to the dimerised form of FN. Preventing FN dimerisation causes defects in 
mesoderm-derived structures of both the embryo proper and extraembryonic tissue. This mutant 
phenotype is consistent with, albeit milder than, mice lacking expression of FN (George et al., 1993; 
George et al., 1997; Georges‐Labouesse et al., 1996) or FN-binding integrin α5β1 (Goh et al., 1997; 
Yang et al., 1993; Yang et al., 1999). Hence, while the lethality of FNCC>SS/CC>SS embryos clearly 
demonstrates that FNCC>SS fails to support normal development, the survival beyond that of FN 
knockout or integrin α5 knock-out implies that FNCC>SS is not a null-mutation. For this thesis, I have 
explored the functional implications of monomerising FN and conclusively show that the FNCC>SS 
fibrillar matrix is both structurally and mechanically compromised. 
9.1 Monomerised FN undergoes de novo  fibrillogenesis 
Reports published more than two decades ago proposed that the minimal requirements for de novo 
fibrillogenesis are (1) the assembly domain within the N-terminal FNI1-5 and (2) the C-terminal 
disulfide bonds bridging two monomers of FN into a dimer (Schwarzbauer, 1991; Ichihara-Tanaka et 
al., 1992). In the FN field, two main criteria are applied to determine the competence of FN (or a 
recombinant, truncated version thereof) in matrix assembly: (1) incorporation of the FN into a DOC-
insoluble fraction and (2) formation of fibrils associated with cells that are detectable by 
immunofluorescence microscopy. In the studies reported by Dr. Schwarzbauer, cultured cells were 
engineered to express and secrete fragments of FN lacking the C-terminal dimerisation motif. The 
result was a complete failure of such FN fragments to become assembled into a fibrillar matrix 
(Schwarzbauer, 1991). From these in vitro studies a dogma emerged stating that FN dimerisation is 
essential for FN fibrillogenesis. Projecting this conclusion to predict the consequences of genetically 
disrupting FN dimerisation in the mouse, the hypothesis would be that cells fail to deposit 
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monomerised FN into the ECM, and the mouse would succumb with lethal defects reminiscent of the 
FN knock-out mouse (George et al., 1993).  
Two decades later, with the analysis of the FNCC>SS/CC>SS mouse and work based on MEFs isolated 
from the FNCC>SS/CC>SS mouse, the requirement for C-terminal disulfide bond-mediated FN 
dimerisation in de novo FN fibrillogenesis has been thoroughly revisited. In both embryonic tissue and 
MEF systems, FNCC>SS protein was confirmed to be exclusively monomeric (fig. 8.13), deposited into 
the ECM at normal levels (fig. 8.14) and, importantly, exhibits a fibrillar nature (fig. 8.15). First and 
foremost, this demonstrates that dimerisation of FN is not strictly essential for FN fibrillogenesis, as 
was once proposed. Yet close examination of the fibrillar monomerised FNCC>SS matrix revealed 
morphological features that suggested a structural compromise in the ability of monomerised FNCC>SS 
to undergo supramolecular remodelling into a complex network of fibrils. In FNCC>SS/CC>SS embryos, 
FNCC>SS fibrils distribute within a distinct regime of short fibril lengths compared to FN fibrils in WT 
embryos. On average, FNCC>SS forms significantly shorter fibrils than WT FN (fig. 8.15). The 
morphological difference was more pronounced between FNCC>SS and WT FN matrices derived from 
cultured MEFs. Within just two days of culture, WT MEFs build an elaborate, highly branched and 
interconnected network of long fibrils of FN, while the matrix of FNCC>SS derived from FNCC>SS/CC>SS 
MEFs consists of only short and thin fibrils, with fewer branch points and a low degree of 
interconnectivity (fig. 8.18). The same was true for pFN matrices deposited by FN-/- fibroblasts 
cultured in the presence of plasma containing either pFNCC>SS or WT pFN (fig. 8.21). It is remarkable 
that this drastic compromise in fibril complexity was not reflected in biochemical DOC fractionation 
assays of chemical cross-linking within the FNCC>SS matrix (fig. 8.23). 
Following the generation of FN matrices in cultures of FNCC>SS/CC>SS MEF and WT MEFs over 
time was particularly informative about the kinetics of FNCC>SS fibrillogenesis (fig. 8.18). Fibrillogenesis 
of both WT FN and FNCC>SS was well underway by eight hours of incubation, and matrices were 
morphologically indistinguishable from one another up until fourty-eight hours of incubation. Beyond 
this time point, the morphological features of FNCC>SS began to deviate substantially from a WT FN 
matrix. As these WT FN fibrils continued to grow longitudinally and associate laterally among each 
other into complex supramolecular structures, the FNCC>SS fibrillar matrix fails to remodel beyond a 
state of short and delicate structures. 
These findings give reason to reconsider the details of the model describing integrin-dependent FN 
fibrillogenesis (Singh et al., 2010). The current model of FN fibrillogenesis predicts that the initial 
unfolding and stretching of FN molecules in nascent adhesions requires that each of the two RGD 
motifs within the dimeric FN molecule become engaged by integrin α5β1, such that each FN molecule 
is ligated by two α5β1 integrins. The mechanical coupling of FN-bound α5β1 integrins to the F-actin 
cytoskeleton allows contractile acto-myosin-generated forces to translocate integrin α5β1 centripetally 
from the cell-peripheral focal adhesions towards the cell body, pulling bound FN along and thereby 
giving rise to fibrillar adhesions. During translocation, the two α5β1 integrins that are bound to the 
same molecule of FN segregate, and this segregation exerts the force required to pry open the globular 
FN dimer. The exposure of FN-binding sites within FN upon unfolding of the globular state allows 
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lateral self-association among multiple FN molecules and thereby drives the transformation of FN into 
a fibrillar form (Ohashi et al., 2002). Subsequently, FN fibrils undergo extensive branching, cross-
linking and bundling as cells continue to remodel the ECM, creating a complex three-dimensional 
matrix with mechanical properties that dictacte cell behaviour. 
Monomerised FNCC>SS presents only a single RGD motif to integrins, yet in a cell-dependent 
manner, FNCC>SS does become deposited into the ECM in a fibrillar state (fig. 8.18). Hence despite the 
presence of only a single intact RGD motif, the integrin-dependent phase of FNCC>SS fibrillogenesis 
was intact,. It became clear that integrin α5β1 could associate with FNCC>SS, both in focal adhesions 
and fibrillar adhesions (figs. 8.21 and 8.22) and that during early time points of FNCC>SS fibrillogenesis, 
this association of integrin α5β1 with FNCC>SS was accompanied by the formation of FNCC>SS fibrillar 
structures. These observations revealed a sufficient degree of integrin-mediated unfolding and lateral 
self-association in FNCC>SS. Whether the binding of one integrin α5β1 to the single RGD motif in 
FNCC>SS is sufficient to promote fibrillogenesis, or whether compensatory mechanisms are needed to 
assist in promoting fibrillogenesis of monomerised FNCC>SS, are issues I will speculate on in the 
following paragraphs. 
In order to achieve the conformational changes in FNCC>SS molecule and expose its FN-binding 
sites for lateral association, tension must build up within FNCC>SS that overcomes the intramolecular 
interactions that maintain FNCC>SS in a globular state. A single integrin α5β1 bound to the one RGD 
motif in FNCC>SS will transduce the contractile force emanating from the actomyosin machinery, but in 
order to establish tension across FNCC>SS, a level of resistance to the contractile force must be met by 
FNCC>SS. In the absence of a second α5β1 integrin bound to FNCC>SS to create this resistance, there 
must be alternative means of inducing the conformational changes. Perhaps the FNCC>SS molecule that 
is bound by integrin and still in its globular state interacts with the microenvironment to an extent that 
integrin α5β1 meets resistance when tugging on FNCC>SS. In cell culture experiments, the FNCC>SS that 
is secreted by FNCC>SS/CC>SS MEFs is likely to become partially absorbed by the uncoated or gelatin-
coated culture surface. In embryonic tissue, FNCC>SS is secreted into a confined three-dimensional 
extracellular environment that offers ample opportunity for FNCC>SS to immobilise through non-
covalent interactions with other glycoproteins, and this might be sufficient to assist integrin α5β1 in 
building the tension required for stretching FNCC>SS molecules. 
Another possibility is that the monomerised state of FNCC>SS is less globular than WT FN and that 
fibrillogenesis of FNCC>SS does not require the same level of integrin-mediated tension to open 
FNCC>SS. The compact, globular conformation of WT pFN is reported to rely on intramolecular ionic 
interactions between FNIII12-14 of one subunit and FNIII2-3 of the other subunit of the FN dimer 
(Johnson et al., 1999). These interactions between subunits are far less likely to exist between 
monomerised FNCC>SS molecules, but given that plasma FNCC>SS is expressed in a solube state there 
must be other intramolecular interactions that maintain a globular conformation. The strength of these 
interactions would determine the degree of integrin-mediated build-up of tension required to induce 
conformational changes in FNCC>SS molecules that expose FN-binding sites. If these intramolecular 
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forces are weak, then one can imagine that contractile forces transmitted to globular FNCC>SS through a 
single integrin would be sufficient to achieve this unfolding.  
Finally, there is the possibility that integrin α5β1 might not be the only integrin involved in the 
extension of FNCC>SS. Hypothetically, extension is achieved through engagement of multiple integrin-
binding sites along the length of the FNCC>SS molecule. Previous studies have demonstrated that the 
RGD motif in FN is dispensable for FN fibrillogenesis, albeit strictly required for mouse development, 
because αV integrins can engage a GNGRG peptide sequence motif within the FNI1-5 domains and 
promote fibrillogenesis (Takahashi et al., 2007). One way of explaining the fibrillogenesis of FNCC>SS is 
that integrin α5β1 and αV integrins cooperate to promote FNCC>SS fibril formation by engaging the 
RGD motif in FNIII10 and the GNGRG motif within FNI1-5 domains, respectively. In such a scenario, 
one would expect the fibrillar adhesions to be stunted because of an inability of αV integrins to 
translocate into fibrillar adhesions like integrin α5β1. 
In a FNCC>SS/CC>SS MEF clonal cell line, the short FNCC>SS fibrils were accompanied by similarly 
stunted fibrillar adhesions (fig. 8.22). Although short fibrillar adhesions were not apparent in FN-/- 
fibroblasts assembling pFNCC>SS (fig. 8.21), it suggests that FNCC>SS either delays the formation or 
affects the stability of fibrillar adhesions. In speculating how FN dimerisation could affect the 
formation and stabilisation of fibrillar adhesions, it is clear that dimerisation of WT FN not only 
duplicates both the number of integrin-binding sites and the number of FN-binding sites within one 
molecule, but also brings these binding potentials into closer proximity of each other. For each FN 
dimer, two integrins can be brought into close proximity of each other and essentially seed an integrin 
cluster. Similarly, for each integrin-bound stretched FN dimer, additional FN dimers can be brought to 
the adhesion complex, which in turn, will favour additional integrin clustering. By reducing the degree 
of freedom between essential components of the fibrillogenesis reaction (i.e. integrin-binding sites and 
FN-binding sites), dimerisation facilitates integrin clustering and FN–FN interactions such that 
fibrillogenesis can occur at a higher rate. In contrast, monomerised FN molecules possess half the 
potential for interacting with integrins and other FN molecules. Here, an increase in the degree of 
freedom between the reaction components of FNCC>SS fibrillogenesis causes the reaction to rely to a 
greater extent on diffusion of each molecule FNCC>SS molecules to integrins compared to dimeric FN. 
The diffusion-limited arrival of globular FNCC>SS molecules will delay their incorporation into fibrillar 
adhesions, and hence at any given point, fibrillar adhesions will appear shorter than normal.  
Once assembled into short fibrillar structures in fibrillar adhesions, FNCC>SS fibrils do not continue 
to mature into as complex a fibrillar matrix as seen with WT FN. The question is, why does the 
disruption of a single pair of interchain disulfide bonds have such a major effect on fibril growth at a 
stage of fibrillogenesis that is driven by lateral association? The limitation in fibrillar remodelling of 
FNCC>SS is most probably related to the fact that fibrils start out so small. Although FNCC>SS protein 
levels are normal and despite that FN-binding sites in FNCC>SS are intact and fully competent to 
associate laterally with each other, the delay in fibril growth at the fibrillar adhesion renders the average 
FNCC>SS fibril shorter and lacking the capacity to build the same complex supramolecular network as 
WT FN. The difference in fibrillar complexity is more obvious in MEF-derived matrices than in tissue, 
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and this might reflect that three-dimensional confinement of tissues creates a favourable environment 
to promote the fibrillar remodelling process.  
The FNCC>SS/CC>SS mouse offers a model for examining the specific requirement for the pair of 
disulfide bonds, constituting the dimerisation motif, for FN fibrillogenesis. This model provides a pure 
system to evaluate the monomerisation of an otherwise full-length FNCC>SS molecule. In contrast, the 
study published by Dr. Schwarzbauer, which established the current dogma on the requirement for the 
dimerisation motif, were based on mammalian cells expressing a fusion construct of FNI1-9 and the 
most extreme 100 kDa of the C-terminus (recFNI1-9/C110) that lacked a twenty-amino acid segment 
containing the C-terminal dimerisation motif (recFNI1-9/C110M). The cells expressing this recombinant 
fragment failed completely to deposit this form of FN into fibrillar matrix, and all the protein was 
released into the medium (Schwarzbauer, 1991). 
Based on the observation that monomerised FNCC>SS is assembled into a matrix of shortened 
fibrils, there appears to be no absolute requirement for FN dimerisation, if simply for the purpose of 
duplicating the number of RGD motifs that can employ integrin α5β1. Nevertheless, the fibrillar 
morphology of monomerised FN is strongly compromised, and I conclude that dimerisation is crucial 
to achieving the appropriate rate of FN fibrillogenesis because it serves to limit the degrees of freedom 
and increases the local concentration of the reaction components. The delay in fibril elongation will 
render fibrils of monomerised FNCC>SS shorter, and these short fibrils will never have the capacity to 
achieve the same matrix complexity as WT FN.  
The discrepancy between the results presented herein and those presented by Dr. Schwarzbauer 
must relate to the design of the recombinant fragment (recFNI1-9/C110M). First of all, deleting a 
twenty-amino acid segment of the C-terminus, including the dimerisation motif, might cause more of a 
change to FN than controlled for. Secondly, and possibly most importantly, although the recFNI1-
9/C110M contains both the N-terminal assembly domain and the cell-binding domain RGD motif, it 
has a large internal deletion of repeats FNIII1-7 such that the collagen-binding domain becomes 
connected to the cell-binding domain. Although the FNIII1-7 segment might not be critical for 
fibrillogenesis of FNI1-9/C110 when both the assembly domain and dimerisation motif are available, 
the FNIII1-7 might very well become essential in the absence of a dimerisation motif because the 
FNIII1-7 repeats offer abundant potential to interact with the N-terminal assembly domain and 
promote the lateral association among extended FN molecules. For example, the 70kDa N-terminal 
assembly domain in FN has been shown to interact with sites in FNIII1 (Hocking et al., 1994), FNIII2 
(Aguirre et al., 1994; Sechler et al., 2001) and FNIII4-5 (HepIII) (Maqueda et al., 2007) in addition to 
sites within FNIII10 and FNIII12-14 (Hocking et al., 1996; Bultmann et al., 1998). Therefore, it is 
conceivable that the failure of recFNI1-9/C110M to undergo conversion into a fibrillar and DOC-
insoluble matrix (Schwarzbauer, 1991) relates to more than just the inability of this form of FN to 
dimerise and highlights the important contributions of the cryptic FN-binding sites to fibrillogenesis. 
With the FNCC>SS/CC>SS mouse, monomerised FNCC>SS is full-length and all FN-binding sites are intact 
as well as in their correct positions relative to each other. 
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9.2 Unique properties of the FNCC>SS fibrillar matrix 
The structural characterisation of the FNCC>SS fibrillar matrix was complemented with an analysis of 
the mechanical properties of cell-derived ECM containing FNCC>SS fibrils (fig. 8.24). Applying the 
state-of-the-art AFM indentation technique to MEF-derived ECM platforms, I found that the unique 
structural features of FNCC>SS fibrillar matrix were associated with a change in the elasticity of ECM 
that forms around FNCC>SS, despite the fact that FN is far beyond the only matrix component of a cell-
derived ECM. In comparing the elasticity of WT ECM with an ECM containing FNCC>SS, I concluded 
that FN dimerisation contributed to make the ECM nearly three times stiffer than an ECM containing 
FNCC>SS. It is quite possible that this difference in elasticity reflects the fibrillar complexity of the FN 
matrix and that of other fibrillar ECM components, whose deposition relies on FN (e.g. LTBP-1). 
The ECM is being recognised for its influential role in controlling cell behaviour, particularly with 
regards to the functional importance of physical/mechanical properties of the ECM. Cells are very 
sensitive to tissue-level elasticity; diverse cell types such as fibroblasts, tumour cells and stem cells have 
the ability to detect and respond to local matrix stiffness and deformability. A collection of seminal 
papers demonstrates the importance of matrix stiffness in development, differentiation, tissue 
morphogenesis, regeneration and disease (Discher et al., 2005; Engler et al., 2006; Guo et al., 2006; 
Levental et al., 2009; Mammoto et al., 2009). In the absence of AFM indentation analysis of 
FNCC>SS/CC>SS embryonic tissue, I can only speculate that the differences in ECM stiffness that were 
shown between MEF-derived ECM are representative of the relative differences in the tissue 
mechanical properties between FNCC>SS/CC>SS and WT embryos. The measured elasticities in MEF-
derived ECM fell in the range of elasticity found in bone marrow ECM (~0.1–0.3 kPa) (Prewitz et al., 
2013). Interesting questions are those that ask what the implication of such stiffness differences is on 
tissue function and cell behaviour, and could an increase in embryonic tissue pliability of ECM 
containing FNCC>SS compared to WT ECM explain the cardiovascular phenotype of the FNCC>SS/CC>SS 
embryo? 
At the cellular level, ECM rigidity is reported to influence morphology, adhesion, contractility 
(Yeung et al., 2005), differentiation (Engler et al., 2004) and motility (Lo et al., 2000). These cellular 
responses to ECM stiffness are largely mediated by active integrins in focal adhesions. Matrix stiffness 
modulates integrin adhesions by strengthening the mechanical link between integrin and the actin 
cytoskeleton and altering the clustering of integrins (Paszek et al., 2005; Levental et al., 2009). A 
number of intracellular signalling kinases associated with the focal adhesion are tension-sensitive, and 
in this way, ECM stiffness can affect the volume of biochemical signals emanating from the adhesion. 
Integrins relay biochemical signals on ECM compliance through major signalling pathways involving 
ROCK, FAK, ERK and Akt (Wozniak et al., 2003; Paszek et al., 2005). For example, FAK activation 
at tyrosine residue 397 is regulated by acto-myosin contractility, integrin-mediated adhesion and matrix 
stiffness in a tension-responsive manner (Tilghman and Parsons, 2008). It is noteworthy that only on 
stiff subtrates are cells found to assemble stress fibres and phosphorylate FAKY397 within focal 
adhesions (Paszek et al., 2005).  
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Integrin α5β1 and F-actin in FNCC>SS/CC>SS MEF clonal cell lines displayed markedly altered fibrillar 
adhesion structures (fig. 8.22). In addition to previously mentioned speculations the stunted 
appeareance of fibrillar adhesions could relate to the compliant FNCC>SS matrix unable to resist the 
contractile force transmitted by integrins to the same degree as a WT FN matrix, and this would cause 
a weakening of the integrin adhesion complex. In an approach to evaluating cell-matrix adhesion 
stability, I compared motility of FN-/- fibroblasts seeded onto tissue-mimetic ECM platforms derived 
from either WT or FNCC>SS/CC>SS MEFs. This analysis showed no difference in migration speed 
between cells migrating in response to PDGF-BB on an ECM platform containing WT FN and 
FNCC>SS (fig. 8.27). In addition, I addressed integrin outside-in signalling through pFAKY397 in (1) WT 
and FNCC>SS/CC>SS MEFs generating their own fibrillar matrix (fig. 8.28), (2) FN-/- fibroblasts seeded 
onto tissue-mimetic ECM derived from WT and FNCC>SS/CC>SS MEFs (fig. 8.29) as well as (3) WT and 
FNCC>SS/CC>SS embryonic tissue (fig. 8.30). In none of these systems did I identify an abnormality in the 
levels of pFAKY397 in response to FNCC>SS matrices. Similiary, I saw no change in the levels of 
pMLC2S19 between FN-/- fibroblasts seeded onto ECM derived from WT and FNCC>SS/CC>SS MEFs, 
indicating that integrin outside-in signalling through the RhoA/ROCK axis is also unaffected by the 
structural and mechanical properties of FNCC>SS matrices. 
Unfortunately, I do not have measurements of Young’s moduli of the ECM preparations that were 
used to perform cell migration assays and integrin outside-in signalling assays. These matrices were 
prepared through decellularisation with EDTA of three-day cultures (fig. 8.26). When prepared in this 
fashion, the resulting ECM platforms are too thin for AFM indentation measurements. Yet, these 
matrices were morphologically similar to the thicker matrices used for AFM indentation analysis. 
Therefore the relative difference in compliance of these matrices is assumed to compare to those of 
thicker matrices prepared through anchorage (cf. fig. 8.24), such that ECM containing FN dimers is 
still about three-fold stiffer than ECM containing FNCC>SS. Despite this assumption, it is not clear why 
the cellular response to the structural and mechanical features of the FNCC>SS matrix is undetectable. It 
could be that even though I find a three-fold difference in stiffness between ECM containing WT FN 
and FNCC>SS, the absolute Young’s moduli for these matrices are very low and hence too soft for 
changes of hundreds of Pascals to trigger differences that are significant enough to detect by the 
biochemical or cell biological techniques employed here. Indeed, when naïve mesenchymal stem cells 
have been shown to commit to a lineage and phenotype with extreme sensitivity to tissue-level 
elasticity, this was on matrices that range between 100 Pa (“soft”) and 40 kPa (“stiff”) (Engler et al., 
2006). When matrix stiffness has been found to regulate focal assembly, modify growth factor 
signalling and cell phenotype through ERK and Rho activity, it was based on culturing cells on soft 
and stiff matrices that range for 400 Pa (“soft”) to 5000 Pa (“stiff”) (Paszek et al., 2005). Also, 
comparison of smooth muscle cell migration speeds have been based on substrates designed with 
Young's moduli values ranging from 1000 Pa (“soft”) to 308 kPa (“stiff”). Hence, while the Young’s 
moduli of both the WT ECM and ECM containing FNCC>SS must be relevant to cells in the developing 
embryo because they were generated by MEFs from E9.5 embryos, it appears that conventional 
PhD Thesis - Josefine Gibson  Discussion 
 
 121 
methods to detect cellular output (e.g. integrin outside-in signalling and migration assays) are 
insufficient to distinguish between differences within such a low stiffness regime. 
9.3 The FNCC>SS knock-in mutation causes cardiovascular remodelling defects  
Even though I could identify no accute change in the cellular response to the unique structural and 
mechanical properties of FNCC>SS matrix, the complete halt in development is evidence that the 
qualities of the FNCC>SS matrix severely disturb cellular function. Most prominent were the defects 
arising within the cardiovascular system. The cardiovascular system is the first functional organ to 
develop in vertebrates, and failure of the cardiac or vascular tissue to perform is lethal. 
9.3.1 Cardiac defects 
The effused pericardial sac and the malformed ventricular structures in the heart of E9.5 
FNCC>SS/CC>SS embryos (fig. 8.4) suggested severe defects of the developing heart. Immunological 
whole mount stainings of the endocardium in FNCC>SS/CC>SS embryos revealed an irregular curvature of 
the endocardium, an inability of the endocardium to interact extensively with the myocardium, the 
stunted growth of the heart tube and a failure of the heart tube to undergo rightward looping 
morphogenesis (figs. 8.10 and 8.11). These heart looping morphogenesis defects could possibly reflect 
a general left/right asymmetry defect in FNCC>SS/CC>SS embryos. FN is known to have an important 
effect on establishing left-right asymmetry along the embryonic body anterior-posterior axis by 
regulating morphogenesis of the node at very early stages of development (Pulina et al., 2011). 
Preventing FN dimeristaion could change structural features of the FN matrix to a degree that 
prevents it from shaping the node and promoting the establishment of asymmetric gene expression 
patterns. Such questions would require electron microscopical analysis of embryonic structures, such as 
the node, and in situ hybridisation to visualise the spatial expression patterns of Nodal and other genes, 
such as Lefty1, Lefty2 and Pitx2c, which are known to be asymmetrically expressed on the left side of 
the lateral plate mesoderm (Pulina et al., 2011). 
At this critical stage of cardiac development, FN is an abundant component of the cardiac jelly, into 
which mesenchymal cells migrate to establish the cardiac cushion that must form in both the outflow 
tract and the atrioventricular channel, a process that involves additional deposition of FN (Mjaatvedt et 
al., 1987; Ffrench-Constant and Hynes, 1988; Roman and McDonald, 1992; Eisenberg and Markwald, 
1995). Cardiac cushion is essential to heart development because it will condense to divide the outflow 
tract into the aorta and the pulmonary artery and contribute both to forming the major valves of the 
heart and closure of the heart septum (Webb et al., 1998; Savolainen et al., 2009). Given the 
morphology of the FNCC>SS/CC>SS cardiac tissue, it is apparent that dimerisation of FN confers specific 
properties that support the formation of these cardiac structures.  
The physical mechanisms that drive and regulate cardiac looping morphogenesis are currently 
incompletely understood (Taber et al., 2010). Elegant work on chick embryos, which, with caution, can 
be extrapolated to that of other vertebrate organisms such as the mouse embryos, has demonstrated 
that the first phase of cardiac looping occurs as specific regions of the heart tube grow and contract. 
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Looping is driven further by forces exerted on the heart tube by surrounding tissues as they press 
against the ventral surface of the heart. One interesting study sheds light on the role of regional 
stiffness along the heart tube in promoting the bending and rightward looping (Zamir et al., 2003). 
Based on microindentation measurements along intact embryonic heart tubes, the tissue lining what 
would become the inner curvature of the embryonic cardiac tube was significantly stiffer than the 
tissues that would line the outer curvature or dorsal and ventral sides of the heart tube. In the process 
of cardiac looping, the tissue lining the outer curvature of the cardiac tube has to stretch and extend 
further than tissue lining the inner curvature and therefore it appears that that modulating the local 
stiffness along the cardiac tube dictates which of the faces of the tube forms the outer and inner 
curvatures in response to the external pushing at the ventral side. The authors of this study suggest 
that this regional variation in stiffness is due to the mechanical properties of the myocardium. FN is 
important for establishing the integrity of myocardial tissue during cardiogenesis (Trinh and Stainier, 
2004b), and perhaps fibrillar FN plays a role in shaping the mechanical properties of the myocardium, 
either by the complexity of the FN fibrillar matrix itself or that of the ECM components that rely of 
the presence of a fibrillar FN matrix. The inability of FNCC>SS/CC>SS cardiac tubes to undergo looping 
morphogenesis could be associated with a decrease in the tissue stiffness caused by the presence of 
FNCC>SS in the myocardial basement membrane, and this alteration in the elasticity of the myocardium 
would cause the failure to establish the regional stiffness that dictates the correct bending of the 
cardiac tube. 
The cardiac malformation in FNCC>SS/CC>SS embryos could also reflect an inadequate level of 
intracardiac shear forces as blood flows through the heart tube. Hemodynamics is considered a key 
epigenetic factor in cardiogenesis, as impaired blood flow disrupts looping morphogenesis and impairs 
the formation of heart valves (Hove et al., 2003). Cardiac endothelial cells have been shown to respond 
to shear forces by reorganising their cytoskeleton and changing their genetic expression profiles 
(Davies, 1995; Topper and Gimbrone, 1999). FN is a core basement membrane component of the 
developing vessel wall (Risau and Lemmon, 1988), which provides mechanical resistance to the 
increasing flow of blood of the growing embryo. Having learned that FNCC>SS causes a softening of the 
ECM, it is plausible that the vascular basement membrane containing FNCC>SS does not provide 
adequate mechanical support to the endothelium. As a result, blood flow would not expose the 
endocardium to normal hemodynamic forces to promote its development. 
9.3.2 Vascular defects 
Another hallmark of the FNCC>SS/CC>SS phenotype are the vascular remodelling defects, both in the 
embryo proper (fig. 8.9) and extraembryonic tissues (figs 8.5, 8.6 and 8.8). Very prominent are both the 
anemic appearance and the failure to form a hierarchical network of branched high-calibre and low-
calibre vessels in the yolk sac (fig. 8.5). The yolk sac is a large, but thin extra-embryonic tissue that 
envelops the embryo proper at E7.0. This tissue is of major importance to the development of the 
embryo because it is a source of the first primitive erythrocytes cells and progenitors of the 
hematopoitic system, which are required until the aorta/gonad/mesonephros-derived hematopoetic 
PhD Thesis - Josefine Gibson  Discussion 
 
 123 
stem cells seed into the fetal liver, where they can differentiate into erythrocytes (Palis and Yoder, 
2001; McGrath and Palis, 2005). The delivery of these first primitive erythrocytes to the embryo 
proper relies on the development of a yolk sac vasculature and its connection to the embryonic 
vasculature. The immunological and histochemical analyses of the FNCC>SS/CC>SS yolk sac revealed that 
vasculogenesis had succeeded to build a primitive vascular plexus, but that the endothelial branching, 
remodelling and pruning events of angiogenesis that must follow the establishment of a primitive 
plexus (Risau, 1997) had failed in FNCC>SS/CC>SS yolk sac. A strong indication of integrity failure of the 
primitive vascular plexus in FNCC>SS/CC>SS yolk sacs was the accumulation of erythrocytes in the yolk 
sac, strongly suggestive of leaky vessels. Immunohistochemical analysis of the E9.5 FNCC>SS/CC>SS 
embryo proper revealed a chaotic vascular infrastructure in the head as well as an abnormal vessel 
length and diameter of the dorsal aorta, pharyngeal arteries and intersomitic vessels. The allantoic 
mesoderm in FNCC>SS/CC>SS had also failed to grow to allow the embryonic vasculature to intermingle 
with the maternal vasculature in the placenta for the effective blood-based exchange of gases and 
nutrients between embryo and mother. These defects in vascular development in both embryonic and 
extra-embryonic tissues appear at the stage of development where the normal mouse embryo can no 
longer survive by direct diffusion-based exchange of gases, nutrients and toxic metabolites with the 
surrounding amniotic fluid (Rossant and Cross, 2001). Hence I conclude that the vascular defects in 
FNCC>SS/CC>SS embryos are the cause of embryonic growth arrest prior to the 20 somite stage of 
development and ultimately result in lethality. 
The expansion and remodelling of the blood vasculature is closely coordinated with the 
development of the embryonic heart. The yolk sac vasculature is particularly sensitive to increasing 
heart fuction, and so it is relevant to explore the possible relationship between the defective cardiac 
tissue in FNCC>SS/CC>SS embryos and the concurrent failure in vascular remodelling. By E8.0 (4-6 
somite stage), the heart has become physically connected to the yolk sac via an extensive network of 
blood vessels such that as the heart begins to beat, primitive erythroblasts originating in blood islands 
of the yolk sac can flow into the blood circulation of the embryo proper (Ji et al., 2003; McGrath, 
2003). The major remodelling events of the yolk sac vasculature take place immediately following the 
established circulation. 
The development of the cardiovascular system has been shown to rely on interplay between a great 
number of genes (e.g. Hedgehog, TGF-β and VEGF-A) (Solloway and Harvey, 2003; Trinh and Stainier, 
2004a; Argraves and Drake, 2005). However, not all genes that are required for vascular remodelling 
are actually expressed by the endothelium; in some cases, genes (e.g. Nkx2.5, Ncx1, MLC2a and Titin 
genes) that are critical for vascular remodelling are primarily expressed by cardiac cell types (Tanaka et 
al., 1999; Koushik et al., 2001; Huang et al., 2003; May et al., 2004). A clear example of the key 
function of the heart in promoting vascular remodelling is given by the rescue of the vascular defects 
in the complete N-cadherin knockout mouse by re-introducing expression of either N- or E-cadherin 
only in heart tissue (Luo et al., 2001). One conclusion from these mouse knockout studies is that 
vascular remodelling defects arise as secondary effects of impaired cardiac contractility and circulation. 
Circulation is essential to the embryo because it delivers both oxygen and nutrients to all tissues of the 
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organism (Conway et al., 2003), but in recent years it has become clear that circulation also positively 
influences developmental angiogenesis by exerting hemodynamic force on the endothelium (Lucitti et 
al., 2007). Endothelial cells respond to the hemodynamic force exerted by blood flow (i.e. shear stress 
and circumferential strain) with changes in cell morphology, activation of intracellular signalling 
pathways and induction of specific genetic expression patterns (Li et al., 2005b). A disturbance or 
reduction in fluid dynamics caused by cardiac defects has been proposed to lead to the disruption of 
the mechanical signals necessary for proper vascular development (Jones et al., 2004). An elegant study 
by Lucitti and colleagues has demonstrated that vascular remodelling in the yolk sac is driven by those 
very first events occurring at E8.0, where the heartbeat-driven entrance of erythrocytes from blood 
islands into circulation (Ji et al., 2003; McGrath, 2003) causes a change in the effective viscosity of the 
blood flow that mechanically stimulates the endothelium and initiates proper remodelling (Lucitti et al., 
2007).  
This intimate coupling between cardiac function and vascular development offers a possibility that 
the vascular remodelling defects of the FNCC>SS/CC>SS embryos are secondary effects of cardiac 
malfunction. Although the cardiac tissue of FNCC>SS/CC>SS embryos show spontaneous contractions, 
the failure of the cardiac tube to remodel and the accumulation of plasma in the pericardial sac suggest 
that its pumping function is compromised and fails to establish the embryonic circulation. 
Furthermore, the anemic appearance of the FNCC>SS/CC>SS yolk sacs, accompanied by an accumulation 
of small amounts of blood in the yolk sac cavity, indicate that the vessels of the primitive vascular 
plexus are leaking erythrocytes into extravascular space. The combination of cardiac failure with the 
loss of erythrocytes from the yolk sac would prevent the heartbeat-driven entrance of erythrocytes into 
the embryonic circulation to elevate the hemodynamic force exerted on the endothelium and drive the 
remodelling of the FNCC>SS/CC>SS yolk sac vasculature. The phenotypic parallels between mice deficient 
in atrial MLC2a (Huang et al., 2003) and FNCC>SS/CC>SS embryos lend support to the possibility that 
cardiac dysfunction in FNCC>SS/CC>SS embryos relates to the inability of FNCC>SS in adhesions to 
stabilise the atrial myofibrillar apparatus and sustain atrial contraction.  
The cardiac and vascular remodelling the FNCC>SS/CC>SS embryos could also be uncoupled events in 
that the vascular defect does not derive from the heart defect. In this case, developmental angiogenesis 
fails to occur because of a negative response of endothelial and/or mural cells to FNCC>SS present 
within the vascular basement membrane. In the FNCC>SS/CC>SS yolk sac, the endothelial cells were 
found to have coalesced into a primitive plexus of lumenised vessels, characterised by several 
abnormalities; but lumens were abnormally wide, mural cell recruitment and investment of the vessel 
wall appeared chaotic, and sprout formation, fusion, pruning and remodelling of these vessels had 
failed. Several studies have shown that endothelial-specific knockout of β1 integrins results in severe 
vascular defects and lethality at E10 (Carlson et al., 2008; Lei et al., 2008; Tanjore et al., 2008; Zovein 
et al., 2010). This prompted the hypothesis that FNCC>SS disrupts developmental angiogenesis by 
interfering with β1 integrin activation in the endothelium. However, my investigation of integrin signal 
activation by western blot analysis of FAKY397 phosphorylation and MLC2S19 in FNCC>SS/CC>SS 
embryonic tissue or highly vascularised tissue such as the yolk sac showed no obvious change in 
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integrin outside-in signalling via FAK or RhoA/ROCK. If FNCC>SS was influencing the activation of 
integrins, the change in pFAKY397 was either below detection level or simply not reflected in the levels 
of pFAKY397 or pMLC2S19 (figs. 8.28, 8.29, 8.30). Interestingly, Richard Hynes and colleagues have very 
recently demonstrated that the endothelial-specific knockout of the FN receptor integrin α5β1 has no 
obvious effect on developmental angiogenesis; in fact neither FN receptors α5β1 or αVβ3 are 
required by the endothelium for vasculogenesis or angiogenesis at early stages of development. 
Instead, they are necessary for the subsequent remodelling of the great vessels and heart occurring 
from E11.5 onwards (van der Flier et al., 2010). This stands in contrast to the early cardiovascular 
defects of Tie2-Cre-mediated endothelial-specific knockout of all β1 integrins (Carlson et al., 2008; Lei 
et al., 2008; Tanjore et al., 2008; Zovein et al., 2010) or the endothelial-specific knockout of integrin 
adhesion scaffolding or signalling molecules, such as ILK (Friedrich et al., 2004) and FAK (Braren et 
al., 2006), all of which succumb to early angiogenesis defects in embryo, placenta and yolk sac and die 
before E11.5. This contrast suggests that at early stages of angiogenesis, (1) the endothelium operates 
with β1 integrins other than FN-binding integrin α5β1 (e.g. receptors for laminin, collagen, 
thrombospondin), and (2) these β1 integrin-mediated signals drive the cellular processes of early 
developmental angiogenesis. Which β1 integrins are responsible for these early angiogenic processes 
awaits further investigation. In light of these studies, the developmental angiogenesis defects found in 
FNCC>SS/CC>SS embryos cannot be interpreted to reflect aberrant activation of endothelial α5β1 integrin 
by FNCC>SS.  
The discrepancy between the vital requirement for FN and integrin α5β1 in vascular development 
on the one hand (Yang et al., 1993; George et al., 1997), and the ability of endothelial cells to manage 
without FN-binding integrins on the other also highlights the likelihood that FN-binding integrin 
function is required in non-endothelial cell types, such as mural cells (pericytes and vSMCs). These 
cells associate with the endothelium, either directly or through a shared basement membrane 
containing FN (Courtoy and Boyles, 1983), among other ECM proteins, and promote vascular 
development and function in part because this association stimulates VEGF-A production by mural 
cells (Darland et al., 2003). A transient, but direct interaction of mural cells with endothelial cells is 
mediated though integrin α4β1 expressed by endothelial cells and VCAM-1 expressed by mural cells 
(Garmy-Susini et al., 2005) and therefore this mode of integrin-dependent interaction between 
endothelial cells and mural cells to interact is probably not influenced by the presence of FNCC>SS in 
the vascular basement membrane. Yet within FNCC>SS/CC>SS yolk sacs, α-SMA-positive mural cells are 
chaotically distributed and aberrantly associated with the endothelium, giving the impression that 
despite the correct differentiation from precursor cells (an observation I will return to shortly), these 
mural cells might not associate properly with the endothelium to support their development. 
Interestingly, there is a reported case showing that FAK plays a role in promoting the motility of 
vSMCs, and this is particularly important for their recruitment to the outflow tract of the heart, which 
they divide into the aorta and pulmonary artery (Cheng et al., 2011). As a signalling molecule that is 
activated within focal adhesions, FAK could propagate motility signals downstream of FN-binding 
integrins expressed on mural cells. Here it is tempting to speculate that FNCC>SS deposited by the 
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developing endothelial cells and mesoderm affects the ability of mural cells to mobilise and invest the 
endothelium. Without the appropriate balance in mural cell investment, the FNCC>SS/CC>SS endothelium 
might not be receiving the necessary levels of VEGF to promote its remodelling (Darland et al., 2003). 
The ability of mural cells to support blood vessels integrity relies on β1 integrin-mediated cell adhesion 
(Abraham et al., 2008), although the requirement of FN-binding integrins remains to be formally 
proven. However this β1 integrin-mediated effect of mural cells on the endothelium is apparently not 
essential at early stages of developmental angiogenesis because mice lacking β1 integrins in mural cell 
die at perinatal stages (Abraham et al., 2008). Clearly there is a very complex interplay between 
endothelial and mural cells, and with both cell types in such close proximity and dependent on each 
other, it is difficult to draw conclusions on which cell type is affected by FNCC>SS and disrupts 
developmental angiogenesis. The proximity of both endothelium and mural cell to FNCC>SS makes it 
very likely that both cell types are challenged by FNCC>SS. 
There is substantial evidence in the scientific literature that both endothelium and mural cells are 
sensitive to the mechanical properties of their microenvironment. The processes of vascular 
differentiation and remodelling are sensitive to tensional homeostasis, of which ECM stiffness is a key 
parameter. Therefore ECM stiffness must be considered as a possible contribution to the vascular 
defects in the FNCC>SS/CC>SS embryos and yolk sacs. In vitro studies have demonstrated that endothelial 
behaviour is regulated by ECM stiffness. For example, increases in collagen gel stiffness increases 
endothelial cell spreading as well as the number and length of angiogenic sprouts extended by 
endothelial spheroids (Mason et al., 2013). Another study addressed the positive effect of hydrogel 
stiffness on endothelial proliferation (Yeh et al., 2012). Furthermore, both the stiffness and shape of 
endothelial cells changes according to the stiffness of a substrate (Byfield et al., 2009; Califano and 
Reinhart-King, 2010). A groundbreaking paper on this topic describes how angiogenesis is directed by 
endothelial cell integration of both chemical cues, such as VEGF gradients, and mechanical cues from 
the substrate. Here, the degree of elasticity of the endothelial substrate governs a complex 
transcriptional programme that regulates the expression of VEGFR2 by the endothelial cell and 
thereby regulates the sensitivity of the endothelium to soluble VEGF gradients (Mammoto et al., 
2009). 
vSMCs are known to show a response to changes in substrate stiffness in terms of cell motility, and 
through intracellular mechanisms that involve Rho-mediated cytoskeletal rearrangements and cell 
contractility, the vSMC reaches an optimum migration speed on a substrate that is “neither too soft 
nor too stiff” (Peyton and Putnam, 2005). Furthermore, the activation and differentiation of α-SMA-
positive myofibroblasts from progenitors cells depends on both TGF-β (Desmoulière et al., 1993; 
Hirschi et al., 2003; Chen and Lechleider, 2004; Ding et al., 2004) and ECM stiffness (Hinz et al., 2001; 
Goffin et al., 2006; Hinz, 2010). The spontaneous contractile activity of myofibroblasts is also 
governed by the mechanical environment, as demonstrated by a very recent study in which the 
mechanical conditions of the extracellular environment controlled the contractile activity of 
myofibroblasts by modulating the oscillation frequency of intracellular calcium ions (Godbout et al., 
2013). It is not only the absolute values of matrix stiffness that determine the cellular response, but 
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also the steepness in the gradient of matrix stiffness sensed by cells. For example, durotaxis of vSMCs 
depends on substrate stiffness gradient strength (Isenberg et al., 2009).  
When it comes to building a functional vasculature, there is still far to go before understanding how 
endothelium and mural cells respond to abnormal mechanical properties of the ECM in vivo, if at all. 
This is because we are still far from defining the stiffness requirements of the embryos and recognising 
defects that relate to tissue stiffness. Perhaps the change in the mechanical properties of the ECM 
lower the proliferation and sprouting activities in the FNCC>SS/CC>SS endothelium. Perhaps it affects the 
expression of VEGFR2 by the endothelium and renders the endothelium insensitive to VEGF 
gradients. Alternatively, the change in the ECM stiffness regime caused by FNCC>SS could affect the 
steepness of the gradient in ECM stiffness, which could be hypothesised to affect the ability of the 
vSMCs to reach their correct destination at the right time. 
9.4 Exploring growth factor signalling defects in the FNCC>SS/CC>SS mouse 
Growth factors and their cognate receptors are in large part responsible for the morphogenetic 
induction and shaping of tissues within the cardiovascular system. Given the defects in cardiac 
development in the FNCC>SS/CC>SS mouse, it was of great importance to investigate the impact of 
monomerised FN on growth factor signalling. A significant part of this project was dedicated to 
investigating the phenotypic parallels between the FNCC>SS/CC>SS mouse and mice in which TGF-β 
signalling is compromised, while a minor part went to exploring the effect of monomerised FNCC>SS 
on VEGF receptor signalling. 
Just like the FNCC>SS/CC>SS mouse, cardiac remodelling defects causing embryonic lethality are a 
common theme of TGF-β (Dickson et al., 1995; Sanford et al., 1997; Bartram et al., 2001), TGF-β 
receptor (Oshima et al., 1996; Oh et al., 2000; Jiao et al., 2006; Seki et al., 2006; Carvalho et al., 2007; 
Sridurongrit et al., 2008) and TGF-β co-receptor knock-out mice (Arthur et al., 2000; Stenvers et al., 
2003). The prominent roles of TGF-β signalling during heart development appears to be in promoting 
endothelial-mesenchymal transition in the endocardium leading up to the formation of the cardiac 
cushions as well as regulating cell-cell contacts to shape the modelling of chambers. 
TGF-β is also a potent regulator of angiogenesis, acting both on the endothelial and the mural cell 
compartments of the developing vasculature. However, TGF-β has context-dependent effects on 
endothelial cells, and different endothelial responses are mediated by signalling through 
ALK1/SMAD1/5 (triggering proliferation) and ALK5/SMAD2/3 (triggering quiescence) (Goumans 
et al., 2002). The expression of endoglin by endothelial cells promotes ALK1 signalling, thereby 
shifting the TGF-β response toward proliferation. In vivo, an important role of TGF-β is to stabilise 
the vasculature post-angiogenesis by inducing a stabilising microenvironment. One way by which 
TGF-β stabilises the vasculature is by promoting the buildup of the vascular basement membrane. 
TGF-β1 is a potent inducer of numerous ECM protein-coing genes, both of provisional matrix 
proteins, such as FN, but also of proteins of the mature ECM, such as collagen (Roberts et al., 1986; 
Ignotz et al., 1987; Keski-Oja et al., 1988). Consistent with this role of TGF-β, the TGF-βRI knockout 
mice show a lack of FN synthesis by extraembryonic mesoderm in the yolk sac vasculature and the 
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vasculature fails to remodel correctly (Larsson et al., 2001). In fibroblast- or endothelial cell-based 
studies, TGF-β was also found to modulate the activity of ECM-degrading enzymes by increasing the 
expression of PAI-1, an inhibitor of the plasminogen activator (Laiho et al., 1986; Pepper et al., 1990), 
tissue inhibitor of metalloprotease (TIMP) as well as inhibiting the expression of collagenase (Edwards 
et al., 1987) so as to minimise the proteolytic degradation of the ECM. Furthermore, TGF-β 
modulates integrin expression, both positively (Heino et al., 1989; Riikonen et al., 1995; Nejjari et al., 
1999; Thibault et al., 2001; Giannelli et al., 2002) and negatively (Heino and Massagué, 1989; Kumar et 
al., 1995; Lim et al., 1998), in a contextual manner.  
Another way by which TGF-β stabilises the endothelium is achieved through the recruitment of 
mural cells. Indeed, as mesenchymal cells are recruited to the endothelium through PDGF-BB 
gradients, they become exposed to TGF-β and differentiate into mural cells which will invest and 
stabilise the vasculature (Hirschi et al., 1998; Sinha, 2004; Wurdak et al., 2005). TGF-β is involved in 
crosstalk between endothelial cells and mural cells, for diisrupted TGF-β signalling in endothelial cells 
impairs the TGF-β/ALK5 signalling in adjacent mesenchymal cells, inhibiting their differentiation into 
mural cells and association with the endothelial tubes (Carvalho et al., 2004).  
In addition to exogenous agents, such as heat, pH and proteolysis, studies have highlighted the 
importance of juxtaposition of endothelial and mural cell types for the activation of latent TGF-β and 
its availability to either cell type (Antonelli-Orlidge et al., 1989; Sato and Rifkin, 1989; Sato et al., 1990). 
Within this system, latent TGF-β is deposited into the vascular basement membrane via LTBP 
(Flaumenhaft et al., 1993), and release mechanisms are in place, possibly involving gap junctions 
(Hirschi et al., 2003), to activate latent TGF-β stored in the ECM in an integrin-dependent manner. 
Analogous to mural cells, astrocytes associate closely with the brain endothelium to help provide 
vascular integrity. This role of astrocytes relies in part on their ability to activate latent TGF-β from the 
vascular basement membrane through integrin αVβ8–dependent metalloproteolytic mechanism of 
latent TGF-β activation (Cambier et al., 2005).  
In the context of exploring the cardiovascular remodelling defects in the FNCC>SS/CC>SS embryo and 
yolk sac, I examined the circumstantial evidence for abnormal TGF-β signalling in the FNCC>SS/CC>SS 
embryo (figs 8.33 and 8.34). With the current understanding of TGF-β-mediated effects on the 
vasculature, one would hypothesise that a distortion in TGF-β signalling would be associated with a 
change in the levels of FN protein in the ECM. However, by RT-PCR analysis of FN mRNA (fig. 
8.13), western blot analysis of FN protein levels (fig. 8.14) and immunofluorescence imaging of FN in 
tissue sections (fig. 8.15), I found comparable levels of FN and FNCC>SS. 
Abnormalities in TGF-β availability would also be expected to disturb the differentiation of 
mesenchymal cells into α-SMA-positive mural cells as they are recruited to the developing 
endothelium. With immunofluorescence stainings of α-SMA in yolk sac, I found an abundance of α-
SMA-positive cells associated with the primitive vascular plexus of FNCC>SS/CC>SS yolk sacs. Although 
the distribution of these mural cells along the endothelium appeared chaotic and abnormal, their 
expression of α-SMA was indicative of successful TGF-β-mediated induction of the mural cell 
phenotype in the presence of FNCC>SS (fig. 8.7).  
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For a direct evaluation of TGF-β receptor activation by TGF-β, I assayed the levels of 
phosphorylated SMAD proteins as well as the transcript level of TGF-β/SMAD target genes that are 
of key relevance to vascular development. By western blot analysis of single E9.5 embryos, I found no 
significant difference in the total levels of pSMAD1/5/8 or pSMAD2/3 (fig. 8.33), and with 
immunofluorescence microscopy of whole mount E9.5 embryos I did not identify any striking change 
in the distribution of pSMAD1/5/8-positive nuclei within heart tissue or yolk sac vasculature in 
response to FNCC>SS (fig. 8.34).  
Despite not identifying changes in SMAD protein phosphorylation by western blot analysis or 
changes in the distribution of phosphorylated SMADs by IF imaging analysis, a final dataset 
highlighted that there are differences in the extent of TGF-βR activation between FNCC>SS/CC>SS and 
WT tissue. By analysis of specific TGF-β/SMAD target gene transcript levels in E8.5 yolk sacs, I could 
show a mild, but significant decrease in the transcript level of Id1 (inhibitor of differentiation or DNA 
binding) in FNCC>SS/CC>SS yolk sacs relative to WT yolk sacs (fig. 8.35). Id1 is a specific downstream 
target gene of TGF-β/ALK1/SMAD1/5/8 in the endothelium (Goumans et al., 2002). Id proteins 
(Id1, -2 and -3) belong to the helix-loop-helix (HLH) family of transcription factors that regulate gene 
expression and thereby orchestrate cell cycle control, cell lineage commitment and cell differentiation 
(Norton, 2000). The Id proteins represent a distinct subtype of the HLH protein family in that they 
lack a DNA-binding region and function solely by dimerising with other transcriptional regulators, 
primarily those of the bHLH type (Norton, 2000). This interaction with Id blocks the ability of bHLH 
proteins to bind DNA, and hence the Id proteins are generally considered negative regulators of 
bHLH proteins and their ability to positively regulate sets of genes that promote cell fate 
determination and cell differentiation (Benezra et al., 1990). Id proteins are expressed by endothelial 
cells in a SMAD-dependent manner (Korchynskyi and ten Dijke, 2002) and promote proliferative, 
migratory and invasive behaviour of endothelial cells in a pro-angiogenic manner (Lyden et al., 1999; 
Goumans et al., 2002). I have demonstrated that the angiogenic remodelling defect of the 
FNCC>SS/CC>SS yolk sac vasculature is accompanied by a significant decrease in the expression of Id1 
target gene. A dimished Id1 expression in FNCC>SS/CC>SS endothelium could explain the inability of the 
endothelium to expand and remodel the primitive vascular plexus, but also suggests that FNCC>SS/CC>SS 
endothelium does not receive adequate TGF-β-induced ALK1 signal. 
A similar trend, albeit statistically insignificant, was found for transcript levels of PAI-1 (fig. 8.35). 
PAI-1 is an inhibitor of the urokinase-type plasminogen activator (uPA). When uPa binds its receptor, 
uPA-R, it converts plasminogen into plasmin, a broad-spectrum serine protease, which in turn 
degrades many components of the ECM. The proteolytic activity of uPA is inhibited by PAI-1, and 
hence PAI-1 serves to promote the accumulation of ECM. Endothelial cells express PAI-1 in response 
to TGF-β/ALK5 activation (Sawdey et al., 1989; Goumans et al., 2002), and by contributing to the 
formation of the vascular basement membrane, TGF-β signalling can promote the quiescence of the 
endothelium and the maturation of the blood vessel wall following angiogenesis. The trend for 
FNCC>SS/CC>SS yolk sacs to contain lower levels of PAI-1 transcript than WT yolk sacs reflects a lower 
extent of activation of the TGF-β/ALK5 pathway, but also shows that the signalling events that would 
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usually put the vasculature in a quiescent phase are mild and therefore cannot explain the lack of 
remodelling of the primitive vascular plexus. 
Collectively, these analyses on TGF-βR activation and downstream signalling provide only weak 
evidence that the FNCC>SS/CC>SS phenotype is related to deficits in classical TGF-β-mediated effects.  
In addition to the phenotypic similarities, the rationale behind exploring the possible involvement 
of TGF-β in the context of the FNCC>SS/CC>SS cardiovascular phenotype was driven by the hypothesis 
that changes in the structural and mechanical properties of ECM or tissue associated with FNCC>SS 
would affect the ability of the ECM to store latent TGF-β or the ability of integrins to activate latent 
TGF-β. The deposition of LTBP-1, a extracellular carrier for latent TGF-β, into ECM containing 
FNCC>SS showed a distinct deviation from normal fibrillar morphology, forming punctate structures 
and short fibrils that very closely resembled that of FNCC>SS (fig. 8.31). Although consistent with a role 
of FN to provide a template for the deposition of LTBP into the ECM (Dallas et al., 2005; Chen et al., 
2007; Kantola et al., 2008), FNCC>SS affected the deposition of LTBP-1 to an extent that was expected 
to diminish the storage capacity of the ECM for latent TGF-β. However, it became apparently from 
MEF-derived matrices that the aberrant morphology of LTBP-1 deposited by FNCC>SS/CC>SS MEFs did 
not influence the amount of latent TGF-β stored in the ECM (fig. 8.32 A). Given the structural 
morphology of LTBP-1 fibrils and the more elastic properties of ECM containing FNCC>SS, I 
hypothesised that the resistance of the LTBP-1 fibrillar matrix would fail to allow integrin-mediated 
activation of latent TGF-β. Yet, the ability of integrin αVβ6 to activate latent TGF-β from MEF-
deposited ECM was unaffected by the presence of FNCC>SS (fig. 8.32 B). 
While I have shown that the ability of integrin αVβ6 to activate latent TGF-β does not appear to 
be affected by the presence of FNCC>SS, I have not tested the effect of FNCC>SS on αVβ8-dependent 
activation of latent TGF-β. This is the predominant mechanism by which astrocytes in the brain 
vasculature activate latent TGF-β (Cambier et al., 2005) and could also be a way by which mural cells 
of the yolk sac vasculature regulate TGF-β availability. This mechanism relies on integrin αVβ8 
binding to LAP and recruiting MT1-MMP to cleave LAP and release TGF-β from latency (Mu et al., 
2002).  
Although the available antibody against LTBP-1 has been used successfully by others, I was not 
able to apply it to to embryonic tissue and detect fibrillar LTBP-1. Therefore I could not discern the 
effect of FNCC>SS on the fibrillar morphology of LTBP-1 in embryonic tissue. Given that the FNCC>SS 
fibrillar matrix in embryonic tissue is characterised by short fibrils (fig. 8.16) it is plausible that LTBP-1 
fibrils are equally distorted in length and complexity in vivo. An inabilty to store latent TGF-β 
deposition is accompanied by abberant levels of active TGF-β, and in various cases, the failure to 
deposit latent TGF-β in tissue results in elevated levels of TGF-β signalling (Neptune et al., 2003; 
Kantola et al., 2008). However, as already discussed, I found no evidence for elevated TGF-β 
signalling associated with the FNCC>SS/CC>SS phenotype. 
TGF-β is not alone in regulating blood vessel development and is also not unique in its 
requirement for ECM to regulate its bioavailability. VEGF is a potent pro-angiogenic factor, and the 
affinity of secreted VEGF for both heparan sulfates and FN is fundamental to the ability of the ECM 
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to establish gradients of VEGF in the extracellular environment. Having found that monomerised 
FNCC>SS distorts the fibrillar morphology of the resulting matrix and that the FNCC>SS/CC>SS phenotype 
is dominated by vascular remodelling defects, I proposed the possibility that preventing FN 
dimerisation could distort the binding of VEGF to FN and that the FNCC>SS/CC>SS phenotype could 
reflect a VEGF hypomorphism. 
To test this hypothesis, I sought to compare the level of VEGF receptor signalling in WT and 
FNCC>SS/CC>SS embryonic and extraembryonic tissue. VEGFR2 phosphorylation is an immediate effect 
of VEGF binding to the extracellular domain and thus reflects the bioavailability of VEGF and the 
represents the initiation of biochemical signalling events downstream of VEGFR2 receptor. Through 
immunoprecipitation of VEGFR2 from either embryo or yolk sac lysates, I was able to biochemically 
analyse the extent of VEGFR2 phosphorylation using a monoclonal antibody against phospho-
tyrosines (4G10) (fig. 8.36). This analysis revealed no difference in the degree of VEGFR2 
phosphorylation between WT and FNCC>SS/CC>SS embryonic or yolk sac tissue. Therefore, the 
FNCC>SS/CC>SS phenotype cannot be explained by reduced levels of VEGF and hence the 
morphological abnormalities of a FNCC>SS fibrillar matrix are not sufficient to ablate or distort the 
ability of the ECM to regulate the bioavailability of VEGF in the developing embryo. 
9.5 Non-cardiovascular defects in FNCC>SS/CC>SS embryos 
FNCC>SS/CC>SS embryos die at mid-gestation because this is a stage of development where 
cardiovascular function is crucial to the survival of the embryo. Midgestation represents a stage of 
development organogenesis, and by E9.5 a multitude of developmental processes are underway to 
shape the organs of the developing embryo. Because FNCC>SS/CC>SS embryos die at mid-gestation, we 
can barely discover the impact of monomerising FN on the formation of other organs. 
Serendipitously, the immunofluorescence imaging of α-SMA in whole mount embryos gave a glimpse 
of the developing myotome in FNCC>SS/CC>SS embryos, and thus an opportunity to examine the 
requirement for FN dimerisation in very early stages of myogenesis. 
Soon after the somites form through segmentation, they undergo a compartmentalisation that gives 
rise to the sclerotome (origin of vertebrae, ribs, and tendons of back muscles) and the epithelial 
dermomyotome (origin of skeletal muscle, dermal, some endothelium, smooth muscle, and brown fat 
precursors). Muscle progenitors that differentiate within the myotomal compartment of the somites 
enter the myogenic program in situ and form the segmented muscle masses, called the myotomes. In 
amniotes the myotome does not become innervated (Deries et al., 2008) and is only a transient 
structure that is transformed into the deep back muscles epaxially and into the intercostal and body 
wall muscles hypaxially (Deries et al., 2010). 
In the mouse, the formation of the myotome starts in the anterior somites at E8.5 (Venters et al., 
1999). At E9.5, myoblasts will have differentiated from myoblasts into myosin-positive myocytes, 
which elongate in the anterior-posterior axis of the embryonic body. By E10.5, myotomal myocytes are 
more numerous and span the entire width of the somite. After multiple stages of expansion in the 
dorso-medial to ventro-lateral direction, the myotome undergoes a developmentally regulated 
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translocation and splitting (Deries et al., 2010), which culminates in a new organisation into muscle 
masses by E12.5. 
The ECM plays an important role in several steps of myogenesis. FN is an abundant component of 
the ECM around the dermomyotome and myotome as well as within the intersegmental (intersomitic) 
boundaries at all stages of myotome development (Deries et al., 2012). Lack of FN in mouse embryos 
leads to defects in somitogenesis and neural tube morphogenesis (George et al., 1993; 
Georges‐Labouesse et al., 1996), and studies in the chick embryo have shown that FN is not only 
needed for somitogenesis, but also, once formed, the maintenance of the epithelial and segmented 
organisation of somites (Martins et al., 2009). In zebrafish, the development of the myotome from 
within the somites is also dependent on FN (Snow et al., 2008). Tenascin, another ECM protein found 
associated with somites, is deposited into a matrix within the intersegmental boundary and is thus 
much more restricted in its distribution than FN (Crossin et al., 1986; Deries et al., 2012). In a recent 
study that applied confocal imaging of whole-mount immunofluorescence-stained embryos followed 
by three dimensional image reconstruction, myotomal myocytes elongating across the full length of the 
segment were found to insert their tips into the FN- and tenascin-rich matrices at the intersegmental 
boundaries. With this FN and tenascin were proposed to serve a tendon-like function for myotomal 
myocytes (Deries et al., 2012). Elongated myocytes have also been found to express integrins on their 
tips, providing a plausible mechanism of achieving attachment to the intersegmental boundary; while 
the expression of integrins α4β1, αVβ3 and α5β1 is thought to enable the attachment of myotomal 
myocytes to FN matrix at the intersegmental border, the expression of αVβ3 would allow myocytes to 
also attach to tenascin (Bajanca et al., 2004; Deries et al., 2012). In addition to lining the intersegmental 
boundary, bundles of FN and tenascin fibrils have been described to run along the elongated 
myocytes, which puts FN and tenascin in a good position to promote the alignment of myocytes 
among each other (Deries et al., 2012). Despite this apparent central role of tenascin in muscle 
attachment, mice develop normally without tenascin (Saga et al., 1992), and hence FN must have the 
predominant role in providing a tendon-like substrate for myocyte attachment to intersegmental 
boundaries at this stage of myogenesis. 
Although myosin heavy chain is the traditional cell marker of myotomal myocytes (Bajanca et al., 
2004; Deries et al., 2012), I have identified this population of differentiated cells within E9.5 embryos 
by IF staining of α-SMA (fig. 8.12). In WT embryos, myotomal myocytes were readily identified as 
clusters of numerous, elongated and fully aligned α-SMA-positive cells that were seemingly attached to 
the intersegmental borders. In contrast, only very few α-SMA-positive cells were identified in the 
anterior-most somites of FNCC>SS/CC>SS embryos, and these were misaligned and misoriented. Hence 
despite somitogenesis proceeding to form around 20-somite pair stage, the subsequent 
compartmentalisation within the somite, which occurs as soon as a somite has formed, is severely 
distorted in the presence of monomerised FNCC>SS. At present, this myotomal myocytes defect is 
perhaps the clearest example of how cells fail to attach to and manoeuver along a substrate of 
monomerised FNCC>SS. However, it is not possible to conclude whether the requirement for dimeric 
FN lies in promoting myocyte differentiation from dermomyotomal myoblasts or whether FN 
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dimerisation ensures that the resulting FN matrix lining the intersegmental boundaries possesses the 
appropriate mechanical properties such that upon attachment, elongating myotomal myocytes will 
remain firmly attached. In a manner analogous to Drosophila muscle attachment defects (Dr. Frank 
Schnorrer, unpublished), myotomal myocytes that fail to attach to a substrate would round up and 
deteriorate. 
9.6 Conclusion and outlook 
In conclusion, the dimerisation motif of FN facilitates its assembly into a structurally complex and 
mechanically robust fibrillar matrix. However, monomerised FNCC>SS can be assembled into a matrix 
network in vivo and in vitro, in contrast to expectations from widely accepted models of FN 
fibrillogenesis. Hence, FN dimerisation is not required to assist integrin-mediated extension of the FN 
molecule to expose the cryptic FN-binding sites. Rather, FN dimerisation is required to promote the 
self-assembly of unfolded FN molecules into long and stable fibrils. FNCC>SS matrices generated in vitro 
show a drastic shortening of fibril length, and although less obvious, this shortening is also a feature of 
FNCC>SS matrices in vivo within the ECM of FNCC>SS/CC>SS embryonic tissue. The structural abnormality 
of the FNCC>SS matrix is associated with a significant reduction in the elastic modulus of the ECM that 
forms around FNCC>SS.  
To the developing FNCC>SS/CC>SS embryo, the consequences of preventing FN dimerisation are 
severe, and hence the requirement for the FN dimerisation motif is important. FNCC>SS/CC>SS embryos 
fail to develop beyond E10.5-11.5 for reasons that are most likely related to an inadequacy of the 
cardiovascular system to support the growing embryo at a stage where it becomes dependent on 
blood-based exchange of nutrients and gases with the mother, which it requires a circulatory system. 
Not only does the development of the heart tube in FNCC>SS/CC>SS embryos stall at the looping 
morphogenesis stage. Also the embryonic and extraembryonic blood vascular systems of FNCC>SS/CC>SS 
embryos show a lack of vascular vessel wall integrity as well as clear signs of endothelial remodelling 
and sprouting defects. A strong co-dependence between the cardiac and vascular system during 
development makes it difficult to discern which tissue is mostly affected by monomerised FNCC>SS, 
and why. An interesting speculation is that the cardiovascular system is the first tissue to develop that 
demands robust physical support from the ECM components of the basemene membrane. That is, the 
cardiovascular system is the first to fail in the absence of FN dimers because it is the first to challenge 
the compromised mechanical properties of the ECM containing monomerised FNCC>SS.  
While defects in the cardiovascular systems are responsible for embryonic lethality, the 
cardiovascular system is not the only tissue that is affected by the monomerisation of FNCC>SS. Such 
additional defects are far less obvious because they either (1) are not severe enough to cause embryonic 
lethality or (2) occur in tissues that have not fully developed by the time the embryo becomes 
dependent on the cardiovascular system. In the latter case, FNCC>SS could cause problems later during 
embryonic or postnatal development. One example of the latter situation was identified in the 
abberant numbers and orientation of the myotomal myocyte developing within the somites of 
FNCC>SS/CC>SS embryos. These myocytes use FN deposited along the borders of the somite for 
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attachment substrate, and it is particularly interesting that this failure to attach, align and elongate in 
the anterior-posterior axis of the embryonic body could reflect an inability of the monomerised 
FNCC>SS matrix to support myotomal myocyte attachment.  
Despite the multiple indications that ECM containing FNCC>SS matrix fails to meet the mechanical 
requirements of the developing tissues, integrin outside-in signalling assays and migration assays led to 
the conclusion that the small, but significant changes in the physical properties of the ECM caused by 
monomerisation of FN do not affect integrin function. In agreement with the role of FN in providing 
a template for the assembly of other ECM components, the assembly of LTBP-1 into a fibrillar matrix 
is indeed affected by the structural features of FN and is heavily distorted in the presence of the 
monomerised FNCC>SS matrix. Suprisingly, the effect of FNCC>SS on the morphology of the LTBP-1 
fibrillar matrix does not affect the abilty of the ECM to store latent TGF-β. Neither do the mechanical 
properties of the ECM containing FNCC>SS affect the abilty of αVβ6 integrins to mechanically release 
TGF-β from latency. Despite the phenotypic similarity between FNCC>SS/CC>SS embryos and mice with 
defects in the TGF-β signalling pathway, FNCC>SS/CC>SS embryos do not contain overtly abnormal 
levels or nuclear distribution of phosphorylated SMAD. Although a reduction in the transcript level of 
the specific phosphorylated SMAD1/5/8 gene target, Id1, was reduced in FNCC>SS/CC>SS embryos, this 
reduction was very mild and probably does not explain the severe phenotype. Similarly, assays of 
VEGFR2 signalling in embryonic tissue led to the conclusion that the dimerisation of FN does not 
affect the abilty of the ECM to regulate VEGF-A bioavailability.  
The FNCC>SS/CC>SS mouse is a model that reveals the role of FN dimerisation in building a robust 
ECM that can support tissue homeostasis and development. To come closer to understanding the 
requirement for FN dimerisation in vascular development would require futher studies in a well-
defined angiogenesis model system. For example, the mouse retina, where astrocyte-derived FN 
induces both integrin-dependent and –independent functions in endothelial cells and pericytes as they 
build the retinal vasculature, could offer a system for studying the requirement for FN dimerisation in 
angiogenesis. In an experiment similar to that described by Stenzel et al. (2011) the FNCC>SS/fl 
heterozygouse mice would be crossed with a mouse strain expressing Cre under the control of a 
astrocyte-specific promoter, such as GFAP-Cre, to generate a mouse model in which all GFAP-
expressing astrocytes no longer express WT FN, but express monomerised FNCC>SS. Analysis of the 
retinal vasculature, e.g. the vessel migratory length and branching as well as alignment and stability of 
tip cells along the FNCC>SS network, would provide an alternative approach to understanding the role 
of FN fibrillar structure imposed by the FN dimerisation motif in angiogenesis. 
Although pFN is dispensable for hemostasis, FN, along with fibrin, is an integral part of a 
thrombus to stop the bleeding from a damaged blood vessel. An alternative approach to examining the 
physical stability of the FNCC>SS matrix and its effect on thrombus stability could involve experiments 
testing bleeding times of FNCC>SS/fl Mx1Cre induced by pI:C. A compromise in thrombus stability 
caused by FNCC>SS matrix would cause longer bleeding times. 
The requirement for FN dimerisation in the regulation of VEGF-A was only addressed briefly in 
this project. Although the accumulated VEGFR2 signalling appeared unaffected by the monomerised 
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FNCC>SS, the effect on VEGF-A gradients was not addressed. The embryonic hindbrain is a tissue in 
which developing blood vessels migrate, expand and anastamose at the midline in effect of a VEGF-A 
gradient that reaches its peak at the midline. Histological analysis of VEGF gradients in the hindbrain 
of FNCC>SS/CC>SS embryos would show if monomerisation of FNCC>SS alters any aspect of the VEGF-A 
gradient, such as its steepness. 
 
 
PhD Thesis - Josefine Gibson  References 
 
 136 
10 REFERENCES 
 
Abe, M., Harpel, J. G., Metz, C. N., Nunes, I., Loskutoff, D. J. and Rifkin, D. B. (1994). An assay for transforming 
growth factor-beta using cells transfected with a plasminogen activator inhibitor-1 promoter-luciferase construct. 
Anal. Biochem. 216, 276–284. 
Abraham, S., Kogata, N., Fassler, R. and Adams, R. H. (2008). Integrin 1 Subunit Controls Mural Cell Adhesion, 
Spreading, and Blood Vessel Wall Stability. Circ. Res. 102, 562–570. 
Abramsson, A., Lindblom, P. and Betsholtz, C. (2003). Endothelial and nonendothelial sources of PDGF-B regulate 
pericyte recruitment and influence vascular pattern formation in tumors. J. Clin. Invest. 112, 1142–1151. 
Adams, J. C. (2001). Thrombospondins: multifunctional regulators of cell interactions. Annu. Rev. Cell Dev. Biol. 17, 25–51. 
Aguirre, K. M., McCormick, R. J. and Schwarzbauer, J. E. (1994). Fibronectin self-association is mediated by 
complementary sites within the amino-terminal one-third of the molecule. J. Biol. Chem. 269, 27863–27868. 
Akhurst, R. J., Lehnert, S. A., Faissner, A. and Duffie, E. (1990). TGF beta in murine morphogenetic processes: the early 
embryo and cardiogenesis. Dev. Camb. Engl. 108, 645–656. 
Akiyama, S. K., Yamada, S. S., Chen, W. T. and Yamada, K. M. (1989). Analysis of fibronectin receptor function with 
monoclonal antibodies: roles in cell adhesion, migration, matrix assembly, and cytoskeletal organization. J. Cell Biol. 
109, 863–875. 
Alexandrova, A. Y., Arnold, K., Schaub, S., Vasiliev, J. M., Meister, J.-J., Bershadsky, A. D. and Verkhovsky, A. B. 
(2008). Comparative dynamics of retrograde actin flow and focal adhesions: formation of nascent adhesions 
triggers transition from fast to slow flow. PloS One 3, e3234. 
Ali, I. U. and Hynes, R. O. (1977). Effects of cytochalasin B and colchicine on attachment of a major surface protein of 
fibroblasts. Biochim. Biophys. Acta 471, 16–24. 
Allio, A. E. and McKeown-Longo, P. J. (1988). Extracellular matrix assembly of cell-derived and plasma-derived 
fibronectins by substrate-attached fibroblasts. J. Cell. Physiol. 135, 459–466. 
Altroff, H. (2004). Interdomain Tilt Angle Determines Integrin-dependent Function of the Ninth and Tenth FIII Domains 
of Human Fibronectin. J. Biol. Chem. 279, 55995–56003. 
Aluwihare, P., Mu, Z., Zhao, Z., Yu, D., Weinreb, P. H., Horan, G. S., Violette, S. M. and Munger, J. S. (2009). Mice 
that lack activity of alphavbeta6- and alphavbeta8-integrins reproduce the abnormalities of Tgfb1- and Tgfb3-null 
mice. J. Cell Sci. 122, 227–232. 
Amano, M., Ito, M., Kimura, K., Fukata, Y., Chihara, K., Nakano, T., Matsuura, Y. and Kaibuchi, K. (1996). 
Phosphorylation and activation of myosin by Rho-associated kinase (Rho-kinase). J. Biol. Chem. 271, 20246–20249. 
Annes, J. P., Rifkin, D. B. and Munger, J. S. (2002). The integrin alphaVbeta6 binds and activates latent TGFbeta3. FEBS 
Lett. 511, 65–68. 
Annes, J. P., Chen, Y., Munger, J. S. and Rifkin, D. B. (2004). Integrin αVβ6-mediated activation of latent TGF-β 
requires the latent TGF-β binding protein-1. J. Cell Biol. 165, 723–734. 
Antonelli-Orlidge, A., Saunders, K. B., Smith, S. R. and D’Amore, P. A. (1989). An activated form of transforming 
growth factor beta is produced by cocultures of endothelial cells and pericytes. Proc. Natl. Acad. Sci. U. S. A. 86, 
4544–4548. 
Aota, S., Nomizu, M. and Yamada, K. M. (1994). The short amino acid sequence Pro-His-Ser-Arg-Asn in human 
fibronectin enhances cell-adhesive function. J. Biol. Chem. 269, 24756–24761. 
Aoudjit, F. and Vuori, K. (2001). Matrix attachment regulates Fas-induced apoptosis in endothelial cells: a role for c-flip and 
implications for anoikis. J. Cell Biol. 152, 633–643. 
PhD Thesis - Josefine Gibson  References 
 
 137 
Araya, J., Cambier, S., Morris, A., Finkbeiner, W. and Nishimura, S. L. (2006). Integrin-mediated transforming growth 
factor-beta activation regulates homeostasis of the pulmonary epithelial-mesenchymal trophic unit. Am. J. Pathol. 
169, 405–415. 
Argraves, W. S. and Drake, C. J. (2005). Genes critical to vasculogenesis as defined by systematic analysis of vascular 
defects in knockout mice. Anat. Rec. A. Discov. Mol. Cell. Evol. Biol. 286, 875–884. 
Arroyo, A. G., Yang, J. T., Rayburn, H. and Hynes, R. O. (1999). Alpha4 integrins regulate the 
proliferation/differentiation balance of multilineage hematopoietic progenitors in vivo. Immunity 11, 555–566. 
Arthur, H. M., Ure, J., Smith, A. J., Renforth, G., Wilson, D. I., Torsney, E., Charlton, R., Parums, D. V., Jowett, T., 
Marchuk, D. A., et al. (2000). Endoglin, an ancillary TGFbeta receptor, is required for extraembryonic 
angiogenesis and plays a key role in heart development. Dev. Biol. 217, 42–53. 
Astrof, S., Crowley, D., George, E. L., Fukuda, T., Sekiguchi, K., Hanahan, D. and Hynes, R. O. (2004). Direct test 
of potential roles of EIIIA and EIIIB alternatively spliced segments of fibronectin in physiological and tumor 
angiogenesis. Mol. Cell. Biol. 24, 8662–8670. 
Astrof, S., Crowley, D. and Hynes, R. O. (2007). Multiple cardiovascular defects caused by the absence of alternatively 
spliced segments of fibronectin. Dev. Biol. 311, 11–24. 
Aszódi, A., Legate, K. R., Nakchbandi, I. and Fässler, R. (2006). What mouse mutants teach us about extracellular 
matrix function. Annu. Rev. Cell Dev. Biol. 22, 591–621. 
Atkin, K. E., Brentnall, A. S., Harris, G., Bingham, R. J., Erat, M. C., Millard, C. J., Schwarz-Linek, U., Staunton, 
D., Vakonakis, I., Campbell, I. D., et al. (2010). The streptococcal binding site in the gelatin-binding domain of 
fibronectin is consistent with a non-linear arrangement of modules. J. Biol. Chem. 285, 36977–36983. 
Avraamides, C. J., Garmy-Susini, B. and Varner, J. A. (2008). Integrins in angiogenesis and lymphangiogenesis. Nat. Rev. 
Cancer 8, 604–617. 
Babaev, V. R., Porro, F., Linton, M. F., Fazio, S., Baralle, F. E. and Muro, A. F. (2008). Absence of regulated splicing 
of fibronectin EDA exon reduces atherosclerosis in mice. Atherosclerosis 197, 534–540. 
Bader, B. L., Rayburn, H., Crowley, D. and Hynes, R. O. (1998). Extensive vasculogenesis, angiogenesis, and 
organogenesis precede lethality in mice lacking all alpha v integrins. Cell 95, 507–519. 
Bajanca, F., Luz, M., Duxson, M. J. and Thorsteinsdóttir, S. (2004). Integrins in the mouse myotome: developmental 
changes and differences between the epaxial and hypaxial lineage. Dev. Dyn. Off. Publ. Am. Assoc. Anat. 231, 402–
415. 
Baneyx, G., Baugh, L. and Vogel, V. (2002). Fibronectin extension and unfolding within cell matrix fibrils controlled by 
cytoskeletal tension. Proc. Natl. Acad. Sci. U. S. A. 99, 5139–5143. 
Barcellos-Hoff, M. H. and Dix, T. A. (1996). Redox-mediated activation of latent transforming growth factor-beta 1. Mol. 
Endocrinol. Baltim. Md 10, 1077–1083. 
Barcellos-Hoff, M. H., Derynck, R., Tsang, M. L. and Weatherbee, J. A. (1994). Transforming growth factor-beta 
activation in irradiated murine mammary gland. J. Clin. Invest. 93, 892–899. 
Barczyk, M., Carracedo, S. and Gullberg, D. (2009). Integrins. Cell Tissue Res. 339, 269–280. 
Barkalow, F. J. and Schwarzbauer, J. E. (1991). Localization of the major heparin-binding site in fibronectin. J. Biol. Chem. 
266, 7812–7818. 
Barkalow, F. J. and Schwarzbauer, J. E. (1994). Interactions between fibronectin and chondroitin sulfate are modulated by 
molecular context. J. Biol. Chem. 269, 3957–3962. 
Baron, M., Main, A. L., Driscoll, P. C., Mardon, H. J., Boyd, J. and Campbell, I. D. (1992). 1H NMR assignment and 
secondary structure of the cell adhesion type III module of fibronectin. Biochemistry (Mosc.) 31, 2068–2073. 
Barry, E. L. and Mosher, D. F. (1989). Factor XIIIa-mediated cross-linking of fibronectin in fibroblast cell layers. Cross-
linking of cellular and plasma fibronectin and of amino-terminal fibronectin fragments. J. Biol. Chem. 264, 4179–
4185. 
Bartram, U., Molin, D. G., Wisse, L. J., Mohamad, A., Sanford, L. P., Doetschman, T., Speer, C. P., Poelmann, R. 
E. and Gittenberger-de Groot, A. C. (2001). Double-outlet right ventricle and overriding tricuspid valve reflect 
PhD Thesis - Josefine Gibson  References 
 
 138 
disturbances of looping, myocardialization, endocardial cushion differentiation, and apoptosis in TGF-beta(2)-
knockout mice. Circulation 103, 2745–2752. 
Bayless, K. J. and Davis, G. E. (2002). The Cdc42 and Rac1 GTPases are required for capillary lumen formation in three-
dimensional extracellular matrices. J. Cell Sci. 115, 1123–1136. 
Bazigou, E., Xie, S., Chen, C., Weston, A., Miura, N., Sorokin, L., Adams, R., Muro, A. F., Sheppard, D. and 
Makinen, T. (2009). Integrin-alpha9 is required for fibronectin matrix assembly during lymphatic valve 
morphogenesis. Dev. Cell 17, 175–186. 
Benezra, R., Davis, R. L., Lockshon, D., Turner, D. L. and Weintraub, H. (1990). The protein Id: a negative regulator 
of helix-loop-helix DNA binding proteins. Cell 61, 49–59. 
Bengtsson, T., Aszodi, A., Nicolae, C., Hunziker, E. B., Lundgren-Akerlund, E. and Fässler, R. (2005). Loss of 
alpha10beta1 integrin expression leads to moderate dysfunction of growth plate chondrocytes. J. Cell Sci. 118, 929–
936. 
Bergwerff, M., Verberne, M. E., DeRuiter, M. C., Poelmann, R. E. and Gittenberger-de Groot, A. C. (1998). Neural 
crest cell contribution to the developing circulatory system: implications for vascular morphology? Circ. Res. 82, 
221–231. 
Bledzka, K., Liu, J., Xu, Z., Perera, H. D., Yadav, S. P., Bialkowska, K., Qin, J., Ma, Y.-Q. and Plow, E. F. (2012). 
Spatial coordination of kindlin-2 with talin head domain in interaction with integrin β cytoplasmic tails. J. Biol. 
Chem. 287, 24585–24594. 
Blum, Y., Belting, H.-G., Ellertsdottir, E., Herwig, L., Lüders, F. and Affolter, M. (2008). Complex cell 
rearrangements during intersegmental vessel sprouting and vessel fusion in the zebrafish embryo. Dev. Biol. 316, 
312–322. 
Bork, P. and Doolittle, R. F. (1992). Proposed acquisition of an animal protein domain by bacteria. Proc. Natl. Acad. Sci. U. 
S. A. 89, 8990–8994. 
Boucaut, J. C. and Darribere, T. (1983). Presence of fibronectin during early embryogenesis in amphibian Pleurodeles 
waltlii. Cell Differ. 12, 77–83. 
Boucaut, J. C., Darribère, T., Boulekbache, H. and Thiery, J. P. (1984a). Prevention of gastrulation but not neurulation 
by antibodies to fibronectin in amphibian embryos. Nature 307, 364–367. 
Boucaut, J. C., Darribère, T., Poole, T. J., Aoyama, H., Yamada, K. M. and Thiery, J. P. (1984b). Biologically active 
synthetic peptides as probes of embryonic development: a competitive peptide inhibitor of fibronectin function 
inhibits gastrulation in amphibian embryos and neural crest cell migration in avian embryos. J. Cell Biol. 99, 1822–
1830. 
Boudreau, N. J. and Varner, J. A. (2004). The homeobox transcription factor Hox D3 promotes integrin alpha5beta1 
expression and function during angiogenesis. J. Biol. Chem. 279, 4862–4868. 
Bouvard, D., Vignoud, L., Dupé-Manet, S., Abed, N., Fournier, H.-N., Vincent-Monegat, C., Retta, S. F., Fassler, 
R. and Block, M. R. (2003). Disruption of focal adhesions by integrin cytoplasmic domain-associated protein-1 
alpha. J. Biol. Chem. 278, 6567–6574. 
Bouvard, D., Pouwels, J., De Franceschi, N. and Ivaska, J. (2013). Integrin inactivators: balancing cellular functions in 
vitro and in vivo. Nat. Rev. Mol. Cell Biol. 14, 432–444. 
Bowditch, R. D., Hariharan, M., Tominna, E. F., Smith, J. W., Yamada, K. M., Getzoff, E. D. and Ginsberg, M. H. 
(1994). Identification of a novel integrin binding site in fibronectin. Differential utilization by beta 3 integrins. J. 
Biol. Chem. 269, 10856–10863. 
Braren, R., Hu, H., Kim, Y. H., Beggs, H. E., Reichardt, L. F. and Wang, R. (2006). Endothelial FAK is essential for 
vascular network stability, cell survival, and lamellipodial formation. J. Cell Biol. 172, 151–162. 
Bretscher, A., Edwards, K. and Fehon, R. G. (2002). ERM proteins and merlin: integrators at the cell cortex. Nat. Rev. Mol. 
Cell Biol. 3, 586–599. 
Brooks, P. C., Clark, R. A. and Cheresh, D. A. (1994a). Requirement of vascular integrin alpha v beta 3 for angiogenesis. 
Science 264, 569–571. 
PhD Thesis - Josefine Gibson  References 
 
 139 
Brooks, P. C., Montgomery, A. M., Rosenfeld, M., Reisfeld, R. A., Hu, T., Klier, G. and Cheresh, D. A. (1994b). 
Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. 
Cell 79, 1157–1164. 
Brooks, P. C., Silletti, S., von Schalscha, T. L., Friedlander, M. and Cheresh, D. A. (1998). Disruption of angiogenesis 
by PEX, a noncatalytic metalloproteinase fragment with integrin binding activity. Cell 92, 391–400. 
Brown, A. J. and Sanders, E. J. (1991). Interactions between mesoderm cells and the extracellular matrix following 
gastrulation in the chick embryo. J. Cell Sci. 99 ( Pt 2), 431–441. 
Brown, P. D., Wakefield, L. M., Levinson, A. D. and Sporn, M. B. (1990). Physicochemical activation of recombinant 
latent transforming growth factor-beta’s 1, 2, and 3. Growth Factors Chur Switz. 3, 35–43. 
Brown, C. M., Hebert, B., Kolin, D. L., Zareno, J., Whitmore, L., Horwitz, A. R. and Wiseman, P. W. (2006). Probing 
the integrin-actin linkage using high-resolution protein velocity mapping. J. Cell Sci. 119, 5204–5214. 
Brunet, A., Bonni, A., Zigmond, M. J., Lin, M. Z., Juo, P., Hu, L. S., Anderson, M. J., Arden, K. C., Blenis, J. and 
Greenberg, M. E. (1999). Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription 
factor. Cell 96, 857–868. 
Bultmann, H., Santas, A. J. and Peters, D. M. (1998). Fibronectin fibrillogenesis involves the heparin II binding domain 
of fibronectin. J. Biol. Chem. 273, 2601–2609. 
Burri, P. H., Hlushchuk, R. and Djonov, V. (2004). Intussusceptive angiogenesis: Its emergence, its characteristics, and its 
significance. Dev. Dyn. 231, 474–488. 
Burton-Wurster, N., Gendelman, R., Chen, H., Gu, D. N., Tetreault, J. W., Lust, G., Schwarzbauer, J. E. and 
MacLeod, J. N. (1999). The cartilage-specific (V+C)- fibronectin isoform exists primarily in homodimeric and 
monomeric configurations. Biochem. J. 341 ( Pt 3), 555–561. 
Buscemi, L., Ramonet, D., Klingberg, F., Formey, A., Smith-Clerc, J., Meister, J.-J. and Hinz, B. (2011). The single-
molecule mechanics of the latent TGF-β1 complex. Curr. Biol. CB 21, 2046–2054. 
Byfield, F. J., Reen, R. K., Shentu, T.-P., Levitan, I. and Gooch, K. J. (2009). Endothelial actin and cell stiffness is 
modulated by substrate stiffness in 2D and 3D. J. Biomech. 42, 1114–1119. 
Byzova, T. V., Goldman, C. K., Pampori, N., Thomas, K. A., Bett, A., Shattil, S. J. and Plow, E. F. (2000). A 
mechanism for modulation of cellular responses to VEGF: activation of the integrins. Mol. Cell 6, 851–860. 
Calalb, M. B., Polte, T. R. and Hanks, S. K. (1995). Tyrosine phosphorylation of focal adhesion kinase at sites in the 
catalytic domain regulates kinase activity: a role for Src family kinases. Mol. Cell. Biol. 15, 954–963. 
Calalb, M. B., Zhang, X., Polte, T. R. and Hanks, S. K. (1996). Focal adhesion kinase tyrosine-861 is a major site of 
phosphorylation by Src. Biochem. Biophys. Res. Commun. 228, 662–668. 
Calderwood, D. A., Yan, B., de Pereda, J. M., Alvarez, B. G., Fujioka, Y., Liddington, R. C. and Ginsberg, M. H. 
(2002). The phosphotyrosine binding-like domain of talin activates integrins. J. Biol. Chem. 277, 21749–21758. 
Calderwood, D. A., Fujioka, Y., de Pereda, J. M., García-Alvarez, B., Nakamoto, T., Margolis, B., McGlade, C. J., 
Liddington, R. C. and Ginsberg, M. H. (2003). Integrin beta cytoplasmic domain interactions with 
phosphotyrosine-binding domains: a structural prototype for diversity in integrin signaling. Proc. Natl. Acad. Sci. U. 
S. A. 100, 2272–2277. 
Califano, J. P. and Reinhart-King, C. A. (2010). Substrate Stiffness and Cell Area Predict Cellular Traction Stresses in 
Single Cells and Cells in Contact. Cell. Mol. Bioeng. 3, 68–75. 
Cambier, S., Gline, S., Mu, D., Collins, R., Araya, J., Dolganov, G., Einheber, S., Boudreau, N. and Nishimura, S. 
L. (2005). Integrin alpha(v)beta8-mediated activation of transforming growth factor-beta by perivascular astrocytes: 
an angiogenic control switch. Am. J. Pathol. 166, 1883–1894. 
Carlson, T. R., Hu, H., Braren, R., Kim, Y. H. and Wang, R. A. (2008). Cell-autonomous requirement for beta1 integrin 
in endothelial cell adhesion, migration and survival during angiogenesis in mice. Dev. Camb. Engl. 135, 2193–2202. 
Carman, C. V. and Springer, T. A. (2003). Integrin avidity regulation: are changes in affinity and conformation 
underemphasized? Curr. Opin. Cell Biol. 15, 547–556. 
PhD Thesis - Josefine Gibson  References 
 
 140 
Carmeliet, P., Ferreira, V., Breier, G., Pollefeyt, S., Kieckens, L., Gertsenstein, M., Fahrig, M., Vandenhoeck, A., 
Harpal, K., Eberhardt, C., et al. (1996). Abnormal blood vessel development and lethality in embryos lacking a 
single VEGF allele. Nature 380, 435–439. 
Carvalho, R. L. C., Jonker, L., Goumans, M.-J., Larsson, J., Bouwman, P., Karlsson, S., Dijke, P. T., Arthur, H. M. 
and Mummery, C. L. (2004). Defective paracrine signalling by TGFbeta in yolk sac vasculature of endoglin 
mutant mice: a paradigm for hereditary haemorrhagic telangiectasia. Dev. Camb. Engl. 131, 6237–6247. 
Carvalho, R. L. C., Itoh, F., Goumans, M.-J., Lebrin, F., Kato, M., Takahashi, S., Ema, M., Itoh, S., Rooijen, M. 
van, Bertolino, P., et al. (2007). Compensatory signalling induced in the yolk sac vasculature by deletion of TGFβ 
receptors in mice. J. Cell Sci. 120, 4269–4277. 
Cary, L. A., Han, D. C., Polte, T. R., Hanks, S. K. and Guan, J. L. (1998). Identification of p130Cas as a mediator of 
focal adhesion kinase-promoted cell migration. J. Cell Biol. 140, 211–221. 
Castellani, P., Borsi, L., Carnemolla, B., Birò, A., Dorcaratto, A., Viale, G. L., Neri, D. and Zardi, L. (2002). 
Differentiation between high- and low-grade astrocytoma using a human recombinant antibody to the extra 
domain-B of fibronectin. Am. J. Pathol. 161, 1695–1700. 
Chada, D., Mather, T. and Nollert, M. U. (2006). The synergy site of fibronectin is required for strong interaction with the 
platelet integrin alphaIIbbeta3. Ann. Biomed. Eng. 34, 1542–1552. 
Chappell, J. C., Taylor, S. M., Ferrara, N. and Bautch, V. L. (2009). Local guidance of emerging vessel sprouts requires 
soluble Flt-1. Dev. Cell 17, 377–386. 
Chauhan, A. K., Iaconcig, A., Baralle, F. E. and Muro, A. F. (2004). Alternative splicing of fibronectin: a mouse model 
demonstrates the identity of in vitro and in vivo systems and the processing autonomy of regulated exons in adult 
mice. Gene 324, 55–63. 
Chauhan, A. K., Kisucka, J., Cozzi, M. R., Walsh, M. T., Moretti, F. A., Battiston, M., Mazzucato, M., De Marco, 
L., Baralle, F. E., Wagner, D. D., et al. (2008). Prothrombotic effects of fibronectin isoforms containing the 
EDA domain. Arterioscler. Thromb. Vasc. Biol. 28, 296–301. 
Chen, S. and Lechleider, R. J. (2004). Transforming growth factor-beta-induced differentiation of smooth muscle from a 
neural crest stem cell line. Circ. Res. 94, 1195–1202. 
Chen, H. and Mosher, D. F. (1996). Formation of sodium dodecyl sulfate-stable fibronectin multimers. Failure to detect 
products of thiol-disulfide exchange in cyanogen bromide or limited acid digests of stabilized matrix fibronectin. J. 
Biol. Chem. 271, 9084–9089. 
Chen, H. C., Appeddu, P. A., Isoda, H. and Guan, J. L. (1996). Phosphorylation of tyrosine 397 in focal adhesion kinase 
is required for binding phosphatidylinositol 3-kinase. J. Biol. Chem. 271, 26329–26334. 
Chen, J., Diacovo, T. G., Grenache, D. G., Santoro, S. A. and Zutter, M. M. (2002). The alpha(2) integrin subunit-
deficient mouse: a multifaceted phenotype including defects of branching morphogenesis and hemostasis. Am. J. 
Pathol. 161, 337–344. 
Chen, Q., Sivakumar, P., Barley, C., Peters, D. M., Gomes, R. R., Farach-Carson, M. C. and Dallas, S. L. (2007). 
Potential role for heparan sulfate proteoglycans in regulation of transforming growth factor-beta (TGF-beta) by 
modulating assembly of latent TGF-beta-binding protein-1. J. Biol. Chem. 282, 26418–26430. 
Cheng, Z., Sundberg-Smith, L. J., Mangiante, L. E., Sayers, R. L., Hakim, Z. S., Musunuri, S., Maguire, C. T., 
Majesky, M. W., Zhou, Z., Mack, C. P., et al. (2011). Focal adhesion kinase regulates smooth muscle cell 
recruitment to the developing vasculature. Arterioscler. Thromb. Vasc. Biol. 31, 2193–2202. 
Cheng, P., Andersen, P., Hassel, D., Kaynak, B. L., Limphong, P., Juergensen, L., Kwon, C. and Srivastava, D. 
(2013). Fibronectin mediates mesendodermal cell fate decisions. Development 140, 2587–2596. 
Cheresh, D. A. and Stupack, D. G. (2002). Integrin-mediated death: An explanation of the integrin-knockout phenotype? 
Nat. Med. 8, 193–194. 
Chernousov, M. A., Metsis, M. L. and Koteliansky, V. E. (1985). Studies of extracellular fibronectin matrix formation 
with fluoresceinated fibronectin and fibronectin fragments. FEBS Lett. 183, 365–369. 
Chernousov, M. A., Faerman, A. I., Frid, M. G., Printseva OYu and Koteliansky, V. E. (1987). Monoclonal antibody to 
fibronectin which inhibits extracellular matrix assembly. FEBS Lett. 217, 124–128. 
PhD Thesis - Josefine Gibson  References 
 
 141 
Chernousov, M. A., Fogerty, F. J., Koteliansky, V. E. and Mosher, D. F. (1991). Role of the I-9 and III-1 modules of 
fibronectin in formation of an extracellular fibronectin matrix. J. Biol. Chem. 266, 10851–10858. 
Cho, J. and Mosher, D. F. (2006). Role of fibronectin assembly in platelet thrombus formation. J. Thromb. Haemost. JTH 4, 
1461–1469. 
Choi, M. G. and Hynes, R. O. (1979). Biosynthesis and processing of fibronectin in NIL.8 hamster cells. J. Biol. Chem. 254, 
12050–12055. 
Choi, C. K., Vicente-Manzanares, M., Zareno, J., Whitmore, L. A., Mogilner, A. and Horwitz, A. R. (2008). Actin and 
alpha-actinin orchestrate the assembly and maturation of nascent adhesions in a myosin II motor-independent 
manner. Nat. Cell Biol. 10, 1039–1050. 
Choquet, D., Felsenfeld, D. P. and Sheetz, M. P. (1997). Extracellular matrix rigidity causes strengthening of integrin-
cytoskeleton linkages. Cell 88, 39–48. 
Christoffels, V. M., Habets, P. E., Franco, D., Campione, M., de Jong, F., Lamers, W. H., Bao, Z. Z., Palmer, S., 
Biben, C., Harvey, R. P., et al. (2000). Chamber formation and morphogenesis in the developing mammalian 
heart. Dev. Biol. 223, 266–278. 
Christopher, R. A., Kowalczyk, A. P. and McKeown-Longo, P. J. (1997). Localization of fibronectin matrix assembly 
sites on fibroblasts and endothelial cells. J. Cell Sci. 110 ( Pt 5), 569–581. 
Chrzanowska-Wodnicka, M. and Burridge, K. (1996). Rho-stimulated contractility drives the formation of stress fibers 
and focal adhesions. J. Cell Biol. 133, 1403–1415. 
Chun, T.-H., Sabeh, F., Ota, I., Murphy, H., McDonagh, K. T., Holmbeck, K., Birkedal-Hansen, H., Allen, E. D. 
and Weiss, S. J. (2004). MT1-MMP-dependent neovessel formation within the confines of the three-dimensional 
extracellular matrix. J. Cell Biol. 167, 757–767. 
Chung, C. Y. and Erickson, H. P. (1997). Glycosaminoglycans modulate fibronectin matrix assembly and are essential for 
matrix incorporation of tenascin-C. J. Cell Sci. 110 ( Pt 12), 1413–1419. 
Clark, R. A., DellaPelle, P., Manseau, E., Lanigan, J. M., Dvorak, H. F. and Colvin, R. B. (1982). Blood vessel 
fibronectin increases in conjunction with endothelial cell proliferation and capillary ingrowth during wound healing. 
J. Invest. Dermatol. 79, 269–276. 
Conway, S. J., Kruzynska-Frejtag, A., Kneer, P. L., Machnicki, M. and Koushik, S. V. (2003). What cardiovascular 
defect does my prenatal mouse mutant have, and why? Genes. N. Y. N 2000 35, 1–21. 
Couchman, J. R. (2010). Transmembrane signaling proteoglycans. Annu. Rev. Cell Dev. Biol. 26, 89–114. 
Courtoy, P. J. and Boyles, J. (1983). Fibronectin in the microvasculature: localization in the pericyte-endothelial interstitium. 
J. Ultrastruct. Res. 83, 258–273. 
Coxon, A., Rieu, P., Barkalow, F. J., Askari, S., Sharpe, A. H., von Andrian, U. H., Arnaout, M. A. and Mayadas, T. 
N. (1996). A novel role for the beta 2 integrin CD11b/CD18 in neutrophil apoptosis: a homeostatic mechanism in 
inflammation. Immunity 5, 653–666. 
Crawford, S. E., Stellmach, V., Murphy-Ullrich, J. E., Ribeiro, S. M., Lawler, J., Hynes, R. O., Boivin, G. P. and 
Bouck, N. (1998). Thrombospondin-1 is a major activator of TGF-beta1 in vivo. Cell 93, 1159–1170. 
Critchley, D. R., England, M. A., Wakely, J. and Hynes, R. O. (1979). Distribution of fibronectin in the ectoderm of 
gastrulating chick embryos. Nature 280, 498–500. 
Crossin, K. L., Hoffman, S., Grumet, M., Thiery, J. P. and Edelman, G. M. (1986). Site-restricted expression of 
cytotactin during development of the chicken embryo. J. Cell Biol. 102, 1917–1930. 
Curnis, F., Longhi, R., Crippa, L., Cattaneo, A., Dondossola, E., Bachi, A. and Corti, A. (2006). Spontaneous 
formation of L-isoaspartate and gain of function in fibronectin. J. Biol. Chem. 281, 36466–36476. 
Dallas, S. L., Sivakumar, P., Jones, C. J. P., Chen, Q., Peters, D. M., Mosher, D. F., Humphries, M. J. and Kielty, C. 
M. (2005). Fibronectin Regulates Latent Transforming Growth Factor-β (TGFβ) by Controlling Matrix Assembly 
of Latent TGFβ-binding Protein-1. J. Biol. Chem. 280, 18871–18880. 
Dallas, S. L., Chen, Q. and Sivakumar, P. (2006). Dynamics of assembly and reorganization of extracellular matrix 
proteins. Curr. Top. Dev. Biol. 75, 1–24. 
PhD Thesis - Josefine Gibson  References 
 
 142 
Danen, E. H., Aota, S., van Kraats, A. A., Yamada, K. M., Ruiter, D. J. and van Muijen, G. N. (1995). Requirement for 
the synergy site for cell adhesion to fibronectin depends on the activation state of integrin alpha 5 beta 1. J. Biol. 
Chem. 270, 21612–21618. 
Danen, E. H. J., Sonneveld, P., Brakebusch, C., Fassler, R. and Sonnenberg, A. (2002). The fibronectin-binding 
integrins alpha5beta1 and alphavbeta3 differentially modulate RhoA-GTP loading, organization of cell matrix 
adhesions, and fibronectin fibrillogenesis. J. Cell Biol. 159, 1071–1086. 
Danussi, C., Del Bel Belluz, L., Pivetta, E., Modica, T. M. E., Muro, A., Wassermann, B., Doliana, R., Sabatelli, P., 
Colombatti, A. and Spessotto, P. (2013). EMILIN1/ 9 1 Integrin Interaction Is Crucial in Lymphatic Valve 
Formation and Maintenance. Mol. Cell. Biol. 33, 4381–4394. 
Darland, D. C., Massingham, L. J., Smith, S. R., Piek, E., Saint-Geniez, M. and D’Amore, P. A. (2003). Pericyte 
production of cell-associated VEGF is differentiation-dependent and is associated with endothelial survival. Dev. 
Biol. 264, 275–288. 
Davidson, L. A., Hoffstrom, B. G., Keller, R. and DeSimone, D. W. (2002). Mesendoderm extension and mantle closure 
in Xenopus laevis gastrulation: combined roles for integrin alpha(5)beta(1), fibronectin, and tissue geometry. Dev. 
Biol. 242, 109–129. 
Davidson, L. A., Marsden, M., Keller, R. and Desimone, D. W. (2006). Integrin alpha5beta1 and fibronectin regulate 
polarized cell protrusions required for Xenopus convergence and extension. Curr. Biol. CB 16, 833–844. 
Davies, P. F. (1995). Flow-mediated endothelial mechanotransduction. Physiol. Rev. 75, 519–560. 
Davis, G. E. and Bayless, K. J. (2003). An Integrin and Rho GTPase-Dependent Pinocytic Vacuole Mechanism Controls 
Capillary Lumen Formation in Collagen and Fibrin Matrices. Microcirculation 10, 27–44. 
Davis, G. E. and Camarillo, C. W. (1996). An alpha 2 beta 1 integrin-dependent pinocytic mechanism involving 
intracellular vacuole formation and coalescence regulates capillary lumen and tube formation in three-dimensional 
collagen matrix. Exp. Cell Res. 224, 39–51. 
Davis, G. E. and Senger, D. R. (2005). Endothelial extracellular matrix: biosynthesis, remodeling, and functions during 
vascular morphogenesis and neovessel stabilization. Circ. Res. 97, 1093–1107. 
Davis, G. E., Koh, W. and Stratman, A. N. (2007). Mechanisms controlling human endothelial lumen formation and tube 
assembly in three-dimensional extracellular matrices. Birth Defects Res. Part C Embryo Today Rev. 81, 270–285. 
De, S., Razorenova, O., McCabe, N. P., O’Toole, T., Qin, J. and Byzova, T. V. (2005). VEGF-integrin interplay 
controls tumor growth and vascularization. Proc. Natl. Acad. Sci. U. S. A. 102, 7589–7594. 
Dejana, E., Languino, L. R., Polentarutti, N., Balconi, G., Ryckewaert, J. J., Larrieu, M. J., Donati, M. B., 
Mantovani, A. and Marguerie, G. (1985). Interaction between fibrinogen and cultured endothelial cells. 
Induction of migration and specific binding. J. Clin. Invest. 75, 11–18. 
Deries, M., Collins, J. J. P. and Duxson, M. J. (2008). The mammalian myotome: a muscle with no innervation. Evol. Dev. 
10, 746–755. 
Deries, M., Schweitzer, R. and Duxson, M. J. (2010). Developmental fate of the mammalian myotome. Dev. Dyn. 239, 
2898–2910. 
Deries, M., Gonçalves, A. B., Vaz, R., Martins, G. G., Rodrigues, G. and Thorsteinsdóttir, S. (2012). Extracellular 
matrix remodeling accompanies axial muscle development and morphogenesis in the mouse. Dev. Dyn. Off. Publ. 
Am. Assoc. Anat. 241, 350–364. 
DeRuiter, M. C., Poelmann, R. E., VanderPlas-de Vries, I., Mentink, M. M. and Gittenberger-de Groot, A. C. 
(1992). The development of the myocardium and endocardium in mouse embryos. Fusion of two heart tubes? 
Anat. Embryol. (Berl.) 185, 461–473. 
Desmoulière, A., Geinoz, A., Gabbiani, F. and Gabbiani, G. (1993). Transforming growth factor-beta 1 induces alpha-
smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured 
fibroblasts. J. Cell Biol. 122, 103–111. 
Dickson, M. C., Martin, J. S., Cousins, F. M., Kulkarni, A. B., Karlsson, S. and Akhurst, R. J. (1995). Defective 
haematopoiesis and vasculogenesis in transforming growth factor-beta 1 knock out mice. Dev. Camb. Engl. 121, 
1845–1854. 
PhD Thesis - Josefine Gibson  References 
 
 143 
Digman, M. A., Brown, C. M., Horwitz, A. R., Mantulin, W. W. and Gratton, E. (2008). Paxillin dynamics measured 
during adhesion assembly and disassembly by correlation spectroscopy. Biophys. J. 94, 2819–2831. 
Ding, R., Darland, D. C., Parmacek, M. S. and D’Amore, P. A. (2004). Endothelial-mesenchymal interactions in vitro 
reveal molecular mechanisms of smooth muscle/pericyte differentiation. Stem Cells Dev. 13, 509–520. 
DiPersio, C. M., Hodivala-Dilke, K. M., Jaenisch, R., Kreidberg, J. A. and Hynes, R. O. (1997). alpha3beta1 Integrin is 
required for normal development of the epidermal basement membrane. J. Cell Biol. 137, 729–742. 
Discher, D. E., Janmey, P. and Wang, Y.-L. (2005). Tissue cells feel and respond to the stiffness of their substrate. Science 
310, 1139–1143. 
Dowling, J., Yu, Q. C. and Fuchs, E. (1996). Beta4 integrin is required for hemidesmosome formation, cell adhesion and 
cell survival. J. Cell Biol. 134, 559–572. 
Downs, K. M. (2003). Florence Sabin and the mechanism of blood vessel lumenization during vasculogenesis. Microcirc. N. Y. 
N 1994 10, 5–25. 
Downward, J. (1998). Mechanisms and consequences of activation of protein kinase B/Akt. Curr. Opin. Cell Biol. 10, 262–
267. 
Drake, C. J., Davis, L. A. and Little, C. D. (1992). Antibodies to beta 1-integrins cause alterations of aortic vasculogenesis, 
in vivo. Dev. Dyn. Off. Publ. Am. Assoc. Anat. 193, 83–91. 
Drake, C. J., Hungerford, J. E. and Little, C. D. (1998). Morphogenesis of the first blood vessels. Ann. N. Y. Acad. Sci. 
857, 155–179. 
Duband, J. L. and Thiery, J. P. (1982). Distribution of fibronectin in the early phase of avian cephalic neural crest cell 
migration. Dev. Biol. 93, 308–323. 
Dubois, C. M., Laprise, M. H., Blanchette, F., Gentry, L. E. and Leduc, R. (1995). Processing of transforming growth 
factor beta 1 precursor by human furin convertase. J. Biol. Chem. 270, 10618–10624. 
Edin, M. L. and Juliano, R. L. (2005). Raf-1 serine 338 phosphorylation plays a key role in adhesion-dependent activation 
of extracellular signal-regulated kinase by epidermal growth factor. Mol. Cell. Biol. 25, 4466–4475. 
Edmondson, D. G., Lyons, G. E., Martin, J. F. and Olson, E. N. (1994). Mef2 gene expression marks the cardiac and 
skeletal muscle lineages during mouse embryogenesis. Dev. Camb. Engl. 120, 1251–1263. 
Edwards, D. R., Murphy, G., Reynolds, J. J., Whitham, S. E., Docherty, A. J., Angel, P. and Heath, J. K. (1987). 
Transforming growth factor beta modulates the expression of collagenase and metalloproteinase inhibitor. EMBO 
J. 6, 1899–1904. 
Eisenberg, L. M. and Markwald, R. R. (1995). Molecular regulation of atrioventricular valvuloseptal morphogenesis. Circ. 
Res. 77, 1–6. 
Eliceiri, B. P., Klemke, R., Strömblad, S. and Cheresh, D. A. (1998). Integrin alphavbeta3 requirement for sustained 
mitogen-activated protein kinase activity during angiogenesis. J. Cell Biol. 140, 1255–1263. 
Enge, M., Bjarnegård, M., Gerhardt, H., Gustafsson, E., Kalén, M., Asker, N., Hammes, H.-P., Shani, M., Fässler, 
R. and Betsholtz, C. (2002). Endothelium-specific platelet-derived growth factor-B ablation mimics diabetic 
retinopathy. EMBO J. 21, 4307–4316. 
Engler, A. J., Griffin, M. A., Sen, S., Bönnemann, C. G., Sweeney, H. L. and Discher, D. E. (2004). Myotubes 
differentiate optimally on substrates with tissue-like stiffness: pathological implications for soft or stiff 
microenvironments. J. Cell Biol. 166, 877–887. 
Engler, A. J., Sen, S., Sweeney, H. L. and Discher, D. E. (2006). Matrix elasticity directs stem cell lineage specification. 
Cell 126, 677–689. 
Engler, A. J., Chan, M., Boettiger, D. and Schwarzbauer, J. E. (2009). A novel mode of cell detachment from fibrillar 
fibronectin matrix under shear. J. Cell Sci. 122, 1647–1653. 
Etchevers, H. C., Couly, G. and Le Douarin, N. M. (2002). Morphogenesis of the branchial vascular sector. Trends 
Cardiovasc. Med. 12, 299–304. 
PhD Thesis - Josefine Gibson  References 
 
 144 
Even-Ram, S., Doyle, A. D., Conti, M. A., Matsumoto, K., Adelstein, R. S. and Yamada, K. M. (2007). Myosin IIA 
regulates cell motility and actomyosin–microtubule crosstalk. Nat. Cell Biol. 9, 299–309. 
Fässler, R. and Meyer, M. (1995). Consequences of lack of beta 1 integrin gene expression in mice. Genes Dev. 9, 1896–
1908. 
Ffrench-Constant, C. and Hynes, R. O. (1988). Patterns of fibronectin gene expression and splicing during cell migration 
in chicken embryos. Dev. Camb. Engl. 104, 369–382. 
Ffrench-Constant, C. and Hynes, R. O. (1989). Alternative splicing of fibronectin is temporally and spatially regulated in 
the chicken embryo. Dev. Camb. Engl. 106, 375–388. 
Ffrench-Constant, C., Van de Water, L., Dvorak, H. F. and Hynes, R. O. (1989). Reappearance of an embryonic pattern 
of fibronectin splicing during wound healing in the adult rat. J. Cell Biol. 109, 903–914. 
Fibronectin (1989). San Diego: Academic Press. 
Fjellbirkeland, L., Cambier, S., Broaddus, V. C., Hill, A., Brunetta, P., Dolganov, G., Jablons, D. and Nishimura, S. 
L. (2003). Integrin alphavbeta8-mediated activation of transforming growth factor-beta inhibits human airway 
epithelial proliferation in intact bronchial tissue. Am. J. Pathol. 163, 533–542. 
Flaumenhaft, R. and Rifkin, D. B. (1992). Cell density dependent effects of TGF-beta demonstrated by a plasminogen 
activator-based assay for TGF-beta. J. Cell. Physiol. 152, 48–55. 
Flaumenhaft, Abe and Rifkin, D. B. (1993). Role of the latent TGF-beta binding protein in the activation of latent TGF-
beta by co-cultures of endothelial and smooth muscle cells. J. Cell Biol. 120, 995–1002. 
Flintoff-Dye, N. L., Welser, J., Rooney, J., Scowen, P., Tamowski, S., Hatton, W. and Burkin, D. J. (2005). Role for 
the alpha7beta1 integrin in vascular development and integrity. Dev. Dyn. Off. Publ. Am. Assoc. Anat. 234, 11–21. 
Fogerty, F. J., Akiyama, S. K., Yamada, K. M. and Mosher, D. F. (1990). Inhibition of binding of fibronectin to matrix 
assembly sites by anti-integrin (alpha 5 beta 1) antibodies. J. Cell Biol. 111, 699–708. 
Folkman, J. and Haudenschild, C. (1980). Angiogenesis in vitro. Nature 288, 551–556. 
Francis, S. E., Goh, K. L., Hodivala-Dilke, K., Bader, B. L., Stark, M., Davidson, D. and Hynes, R. O. (2002). 
Central roles of alpha5beta1 integrin and fibronectin in vascular development in mouse embryos and embryoid 
bodies. Arterioscler. Thromb. Vasc. Biol. 22, 927–933. 
Friedland, J. C., Lee, M. H. and Boettiger, D. (2009). Mechanically activated integrin switch controls alpha5beta1 
function. Science 323, 642–644. 
Friedlander, M., Brooks, P. C., Shaffer, R. W., Kincaid, C. M., Varner, J. A. and Cheresh, D. A. (1995). Definition of 
two angiogenic pathways by distinct alpha v integrins. Science 270, 1500–1502. 
Friedlander, M., Theesfeld, C. L., Sugita, M., Fruttiger, M., Thomas, M. A., Chang, S. and Cheresh, D. A. (1996). 
Involvement of integrins alpha v beta 3 and alpha v beta 5 in ocular neovascular diseases. Proc. Natl. Acad. Sci. U. S. 
A. 93, 9764–9769. 
Friedrich, E. B., Liu, E., Sinha, S., Cook, S., Milstone, D. S., MacRae, C. A., Mariotti, M., Kuhlencordt, P. J., Force, 
T., Rosenzweig, A., et al. (2004). Integrin-Linked Kinase Regulates Endothelial Cell Survival and Vascular 
Development. Mol. Cell. Biol. 24, 8134–8144. 
Frisch, S. M. and Francis, H. (1994). Disruption of epithelial cell-matrix interactions induces apoptosis. J. Cell Biol. 124, 
619–626. 
Fukuda, T., Yoshida, N., Kataoka, Y., Manabe, R.-I., Mizuno-Horikawa, Y., Sato, M., Kuriyama, K., Yasui, N. and 
Sekiguchi, K. (2002). Mice lacking the EDB segment of fibronectin develop normally but exhibit reduced cell 
growth and fibronectin matrix assembly in vitro. Cancer Res. 62, 5603–5610. 
Gallant, N. D. (2005). Cell Adhesion Strengthening: Contributions of Adhesive Area, Integrin Binding, and Focal Adhesion 
Assembly. Mol. Biol. Cell 16, 4329–4340. 
Gardner, H., Broberg, A., Pozzi, A., Laato, M. and Heino, J. (1999). Absence of integrin alpha1beta1 in the mouse 
causes loss of feedback regulation of collagen synthesis in normal and wounded dermis. J. Cell Sci. 112 ( Pt 3), 263–
272. 
PhD Thesis - Josefine Gibson  References 
 
 145 
Garmy-Susini, B., Jin, H., Zhu, Y., Sung, R.-J., Hwang, R. and Varner, J. (2005). Integrin alpha4beta1-VCAM-1-
mediated adhesion between endothelial and mural cells is required for blood vessel maturation. J. Clin. Invest. 115, 
1542–1551. 
Ge, G. and Greenspan, D. S. (2006). BMP1 controls TGFβ1 activation via cleavage of latent TGFβ-binding protein. J. Cell 
Biol. 175, 111–120. 
Geiger, B., Spatz, J. P. and Bershadsky, A. D. (2009). Environmental sensing through focal adhesions. Nat. Rev. Mol. Cell 
Biol. 10, 21–33. 
George, E. L., Georges-Labouesse, E. N., Patel-King, R. S., Rayburn, H. and Hynes, R. O. (1993). Defects in 
mesoderm, neural tube and vascular development in mouse embryos lacking fibronectin. Dev. Camb. Engl. 119, 
1079–1091. 
George, E. L., Baldwin, H. S. and Hynes, R. O. (1997). Fibronectins are essential for heart and blood vessel 
morphogenesis but are dispensable for initial specification of precursor cells. Blood 90, 3073–3081. 
Georges-Labouesse, E., Messaddeq, N., Yehia, G., Cadalbert, L., Dierich, A. and Le Meur, M. (1996). Absence of 
integrin α6 leads to epidermolysis bullosa and neonatal death in mice. Nat. Genet. 13, 370–373. 
Georges‐Labouesse, E. N., George, E. L., Rayburn, H. and Hynes, R. O. (1996). Mesodermal development in mouse 
embryos mutant for fibronectin. Dev. Dyn. 207, 145–156. 
Gerhardt, H. (2008). VEGF and endothelial guidance in angiogenic sprouting. Organogenesis 4, 241–246. 
Gerhardt, H. and Betsholtz, C. (2003). Endothelial-pericyte interactions in angiogenesis. Cell Tissue Res. 314, 15–23. 
Gerhardt, H. and Betsholtz, C. (2005). How do endothelial cells orientate? EXS 3–15. 
Gerhardt, H., Golding, M., Fruttiger, M., Ruhrberg, C., Lundkvist, A., Abramsson, A., Jeltsch, M., Mitchell, C., 
Alitalo, K., Shima, D., et al. (2003). VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia. J. 
Cell Biol. 161, 1163–1177. 
Giancotti, F. G. and Ruoslahti, E. (1990). Elevated levels of the alpha 5 beta 1 fibronectin receptor suppress the 
transformed phenotype of Chinese hamster ovary cells. Cell 60, 849–859. 
Giannelli, G., Fransvea, E., Marinosci, F., Bergamini, C., Colucci, S., Schiraldi, O. and Antonaci, S. (2002). 
Transforming growth factor-beta1 triggers hepatocellular carcinoma invasiveness via alpha3beta1 integrin. Am. J. 
Pathol. 161, 183–193. 
Ginsberg, M., Pierschbacher, M. D., Ruoslahti, E., Marguerie, G. and Plow, E. (1985). Inhibition of fibronectin 
binding to platelets by proteolytic fragments and synthetic peptides which support fibroblast adhesion. J. Biol. Chem. 
260, 3931–3936. 
Gleizes, P. E., Beavis, R. C., Mazzieri, R., Shen, B. and Rifkin, D. B. (1996). Identification and characterization of an 
eight-cysteine repeat of the latent transforming growth factor-beta binding protein-1 that mediates bonding to the 
latent transforming growth factor-beta1. J. Biol. Chem. 271, 29891–29896. 
Godbout, C., Follonier Castella, L., Smith, E. A., Talele, N., Chow, M. L., Garonna, A. and Hinz, B. (2013). The 
mechanical environment modulates intracellular calcium oscillation activities of myofibroblasts. PloS One 8, e64560. 
Godyna, S., Mann, D. M. and Argraves, W. S. (1995). A quantitative analysis of the incorporation of fibulin-1 into 
extracellular matrix indicates that fibronectin assembly is required. Matrix Biol. J. Int. Soc. Matrix Biol. 14, 467–477. 
Goetz, R. and Mohammadi, M. (2013). Exploring mechanisms of FGF signalling through the lens of structural biology. 
Nat. Rev. Mol. Cell Biol. 14, 166–180. 
Goffin, J. M., Pittet, P., Csucs, G., Lussi, J. W., Meister, J.-J. and Hinz, B. (2006). Focal adhesion size controls tension-
dependent recruitment of -smooth muscle actin to stress fibers. J. Cell Biol. 172, 259–268. 
Goh, K. L., Yang, J. T. and Hynes, R. O. (1997). Mesodermal defects and cranial neural crest apoptosis in alpha5 integrin-
null embryos. Dev. Camb. Engl. 124, 4309–4319. 
Goksoy, E., Ma, Y.-Q., Wang, X., Kong, X., Perera, D., Plow, E. F. and Qin, J. (2008). Structural basis for the 
autoinhibition of talin in regulating integrin activation. Mol. Cell 31, 124–133. 
PhD Thesis - Josefine Gibson  References 
 
 146 
Gottschalk, K.-E. (2005). A coiled-coil structure of the alphaIIbbeta3 integrin transmembrane and cytoplasmic domains in 
its resting state. Struct. Lond. Engl. 1993 13, 703–712. 
Goumans, M.-J., Valdimarsdottir, G., Itoh, S., Rosendahl, A., Sideras, P. and Dijke, P. ten (2002). Balancing the 
activation state of the endothelium via two distinct TGF-β type I receptors. EMBO J. 21, 1743–1753. 
Grazioli, A., Alves, C. S., Konstantopoulos, K. and Yang, J. T. (2006). Defective blood vessel development and 
pericyte/pvSMC distribution in alpha 4 integrin-deficient mouse embryos. Dev. Biol. 293, 165–177. 
Green, J. A., Berrier, A. L., Pankov, R. and Yamada, K. M. (2009). beta1 integrin cytoplasmic domain residues selectively 
modulate fibronectin matrix assembly and cell spreading through talin and Akt-1. J. Biol. Chem. 284, 8148–8159. 
Gregory, K. E., Ono, R. N., Charbonneau, N. L., Kuo, C.-L., Keene, D. R., Bächinger, H. P. and Sakai, L. Y. (2005). 
The prodomain of BMP-7 targets the BMP-7 complex to the extracellular matrix. J. Biol. Chem. 280, 27970–27980. 
Guan, J. L. and Hynes, R. O. (1990). Lymphoid cells recognize an alternatively spliced segment of fibronectin via the 
integrin receptor alpha 4 beta 1. Cell 60, 53–61. 
Guan, J. L., Trevithick, J. E. and Hynes, R. O. (1990). Retroviral expression of alternatively spliced forms of rat 
fibronectin. J. Cell Biol. 110, 833–847. 
Guertin, D. A., Stevens, D. M., Thoreen, C. C., Burds, A. A., Kalaany, N. Y., Moffat, J., Brown, M., Fitzgerald, K. J. 
and Sabatini, D. M. (2006). Ablation in mice of the mTORC components raptor, rictor, or mLST8 reveals that 
mTORC2 is required for signaling to Akt-FOXO and PKCalpha, but not S6K1. Dev. Cell 11, 859–871. 
Guo, W., Frey, M. T., Burnham, N. A. and Wang, Y. (2006). Substrate rigidity regulates the formation and maintenance 
of tissues. Biophys. J. 90, 2213–2220. 
Hammes, H. P., Brownlee, M., Jonczyk, A., Sutter, A. and Preissner, K. T. (1996). Subcutaneous injection of a cyclic 
peptide antagonist of vitronectin receptor-type integrins inhibits retinal neovascularization. Nat. Med. 2, 529–533. 
Harvey, R. P. (1998). Cardiac looping--an uneasy deal with laterality. Semin. Cell Dev. Biol. 9, 101–108. 
Harvey, R. P. (2002). Organogenesis: Patterning the vertebrate heart. Nat. Rev. Genet. 3, 544–556. 
Hayman, E. G. and Ruoslahti, E. (1979). Distribution of fetal bovine serum fibronectin and endogenous rat cell 
fibronectin in extracellular matrix. J. Cell Biol. 83, 255–259. 
Heikinheimo, M., Scandrett, J. M. and Wilson, D. B. (1994). Localization of transcription factor GATA-4 to regions of 
the mouse embryo involved in cardiac development. Dev. Biol. 164, 361–373. 
Heino, J. and Massagué, J. (1989). Transforming growth factor-beta switches the pattern of integrins expressed in MG-63 
human osteosarcoma cells and causes a selective loss of cell adhesion to laminin. J. Biol. Chem. 264, 21806–21811. 
Heino, J., Ignotz, R. A., Hemler, M. E., Crouse, C. and Massagué, J. (1989). Regulation of cell adhesion receptors by 
transforming growth factor-beta. Concomitant regulation of integrins that share a common beta 1 subunit. J. Biol. 
Chem. 264, 380–388. 
Hellström, M., Kalén, M., Lindahl, P., Abramsson, A. and Betsholtz, C. (1999). Role of PDGF-B and PDGFR-beta in 
recruitment of vascular smooth muscle cells and pericytes during embryonic blood vessel formation in the mouse. 
Dev. Camb. Engl. 126, 3047–3055. 
Hellström, M., Gerhardt, H., Kalén, M., Li, X., Eriksson, U., Wolburg, H. and Betsholtz, C. (2001). Lack of pericytes 
leads to endothelial hyperplasia and abnormal vascular morphogenesis. J. Cell Biol. 153, 543–553. 
Hellström, M., Phng, L.-K., Hofmann, J. J., Wallgard, E., Coultas, L., Lindblom, P., Alva, J., Nilsson, A.-K., 
Karlsson, L., Gaiano, N., et al. (2007). Dll4 signalling through Notch1 regulates formation of tip cells during 
angiogenesis. Nature 445, 776–780. 
Hinz, B. (2010). The myofibroblast: paradigm for a mechanically active cell. J. Biomech. 43, 146–155. 
Hinz, B., Mastrangelo, D., Iselin, C. E., Chaponnier, C. and Gabbiani, G. (2001). Mechanical Tension Controls 
Granulation Tissue Contractile Activity and Myofibroblast Differentiation. Am. J. Pathol. 159, 1009–1020. 
Hirschi, K. K., Rohovsky, S. A. and D’Amore, P. A. (1998). PDGF, TGF-beta, and heterotypic cell-cell interactions 
mediate endothelial cell-induced recruitment of 10T1/2 cells and their differentiation to a smooth muscle fate. J. 
Cell Biol. 141, 805–814. 
PhD Thesis - Josefine Gibson  References 
 
 147 
Hirschi, K. K., Rohovsky, S. A., Beck, L. H., Smith, S. R. and D’Amore, P. A. (1999). Endothelial cells modulate the 
proliferation of mural cell precursors via platelet-derived growth factor-BB and heterotypic cell contact. Circ. Res. 
84, 298–305. 
Hirschi, K. K., Burt, J. M., Hirschi, K. D. and Dai, C. (2003). Gap junction communication mediates transforming 
growth factor-beta activation and endothelial-induced mural cell differentiation. Circ. Res. 93, 429–437. 
Hocking, D. C., Sottile, J. and McKeown-Longo, P. J. (1994). Fibronectin’s III-1 module contains a conformation-
dependent binding site for the amino-terminal region of fibronectin. J. Biol. Chem. 269, 19183–19187. 
Hocking, D. C., Smith, R. K. and McKeown-Longo, P. J. (1996). A novel role for the integrin-binding III-10 module in 
fibronectin matrix assembly. J. Cell Biol. 133, 431–444. 
Hodivala-Dilke, K. M., McHugh, K. P., Tsakiris, D. A., Rayburn, H., Crowley, D., Ullman-Culleré, M., Ross, F. P., 
Coller, B. S., Teitelbaum, S. and Hynes, R. O. (1999). Beta3-integrin-deficient mice are a model for Glanzmann 
thrombasthenia showing placental defects and reduced survival. J. Clin. Invest. 103, 229–238. 
Holtkötter, O., Nieswandt, B., Smyth, N., Müller, W., Hafner, M., Schulte, V., Krieg, T. and Eckes, B. (2002). 
Integrin alpha 2-deficient mice develop normally, are fertile, but display partially defective platelet interaction with 
collagen. J. Biol. Chem. 277, 10789–10794. 
Hove, J. R., Köster, R. W., Forouhar, A. S., Acevedo-Bolton, G., Fraser, S. E. and Gharib, M. (2003). Intracardiac fluid 
forces are an essential epigenetic factor for embryonic cardiogenesis. Nature 421, 172–177. 
Huang, X. Z., Wu, J. F., Cass, D., Erle, D. J., Corry, D., Young, S. G., Farese, R. V., Jr and Sheppard, D. (1996). 
Inactivation of the integrin beta 6 subunit gene reveals a role of epithelial integrins in regulating inflammation in the 
lung and skin. J. Cell Biol. 133, 921–928. 
Huang, X., Griffiths, M., Wu, J., Farese, R. V., Jr and Sheppard, D. (2000a). Normal development, wound healing, and 
adenovirus susceptibility in beta5-deficient mice. Mol. Cell. Biol. 20, 755–759. 
Huang, X. Z., Wu, J. F., Ferrando, R., Lee, J. H., Wang, Y. L., Farese, R. V., Jr and Sheppard, D. (2000b). Fatal 
bilateral chylothorax in mice lacking the integrin alpha9beta1. Mol. Cell. Biol. 20, 5208–5215. 
Huang, C., Sheikh, F., Hollander, M., Cai, C., Becker, D., Chu, P.-H., Evans, S. and Chen, J. (2003). Embryonic 
atrial function is essential for mouse embryogenesis, cardiac morphogenesis and angiogenesis. Dev. Camb. Engl. 130, 
6111–6119. 
Humphries, J. D. (2006). Integrin ligands at a glance. J. Cell Sci. 119, 3901–3903. 
Humphries, J. D., Wang, P., Streuli, C., Geiger, B., Humphries, M. J. and Ballestrem, C. (2007). Vinculin controls 
focal adhesion formation by direct interactions with talin and actin. J. Cell Biol. 179, 1043–1057. 
Hungerford, J. E. and Little, C. D. (1999). Developmental biology of the vascular smooth muscle cell: building a 
multilayered vessel wall. J. Vasc. Res. 36, 2–27. 
Huveneers, S., Truong, H., Fässler, R., Sonnenberg, A. and Danen, E. H. J. (2008). Binding of soluble fibronectin to 
integrin alpha5 beta1 - link to focal adhesion redistribution and contractile shape. J. Cell Sci. 121, 2452–2462. 
Hynes, R. O. (1990). Fibronectins. New York: Springer-Verlag. 
Hynes, R. O. (2002a). A reevaluation of integrins as regulators of angiogenesis. Nat. Med. 8, 918–921. 
Hynes, R. O. (2002b). Integrins: bidirectional, allosteric signaling machines. Cell 110, 673–687. 
Hynes, R. O. and Zhao, Q. (2000). The evolution of cell adhesion. J. Cell Biol. 150, F89–96. 
Icardo, J. M., Nakamura, A., Fernandez-Teran, M. A. and Manasek, F. J. (1992). Effects of injecting fibronectin and 
antifibronectin antibodies on cushion mesenchyme formation in the chick. An in vivo study. Anat. Embryol. (Berl.) 
185, 239–247. 
Ichihara-Tanaka, K., Maeda, T., Titani, K. and Sekiguchi, K. (1992). Matrix assembly of recombinant fibronectin 
polypeptide consisting of amino-terminal 70 kDa and carboxyl-terminal 37 kDa regions. FEBS Lett. 299, 155–158. 
Ignotz, R. A., Endo, T. and Massagué, J. (1987). Regulation of fibronectin and type I collagen mRNA levels by 
transforming growth factor-beta. J. Biol. Chem. 262, 6443–6446. 
PhD Thesis - Josefine Gibson  References 
 
 148 
Ikenoue, T., Inoki, K., Yang, Q., Zhou, X. and Guan, K.-L. (2008). Essential function of TORC2 in PKC and Akt turn 
motif phosphorylation, maturation and signalling. EMBO J. 27, 1919–1931. 
Ilić, D., Kovacic, B., Johkura, K., Schlaepfer, D. D., Tomasević, N., Han, Q., Kim, J.-B., Howerton, K., 
Baumbusch, C., Ogiwara, N., et al. (2004). FAK promotes organization of fibronectin matrix and fibrillar 
adhesions. J. Cell Sci. 117, 177–187. 
Ingham, K. C., Brew, S. A. and Erickson, H. P. (2004a). Localization of a cryptic binding site for tenascin on fibronectin. 
J. Biol. Chem. 279, 28132–28135. 
Ingham, K. C., Brew, S., Vaz, D., Sauder, D. N. and McGavin, M. J. (2004b). Interaction of Staphylococcus aureus 
fibronectin-binding protein with fibronectin: affinity, stoichiometry, and modular requirements. J. Biol. Chem. 279, 
42945–42953. 
Iruela-Arispe, M. L. and Davis, G. E. (2009). Cellular and molecular mechanisms of vascular lumen formation. Dev. Cell 16, 
222–231. 
Iruela-Arispe, M. L., Hasselaar, P. and Sage, H. (1991a). Differential expression of extracellular proteins is correlated 
with angiogenesis in vitro. Lab. Investig. J. Tech. Methods Pathol. 64, 174–186. 
Iruela-Arispe, M. L., Diglio, C. A. and Sage, E. H. (1991b). Modulation of extracellular matrix proteins by endothelial 
cells undergoing angiogenesis in vitro. Arterioscler. Thromb. J. Vasc. Biol. Am. Heart Assoc. 11, 805–815. 
Isenberg, B. C., Dimilla, P. A., Walker, M., Kim, S. and Wong, J. Y. (2009). Vascular smooth muscle cell durotaxis 
depends on substrate stiffness gradient strength. Biophys. J. 97, 1313–1322. 
Isogai, Z., Ono, R. N., Ushiro, S., Keene, D. R., Chen, Y., Mazzieri, R., Charbonneau, N. L., Reinhardt, D. P., 
Rifkin, D. B. and Sakai, L. Y. (2003). Latent Transforming Growth Factor β-binding Protein 1 Interacts with 
Fibrillin and Is a Microfibril-associated Protein. J. Biol. Chem. 278, 2750–2757. 
Jaffe, A. B. and Hall, A. (2005). Rho GTPases: biochemistry and biology. Annu. Rev. Cell Dev. Biol. 21, 247–269. 
Ji, R. P., Phoon, C. K. L., Aristizábal, O., McGrath, K. E., Palis, J. and Turnbull, D. H. (2003). Onset of cardiac 
function during early mouse embryogenesis coincides with entry of primitive erythroblasts into the embryo proper. 
Circ. Res. 92, 133–135. 
Jiang, B., Liou, G. I., Behzadian, M. A. and Caldwell, R. B. (1994). Astrocytes modulate retinal vasculogenesis: effects 
on fibronectin expression. J. Cell Sci. 107 ( Pt 9), 2499–2508. 
Jiang, X., Rowitch, D. H., Soriano, P., McMahon, A. P. and Sucov, H. M. (2000). Fate of the mammalian cardiac neural 
crest. Dev. Camb. Engl. 127, 1607–1616. 
Jiang, G., Giannone, G., Critchley, D. R., Fukumoto, E. and Sheetz, M. P. (2003). Two-piconewton slip bond between 
fibronectin and the cytoskeleton depends on talin. Nature 424, 334–337. 
Jiao, K., Langworthy, M., Batts, L., Brown, C. B., Moses, H. L. and Baldwin, H. S. (2006). Tgfbeta signaling is 
required for atrioventricular cushion mesenchyme remodeling during in vivo cardiac development. Dev. Camb. Engl. 
133, 4585–4593. 
Jiménez, B., Volpert, O. V., Crawford, S. E., Febbraio, M., Silverstein, R. L. and Bouck, N. (2000). Signals leading to 
apoptosis-dependent inhibition of neovascularization by thrombospondin-1. Nat. Med. 6, 41–48. 
Johnson, K. J., Sage, H., Briscoe, G. and Erickson, H. P. (1999). The compact conformation of fibronectin is determined 
by intramolecular ionic interactions. J. Biol. Chem. 274, 15473–15479. 
Jones, E. A. V., Baron, M. H., Fraser, S. E. and Dickinson, M. E. (2004). Measuring hemodynamic changes during 
mammalian development. Am. J. Physiol. Heart Circ. Physiol. 287, H1561–1569. 
Jülich, D., Geisler, R. and Holley, S. A. (2005). Integrinalpha5 and delta/notch signaling have complementary 
spatiotemporal requirements during zebrafish somitogenesis. Dev. Cell 8, 575–586. 
Kaartinen, V., Voncken, J. W., Shuler, C., Warburton, D., Bu, D., Heisterkamp, N. and Groffen, J. (1995). Abnormal 
lung development and cleft palate in mice lacking TGF-beta 3 indicates defects of epithelial-mesenchymal 
interaction. Nat. Genet. 11, 415–421. 
Kadler, K. E., Hill, A. and Canty-Laird, E. G. (2008). Collagen fibrillogenesis: fibronectin, integrins, and minor collagens 
as organizers and nucleators. Curr. Opin. Cell Biol. 20, 495–501. 
PhD Thesis - Josefine Gibson  References 
 
 149 
Kahner, B. N., Kato, H., Banno, A., Ginsberg, M. H., Shattil, S. J. and Ye, F. (2012). Kindlins, integrin activation and 
the regulation of talin recruitment to αIIbβ3. PloS One 7, e34056. 
Kamei, M., Saunders, W. B., Bayless, K. J., Dye, L., Davis, G. E. and Weinstein, B. M. (2006). Endothelial tubes 
assemble from intracellular vacuoles in vivo. Nature 442, 453–456. 
Kanchanawong, P., Shtengel, G., Pasapera, A. M., Ramko, E. B., Davidson, M. W., Hess, H. F. and Waterman, C. 
M. (2010). Nanoscale architecture of integrin-based cell adhesions. Nature 468, 580–584. 
Kantola, A. K., Keski-Oja, J. and Koli, K. (2008). Fibronectin and heparin binding domains of latent TGF-β binding 
protein (LTBP)-4 mediate matrix targeting and cell adhesion. Exp. Cell Res. 314, 2488–2500. 
Katz, B.-Z., Zamir, E., Bershadsky, A., Kam, Z., Yamada, K. M. and Geiger, B. (2000). Physical State of the 
Extracellular Matrix Regulates the Structure and Molecular Composition of Cell-Matrix Adhesions. Mol. Biol. Cell 
11, 1047–1060. 
Kaufman, M. H. and Navaratnam, V. (1981). Early differentiation of the heart in mouse embryos. J. Anat. 133, 235–246. 
Kelly, R. G., Brown, N. A. and Buckingham, M. E. (2001). The arterial pole of the mouse heart forms from Fgf10-
expressing cells in pharyngeal mesoderm. Dev. Cell 1, 435–440. 
Kennedy, S. G., Wagner, A. J., Conzen, S. D., Jordán, J., Bellacosa, A., Tsichlis, P. N. and Hay, N. (1997). The PI 3-
kinase/Akt signaling pathway delivers an anti-apoptotic signal. Genes Dev. 11, 701–713. 
Kesavan, G., Sand, F. W., Greiner, T. U., Johansson, J. K., Kobberup, S., Wu, X., Brakebusch, C. and Semb, H. 
(2009). Cdc42-mediated tubulogenesis controls cell specification. Cell 139, 791–801. 
Keski-Oja, J., Raghow, R., Sawdey, M., Loskutoff, D. J., Postlethwaite, A. E., Kang, A. H. and Moses, H. L. (1988). 
Regulation of mRNAs for type-1 plasminogen activator inhibitor, fibronectin, and type I procollagen by 
transforming growth factor-beta. Divergent responses in lung fibroblasts and carcinoma cells. J. Biol. Chem. 263, 
3111–3115. 
Kilian, O., Dahse, R., Alt, V., Zardi, L., Hentschel, J., Schnettler, R. and Kosmehl, H. (2008). mRNA expression and 
protein distribution of fibronectin splice variants and high-molecular weight tenascin-C in different phases of 
human fracture healing. Calcif. Tissue Int. 83, 101–111. 
Kim, S.-H. and Kim, S. H. (2008). Antagonistic effect of EGF on FAK phosphorylation/dephosphorylation in a cell. Cell 
Biochem. Funct. 26, 539–547. 
Kim, S., Bell, K., Mousa, S. A. and Varner, J. A. (2000). Regulation of angiogenesis in vivo by ligation of integrin 
alpha5beta1 with the central cell-binding domain of fibronectin. Am. J. Pathol. 156, 1345–1362. 
Kim, M., Carman, C. V. and Springer, T. A. (2003). Bidirectional transmembrane signaling by cytoplasmic domain 
separation in integrins. Science 301, 1720–1725. 
Kimura, K., Ito, M., Amano, M., Chihara, K., Fukata, Y., Nakafuku, M., Yamamori, B., Feng, J., Nakano, T., 
Okawa, K., et al. (1996). Regulation of myosin phosphatase by Rho and Rho-associated kinase (Rho-kinase). 
Science 273, 245–248. 
King, W. G., Mattaliano, M. D., Chan, T. O., Tsichlis, P. N. and Brugge, J. S. (1997). Phosphatidylinositol 3-kinase is 
required for integrin-stimulated AKT and Raf-1/mitogen-activated protein kinase pathway activation. Mol. Cell. 
Biol. 17, 4406–4418. 
Kinsey, R., Williamson, M. R., Chaudhry, S., Mellody, K. T., McGovern, A., Takahashi, S., Shuttleworth, C. A. and 
Kielty, C. M. (2008). Fibrillin-1 microfibril deposition is dependent on fibronectin assembly. J. Cell Sci. 121, 2696–
2704. 
Kiyokawa, E., Hashimoto, Y., Kobayashi, S., Sugimura, H., Kurata, T. and Matsuda, M. (1998). Activation of Rac1 by 
a Crk SH3-binding protein, DOCK180. Genes Dev. 12, 3331–3336. 
Klass, C. M., Couchman, J. R. and Woods, A. (2000). Control of extracellular matrix assembly by syndecan-2 
proteoglycan. J. Cell Sci. 113 ( Pt 3), 493–506. 
Klotzsch, E., Smith, M. L., Kubow, K. E., Muntwyler, S., Little, W. C., Beyeler, F., Gourdon, D., Nelson, B. J. and 
Vogel, V. (2009). Fibronectin forms the most extensible biological fibers displaying switchable force-exposed 
cryptic binding sites. Proc. Natl. Acad. Sci. U. S. A. 106, 18267–18272. 
PhD Thesis - Josefine Gibson  References 
 
 150 
Koh, W., Mahan, R. D. and Davis, G. E. (2008). Cdc42- and Rac1-mediated endothelial lumen formation requires Pak2, 
Pak4 and Par3, and PKC-dependent signaling. J. Cell Sci. 121, 989–1001. 
Koli, K., Hyytiäinen, M., Ryynänen, M. J. and Keski-Oja, J. (2005). Sequential deposition of latent TGF-β binding 
proteins (LTBPs) during formation of the extracellular matrix in human lung fibroblasts. Exp. Cell Res. 310, 370–
382. 
Komiyama, M., Ito, K. and Shimada, Y. (1987). Origin and development of the epicardium in the mouse embryo. Anat. 
Embryol. (Berl.) 176, 183–189. 
Kong, F., García, A. J., Mould, A. P., Humphries, M. J. and Zhu, C. (2009). Demonstration of catch bonds between an 
integrin and its ligand. J. Cell Biol. 185, 1275–1284. 
Korchynskyi, O. and ten Dijke, P. (2002). Identification and functional characterization of distinct critically important bone 
morphogenetic protein-specific response elements in the Id1 promoter. J. Biol. Chem. 277, 4883–4891. 
Kornblihtt, A. R., Vibe-Pedersen, K. and Baralle, F. E. (1984). Human fibronectin: cell specific alternative mRNA 
splicing generates polypeptide chains differing in the number of internal repeats. Nucleic Acids Res. 12, 5853–5868. 
Kornblihtt, A. R., Umezawa, K., Vibe-Pedersen, K. and Baralle, F. E. (1985). Primary structure of human fibronectin: 
differential splicing may generate at least 10 polypeptides from a single gene. EMBO J. 4, 1755–1759. 
Koshida, S., Kishimoto, Y., Ustumi, H., Shimizu, T., Furutani-Seiki, M., Kondoh, H. and Takada, S. (2005). 
Integrinα5-Dependent Fibronectin Accumulation for Maintenance of Somite Boundaries in Zebrafish Embryos. 
Dev. Cell 8, 587–598. 
Koukoulis, G. K., Howeedy, A. A., Korhonen, M., Virtanen, I. and Gould, V. E. (1993). Distribution of tenascin, 
cellular fibronectins and integrins in the normal, hyperplastic and neoplastic breast. J. Submicrosc. Cytol. Pathol. 25, 
285–295. 
Koushik, S. V., Wang, J., Rogers, R., Moskophidis, D., Lambert, N. A., Creazzo, T. L. and Conway, S. J. (2001). 
Targeted inactivation of the sodium-calcium exchanger (Ncx1) results in the lack of a heartbeat and abnormal 
myofibrillar organization. FASEB J. Off. Publ. Fed. Am. Soc. Exp. Biol. 15, 1209–1211. 
Kragtorp, K. A. and Miller, J. R. (2006). Regulation of somitogenesis by Ena/VASP proteins and FAK during Xenopus 
development. Dev. Camb. Engl. 133, 685–695. 
Kreidberg, J. A., Donovan, M. J., Goldstein, S. L., Rennke, H., Shepherd, K., Jones, R. C. and Jaenisch, R. (1996). 
Alpha 3 beta 1 integrin has a crucial role in kidney and lung organogenesis. Dev. Camb. Engl. 122, 3537–3547. 
Kühn, R., Schwenk, F., Aguet, M. and Rajewsky, K. (1995). Inducible gene targeting in mice. Science 269, 1427–1429. 
Kumar, N. M., Sigurdson, S. L., Sheppard, D. and Lwebuga-Mukasa, J. S. (1995). Differential modulation of integrin 
receptors and extracellular matrix laminin by transforming growth factor-beta 1 in rat alveolar epithelial cells. Exp. 
Cell Res. 221, 385–394. 
Kuo, J.-C., Han, X., Hsiao, C.-T., Yates, J. R., 3rd and Waterman, C. M. (2011). Analysis of the myosin-II-responsive 
focal adhesion proteome reveals a role for β-Pix in negative regulation of focal adhesion maturation. Nat. Cell Biol. 
13, 383–393. 
LaFlamme, S. E. (1994). Single subunit chimeric integrins as mimics and inhibitors of endogenous integrin functions in 
receptor localization, cell spreading and migration, and matrix assembly. J. Cell Biol. 126, 1287–1298. 
Laiho, M., Saksela, O., Andreasen, P. A. and Keski-Oja, J. (1986). Enhanced production and extracellular deposition of 
the endothelial-type plasminogen activator inhibitor in cultured human lung fibroblasts by transforming growth 
factor-beta. J. Cell Biol. 103, 2403–2410. 
Langenbach, K. J. and Sottile, J. (1999). Identification of protein-disulfide isomerase activity in fibronectin. J. Biol. Chem. 
274, 7032–7038. 
Larsson, J., Goumans, M. J., Sjöstrand, L. J., van Rooijen, M. A., Ward, D., Levéen, P., Xu, X., ten Dijke, P., 
Mummery, C. L. and Karlsson, S. (2001). Abnormal angiogenesis but intact hematopoietic potential in TGF-beta 
type I receptor-deficient mice. EMBO J. 20, 1663–1673. 
Laukaitis, C. M., Webb, D. J., Donais, K. and Horwitz, A. F. (2001). Differential dynamics of alpha 5 integrin, paxillin, 
and alpha-actinin during formation and disassembly of adhesions in migrating cells. J. Cell Biol. 153, 1427–1440. 
PhD Thesis - Josefine Gibson  References 
 
 151 
Lawler, J. (2000). The functions of thrombospondin-1 and-2. Curr. Opin. Cell Biol. 12, 634–640. 
Lawrence, D. A., Pircher, R., Krycève-Martinerie, C. and Jullien, P. (1984). Normal embryo fibroblasts release 
transforming growth factors in a latent form. J. Cell. Physiol. 121, 184–188. 
Leahy, D. J., Hendrickson, W. A., Aukhil, I. and Erickson, H. P. (1992). Structure of a fibronectin type III domain from 
tenascin phased by MAD analysis of the selenomethionyl protein. Science 258, 987–991. 
Lebrin, F., Goumans, M.-J., Jonker, L., Carvalho, R. L. C., Valdimarsdottir, G., Thorikay, M., Mummery, C., 
Arthur, H. M. and ten Dijke, P. (2004). Endoglin promotes endothelial cell proliferation and TGF-beta/ALK1 
signal transduction. EMBO J. 23, 4018–4028. 
Lee, G., Hynes, R. and Kirschner, M. (1984). Temporal and spatial regulation of fibronectin in early Xenopus 
development. Cell 36, 729–740. 
Legate, K. R. and Fässler, R. (2009). Mechanisms that regulate adaptor binding to beta-integrin cytoplasmic tails. J. Cell Sci. 
122, 187–198. 
Legate, K. R., Montañez, E., Kudlacek, O. and Fässler, R. (2006). ILK, PINCH and parvin: the tIPP of integrin 
signalling. Nat. Rev. Mol. Cell Biol. 7, 20–31. 
Legate, K. R., Wickstrom, S. A. and Fassler, R. (2009). Genetic and cell biological analysis of integrin outside-in signaling. 
Genes Dev. 23, 397–418. 
Legate, K. R., Takahashi, S., Bonakdar, N., Fabry, B., Boettiger, D., Zent, R. and Fässler, R. (2011). Integrin 
adhesion and force coupling are independently regulated by localized PtdIns(4,5)2 synthesis. EMBO J. 30, 4539–
4553. 
Lei, L., Liu, D., Huang, Y., Jovin, I., Shai, S.-Y., Kyriakides, T., Ross, R. S. and Giordano, F. J. (2008). Endothelial 
expression of beta1 integrin is required for embryonic vascular patterning and postnatal vascular remodeling. Mol. 
Cell. Biol. 28, 794–802. 
Leiss, M., Beckmann, K., Girós, A., Costell, M. and Fässler, R. (2008). The role of integrin binding sites in fibronectin 
matrix assembly in vivo. Curr. Opin. Cell Biol. 20, 502–507. 
Leslie, J. D., Ariza-McNaughton, L., Bermange, A. L., McAdow, R., Johnson, S. L. and Lewis, J. (2007). Endothelial 
signalling by the Notch ligand Delta-like 4 restricts angiogenesis. Dev. Camb. Engl. 134, 839–844. 
Lessey, E. C., Guilluy, C. and Burridge, K. (2012). From mechanical force to RhoA activation. Biochemistry (Mosc.) 51, 
7420–7432. 
Levental, K. R., Yu, H., Kass, L., Lakins, J. N., Egeblad, M., Erler, J. T., Fong, S. F. T., Csiszar, K., Giaccia, A., 
Weninger, W., et al. (2009). Matrix crosslinking forces tumor progression by enhancing integrin signaling. Cell 
139, 891–906. 
Li, F. and Higgs, H. N. (2003). The mouse Formin mDia1 is a potent actin nucleation factor regulated by autoinhibition. 
Curr. Biol. CB 13, 1335–1340. 
Li, S., Van Den Diepstraten, C., D’Souza, S. J., Chan, B. M. C. and Pickering, J. G. (2003). Vascular smooth muscle 
cells orchestrate the assembly of type I collagen via alpha2beta1 integrin, RhoA, and fibronectin polymerization. 
Am. J. Pathol. 163, 1045–1056. 
Li, S., Guan, J.-L. and Chien, S. (2005a). Biochemistry and biomechanics of cell motility. Annu. Rev. Biomed. Eng. 7, 105–
150. 
Li, Y.-S. J., Haga, J. H. and Chien, S. (2005b). Molecular basis of the effects of shear stress on vascular endothelial cells. J. 
Biomech. 38, 1949–1971. 
Li, L., Welser-Alves, J., van der Flier, A., Boroujerdi, A., Hynes, R. O. and Milner, R. (2012). An angiogenic role for 
the α5β1 integrin in promoting endothelial cell proliferation during cerebral hypoxia. Exp. Neurol. 237, 46–54. 
Liao, Y.-F., Gotwals, P. J., Koteliansky, V. E., Sheppard, D. and Van De Water, L. (2002). The EIIIA segment of 
fibronectin is a ligand for integrins alpha 9beta 1 and alpha 4beta 1 providing a novel mechanism for regulating cell 
adhesion by alternative splicing. J. Biol. Chem. 277, 14467–14474. 
Lim, S. P., Leung, E. and Krissansen, G. W. (1998). The beta7 integrin gene (Itgb-7) promoter is responsive to TGF-
beta1: defining control regions. Immunogenetics 48, 184–195. 
PhD Thesis - Josefine Gibson  References 
 
 152 
Linask, K. K. and Lash, J. W. (1986). Precardiac cell migration: Fibronectin localization at mesoderm-endoderm interface 
during directional movement. Dev. Biol. 114, 87–101. 
Lints, T. J., Parsons, L. M., Hartley, L., Lyons, I. and Harvey, R. P. (1993). Nkx-2.5: a novel murine homeobox gene 
expressed in early heart progenitor cells and their myogenic descendants. Dev. Camb. Engl. 119, 969. 
Liu, J., Fukuda, K., Xu, Z., Ma, Y.-Q., Hirbawi, J., Mao, X., Wu, C., Plow, E. F. and Qin, J. (2011). Structural basis of 
phosphoinositide binding to kindlin-2 protein pleckstrin homology domain in regulating integrin activation. J. Biol. 
Chem. 286, 43334–43342. 
Lo, S. H., Janmey, P. A., Hartwig, J. H. and Chen, L. B. (1994). Interactions of tensin with actin and identification of its 
three distinct actin-binding domains. J. Cell Biol. 125, 1067–1075. 
Lo, C. M., Wang, H. B., Dembo, M. and Wang, Y. L. (2000). Cell movement is guided by the rigidity of the substrate. 
Biophys. J. 79, 144–152. 
Lobov, I. B., Renard, R. A., Papadopoulos, N., Gale, N. W., Thurston, G., Yancopoulos, G. D. and Wiegand, S. J. 
(2007). Delta-like ligand 4 (Dll4) is induced by VEGF as a negative regulator of angiogenic sprouting. Proc. Natl. 
Acad. Sci. U. S. A. 104, 3219–3224. 
Loeber, C. P. and Runyan, R. B. (1990). A comparison of fibronectin, laminin, and galactosyltransferase adhesion 
mechanisms during embryonic cardiac mesenchymal cell migration in vitro. Dev. Biol. 140, 401–412. 
Lucitti, J. L., Jones, E. A. V., Huang, C., Chen, J., Fraser, S. E. and Dickinson, M. E. (2007). Vascular remodeling of 
the mouse yolk sac requires hemodynamic force. Dev. Camb. Engl. 134, 3317–3326. 
Luo, Y., Ferreira-Cornwell, M., Baldwin, H., Kostetskii, I., Lenox, J., Lieberman, M. and Radice, G. (2001). Rescuing 
the N-cadherin knockout by cardiac-specific expression of N- or E-cadherin. Dev. Camb. Engl. 128, 459–469. 
Luo, B.-H., Carman, C. V. and Springer, T. A. (2007). Structural basis of integrin regulation and signaling. Annu. Rev. 
Immunol. 25, 619–647. 
Lyden, D., Young, A. Z., Zagzag, D., Yan, W., Gerald, W., O’Reilly, R., Bader, B. L., Hynes, R. O., Zhuang, Y., 
Manova, K., et al. (1999). Id1 and Id3 are required for neurogenesis, angiogenesis and vascularization of tumour 
xenografts. Nature 401, 670–677. 
Ma, Y.-Q., Qin, J., Wu, C. and Plow, E. F. (2008). Kindlin-2 (Mig-2): a co-activator of beta3 integrins. J. Cell Biol. 181, 439–
446. 
MacLeod, J. N., Burton-Wurster, N., Gu, D. N. and Lust, G. (1996). Fibronectin mRNA splice variant in articular 
cartilage lacks bases encoding the V, III-15, and I-10 protein segments. J. Biol. Chem. 271, 18954–18960. 
Maekawa, M. (1999). Signaling from Rho to the Actin Cytoskeleton Through Protein Kinases ROCK and LIM-kinase. 
Science 285, 895–898. 
Maeshima, Y., Colorado, P. C. and Kalluri, R. (2000). Two RGD-independent alpha vbeta 3 integrin binding sites on 
tumstatin regulate distinct anti-tumor properties. J. Biol. Chem. 275, 23745–23750. 
Main, A. L., Harvey, T. S., Baron, M., Boyd, J. and Campbell, I. D. (1992). The three-dimensional structure of the tenth 
type III module of fibronectin: an insight into RGD-mediated interactions. Cell 71, 671–678. 
Mammoto, A., Connor, K. M., Mammoto, T., Yung, C. W., Huh, D., Aderman, C. M., Mostoslavsky, G., Smith, L. 
E. H. and Ingber, D. E. (2009). A mechanosensitive transcriptional mechanism that controls angiogenesis. Nature 
457, 1103–1108. 
Manabe, R., Ohe, N., Maeda, T., Fukuda, T. and Sekiguchi, K. (1997). Modulation of cell-adhesive activity of 
fibronectin by the alternatively spliced EDA segment. J. Cell Biol. 139, 295–307. 
Mandarino, L. J., Sundarraj, N., Finlayson, J. and Hassell, H. R. (1993). Regulation of fibronectin and laminin synthesis 
by retinal capillary endothelial cells and pericytes in vitro. Exp. Eye Res. 57, 609–621. 
Maqueda, A., Moyano, J. V., Hernández Del Cerro, M., Peters, D. M. and Garcia-Pardo, A. (2007). The heparin III-
binding domain of fibronectin (III4-5 repeats) binds to fibronectin and inhibits fibronectin matrix assembly. Matrix 
Biol. J. Int. Soc. Matrix Biol. 26, 642–651. 
Marcoux, N. and Vuori, K. (2003). EGF receptor mediates adhesion-dependent activation of the Rac GTPase: a role for 
phosphatidylinositol 3-kinase and Vav2. Oncogene 22, 6100–6106. 
PhD Thesis - Josefine Gibson  References 
 
 153 
Marsden, M. and DeSimone, D. W. (2001). Regulation of cell polarity, radial intercalation and epiboly in Xenopus: novel 
roles for integrin and fibronectin. Dev. Camb. Engl. 128, 3635–3647. 
Marsden, M. and DeSimone, D. W. (2003). Integrin-ECM interactions regulate cadherin-dependent cell adhesion and are 
required for convergent extension in Xenopus. Curr. Biol. CB 13, 1182–1191. 
Martins, G. G., Rifes, P., Amândio, R., Rodrigues, G., Palmeirim, I. and Thorsteinsdóttir, S. (2009). Dynamic 3D cell 
rearrangements guided by a fibronectin matrix underlie somitogenesis. PloS One 4, e7429. 
Mason, B. N., Starchenko, A., Williams, R. M., Bonassar, L. J. and Reinhart-King, C. A. (2013). Tuning three-
dimensional collagen matrix stiffness independently of collagen concentration modulates endothelial cell behavior. 
Acta Biomater. 9, 4635–4644. 
Massam-Wu, T., Chiu, M., Choudhury, R., Chaudhry, S. S., Baldwin, A. K., McGovern, A., Baldock, C., 
Shuttleworth, C. A. and Kielty, C. M. (2010). Assembly of fibrillin microfibrils governs extracellular deposition 
of latent TGFβ. J. Cell Sci. 123, 3006 –3018. 
Matter, C. M., Schuler, P. K., Alessi, P., Meier, P., Ricci, R., Zhang, D., Halin, C., Castellani, P., Zardi, L., Hofer, 
C. K., et al. (2004). Molecular imaging of atherosclerotic plaques using a human antibody against the extra-domain 
B of fibronectin. Circ. Res. 95, 1225–1233. 
May, S. R., Stewart, N. J., Chang, W. and Peterson, A. S. (2004). A Titin mutation defines roles for circulation in 
endothelial morphogenesis. Dev. Biol. 270, 31–46. 
Mayer, U., Saher, G., Fässler, R., Bornemann, A., Echtermeyer, F., von der Mark, H., Miosge, N., Pöschl, E. and 
von der Mark, K. (1997). Absence of integrin alpha 7 causes a novel form of muscular dystrophy. Nat. Genet. 17, 
318–323. 
McCarty, J. H., Monahan-Earley, R. A., Brown, L. F., Keller, M., Gerhardt, H., Rubin, K., Shani, M., Dvorak, H. F., 
Wolburg, H., Bader, B. L., et al. (2002). Defective associations between blood vessels and brain parenchyma lead 
to cerebral hemorrhage in mice lacking alphav integrins. Mol. Cell. Biol. 22, 7667–7677. 
McCarty, J. H., Lacy-Hulbert, A., Charest, A., Bronson, R. T., Crowley, D., Housman, D., Savill, J., Roes, J. and 
Hynes, R. O. (2005). Selective ablation of alphav integrins in the central nervous system leads to cerebral 
hemorrhage, seizures, axonal degeneration and premature death. Dev. Camb. Engl. 132, 165–176. 
McDonald, J. A., Kelley, D. G. and Broekelmann, T. J. (1982). Role of fibronectin in collagen deposition: Fab’ to the 
gelatin-binding domain of fibronectin inhibits both fibronectin and collagen organization in fibroblast extracellular 
matrix. J. Cell Biol. 92, 485–492. 
McDonald, J. A., Quade, B. J., Broekelmann, T. J., LaChance, R., Forsman, K., Hasegawa, E. and Akiyama, S. 
(1987). Fibronectin’s cell-adhesive domain and an amino-terminal matrix assembly domain participate in its 
assembly into fibroblast pericellular matrix. J. Biol. Chem. 262, 2957–2967. 
McDonald, P. C., Oloumi, A., Mills, J., Dobreva, I., Maidan, M., Gray, V., Wederell, E. D., Bally, M. B., Foster, L. 
J. and Dedhar, S. (2008). Rictor and integrin-linked kinase interact and regulate Akt phosphorylation and cancer 
cell survival. Cancer Res. 68, 1618–1624. 
McGrath, K. E. (2003). Circulation is established in a stepwise pattern in the mammalian embryo. Blood 101, 1669–1675. 
McGrath, K. E. and Palis, J. (2005). Hematopoiesis in the yolk sac: more than meets the eye. Exp. Hematol. 33, 1021–1028. 
McHugh, K. P., Hodivala-Dilke, K., Zheng, M. H., Namba, N., Lam, J., Novack, D., Feng, X., Ross, F. P., Hynes, 
R. O. and Teitelbaum, S. L. (2000). Mice lacking beta3 integrins are osteosclerotic because of dysfunctional 
osteoclasts. J. Clin. Invest. 105, 433–440. 
McKeown-Longo, P. J. and Mosher, D. F. (1983). Binding of plasma fibronectin to cell layers of human skin fibroblasts. J. 
Cell Biol. 97, 466–472. 
McKeown-Longo, P. J. and Mosher, D. F. (1985). Interaction of the 70,000-mol-wt amino-terminal fragment of 
fibronectin with the matrix-assembly receptor of fibroblasts. J. Cell Biol. 100, 364–374. 
Meredith, J. E., Jr, Fazeli, B. and Schwartz, M. A. (1993). The extracellular matrix as a cell survival factor. Mol. Biol. Cell 4, 
953–961. 
Millis, A. J., Hoyle, M., Mann, D. M. and Brennan, M. J. (1985). Incorporation of cellular and plasma fibronectins into 
smooth muscle cell extracellular matrix in vitro. Proc. Natl. Acad. Sci. U. S. A. 82, 2746–2750. 
PhD Thesis - Josefine Gibson  References 
 
 154 
Mittal, A., Pulina, M., Hou, S.-Y. and Astrof, S. (2010). Fibronectin and integrin alpha 5 play essential roles in the 
development of the cardiac neural crest. Mech. Dev. 127, 472–484. 
Miyamoto, S., Akiyama, S. K. and Yamada, K. M. (1995). Synergistic roles for receptor occupancy and aggregation in 
integrin transmembrane function. Science 267, 883–885. 
Miyamoto, S., Teramoto, H., Gutkind, J. S. and Yamada, K. M. (1996). Integrins can collaborate with growth factors for 
phosphorylation of receptor tyrosine kinases and MAP kinase activation: roles of integrin aggregation and 
occupancy of receptors. J. Cell Biol. 135, 1633–1642. 
Miyazono, K. and Heldin, C. H. (1989). Role for carbohydrate structures in TGF-beta 1 latency. Nature 338, 158–160. 
Miyazono, K., Olofsson, A., Colosetti, P. and Heldin, C. H. (1991). A role of the latent TGF-beta 1-binding protein in 
the assembly and secretion of TGF-beta 1. EMBO J. 10, 1091–1101. 
Miyazono, K., Maeda, S. and Imamura, T. (2005). BMP receptor signaling: transcriptional targets, regulation of signals, 
and signaling cross-talk. Cytokine Growth Factor Rev. 16, 251–263. 
Mjaatvedt, C. H., Lepera, R. C. and Markwald, R. R. (1987). Myocardial specificity for initiating endothelial-
mesenchymal cell transition in embryonic chick heart correlates with a particulate distribution of fibronectin. Dev. 
Biol. 119, 59–67. 
Mjaatvedt, C. H., Nakaoka, T., Moreno-Rodriguez, R., Norris, R. A., Kern, M. J., Eisenberg, C. A., Turner, D. and 
Markwald, R. R. (2001). The outflow tract of the heart is recruited from a novel heart-forming field. Dev. Biol. 
238, 97–109. 
Montanez, E., Ussar, S., Schifferer, M., Bösl, M., Zent, R., Moser, M. and Fässler, R. (2008). Kindlin-2 controls 
bidirectional signaling of integrins. Genes Dev. 22, 1325–1330. 
Moore, S. W., Keller, R. E. and Koehl, M. A. (1995). The dorsal involuting marginal zone stiffens anisotropically during its 
convergent extension in the gastrula of Xenopus laevis. Dev. Camb. Engl. 121, 3131–3140. 
Moorman, A. F. M., de Jong, F., Denyn, M. M. F. J. and Lamers, W. H. (1998). Development of the Cardiac 
Conduction System. Circ. Res. 82, 629–644. 
Moretti, F. A., Chauhan, A. K., Iaconcig, A., Porro, F., Baralle, F. E. and Muro, A. F. (2007). A major fraction of 
fibronectin present in the extracellular matrix of tissues is plasma-derived. J. Biol. Chem. 282, 28057–28062. 
Morgan, M. R., Humphries, M. J. and Bass, M. D. (2007). Synergistic control of cell adhesion by integrins and syndecans. 
Nat. Rev. Mol. Cell Biol. 8, 957–969. 
Moro, L., Venturino, M., Bozzo, C., Silengo, L., Altruda, F., Beguinot, L., Tarone, G. and Defilippi, P. (1998). 
Integrins induce activation of EGF receptor: role in MAP kinase induction and adhesion-dependent cell survival. 
EMBO J. 17, 6622–6632. 
Moro, L., Dolce, L., Cabodi, S., Bergatto, E., Boeri Erba, E., Smeriglio, M., Turco, E., Retta, S. F., Giuffrida, M. G., 
Venturino, M., et al. (2002). Integrin-induced epidermal growth factor (EGF) receptor activation requires c-Src 
and p130Cas and leads to phosphorylation of specific EGF receptor tyrosines. J. Biol. Chem. 277, 9405–9414. 
Moser, M., Nieswandt, B., Ussar, S., Pozgajova, M. and Fässler, R. (2008). Kindlin-3 is essential for integrin activation 
and platelet aggregation. Nat. Med. 14, 325–330. 
Moser, M., Bauer, M., Schmid, S., Ruppert, R., Schmidt, S., Sixt, M., Wang, H.-V., Sperandio, M. and Fässler, R. 
(2009a). Kindlin-3 is required for beta2 integrin-mediated leukocyte adhesion to endothelial cells. Nat. Med. 15, 
300–305. 
Moser, M., Legate, K. R., Zent, R. and Fässler, R. (2009b). The tail of integrins, talin, and kindlins. Science 324, 895–899. 
Mosher, D. F. (1975). Cross-linking of cold-insoluble globulin by fibrin-stabilizing factor. J. Biol. Chem. 250, 6614–6621. 
Mould, A. P., Komoriya, A., Yamada, K. M. and Humphries, M. J. (1991). The CS5 peptide is a second site in the IIICS 
region of fibronectin recognized by the integrin alpha 4 beta 1. Inhibition of alpha 4 beta 1 function by RGD 
peptide homologues. J. Biol. Chem. 266, 3579–3585. 
Mu, D., Cambier, S., Fjellbirkeland, L., Baron, J. L., Munger, J. S., Kawakatsu, H., Sheppard, D., Broaddus, V. C. 
and Nishimura, S. L. (2002). The integrin αvβ8 mediates epithelial homeostasis through MT1-MMP–dependent 
activation of TGF-β1. J. Cell Biol. 157, 493–507. 
PhD Thesis - Josefine Gibson  References 
 
 155 
Muether, P. S., Dell, S., Kociok, N., Zahn, G., Stragies, R., Vossmeyer, D. and Joussen, A. M. (2007). The role of 
integrin alpha5beta1 in the regulation of corneal neovascularization. Exp. Eye Res. 85, 356–365. 
Müller, U., Wang, D., Denda, S., Meneses, J. J., Pedersen, R. A. and Reichardt, L. F. (1997). Integrin alpha8beta1 is 
critically important for epithelial-mesenchymal interactions during kidney morphogenesis. Cell 88, 603–613. 
Munger, J. S., Huang, X., Kawakatsu, H., Griffiths, M. J., Dalton, S. L., Wu, J., Pittet, J. F., Kaminski, N., Garat, C., 
Matthay, M. A., et al. (1999). The integrin alpha v beta 6 binds and activates latent TGF beta 1: a mechanism for 
regulating pulmonary inflammation and fibrosis. Cell 96, 319–328. 
Muro, A. F., Chauhan, A. K., Gajovic, S., Iaconcig, A., Porro, F., Stanta, G. and Baralle, F. E. (2003). Regulated 
splicing of the fibronectin EDA exon is essential for proper skin wound healing and normal lifespan. J. Cell Biol. 
162, 149–160. 
Muro, A. F., Moretti, F. A., Moore, B. B., Yan, M., Atrasz, R. G., Wilke, C. A., Flaherty, K. R., Martinez, F. J., Tsui, 
J. L., Sheppard, D., et al. (2008). An essential role for fibronectin extra type III domain A in pulmonary fibrosis. 
Am. J. Respir. Crit. Care Med. 177, 638–645. 
Nagai, T., Yamakawa, N., Aota, S., Yamada, S. S., Akiyama, S. K., Olden, K. and Yamada, K. M. (1991). Monoclonal 
antibody characterization of two distant sites required for function of the central cell-binding domain of fibronectin 
in cell adhesion, cell migration, and matrix assembly. J. Cell Biol. 114, 1295–1305. 
Nejjari, M., Hafdi, Z., Dumortier, J., Bringuier, A. F., Feldmann, G. and Scoazec, J. Y. (1999). alpha6beta1 integrin 
expression in hepatocarcinoma cells: regulation and role in cell adhesion and migration. Int. J. Cancer J. Int. Cancer 
83, 518–525. 
Neptune, E. R., Frischmeyer, P. A., Arking, D. E., Myers, L., Bunton, T. E., Gayraud, B., Ramirez, F., Sakai, L. Y. 
and Dietz, H. C. (2003). Dysregulation of TGF-beta activation contributes to pathogenesis in Marfan syndrome. 
Nat. Genet. 33, 407–411. 
Ni, H., Yuen, P. S. T., Papalia, J. M., Trevithick, J. E., Sakai, T., Fässler, R., Hynes, R. O. and Wagner, D. D. 
(2003). Plasma fibronectin promotes thrombus growth and stability in injured arterioles. Proc. Natl. Acad. Sci. U. S. 
A. 100, 2415–2419. 
Nielsen, J. S. and McNagny, K. M. (2008). Novel functions of the CD34 family. J. Cell Sci. 121, 3683–3692. 
Nojima, Y., Humphries, M. J., Mould, A. P., Komoriya, A., Yamada, K. M., Schlossman, S. F. and Morimoto, C. 
(1990). VLA-4 mediates CD3-dependent CD4+ T cell activation via the CS1 alternatively spliced domain of 
fibronectin. J. Exp. Med. 172, 1185–1192. 
Norton, J. D. (2000). ID helix-loop-helix proteins in cell growth, differentiation and tumorigenesis. J. Cell Sci. 113 ( Pt 22), 
3897–3905. 
Nunes, I., Gleizes, P. E., Metz, C. N. and Rifkin, D. B. (1997). Latent transforming growth factor-beta binding protein 
domains involved in activation and transglutaminase-dependent cross-linking of latent transforming growth factor-
beta. J. Cell Biol. 136, 1151–1163. 
Oh, S. P., Seki, T., Goss, K. A., Imamura, T., Yi, Y., Donahoe, P. K., Li, L., Miyazono, K., ten Dijke, P., Kim, S., et 
al. (2000). Activin receptor-like kinase 1 modulates transforming growth factor-beta 1 signaling in the regulation of 
angiogenesis. Proc. Natl. Acad. Sci. U. S. A. 97, 2626–2631. 
Ohashi, K. (2000). Rho-associated Kinase ROCK Activates LIM-kinase 1 by Phosphorylation at Threonine 508 within the 
Activation Loop. J. Biol. Chem. 275, 3577–3582. 
Ohashi, T. and Erickson, H. P. (2009). Revisiting the mystery of fibronectin multimers: the fibronectin matrix is composed 
of fibronectin dimers cross-linked by non-covalent bonds. Matrix Biol. J. Int. Soc. Matrix Biol. 28, 170–175. 
Ohashi, T., Kiehart, D. P. and Erickson, H. P. (2002). Dual labeling of the fibronectin matrix and actin cytoskeleton with 
green fluorescent protein variants. J. Cell Sci. 115, 1221–1229. 
Olorundare, O. E., Peyruchaud, O., Albrecht, R. M. and Mosher, D. F. (2001). Assembly of a fibronectin matrix by 
adherent platelets stimulated by lysophosphatidic acid and other agonists. Blood 98, 117–124. 
Orlidge, A. and D’Amore, P. A. (1987). Inhibition of capillary endothelial cell growth by pericytes and smooth muscle cells. 
J. Cell Biol. 105, 1455 –1462. 
Oshima, M., Oshima, H. and Taketo, M. M. (1996). TGF-beta receptor type II deficiency results in defects of yolk sac 
hematopoiesis and vasculogenesis. Dev. Biol. 179, 297–302. 
PhD Thesis - Josefine Gibson  References 
 
 156 
Oyama, F., Murata, Y., Suganuma, N., Kimura, T., Titani, K. and Sekiguchi, K. (1989). Patterns of alternative splicing 
of fibronectin pre-mRNA in human adult and fetal tissues. Biochemistry (Mosc.) 28, 1428–1434. 
Pagani, F., Zagato, L., Vergani, C., Casari, G., Sidoli, A. and Baralle, F. E. (1991). Tissue-specific splicing pattern of 
fibronectin messenger RNA precursor during development and aging in rat. J. Cell Biol. 113, 1223–1229. 
Palis, J. and Yoder, M. C. (2001). Yolk-sac hematopoiesis: the first blood cells of mouse and man. Exp. Hematol. 29, 927–
936. 
Pankov, R. and Yamada, K. M. (2004). Non-radioactive quantification of fibronectin matrix assembly. Curr. Protoc. Cell Biol. 
Editor. Board Juan Bonifacino Al Chapter 10, Unit 10.13. 
Pankov, R., Cukierman, E., Katz, B. Z., Matsumoto, K., Lin, D. C., Lin, S., Hahn, C. and Yamada, K. M. (2000). 
Integrin dynamics and matrix assembly: tensin-dependent translocation of alpha(5)beta(1) integrins promotes early 
fibronectin fibrillogenesis. J. Cell Biol. 148, 1075–1090. 
Park, J. E., Keller, G. A. and Ferrara, N. (1993). The vascular endothelial growth factor (VEGF) isoforms: differential 
deposition into the subepithelial extracellular matrix and bioactivity of extracellular matrix-bound VEGF. Mol. Biol. 
Cell 4, 1317–1326. 
Parsons, J. T., Horwitz, A. R. and Schwartz, M. A. (2010). Cell adhesion: integrating cytoskeletal dynamics and cellular 
tension. Nat. Rev. Mol. Cell Biol. 11, 633–643. 
Paszek, M. J., Zahir, N., Johnson, K. R., Lakins, J. N., Rozenberg, G. I., Gefen, A., Reinhart-King, C. A., Margulies, 
S. S., Dembo, M., Boettiger, D., et al. (2005). Tensional homeostasis and the malignant phenotype. Cancer Cell 8, 
241–254. 
Pelham, R. J., Jr and Wang, Y. l (1997). Cell locomotion and focal adhesions are regulated by substrate flexibility. Proc. Natl. 
Acad. Sci. U. S. A. 94, 13661–13665. 
Pepper, M. S. (1997). Transforming growth factor-beta: vasculogenesis, angiogenesis, and vessel wall integrity. Cytokine 
Growth Factor Rev. 8, 21–43. 
Pepper, M. S. (2001). Role of the matrix metalloproteinase and plasminogen activator-plasmin systems in angiogenesis. 
Arterioscler. Thromb. Vasc. Biol. 21, 1104–1117. 
Pepper, M. S., Belin, D., Montesano, R., Orci, L. and Vassalli, J. D. (1990). Transforming growth factor-beta 1 
modulates basic fibroblast growth factor-induced proteolytic and angiogenic properties of endothelial cells in vitro. 
J. Cell Biol. 111, 743–755. 
Pereira, M., Rybarczyk, B. J., Odrljin, T. M., Hocking, D. C., Sottile, J. and Simpson-Haidaris, P. J. (2002). The 
incorporation of fibrinogen into extracellular matrix is dependent on active assembly of a fibronectin matrix. J. Cell 
Sci. 115, 609–617. 
Perruzzi, C. A., de Fougerolles, A. R., Koteliansky, V. E., Whelan, M. C., Westlin, W. F. and Senger, D. R. (2003). 
Functional overlap and cooperativity among alphav and beta1 integrin subfamilies during skin angiogenesis. J. 
Invest. Dermatol. 120, 1100–1109. 
Peters, J., Sechrist, J., Luetolf, S., Loredo, G. and Bronner-Fraser, M. (2002). Spatial expression of the alternatively 
spliced EIIIB and EIIIA segments of fibronectin in the early chicken embryo. Cell Commun. Adhes. 9, 221–238. 
Petersen, T. E., Thøgersen, H. C., Skorstengaard, K., Vibe-Pedersen, K., Sahl, P., Sottrup-Jensen, L. and 
Magnusson, S. (1983). Partial primary structure of bovine plasma fibronectin: three types of internal homology. 
Proc. Natl. Acad. Sci. U. S. A. 80, 137–141. 
Petitclerc, E., Boutaud, A., Prestayko, A., Xu, J., Sado, Y., Ninomiya, Y., Sarras, M. P., Jr, Hudson, B. G. and 
Brooks, P. C. (2000). New functions for non-collagenous domains of human collagen type IV. Novel integrin 
ligands inhibiting angiogenesis and tumor growth in vivo. J. Biol. Chem. 275, 8051–8061. 
Peyton, S. R. and Putnam, A. J. (2005). Extracellular matrix rigidity governs smooth muscle cell motility in a biphasic 
fashion. J. Cell. Physiol. 204, 198–209. 
Pierschbacher, M. D. and Ruoslahti, E. (1984a). Cell attachment activity of fibronectin can be duplicated by small 
synthetic fragments of the molecule. Nature 309, 30–33. 
Pierschbacher, M. D. and Ruoslahti, E. (1984b). Variants of the cell recognition site of fibronectin that retain attachment-
promoting activity. Proc. Natl. Acad. Sci. U. S. A. 81, 5985–5988. 
PhD Thesis - Josefine Gibson  References 
 
 157 
Pierschbacher, M., Hayman, E. G. and Ruoslahti, E. (1983). Synthetic peptide with cell attachment activity of 
fibronectin. Proc. Natl. Acad. Sci. U. S. A. 80, 1224–1227. 
Plow, E. F., Pierschbacher, M. D., Ruoslahti, E., Marguerie, G. A. and Ginsberg, M. H. (1985). The effect of Arg-
Gly-Asp-containing peptides on fibrinogen and von Willebrand factor binding to platelets. Proc. Natl. Acad. Sci. U. 
S. A. 82, 8057–8061. 
Podar, K., Tai, Y.-T., Lin, B. K., Narsimhan, R. P., Sattler, M., Kijima, T., Salgia, R., Gupta, D., Chauhan, D. and 
Anderson, K. C. (2002). Vascular endothelial growth factor-induced migration of multiple myeloma cells is 
associated with beta 1 integrin- and phosphatidylinositol 3-kinase-dependent PKC alpha activation. J. Biol. Chem. 
277, 7875–7881. 
Popova, S. N., Barczyk, M., Tiger, C.-F., Beertsen, W., Zigrino, P., Aszodi, A., Miosge, N., Forsberg, E. and 
Gullberg, D. (2007). Alpha11 beta1 integrin-dependent regulation of periodontal ligament function in the erupting 
mouse incisor. Mol. Cell. Biol. 27, 4306–4316. 
Pozzi, A., Moberg, P. E., Miles, L. A., Wagner, S., Soloway, P. and Gardner, H. A. (2000). Elevated matrix 
metalloprotease and angiostatin levels in integrin alpha 1 knockout mice cause reduced tumor vascularization. Proc. 
Natl. Acad. Sci. U. S. A. 97, 2202–2207. 
Prewitz, M. C., Seib, F. P., von Bonin, M., Friedrichs, J., Stißel, A., Niehage, C., Müller, K., Anastassiadis, K., 
Waskow, C., Hoflack, B., et al. (2013). Tightly anchored tissue-mimetic matrices as instructive stem cell 
microenvironments. Nat. Methods 10, 788–794. 
Priestley, G. V., Ulyanova, T. and Papayannopoulou, T. (2007). Sustained alterations in biodistribution of 
stem/progenitor cells in Tie2Cre+ alpha4(f/f) mice are hematopoietic cell autonomous. Blood 109, 109–111. 
Pulina, M. V., Hou, S.-Y., Mittal, A., Julich, D., Whittaker, C. A., Holley, S. A., Hynes, R. O. and Astrof, S. (2011). 
Essential roles of fibronectin in the development of the left–right embryonic body plan. Dev. Biol. 354, 208–220. 
Qu, H., Tu, Y., Shi, X., Larjava, H., Saleem, M. A., Shattil, S. J., Fukuda, K., Qin, J., Kretzler, M. and Wu, C. (2011). 
Kindlin-2 regulates podocyte adhesion and fibronectin matrix deposition through interactions with 
phosphoinositides and integrins. J. Cell Sci. 124, 879–891. 
Quade, B. J. and McDonald, J. A. (1988). Fibronectin’s amino-terminal matrix assembly site is located within the 29-kDa 
amino-terminal domain containing five type I repeats. J. Biol. Chem. 263, 19602–19609. 
Rahman, S., Patel, Y., Murray, J., Patel, K. V., Sumathipala, R., Sobel, M. and Wijelath, E. S. (2005). Novel 
hepatocyte growth factor (HGF) binding domains on fibronectin and vitronectin coordinate a distinct and 
amplified Met-integrin induced signalling pathway in endothelial cells. BMC Cell Biol. 6, 8. 
Ramasubramanian, A., Nerurkar, N. L., Achtien, K. H., Filas, B. A., Voronov, D. A. and Taber, L. A. (2008). On 
modeling morphogenesis of the looping heart following mechanical perturbations. J. Biomech. Eng. 130, 061018. 
Ramirez, F. and Pereira, L. (1999). The fibrillins. Int. J. Biochem. Cell Biol. 31, 255–259. 
Rantala, J. K., Pouwels, J., Pellinen, T., Veltel, S., Laasola, P., Mattila, E., Potter, C. S., Duffy, T., Sundberg, J. P., 
Kallioniemi, O., et al. (2011). SHARPIN is an endogenous inhibitor of β1-integrin activation. Nat. Cell Biol. 13, 
1315–1324. 
Redick, S. D., Settles, D. L., Briscoe, G. and Erickson, H. P. (2000). Defining fibronectin’s cell adhesion synergy site by 
site-directed mutagenesis. J. Cell Biol. 149, 521–527. 
Rehn, M., Veikkola, T., Kukk-Valdre, E., Nakamura, H., Ilmonen, M., Lombardo, C., Pihlajaniemi, T., Alitalo, K. 
and Vuori, K. (2001). Interaction of endostatin with integrins implicated in angiogenesis. Proc. Natl. Acad. Sci. U. S. 
A. 98, 1024–1029. 
Reynolds, L. E., Wyder, L., Lively, J. C., Taverna, D., Robinson, S. D., Huang, X., Sheppard, D., Hynes, R. O. and 
Hodivala-Dilke, K. M. (2002). Enhanced pathological angiogenesis in mice lacking beta3 integrin or beta3 and 
beta5 integrins. Nat. Med. 8, 27–34. 
Ribeiro, S. M., Poczatek, M., Schultz-Cherry, S., Villain, M. and Murphy-Ullrich, J. E. (1999). The activation sequence 
of thrombospondin-1 interacts with the latency-associated peptide to regulate activation of latent transforming 
growth factor-beta. J. Biol. Chem. 274, 13586–13593. 
Rifkin, D. B. (2005). Latent Transforming Growth Factor-β (TGF-β) Binding Proteins: Orchestrators of TGF-β Availability. 
J. Biol. Chem. 280, 7409–7412. 
PhD Thesis - Josefine Gibson  References 
 
 158 
Riikonen, T., Koivisto, L., Vihinen, P. and Heino, J. (1995). Transforming growth factor-beta regulates collagen gel 
contraction by increasing alpha 2 beta 1 integrin expression in osteogenic cells. J. Biol. Chem. 270, 376–382. 
Risau, W. (1997). Mechanisms of angiogenesis. Nature 386, 671–674. 
Risau, W. and Flamme, I. (1995). Vasculogenesis. Annu. Rev. Cell Dev. Biol. 11, 73–91. 
Risau, W. and Lemmon, V. (1988). Changes in the vascular extracellular matrix during embryonic vasculogenesis and 
angiogenesis. Dev. Biol. 125, 441–450. 
Riveline, D., Zamir, E., Balaban, N. Q., Schwarz, U. S., Ishizaki, T., Narumiya, S., Kam, Z., Geiger, B. and 
Bershadsky, A. D. (2001). Focal contacts as mechanosensors: externally applied local mechanical force induces 
growth of focal contacts by an mDia1-dependent and ROCK-independent mechanism. J. Cell Biol. 153, 1175–1186. 
Roberts, A. B., Sporn, M. B., Assoian, R. K., Smith, J. M., Roche, N. S., Wakefield, L. M., Heine, U. I., Liotta, L. A., 
Falanga, V. and Kehrl, J. H. (1986). Transforming growth factor type beta: rapid induction of fibrosis and 
angiogenesis in vivo and stimulation of collagen formation in vitro. Proc. Natl. Acad. Sci. U. S. A. 83, 4167–4171. 
Roca, C. and Adams, R. H. (2007). Regulation of vascular morphogenesis by Notch signaling. Genes Dev. 21, 2511–2524. 
Rodriguez-Manzaneque, J. C., Lane, T. F., Ortega, M. A., Hynes, R. O., Lawler, J. and Iruela-Arispe, M. L. (2001). 
Thrombospondin-1 suppresses spontaneous tumor growth and inhibits activation of matrix metalloproteinase-9 
and mobilization of vascular endothelial growth factor. Proc. Natl. Acad. Sci. U. S. A. 98, 12485–12490. 
Roman, J. and McDonald, J. A. (1992). Expression of fibronectin, the integrin alpha 5, and alpha-smooth muscle actin in 
heart and lung development. Am. J. Respir. Cell Mol. Biol. 6, 472–480. 
Roman, J. and McDonald, J. A. (1993). Fibulin’s organization into the extracellular matrix of fetal lung fibroblasts is 
dependent on fibronectin matrix assembly. Am. J. Respir. Cell Mol. Biol. 8, 538–545. 
Roovers, K., Davey, G., Zhu, X., Bottazzi, M. E. and Assoian, R. K. (1999). Alpha5beta1 integrin controls cyclin D1 
expression by sustaining mitogen-activated protein kinase activity in growth factor-treated cells. Mol. Biol. Cell 10, 
3197–3204. 
Rossant, J. and Cross, J. C. (2001). Placental development: lessons from mouse mutants. Nat. Rev. Genet. 2, 538–548. 
Rucker, H. K., Wynder, H. J. and Thomas, W. E. (2000). Cellular mechanisms of CNS pericytes. Brain Res. Bull. 51, 363–
369. 
Ruhrberg, C. (2003). Growing and shaping the vascular tree: multiple roles for VEGF. BioEssays News Rev. Mol. Cell. Dev. 
Biol. 25, 1052–1060. 
Ruhrberg, C., Gerhardt, H., Golding, M., Watson, R., Ioannidou, S., Fujisawa, H., Betsholtz, C. and Shima, D. T. 
(2002). Spatially restricted patterning cues provided by heparin-binding VEGF-A control blood vessel branching 
morphogenesis. Genes Dev. 16, 2684–2698. 
Sabatier, L., Chen, D., Fagotto-Kaufmann, C., Hubmacher, D., McKee, M. D., Annis, D. S., Mosher, D. F. and 
Reinhardt, D. P. (2009). Fibrillin Assembly Requires Fibronectin. Mol. Biol. Cell 20, 846–858. 
Saga, Y., Yagi, T., Ikawa, Y., Sakakura, T. and Aizawa, S. (1992). Mice develop normally without tenascin. Genes Dev. 6, 
1821–1831. 
Saharinen, J. and Keski-Oja, J. (2000). Specific sequence motif of 8-Cys repeats of TGF-beta binding proteins, LTBPs, 
creates a hydrophobic interaction surface for binding of small latent TGF-beta. Mol. Biol. Cell 11, 2691–2704. 
Saharinen, J., Taipale, J. and Keski-Oja, J. (1996). Association of the small latent transforming growth factor-beta with an 
eight cysteine repeat of its binding protein LTBP-1. EMBO J. 15, 245–253. 
Sakai, T., Johnson, K. J., Murozono, M., Sakai, K., Magnuson, M. A., Wieloch, T., Cronberg, T., Isshiki, A., 
Erickson, H. P. and Fässler, R. (2001). Plasma fibronectin supports neuronal survival and reduces brain injury 
following transient focal cerebral ischemia but is not essential for skin-wound healing and hemostasis. Nat. Med. 7, 
324–330. 
Sakai, T., Larsen, M. and Yamada, K. M. (2003). Fibronectin requirement in branching morphogenesis. Nature 423, 876–
881. 
PhD Thesis - Josefine Gibson  References 
 
 159 
Saltel, F., Mortier, E., Hytönen, V. P., Jacquier, M.-C., Zimmermann, P., Vogel, V., Liu, W. and Wehrle-Haller, B. 
(2009). New PI(4,5)P2- and membrane proximal integrin-binding motifs in the talin head control beta3-integrin 
clustering. J. Cell Biol. 187, 715–731. 
Sanders, E. J. (1982). Ultrastructural immunocytochemical localization of fibronectin in the early chick embryo. J. Embryol. 
Exp. Morphol. 71, 155–170. 
Sanford, L. P., Ormsby, I., Gittenberger-de Groot, A. C., Sariola, H., Friedman, R., Boivin, G. P., Cardell, E. L. and 
Doetschman, T. (1997). TGFbeta2 knockout mice have multiple developmental defects that are non-overlapping 
with other TGFbeta knockout phenotypes. Dev. Camb. Engl. 124, 2659–2670. 
Sato and Rifkin, D. B. (1989). Inhibition of endothelial cell movement by pericytes and smooth muscle cells: activation of a 
latent transforming growth factor-beta 1-like molecule by plasmin during co-culture. J. Cell Biol. 109, 309–315. 
Sato, Y., Tsuboi, R., Lyons, R., Moses, H. and Rifkin, D. B. (1990). Characterization of the activation of latent TGF-
beta by co-cultures of endothelial cells and pericytes or smooth muscle cells: a self-regulating system. J. Cell Biol. 
111, 757–763. 
Saunders, S. and Bernfield, M. (1988). Cell surface proteoglycan binds mouse mammary epithelial cells to fibronectin and 
behaves as a receptor for interstitial matrix. J. Cell Biol. 106, 423–430. 
Savolainen, S. M., Foley, J. F. and Elmore, S. A. (2009). Histology atlas of the developing mouse heart with emphasis on 
E11.5 to E18.5. Toxicol. Pathol. 37, 395–414. 
Sawdey, M., Podor, T. J. and Loskutoff, D. J. (1989). Regulation of type 1 plasminogen activator inhibitor gene expression 
in cultured bovine aortic endothelial cells. Induction by transforming growth factor-beta, lipopolysaccharide, and 
tumor necrosis factor-alpha. J. Biol. Chem. 264, 10396–10401. 
Schaller, M. D., Hildebrand, J. D., Shannon, J. D., Fox, J. W., Vines, R. R. and Parsons, J. T. (1994). 
Autophosphorylation of the focal adhesion kinase, pp125FAK, directs SH2-dependent binding of pp60src. Mol. 
Cell. Biol. 14, 1680–1688. 
Scharffetter-Kochanek, K., Lu, H., Norman, K., van Nood, N., Munoz, F., Grabbe, S., McArthur, M., Lorenzo, I., 
Kaplan, S., Ley, K., et al. (1998). Spontaneous skin ulceration and defective T cell function in CD18 null mice. J. 
Exp. Med. 188, 119–131. 
Schiefner, A., Gebauer, M. and Skerra, A. (2012). Extra-domain B in oncofetal fibronectin structurally promotes fibrillar 
head-to-tail dimerization of extracellular matrix protein. J. Biol. Chem. 287, 17578–17588. 
Schiller, H. B. and Fässler, R. (2013). Mechanosensitivity and compositional dynamics of cell-matrix adhesions. EMBO 
Rep. 14, 509–519. 
Schlaepfer, D. D., Hanks, S. K., Hunter, T. and van der Geer, P. (1994). Integrin-mediated signal transduction linked to 
Ras pathway by GRB2 binding to focal adhesion kinase. Nature 372, 786–791. 
Schmits, R., Kündig, T. M., Baker, D. M., Shumaker, G., Simard, J. J., Duncan, G., Wakeham, A., Shahinian, A., 
van der Heiden, A., Bachmann, M. F., et al. (1996). LFA-1-deficient mice show normal CTL responses to virus 
but fail to reject immunogenic tumor. J. Exp. Med. 183, 1415–1426. 
Schneider, A., Zhang, Y., Guan, Y., Davis, L. S. and Breyer, M. D. (2003). Differential, inducible gene targeting in renal 
epithelia, vascular endothelium, and viscera of Mx1Cre mice. Am. J. Physiol. Renal Physiol. 284, F411–417. 
Schön, M. P., Arya, A., Murphy, E. A., Adams, C. M., Strauch, U. G., Agace, W. W., Marsal, J., Donohue, J. P., Her, 
H., Beier, D. R., et al. (1999). Mucosal T lymphocyte numbers are selectively reduced in integrin alpha E 
(CD103)-deficient mice. J. Immunol. Baltim. Md 1950 162, 6641–6649. 
Schwarz-Linek, U., Höök, M. and Potts, J. R. (2006). Fibronectin-binding proteins of gram-positive cocci. Microbes Infect. 
Inst. Pasteur 8, 2291–2298. 
Schwarzbauer, J. E. (1991). Identification of the fibronectin sequences required for assembly of a fibrillar matrix. J. Cell Biol. 
113, 1463–1473. 
Schwarzbauer, J. E. and DeSimone, D. W. (2011). Fibronectins, their fibrillogenesis, and in vivo functions. Cold Spring 
Harb. Perspect. Biol. 3,. 
Schwarzbauer, J. E., Tamkun, J. W., Lemischka, I. R. and Hynes, R. O. (1983). Three different fibronectin mRNAs 
arise by alternative splicing within the coding region. Cell 35, 421–431. 
PhD Thesis - Josefine Gibson  References 
 
 160 
Schwarzbauer, J. E., Patel, R. S., Fonda, D. and Hynes, R. O. (1987). Multiple sites of alternative splicing of the rat 
fibronectin gene transcript. EMBO J. 6, 2573–2580. 
Sechler, J. L., Corbett, S. A. and Schwarzbauer, J. E. (1997). Modulatory roles for integrin activation and the synergy site 
of fibronectin during matrix assembly. Mol. Biol. Cell 8, 2563–2573. 
Sechler, J. L., Cumiskey, A. M., Gazzola, D. M. and Schwarzbauer, J. E. (2000). A novel RGD-independent fibronectin 
assembly pathway initiated by alpha4beta1 integrin binding to the alternatively spliced V region. J. Cell Sci. 113 ( Pt 
8), 1491–1498. 
Sechler, J. L., Rao, H., Cumiskey, A. M., Vega-Colón, I., Smith, M. S., Murata, T. and Schwarzbauer, J. E. (2001). A 
novel fibronectin binding site required for fibronectin fibril growth during matrix assembly. J. Cell Biol. 154, 1081–
1088. 
Seki, T., Hong, K.-H. and Oh, S. P. (2006). Nonoverlapping expression patterns of ALK1 and ALK5 reveal distinct roles 
of each receptor in vascular development. Lab. Investig. J. Tech. Methods Pathol. 86, 116–129. 
Sengbusch, J. K., He, W., Pinco, K. A. and Yang, J. T. (2002). Dual functions of [alpha]4[beta]1 integrin in epicardial 
development: initial migration and long-term attachment. J. Cell Biol. 157, 873–882. 
Senger, D. R., Perruzzi, C. A., Streit, M., Koteliansky, V. E., de Fougerolles, A. R. and Detmar, M. (2002). The 
alpha(1)beta(1) and alpha(2)beta(1) integrins provide critical support for vascular endothelial growth factor 
signaling, endothelial cell migration, and tumor angiogenesis. Am. J. Pathol. 160, 195–204. 
Shattil, S. J., Kim, C. and Ginsberg, M. H. (2010). The final steps of integrin activation: the end game. Nat. Rev. Mol. Cell 
Biol. 11, 288–300. 
Shepro, D. and Morel, N. M. (1993). Pericyte physiology. FASEB J. Off. Publ. Fed. Am. Soc. Exp. Biol. 7, 1031–1038. 
Shi, Q. and Boettiger, D. (2003). A novel mode for integrin-mediated signaling: tethering is required for phosphorylation of 
FAK Y397. Mol. Biol. Cell 14, 4306–4315. 
Shi, X., Ma, Y.-Q., Tu, Y., Chen, K., Wu, S., Fukuda, K., Qin, J., Plow, E. F. and Wu, C. (2007). The MIG-2/integrin 
interaction strengthens cell-matrix adhesion and modulates cell motility. J. Biol. Chem. 282, 20455–20466. 
Shier, P., Otulakowski, G., Ngo, K., Panakos, J., Chourmouzis, E., Christjansen, L., Lau, C. Y. and Fung-Leung, 
W. P. (1996). Impaired immune responses toward alloantigens and tumor cells but normal thymic selection in mice 
deficient in the beta2 integrin leukocyte function-associated antigen-1. J. Immunol. Baltim. Md 1950 157, 5375–5386. 
Shinde, A. V., Bystroff, C., Wang, C., Vogelezang, M. G., Vincent, P. A., Hynes, R. O. and Van De Water, L. (2008). 
Identification of the peptide sequences within the EIIIA (EDA) segment of fibronectin that mediate integrin 
alpha9beta1-dependent cellular activities. J. Biol. Chem. 283, 2858–2870. 
Short, S. M., Talbott, G. A. and Juliano, R. L. (1998). Integrin-mediated signaling events in human endothelial cells. Mol. 
Biol. Cell 9, 1969–1980. 
Shull, M. M., Ormsby, I., Kier, A. B., Pawlowski, S., Diebold, R. J., Yin, M., Allen, R., Sidman, C., Proetzel, G. and 
Calvin, D. (1992). Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal 
inflammatory disease. Nature 359, 693–699. 
Siekmann, A. F. and Lawson, N. D. (2007). Notch signalling limits angiogenic cell behaviour in developing zebrafish 
arteries. Nature 445, 781–784. 
Singh, P., Carraher, C. and Schwarzbauer, J. E. (2010). Assembly of fibronectin extracellular matrix. Annu. Rev. Cell Dev. 
Biol. 26, 397–419. 
Sinha, S. (2004). Transforming growth factor- 1 signaling contributes to development of smooth muscle cells from 
embryonic stem cells. AJP Cell Physiol. 287, C1560–C1568. 
Slack-Davis, J. K., Eblen, S. T., Zecevic, M., Boerner, S. A., Tarcsafalvi, A., Diaz, H. B., Marshall, M. S., Weber, M. 
J., Parsons, J. T. and Catling, A. D. (2003). PAK1 phosphorylation of MEK1 regulates fibronectin-stimulated 
MAPK activation. J. Cell Biol. 162, 281–291. 
Smith, M. L., Gourdon, D., Little, W. C., Kubow, K. E., Eguiluz, R. A., Luna-Morris, S. and Vogel, V. (2007). Force-
induced unfolding of fibronectin in the extracellular matrix of living cells. PLoS Biol. 5, e268. 
Snow, C. J., Peterson, M. T., Khalil, A. and Henry, C. A. (2008). Muscle development is disrupted in zebrafish embryos 
deficient for fibronectin. Dev. Dyn. Off. Publ. Am. Assoc. Anat. 237, 2542–2553. 
PhD Thesis - Josefine Gibson  References 
 
 161 
Soldi, R., Mitola, S., Strasly, M., Defilippi, P., Tarone, G. and Bussolino, F. (1999). Role of alphavbeta3 integrin in the 
activation of vascular endothelial growth factor receptor-2. EMBO J. 18, 882–892. 
Solloway, M. J. and Harvey, R. P. (2003). Molecular pathways in myocardial development: a stem cell perspective. 
Cardiovasc. Res. 58, 264–277. 
Sottile, J. and Hocking, D. C. (2002). Fibronectin polymerization regulates the composition and stability of extracellular 
matrix fibrils and cell-matrix adhesions. Mol. Biol. Cell 13, 3546–3559. 
Sridurongrit, S., Larsson, J., Schwartz, R., Ruiz-Lozano, P. and Kaartinen, V. (2008). Signaling via the Tgf-beta type I 
receptor Alk5 in heart development. Dev. Biol. 322, 208–218. 
Stenvers, K. L., Tursky, M. L., Harder, K. W., Kountouri, N., Amatayakul-Chantler, S., Grail, D., Small, C., 
Weinberg, R. A., Sizeland, A. M. and Zhu, H.-J. (2003). Heart and liver defects and reduced transforming 
growth factor beta2 sensitivity in transforming growth factor beta type III receptor-deficient embryos. Mol. Cell. 
Biol. 23, 4371–4385. 
Stenzel, D., Lundkvist, A., Sauvaget, D., Busse, M., Graupera, M., van der Flier, A., Wijelath, E. S., Murray, J., 
Sobel, M., Costell, M., et al. (2011). Integrin-dependent and -independent functions of astrocytic fibronectin in 
retinal angiogenesis. Dev. Camb. Engl. 138, 4451–4463. 
Stephens, L. E., Sutherland, A. E., Klimanskaya, I. V., Andrieux, A., Meneses, J., Pedersen, R. A. and Damsky, C. 
H. (1995). Deletion of beta 1 integrins in mice results in inner cell mass failure and peri-implantation lethality. Genes 
Dev. 9, 1883–1895. 
Stone, J., Itin, A., Alon, T., Pe’er, J., Gnessin, H., Chan-Ling, T. and Keshet, E. (1995). Development of retinal 
vasculature is mediated by hypoxia-induced vascular endothelial growth factor (VEGF) expression by neuroglia. J. 
Neurosci. Off. J. Soc. Neurosci. 15, 4738–4747. 
Stratman, A. N., Malotte, K. M., Mahan, R. D., Davis, M. J. and Davis, G. E. (2009). Pericyte recruitment during 
vasculogenic tube assembly stimulates endothelial basement membrane matrix formation. Blood 114, 5091–5101. 
Stricker, J., Beckham, Y., Davidson, M. W. and Gardel, M. L. (2013). Myosin II-mediated focal adhesion maturation is 
tension insensitive. PloS One 8, e70652. 
Strilić, B., Kucera, T., Eglinger, J., Hughes, M. R., McNagny, K. M., Tsukita, S., Dejana, E., Ferrara, N. and 
Lammert, E. (2009). The molecular basis of vascular lumen formation in the developing mouse aorta. Dev. Cell 17, 
505–515. 
Strilić, B., Eglinger, J., Krieg, M., Zeeb, M., Axnick, J., Babál, P., Müller, D. J. and Lammert, E. (2010). Electrostatic 
cell-surface repulsion initiates lumen formation in developing blood vessels. Curr. Biol. CB 20, 2003–2009. 
Strömblad, S., Becker, J. C., Yebra, M., Brooks, P. C. and Cheresh, D. A. (1996). Suppression of p53 activity and 
p21WAF1/CIP1 expression by vascular cell integrin alphaVbeta3 during angiogenesis. J. Clin. Invest. 98, 426–433. 
Suchting, S., Freitas, C., le Noble, F., Benedito, R., Bréant, C., Duarte, A. and Eichmann, A. (2007). The Notch 
ligand Delta-like 4 negatively regulates endothelial tip cell formation and vessel branching. Proc. Natl. Acad. Sci. U. S. 
A. 104, 3225–3230. 
Sundberg, C. and Rubin, K. (1996). Stimulation of beta1 integrins on fibroblasts induces PDGF independent tyrosine 
phosphorylation of PDGF beta-receptors. J. Cell Biol. 132, 741–752. 
Suzuki, A. and Ohno, S. (2006). The PAR-aPKC system: lessons in polarity. J. Cell Sci. 119, 979–987. 
Taber, L. A., Voronov, D. A. and Ramasubramanian, A. (2010). The role of mechanical forces in the torsional 
component of cardiac looping. Ann. N. Y. Acad. Sci. 1188, 103–110. 
Taipale, J. and Keski-Oja, J. (1997). Growth factors in the extracellular matrix. FASEB J. Off. Publ. Fed. Am. Soc. Exp. Biol. 
11, 51–59. 
Taipale, J., Keski-Oja, J., Miyazono, K. and Heldin, C. H. (1994). Latent transforming growth factor-beta 1 associates to 
fibroblast extracellular matrix via latent TGF-beta binding protein. J. Cell Biol. 124, 171–181. 
Taipale, J., Saharinen, J., Hedman, K. and Keski-Oja, J. (1996). Latent transforming growth factor-beta 1 and its binding 
protein are components of extracellular matrix microfibrils. J. Histochem. Cytochem. Off. J. Histochem. Soc. 44, 875–889. 
PhD Thesis - Josefine Gibson  References 
 
 162 
Taipale, J., Saharinen, J. and Keski-Oja, J. (1998). Extracellular matrix-associated transforming growth factor-beta: role in 
cancer cell growth and invasion. Adv. Cancer Res. 75, 87–134. 
Takagi, J., Strokovich, K., Springer, T. A. and Walz, T. (2003). Structure of integrin alpha5beta1 in complex with 
fibronectin. EMBO J. 22, 4607–4615. 
Takahashi, S., Leiss, M., Moser, M., Ohashi, T., Kitao, T., Heckmann, D., Pfeifer, A., Kessler, H., Takagi, J., 
Erickson, H. P., et al. (2007). The RGD motif in fibronectin is essential for development but dispensable for 
fibril assembly. J. Cell Biol. 178, 167–178. 
Tam, P. P., Parameswaran, M., Kinder, S. J. and Weinberger, R. P. (1997). The allocation of epiblast cells to the 
embryonic heart and other mesodermal lineages: the role of ingression and tissue movement during gastrulation. 
Dev. Camb. Engl. 124, 1631–1642. 
Tan, M. H., Sun, Z., Opitz, S. L., Schmidt, T. E., Peters, J. H. and George, E. L. (2004). Deletion of the alternatively 
spliced fibronectin EIIIA domain in mice reduces atherosclerosis. Blood 104, 11–18. 
Tanaka, M., Chen, Z., Bartunkova, S., Yamasaki, N. and Izumo, S. (1999). The cardiac homeobox gene Csx/Nkx2.5 
lies genetically upstream of multiple genes essential for heart development. Dev. Camb. Engl. 126, 1269–1280. 
Tanjore, H., Zeisberg, E. M., Gerami-Naini, B. and Kalluri, R. (2008). Beta1 integrin expression on endothelial cells is 
required for angiogenesis but not for vasculogenesis. Dev. Dyn. Off. Publ. Am. Assoc. Anat. 237, 75–82. 
Tarui, T., Miles, L. A. and Takada, Y. (2001). Specific interaction of angiostatin with integrin alpha(v)beta(3) in endothelial 
cells. J. Biol. Chem. 276, 39562–39568. 
Ten Dijke, P. and Arthur, H. M. (2007). Extracellular control of TGF[beta] signalling in vascular development and disease. 
Nat Rev Mol Cell Biol 8, 857–869. 
Thibault, G., Lacombe, M. J., Schnapp, L. M., Lacasse, A., Bouzeghrane, F. and Lapalme, G. (2001). Upregulation of 
alpha(8)beta(1)-integrin in cardiac fibroblast by angiotensin II and transforming growth factor-beta1. Am. J. Physiol. 
Cell Physiol. 281, C1457–1467. 
Thomas, J. W., Ellis, B., Boerner, R. J., Knight, W. B., White, G. C., 2nd and Schaller, M. D. (1998). SH2- and SH3-
mediated interactions between focal adhesion kinase and Src. J. Biol. Chem. 273, 577–583. 
Tilghman, R. W. and Parsons, J. T. (2008). Focal adhesion kinase as a regulator of cell tension in the progression of 
cancer. Semin. Cancer Biol. 18, 45–52. 
Tomasini-Johansson, B. R., Kaufman, N. R., Ensenberger, M. G., Ozeri, V., Hanski, E. and Mosher, D. F. (2001). A 
49-residue peptide from adhesin F1 of Streptococcus pyogenes inhibits fibronectin matrix assembly. J. Biol. Chem. 
276, 23430–23439. 
Topper, J. N. and Gimbrone, M. A., Jr (1999). Blood flow and vascular gene expression: fluid shear stress as a modulator 
of endothelial phenotype. Mol. Med. Today 5, 40–46. 
Totsukawa, G., Yamakita, Y., Yamashiro, S., Hartshorne, D. J., Sasaki, Y. and Matsumura, F. (2000). Distinct roles 
of ROCK (Rho-kinase) and MLCK in spatial regulation of MLC phosphorylation for assembly of stress fibers and 
focal adhesions in 3T3 fibroblasts. J. Cell Biol. 150, 797–806. 
Treisman, R. (1996). Regulation of transcription by MAP kinase cascades. Curr. Opin. Cell Biol. 8, 205–215. 
Trinh, L. A. and Stainier, D. Y. R. (2004a). Cardiac development. Methods Cell Biol. 76, 455–473. 
Trinh, L. A. and Stainier, D. Y. . (2004b). Fibronectin Regulates Epithelial Organization during Myocardial Migration in 
Zebrafish. Dev. Cell 6, 371–382. 
Tronik-Le Roux, D., Roullot, V., Poujol, C., Kortulewski, T., Nurden, P. and Marguerie, G. (2000). Thrombasthenic 
mice generated by replacement of the integrin alpha(IIb) gene: demonstration that transcriptional activation of this 
megakaryocytic locus precedes lineage commitment. Blood 96, 1399–1408. 
Tsyguelnaia, I. and Doolittle, R. F. (1998). Presence of a fibronectin type III domain in a plant protein. J. Mol. Evol. 46, 
612–614. 
Tu, Y., Wu, S., Shi, X., Chen, K. and Wu, C. (2003). Migfilin and Mig-2 link focal adhesions to filamin and the actin 
cytoskeleton and function in cell shape modulation. Cell 113, 37–47. 
PhD Thesis - Josefine Gibson  References 
 
 163 
Turlo, K. A., Noel, O. D. V., Vora, R., LaRussa, M., Fassler, R., Hall-Glenn, F. and Iruela-Arispe, M. L. (2012). An 
essential requirement for β1 integrin in the assembly of extracellular matrix proteins within the vascular wall. Dev. 
Biol. 365, 23–35. 
Uemura, A., Kusuhara, S., Wiegand, S. J., Yu, R. T. and Nishikawa, S. (2006). Tlx acts as a proangiogenic switch by 
regulating extracellular assembly of fibronectin matrices in retinal astrocytes. J. Clin. Invest. 116, 369–377. 
Unsöld, C., Hyytiäinen, M., Bruckner-Tuderman, L. and Keski-Oja, J. (2001). Latent TGF-beta binding protein LTBP-
1 contains three potential extracellular matrix interacting domains. J. Cell Sci. 114, 187–197. 
Ussar, S., Moser, M., Widmaier, M., Rognoni, E., Harrer, C., Genzel-Boroviczeny, O. and Fässler, R. (2008). Loss of 
Kindlin-1 causes skin atrophy and lethal neonatal intestinal epithelial dysfunction. PLoS Genet. 4, e1000289. 
Van der Flier, A., Badu-Nkansah, K., Whittaker, C. A., Crowley, D., Bronson, R. T., Lacy-Hulbert, A. and Hynes, 
R. O. (2010). Endothelial alpha5 and alphav integrins cooperate in remodeling of the vasculature during 
development. Dev. Camb. Engl. 137, 2439–2449. 
Van der Neut, R., Krimpenfort, P., Calafat, J., Niessen, C. M. and Sonnenberg, A. (1996). Epithelial detachment due to 
absence of hemidesmosomes in integrin beta 4 null mice. Nat. Genet. 13, 366–369. 
Van Vliet, A., Baelde, H. J., Vleming, L. J., de Heer, E. and Bruijn, J. A. (2001). Distribution of fibronectin isoforms in 
human renal disease. J. Pathol. 193, 256–262. 
Vanhaesebroeck, B. and Alessi, D. R. (2000). The PI3K-PDK1 connection: more than just a road to PKB. Biochem. J. 346 
Pt 3, 561–576. 
Vehviläinen, P., Hyytiäinen, M. and Keski-Oja, J. (2009). Matrix association of latent TGF-beta binding protein-2 
(LTBP-2) is dependent on fibrillin-1. J. Cell. Physiol. 221, 586–593. 
Velling, T., Risteli, J., Wennerberg, K., Mosher, D. F. and Johansson, S. (2002). Polymerization of Type I and III 
Collagens Is Dependent On Fibronectin and Enhanced By Integrins α11β1and α2β1. J. Biol. Chem. 277, 37377–
37381. 
Venters, S. J., Thorsteinsdóttir, S. and Duxson, M. J. (1999). Early development of the myotome in the mouse. Dev. Dyn. 
Off. Publ. Am. Assoc. Anat. 216, 219–232. 
Villa, A., Trachsel, E., Kaspar, M., Schliemann, C., Sommavilla, R., Rybak, J.-N., Rösli, C., Borsi, L. and Neri, D. 
(2008). A high-affinity human monoclonal antibody specific to the alternatively spliced EDA domain of fibronectin 
efficiently targets tumor neo-vasculature in vivo. Int. J. Cancer J. Int. Cancer 122, 2405–2413. 
Vinogradova, O., Haas, T., Plow, E. F. and Qin, J. (2000). A structural basis for integrin activation by the cytoplasmic tail 
of the alpha IIb-subunit. Proc. Natl. Acad. Sci. U. S. A. 97, 1450–1455. 
Vinogradova, O., Velyvis, A., Velyviene, A., Hu, B., Haas, T., Plow, E. and Qin, J. (2002). A structural mechanism of 
integrin alpha(IIb)beta(3) “inside-out” activation as regulated by its cytoplasmic face. Cell 110, 587–597. 
Vlahakis, N. E., Young, B. A., Atakilit, A. and Sheppard, D. (2005). The lymphangiogenic vascular endothelial growth 
factors VEGF-C and -D are ligands for the integrin alpha9beta1. J. Biol. Chem. 280, 4544–4552. 
Vrancken Peeters, M. P., Gittenberger-de Groot, A. C., Mentink, M. M. and Poelmann, R. E. (1999). Smooth muscle 
cells and fibroblasts of the coronary arteries derive from epithelial-mesenchymal transformation of the epicardium. 
Anat. Embryol. (Berl.) 199, 367–378. 
Wacker, A. and Gerhardt, H. (2011). Endothelial development taking shape. Curr. Opin. Cell Biol. 23, 676–685. 
Wagner, N., Löhler, J., Kunkel, E. J., Ley, K., Leung, E., Krissansen, G., Rajewsky, K. and Müller, W. (1996). Critical 
role for beta7 integrins in formation of the gut-associated lymphoid tissue. Nature 382, 366–370. 
Walker, J. L., Fournier, A. K. and Assoian, R. K. (2005). Regulation of growth factor signaling and cell cycle progression 
by cell adhesion and adhesion-dependent changes in cellular tension. Cytokine Growth Factor Rev. 16, 395–405. 
Wang, H. B., Dembo, M., Hanks, S. K. and Wang, Y. (2001a). Focal adhesion kinase is involved in mechanosensing 
during fibroblast migration. Proc. Natl. Acad. Sci. U. S. A. 98, 11295–11300. 
Wang, J. F., Zhang, X. F. and Groopman, J. E. (2001b). Stimulation of beta 1 integrin induces tyrosine phosphorylation 
of vascular endothelial growth factor receptor-3 and modulates cell migration. J. Biol. Chem. 276, 41950–41957. 
PhD Thesis - Josefine Gibson  References 
 
 164 
Wang, Y., Kaiser, M. S., Larson, J. D., Nasevicius, A., Clark, K. J., Wadman, S. A., Roberg-Perez, S. E., Ekker, S. 
C., Hackett, P. B., McGrail, M., et al. (2010). Moesin1 and Ve-cadherin are required in endothelial cells during 
in vivo tubulogenesis. Dev. Camb. Engl. 137, 3119–3128. 
Watanabe, N., Kato, T., Fujita, A., Ishizaki, T. and Narumiya, S. (1999). Cooperation between mDia1 and ROCK in 
Rho-induced actin reorganization. Nat. Cell Biol. 1, 136–143. 
Wayner, E. A., Garcia-Pardo, A., Humphries, M. J., McDonald, J. A. and Carter, W. G. (1989). Identification and 
characterization of the T lymphocyte adhesion receptor for an alternative cell attachment domain (CS-1) in plasma 
fibronectin. J. Cell Biol. 109, 1321–1330. 
Webb, S., Brown, N. A. and Anderson, R. H. (1998). Formation of the atrioventricular septal structures in the normal 
mouse. Circ. Res. 82, 645–656. 
Webb, D. J., Donais, K., Whitmore, L. A., Thomas, S. M., Turner, C. E., Parsons, J. T. and Horwitz, A. F. (2004). 
FAK-Src signalling through paxillin, ERK and MLCK regulates adhesion disassembly. Nat. Cell Biol. 6, 154–161. 
Weinacker, A., Chen, A., Agrez, M., Cone, R. I., Nishimura, S., Wayner, E., Pytela, R. and Sheppard, D. (1994). Role 
of the integrin alpha v beta 6 in cell attachment to fibronectin. Heterologous expression of intact and secreted 
forms of the receptor. J. Biol. Chem. 269, 6940–6948. 
Wennerberg, K., Lohikangas, L., Gullberg, D., Pfaff, M., Johansson, S. and Fässler, R. (1996). Beta 1 integrin-
dependent and -independent polymerization of fibronectin. J. Cell Biol. 132, 227–238. 
Wickström, S. A., Lange, A., Montanez, E. and Fässler, R. (2010). The ILK/PINCH/parvin complex: the kinase is dead, 
long live the pseudokinase! EMBO J. 29, 281–291. 
Wierzbicka-Patynowski, I. and Schwarzbauer, J. E. (2002). Regulatory role for SRC and phosphatidylinositol 3-kinase in 
initiation of fibronectin matrix assembly. J. Biol. Chem. 277, 19703–19708. 
Wierzbicka-Patynowski, I., Mao, Y. and Schwarzbauer, J. E. (2007). Continuous requirement for pp60-Src and 
phospho-paxillin during fibronectin matrix assembly by transformed cells. J. Cell. Physiol. 210, 750–756. 
Wijelath, E. S., Murray, J., Rahman, S., Patel, Y., Ishida, A., Strand, K., Aziz, S., Cardona, C., Hammond, W. P., 
Savidge, G. F., et al. (2002). Novel vascular endothelial growth factor binding domains of fibronectin enhance 
vascular endothelial growth factor biological activity. Circ. Res. 91, 25–31. 
Wijelath, E. S., Rahman, S., Namekata, M., Murray, J., Nishimura, T., Mostafavi-Pour, Z., Patel, Y., Suda, Y., 
Humphries, M. J. and Sobel, M. (2006). Heparin-II domain of fibronectin is a vascular endothelial growth 
factor-binding domain: enhancement of VEGF biological activity by a singular growth factor/matrix protein 
synergism. Circ. Res. 99, 853–860. 
Winklbauer, R. and Keller, R. E. (1996). Fibronectin, mesoderm migration, and gastrulation in Xenopus. Dev. Biol. 177, 
413–426. 
Wipff, P.-J. and Hinz, B. (2008). Integrins and the activation of latent transforming growth factor beta1 - an intimate 
relationship. Eur. J. Cell Biol. 87, 601–615. 
Wipff, P.-J., Rifkin, D. B., Meister, J.-J. and Hinz, B. (2007). Myofibroblast contraction activates latent TGF-beta1 from 
the extracellular matrix. J. Cell Biol. 179, 1311–1323. 
Woods, A. and Couchman, J. R. (1998). Syndecans: synergistic activators of cell adhesion. Trends Cell Biol. 8, 189–192. 
Woods, A. and Couchman, J. R. (2001). Syndecan-4 and focal adhesion function. Curr. Opin. Cell Biol. 13, 578–583. 
Wozniak, M. A., Desai, R., Solski, P. A., Der, C. J. and Keely, P. J. (2003). ROCK-generated contractility regulates breast 
epithelial cell differentiation in response to the physical properties of a three-dimensional collagen matrix. J. Cell 
Biol. 163, 583–595. 
Wu, C., Keivens, V. M., O’Toole, T. E., McDonald, J. A. and Ginsberg, M. H. (1995). Integrin activation and 
cytoskeletal interaction are essential for the assembly of a fibronectin matrix. Cell 83, 715–724. 
Wu, C., Hughes, P. E., Ginsberg, M. H. and McDonald, J. A. (1996). Identification of a new biological function for the 
integrin alpha v beta 3: initiation of fibronectin matrix assembly. Cell Adhes. Commun. 4, 149–158. 
Wu, H., Rodgers, J. R., Perrard, X.-Y. D., Perrard, J. L., Prince, J. E., Abe, Y., Davis, B. K., Dietsch, G., Smith, C. 
W. and Ballantyne, C. M. (2004). Deficiency of CD11b or CD11d results in reduced staphylococcal enterotoxin-
induced T cell response and T cell phenotypic changes. J. Immunol. Baltim. Md 1950 173, 297–306. 
PhD Thesis - Josefine Gibson  References 
 
 165 
Wu, H., Gower, R. M., Wang, H., Perrard, X.-Y. D., Ma, R., Bullard, D. C., Burns, A. R., Paul, A., Smith, C. W., 
Simon, S. I., et al. (2009). Functional Role of CD11c+ Monocytes in Atherogenesis Associated With 
Hypercholesterolemia. Circulation 119, 2708–2717. 
Wurdak, H., Ittner, L. M., Lang, K. S., Leveen, P., Suter, U., Fischer, J. A., Karlsson, S., Born, W. and Sommer, L. 
(2005). Inactivation of TGFbeta signaling in neural crest stem cells leads to multiple defects reminiscent of 
DiGeorge syndrome. Genes Dev. 19, 530–535. 
Xiao, T., Takagi, J., Coller, B. S., Wang, J.-H. and Springer, T. A. (2004). Structural basis for allostery in integrins and 
binding to fibrinogen-mimetic therapeutics. Nature 432, 59–67. 
Xiong, J. P., Stehle, T., Diefenbach, B., Zhang, R., Dunker, R., Scott, D. L., Joachimiak, A., Goodman, S. L. and 
Arnaout, M. A. (2001). Crystal structure of the extracellular segment of integrin alpha Vbeta3. Science 294, 339–345. 
Xu, K., Sacharidou, A., Fu, S., Chong, D. C., Skaug, B., Chen, Z. J., Davis, G. E. and Cleaver, O. (2011). Blood vessel 
tubulogenesis requires Rasip1 regulation of GTPase signaling. Dev. Cell 20, 526–539. 
Yamada, K. M., Pankov, R. and Cukierman, E. (2003). Dimensions and dynamics in integrin function. Braz. J. Med. Biol. 
Res. Rev. Bras. Pesqui. Médicas E Biológicas Soc. Bras. Biofísica Al 36, 959–966. 
Yang, J. T. and Hynes, R. O. (1996). Fibronectin receptor functions in embryonic cells deficient in alpha 5 beta 1 integrin 
can be replaced by alpha V integrins. Mol. Biol. Cell 7, 1737–1748. 
Yang, J. T., Rayburn, H. and Hynes, R. O. (1993). Embryonic mesodermal defects in alpha 5 integrin-deficient mice. Dev. 
Camb. Engl. 119, 1093–1105. 
Yang, J. T., Rayburn, H. and Hynes, R. O. (1995). Cell adhesion events mediated by alpha 4 integrins are essential in 
placental and cardiac development. Dev. Camb. Engl. 121, 549–560. 
Yang, J. T., Bader, B. L., Kreidberg, J. A., Ullman-Culleré, M., Trevithick, J. E. and Hynes, R. O. (1999). 
Overlapping and independent functions of fibronectin receptor integrins in early mesodermal development. Dev. 
Biol. 215, 264–277. 
Yang, Z., Mu, Z., Dabovic, B., Jurukovski, V., Yu, D., Sung, J., Xiong, X. and Munger, J. S. (2007). Absence of 
integrin-mediated TGFbeta1 activation in vivo recapitulates the phenotype of TGFbeta1-null mice. J. Cell Biol. 176, 
787–793. 
Yeh, Y.-T., Hur, S. S., Chang, J., Wang, K.-C., Chiu, J.-J., Li, Y.-S. and Chien, S. (2012). Matrix stiffness regulates 
endothelial cell proliferation through septin 9. PloS One 7, e46889. 
Yeung, T., Georges, P. C., Flanagan, L. A., Marg, B., Ortiz, M., Funaki, M., Zahir, N., Ming, W., Weaver, V. and 
Janmey, P. A. (2005). Effects of substrate stiffness on cell morphology, cytoskeletal structure, and adhesion. Cell 
Motil. Cytoskeleton 60, 24–34. 
Yoneda, A., Multhaupt, H. A. B. and Couchman, J. R. (2005). The Rho kinases I and II regulate different aspects of 
myosin II activity. J. Cell Biol. 170, 443–453. 
Yoneda, A., Ushakov, D., Multhaupt, H. A. B. and Couchman, J. R. (2007). Fibronectin matrix assembly requires 
distinct contributions from Rho kinases I and -II. Mol. Biol. Cell 18, 66–75. 
Yoshinaga, K., Obata, H., Jurukovski, V., Mazzieri, R., Chen, Y., Zilberberg, L., Huso, D., Melamed, J., Prijatelj, 
P., Todorovic, V., et al. (2008). Perturbation of transforming growth factor (TGF)-beta1 association with latent 
TGF-beta binding protein yields inflammation and tumors. Proc. Natl. Acad. Sci. U. S. A. 105, 18758–18763. 
Yu, Q. and Stamenkovic, I. (2000). Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and 
promotes tumor invasion and angiogenesis. Genes Dev. 14, 163–176. 
Zaidel-Bar, R., Ballestrem, C., Kam, Z. and Geiger, B. (2003). Early molecular events in the assembly of matrix 
adhesions at the leading edge of migrating cells. J. Cell Sci. 116, 4605–4613. 
Zaidel-Bar, R., Cohen, M., Addadi, L. and Geiger, B. (2004). Hierarchical assembly of cell-matrix adhesion complexes. 
Biochem. Soc. Trans. 32, 416–420. 
Zaidel-Bar, R., Itzkovitz, S., Ma’ayan, A., Iyengar, R. and Geiger, B. (2007). Functional atlas of the integrin adhesome. 
Nat. Cell Biol. 9, 858–867. 
Zamir, E., Katz, M., Posen, Y., Erez, N., Yamada, K. M., Katz, B. Z., Lin, S., Lin, D. C., Bershadsky, A., Kam, Z., 
et al. (2000). Dynamics and segregation of cell-matrix adhesions in cultured fibroblasts. Nat. Cell Biol. 2, 191–196. 
PhD Thesis - Josefine Gibson  References 
 
 166 
Zamir, E. A., Srinivasan, V., Perucchio, R. and Taber, L. A. (2003). Mechanical asymmetry in the embryonic chick heart 
during looping. Ann. Biomed. Eng. 31, 1327–1336. 
Zeeb, M., Strilic, B. and Lammert, E. (2010). Resolving cell-cell junctions: lumen formation in blood vessels. Curr. Opin. 
Cell Biol. 22, 626–632. 
Zhai, J., Lin, H., Nie, Z., Wu, J., Cañete-Soler, R., Schlaepfer, W. W. and Schlaepfer, D. D. (2003). Direct interaction 
of focal adhesion kinase with p190RhoGEF. J. Biol. Chem. 278, 24865–24873. 
Zhang, Z., Morla, A. O., Vuori, K., Bauer, J. S., Juliano, R. L. and Ruoslahti, E. (1993). The alpha v beta 1 integrin 
functions as a fibronectin receptor but does not support fibronectin matrix assembly and cell migration on 
fibronectin. J. Cell Biol. 122, 235–242. 
Zhao, Q., Liu, X. and Collodi, P. (2001). Identification and characterization of a novel fibronectin in zebrafish. Exp. Cell 
Res. 268, 211–219. 
Zhou, X., Rowe, R. G., Hiraoka, N., George, J. P., Wirtz, D., Mosher, D. F., Virtanen, I., Chernousov, M. A. and 
Weiss, S. J. (2008). Fibronectin fibrillogenesis regulates three-dimensional neovessel formation. Genes Dev. 22, 
1231–1243. 
Zhu, J., Motejlek, K., Wang, D., Zang, K., Schmidt, A. and Reichardt, L. F. (2002). beta8 integrins are required for 
vascular morphogenesis in mouse embryos. Dev. Camb. Engl. 129, 2891–2903. 
Zhu, J., Boylan, B., Luo, B.-H., Newman, P. J. and Springer, T. A. (2007). Tests of the extension and deadbolt models 
of integrin activation. J. Biol. Chem. 282, 11914–11920. 
Zilberberg, L., Todorovic, V., Dabovic, B., Horiguchi, M., Couroussé, T., Sakai, L. Y. and Rifkin, D. B. (2012). 
Specificity of latent TGF-ß binding protein (LTBP) incorporation into matrix: role of fibrillins and fibronectin. J. 
Cell. Physiol. 
Zou, L., Cao, S., Kang, N., Huebert, R. C. and Shah, V. H. (2012). Fibronectin Induces Endothelial Cell Migration 
through 1 Integrin and Src-dependent Phosphorylation of Fibroblast Growth Factor Receptor-1 at Tyrosines 
653/654 and 766. J. Biol. Chem. 287, 7190–7202. 
Zovein, A. C., Luque, A., Turlo, K. A., Hofmann, J. J., Yee, K. M., Becker, M. S., Fassler, R., Mellman, I., Lane, T. 
F. and Iruela-Arispe, M. L. (2010). Beta1 integrin establishes endothelial cell polarity and arteriolar lumen 
formation via a Par3-dependent mechanism. Dev. Cell 18, 39–51. 
 
 
PhD Thesis - Josefine Gibson  Acknowledgements 
 
 167 
11 ACKNOWLEDGEMENTS 
 
I am deeply grateful to the following people: 
 
Prof. Dr. Reinhard Fässler, for supervising and mentoring me through the world of integrins and 
extracellular matrix. 
 
My Thesis Advisory Committee members, Prof. Dr. Hellmut Augustin and Prof. Dr. Cord 
Brakebusch, for attending annual meetings with me and providing their constructive critisism of my 
work within the TAC framework. 
 
Prof. Dr. Angelika Vollmar, for her willingness to stand as my second Gutachter and Prof. Dr. 
Stefan Zahler, Prof. Dr. Martin Biel, Prof. Dr. Christian Wahl-Schott and Prof. Dr. Karl-Peter 
Hopfner for making the time and effort to join my examination board. 
 
Dr. Michael Leiss, for his support in transitioning me into this project and providing data.  
 
Dr. Eloi Montañez Miralles, for guiding me through my first steps in embryo stainings. 
 
Prof. Dr. An Zwijsen and Michael Staring, for hosting me at the VIB in Leuven, teaching me the 
art of embryo histology and sharing valuable protocols. 
 
Dr. Julian Polleux and Dr. Kyle Legate, for support in preparing for and performing AFM. 
 
Dr. Armin Lambacher, for his brilliant touch with computers and microscopes.  
 
Mrs. Ines Lach-Kusevic, for her openness and her kindness in assistance with paperwork and 
translations. 
 
Mr. Klaus Weber, for rapidly managing every chemical order and lending his help to keep the lab 
running, always with a smile. 
 
Lab members of the Department of Molecular Medicine. 
 
Animal house staff, Jens, Florian and Bianca, for taking care of my mouse colonies.  
 
IMPRS, for the academic and social network, and the IMPRS head-coordinator, Dr. Hans-Joerg 
Schäffer, for his outstanding capacity to offer answers, guidance and solutions to any difficulty. 
 
My auntie Jenny and uncle Anthony, as well as all my dear cousins, for believing in me the most. 
 
Both of my grandmothers, none of which could live to see me graduate, but who have guided me in 
spirit and been my greatest source of strength, courage and inspiration. 
